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ABSTRACT 
Health systems in central Asia (the former Soviet Union) face challenges to control TB and 
HIV/AIDS epidemics. Integration of communicable disease control programmes with the 
broader health system has been recommended to ensure programmes' sustainability. An 
important constraint for studying sustainability and integration has been a lack of conceptual 
clarity. Drawing on a critical assessment of published literature, a novel conceptual framework 
for the analysis of sustainability and integration in health systems has been developed. A 
sustainable communicable disease programme is defined as continuously effective in reducing a 
disease problem, responsive and adaptive to changes in the nature of disease epidemics, 
population needs or the contextual environment. Sustainability of a programme is 
conceptualised as having five dimensions: leadership, capacity, interactions, flexibility 
(adaptability) and performance (effectiveness, efficiency, equity). Existing frameworks of 
integration and health systems have been extended; defining levels of formal interactions 
between the system components. The research applied a case study approach. The case study 
was conducted in Kyrgyzstan, and relied on documentary review, qualitative interviews with 
key informants, and framework analysis. 
This study revealed several inter-related factors that affect the potential for sustainability of TB 
and HIV/AIDS programmes in Kyrgyzstan. Among overarching challenges for sustainability of 
both programmes are overall weak capacity of the health system and the reliance on 
international assistance for implementing the efforts to control the epidemics. This thesis 
highlights the importance of health system's structural and functional arrangements in 
sustaining the programmes into the future. In Kyrgyzstan, the factors such as fragmentation of 
governance and financing impede the development of effective interactions at the level of 
service delivery. In turn, fragmentation of service delivery remains the key impediment for 
efficiency, effectiveness and equity of disease control interventions. The prospects for 
sustainability of both programmes are constrained by institutional interests of domestic and 
international actors, who rarely consider the central question for sustainability that is efficiency 
of resources allocation and use. Weak disease surveillance and M&E systems emerged as one 
of the key barrier for development of effective disease control policies in the country and 
efficient planning of resources. Because of weaknesses of surveillance, this study could not 
provide the answer whether disease control efforts have resulted in the reduction of mortality 
and morbidity associated with TB and/or HIV/AIDS. 
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CHAPTER 1 STUDY RATIONALE, AIMS, OBJECTIVES AND 
APPROACH TAKEN 
INTRODUCTION 
This thesis is focused on health systems' responses to TB and HIV/AIDS epidemics in the 
central Asia region of the former Soviet Union (FSU). The region is experiencing the fastest 
growing HIV/AIDS epidemics in the world, substantial burden of TB and exceptionally high 
rates of multi-drug resistant TB (MDRTB) (UNAIDS, 2010 , WHO, 2010a, WHO/IUATLD, 
2008). 
The control of communicable diseases of public health importance requires long-term efforts, 
unless transmission in humans has been interrupted or a pathogen has been eliminated globally 
(Dowdle, 1998, Fine, Oblapenko, and Sutter, 2004, Heymann, 2006, Moss, 2009, Noordeen and 
others, 1996). Communicable diseases epidemics evolve as a result of complex relationships 
among pathogens, social, ecological and health systems, and broader political and economic 
contexts (Anderson and others, 2004, Anderson, 1991, Atun and others, 2004, Coker, Atun, and 
McKee, 2004a, Coker, Atun, and McKee, 2008, Heymann, 2005, Woolhouse and others, 1997). 
These relations are dynamic, changing over time. A key challenge for health systems is to 
ensure the sustainability of disease control programmes, that is continuously effective programs 
which are responsive to changes in the nature of disease epidemics (actual or perceived), 
population needs or contextual environment. 
Among many factors that potentially influence sustainability (e. g. social, biological, ecological), 
contextual factors historically play a role in controlling major endemic diseases. Communicable 
diseases have been subjected to cycles of political attention, which either put them at the top of 
public health priorities (Mills, 2005, Unger, De Paepe, and Green, 2003) or kept them in neglect 
despite their persistence (Raviglione and Pio, 2002). Ideological factors also play a role in 
shaping responses to communicable disease epidemics. For example, a denial of the HIV/AIDS 
problem in Turkmenistan (Anon, 2003, Rechel, Sikorskaya, and McKee, 2009), and fierce 
resistance to the implementation of opioid replacement therapy in Russia (Sarang, Stuikyte, and 
Bykov, 2007) have been impeding effective responses to HIV/AIDS epidemics in these 
countries. 
During the last decade, there has been increased global political commitment and input of 
financial resources towards the control of TB, HIV/AIDS and malaria in endemic countries. 
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However, evaluating the impact of these substantial investments on disease transmission 
dynamics or public health outcomes has been challenging (Biesma, 2009, Global Fund, 2009). 
Questions still exist as to whether increased funding or other resource inputs improve the 
effectiveness, efficiency and equity of disease control programmes. Emerging evidence has 
shown that it is often not how many resources are available, but how these financial resources 
are planned, spent and evaluated (Atun and others, 2008, Floyd and others, 2006). 
Empirical research suggests that the arrangements of health systems, within which programmes 
function, determine programmatic responses to disease epidemics (Atun and Coker, 2008, 
Coker, Atun, and McKee, 2004a). Integration of communicable disease programmes with the 
broader health system has been often advocated, particularly in international development 
discourse, in order to improve health benefits or programme performance. There has also been 
acknowledgement that the sustainability of communicable disease programmes is likely 
improved where programmes are integrated with other formal health system functions and are 
sensitive to the prevailing health culture of the affected populations (Allotey and others, 2008, 
Atun and others, 2005e, Gruen and others, 2008, Lienhardt and Ogden, 2004, Streefland, 1995). 
Despite the contemporary importance of sustainability of communicable disease programmes, 
there has been a lack of common conceptual understanding of this notion. Similarly, what 
constitutes a notion of integration in a health system lacks conceptual agreement. Despite 
frequently used rhetoric on the influence of integration on sustainability (Feenstra, 1994, Segall, 
2003, Unger, De Paepe, and Green, 2003, Visschedijk and others, 2003), there is a lack of 
clarity on the relationships between sustainability and integration concepts. Consequently, there 
is paucity of empirical evidence. Empirical evaluations of the sustainability of communicable 
disease programmes that systematically take into account health systems' arrangements are 
absent. 
This research assesses the sustainability of TB and HIV/AIDS programmes within a health 
system, and explores the role of integration in sustaining these programmes. This PhD thesis 
aims to address the conceptual gaps outlined above. The most important part of this research 
has been the conceptualisation of two notions: (i) the sustainability of a communicable disease 
control programme, and (ii) the integration of a programme with other health system 
components. The case country used for exploring sustainability questions is Kyrgyzstan, a small 
low-income country in central Asia. 
This chapter further outlines the background to the research questions for this PhD thesis. The 
chapter outlines the contemporary importance of integration and sustainability concepts as they 
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relate to the control of TB and HIV/AIDS epidemics in low- and middle-income country 
settings. Additionally, the background section highlights key challenges in controlling TB and 
HIV/AIDS in the former Soviet Union (FSU) as has been shown in empirical studies, 
highlighting remaining gaps. The chapter also set the aims and objectives of this thesis, and 
briefly presents the approach taken to address the research questions. Lastly, I outline the 
structure and content of this thesis. 
1.1. BACKGROUND AND RATIONALE FOR THIS THESIS 
1.1.1. Tuberculosis and HIV/AIDS 
The contemporary nature of the HIV/AIDS and TB epidemics poses substantial challenges to 
health systems. These two communicable diseases caused by different pathogens with different 
transmission routes are closely linked epidemiologically and clinically, affecting many of the 
same populations and co-infecting many individuals (Corbett and others, 2003, Maher, Harries, 
and Getahun, 2005). TB and HIV/AIDS, each separately, are leading causes of mortality and 
morbidity from a communicable disease. According to the most recent estimates at the time of 
writing, globally around 9.4 million incident TB cases occur annually and 1.3 million people 
with TB disease (HIV-negative) die (WHO, 2010a). By the end 2009, there were an estimated 
33.3 million people living with HIV/AIDS, and approximately 1.8 million die yearly from 
HIV/AIDS associated causes (UNAIDS, 2010 ). 
TB is an ancient disease that has affected humans for centuries. TB infection is caused by the 
bacteria Mycobacterium tuberculosis, which is transmissible through airborne droplets. 
Without any predisposing factors, humans have a strong innate immunity against developing TB 
disease after infection (Comstock, Livesay, and Woolpert, 1974, Dye and Floyd, 2006, 
Vynnycky and Fine, 1997). TB is fully curable with effective and inexpensive anti-tuberculosis 
drugs (Dye and Floyd, 2006, Fox, Ellard, and Mitchison, 1999). However, TB treatment is 
long, at 6-8 months (Fox, Ellard, and Mitchison, 1999). Human immunodeficiency virus (HIV) 
infection and its disease sequele referred as AIDS are caused by a genetically diverse group of 
RNA viruses (HIV-1, HIV-2 types) that belong to the class retroviruses (Carpenter and others, 
1997). HIV was confirmed as a causative pathogen for humans in 1983 after its isolation from 
an AIDS patient. Infection with HIV is progressively fatal. However, with the discovery of 
combination therapy with antiretroviral drugs, known as HAART (or ART) (Carpenter and 
others, 1997), HIV-infection has become a potentially manageable chronic condition (Montaner 
and others, 2006, Simon, Ho, and Abdool Karim, 2006). HIV infection substantially increases 
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the risk of reactivation of latent TB infection, and causes rapid progression to disease after 
infection or re-infection (Corbett and others, 2003). TB is the most common opportunistic 
condition among HIV-positive individuals, even after initiation of ART (Girardi and others, 
2004, Havlir and others, 2008) and a major cause of death (Harries and others, 2001, Mohar and 
others, 1992). One of the main challenges for patients and providers alike has been the 
diagnosis and treatment of TB and HIV infection, including management of TB/HIV co- 
infections and co-morbidities (Frieden and others, 2003, Havlir and others, 2008). Diagnosis of 
TB is often challenging because of suboptimal TB diagnostic techniques (Frieden and others, 
2003). TB diagnosis is particularly difficult in HIV-positive persons due to atypical 
presentation (Havlir and others, 2008, Palmieri and others, 2002). Ensuring patients' 
compliance with long-term or lifelong treatment, which is often associated with toxicity and 
side effects, is a difficult task. Clinical management of TB/HIV patients is complicated due to 
drug interactions, side effects and complications (Maartens, Decloedt, and Cohen, 2009, 
Mcllleron and others, 2007). In weak health systems, inappropriate or erratic treatment and lack 
of infection control further compound an already complex situation and contribute to the 
emergence and transmission of MDRTB (Caminero, 2010, Coker, 2004, Coker, Atun, and 
McKee, 2008, Dorman and Chaisson, 2007), and resistant HIV strains (Este and Cihlar, 2010). 
Treatment for MDRTB (i. e., TB resistant at least to both isoniazid and rifampicin) is 18-24 
months; treatment strategies depend on professional experience and clinical response to 
treatment is often suboptimal (Coker, 2004). 
TB and HIV/AIDS affect persons who frequently face social problems such as poverty, 
unemployment, a lack of housing or means for transportation. HIV/AIDS and TB epidemics are 
often associated with a complex nexus of social and behavioural drivers of disease, including 
epidemics of intravenous drug use (Aceijas and others, 2004, Carrieri and others, 2006, Li and 
others, 2009, Mathers and others, 2010) and alcoholism (Mathew and others, 2009b). Patients 
often suffer from co-morbidities with chronic non-communicable diseases such as diabetes, 
chronic lung diseases, or mental health problems (Freeman and others, 2005a, Lonnroth and 
others, 2009, Stevenson and others, 2007, Stuckler, Basu, and McKee, 2010, van Zyl Smit and 
others, 2010). Management of patients with co-morbidities is complicated, presenting clinical 
challenges due to drug interactions, drugs dosing, and serious side effects (Abdool-Karim and 
others, 2004, Andrews and others, 2007b, Harries, Zachariab, and Lawn, 2009). 
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1.1.2. TB and HIV/AIDS epidemics in the former Soviet Union 
It is nearly two decades since the USSR collapsed, leading to the establishment of 15 sovereign 
states. The trajectory of their political, socio-economic and health systems development since 
then has been different. However, a common feature of most FSU countries is a public health 
crisis, which has been exacerbated in the 1990s during a rapid political and socio-economic 
transition from the communist regime. The negative effect of this transition upon epidemics of 
TB and HIV/AIDS has been profound (Atlani and others, 2000, Atun and Coker, 2008, Coker, 
Atun, and McKee, 2004b, DeBell and Carter, 2005, Drobniewski and others, 2004, Drobniewski 
and others, 2005, Rhodes and others, 1999a, Ruddy and others, 2005). TB and HIV/AIDS are 
colliding with epidemics of chronic non-communicable diseases, alcoholism, intravenous drug 
use (IDU), and other communicable diseases such as sexually transmitted diseases (STDs), 
hepatitis B and C (Aceijas and others, 2004, Coker, Atun, and McKee, 2008, Perelman, 2000). 
At the time of the inception of this PhD research and to the date of writing, rigorous studies that 
have systematically assessed health system responses to epidemics of TB and HIV/AIDS in the 
FSU have been conducted largely in Russia. This research in Russia covered a time period in 
the early 2000s when international actors had just entered the region, prior to the growing global 
funding for TB and HIV/AIDS. Notably nevertheless, the research demonstrated that 
programmatic responses to communicable disease epidemics in Russia have been to a 
considerable extent determined by the legacy of the Soviet health system's arrangements, and 
pre-existing ideological, political, social, and cultural factors (Atun and others, 2005c, Atun and 
others, 2005e, Coker and others, 2003, Floyd and others, 2006, Marx and others, 2007, 
Tkatchenko-Schmidt and others, 2008). 
The Soviet health system was organised hierarchically with strict top-down planning, regulation 
and management. Health care and social care services were operated separately under different 
Ministerial jurisdictions. A number of parallel and specialised services existed, each addressing 
its own speciality, e. g. TB, HIV/AIDS, STDs, mental health, narcology (e. g substance abuse), 
oncology, maternal and child health. Each specialised service had also been organised 
hierarchically on all levels of care provision (including the primary care level), had a separate 
governance unit, and was fmanced according to norms based on inputs. The focus was on 
curative care delivered primarily in inpatient settings; health promotion was weak. The Soviet 
health system evolved to have extensive physical infrastructure and a high number of health 
care personnel (Field, 2002). This large health system was substantially impoverished by years 
of underfunding starting in the late 1960s (Rowland and Telyukov, 1991). 
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Tuberculosis 
TB has been historically a cause of mortality and morbidity in populations living on territories 
which became part of the USSR (Mishin and others, 2006, Raviglione and others, 1994). 
Though data are fragmented, the magnitude of TB and other communicable diseases was 
considerable in 1917 when the Communist Party undertook power. Since the first days of their 
rule, the fight against communicable diseases was proclaimed as a political priority for the 
Communist Party (Barr and Field, 1996, Mishin and others, 2006). `Either the louse defeats 
socialism or socialism defeats the louse', stated Vladimir Lenin in 1919. TB received special 
political attention. The Soviet ideology postulated that socialism by its very nature gets rid of 
inequality, unemployment, poverty, and malnutrition. It was clearly recognised by the political 
elite in the USSR that TB is associated with these societal causes, thus reducing the TB problem 
was of critical importance. In 1937, it was announced that socialism had eliminated the societal 
`roots of the development of tuberculosis' (Boldyrev, Commissioner of Health, 1937; cited in 
(Mishin and others, 2006). 
It is understood that TB was under control during the Soviet period. TB mortality and morbidity 
have been declining since the 1950s (Mishin and others, 2006, Perelman, 2000, Raviglione and 
others, "1994, Zhukova and others, 1991). At the beginning of the 1990s, this decline was 
haltedt All former Soviet states witnessed a considerable increase in TB notification and death 
rates, which doubled or tripled by the middle of the 2000s (Figure 1.1). The estimated TB 
incidence and mortality in the FSU region remain the highest in the European region (WHO, 
2008). Though global data are fragmented, the FSU region has the highest registered rates of 
MDRTB. Rates of MDRTB among newly diagnosed cases of TB range from 14.1% in 
Kazakhstan to 22.3% in Baku, Azerbaijan. Roughly 50-60% of previously treated TB patients 
were MDRTB (WHO/IUATLD, 2008). 
The reduction of the TB burden during the Soviet period has been viewed as one of successes of 
the Soviet health care system and a matter of professional pride for the Soviet school of 
phthisiatry' (Perelman, 2000, Rabuhin, 1960). The TB control system was one of the oldest 
organisational systems, having its roots in the first Russian TB societies established in the 1890s 
in Moscow and St. Petersburg (Mishin and others, 2006, Perelman, 2000). The Soviet 
phthisiatry referred to TB treatment as `complex measures of medico-social rehabilitation', 
which encompasses principles of complete clinical recovery, social and psychological support 
for treatment completion, restoring working and social capabilities (Rubachin, 1970, Mishin, 
1 Derivative from Greek phthisis - pulmonary TB 2 Available at: http: //data. euro. who. int/hfadb 
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2006). An individual approach to TB treatment has been encouraged, depending on the 
patient's tolerance to standardised regimens (e. g. side-effects), drug susceptibility patterns or 
concurrent co-morbidities (Perelman, 2000). The evolved Soviet TB control system consisted 
of a large network of vertically organised TB hospitals and dispensaries. There was separation 
of TB services under different Ministerial jurisdictions, for example TB services in the 
penitentiary system were under the Ministry of Justice (MOJ) and TB services in the civilian 
sector were under the Ministry of Health (MOH). Treatment of TB patients was hospital-based, 
with continuous rehabilitation in TB sanatoria and repeated hospitalisations. 
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Figure 1.1 TB case notification rate per 100 000 population, selected countries of the 
former Soviet Union, 1989-2009 
Source: European Health for All database, WHO Regional Office for Europe. 2 
It has been documented that the main factors contributing to the resurgence of TB in the FSU 
has been years of underfunding and decreased attention to the health system overall, including 
TB services, which started around the end of the 1960s. By the time of the USSR's collapse, the 
underfunded TB system operated with shortages and interruptions in anti-TB drugs supply; 
failures to detect TB cases; poor patient management; and treatment interruption and 
incompletion (Perelman, 2000, Shilova and Dye, 2001). Coordination and communication 
between TB services under different jurisdictions were inadequate, most notably between 
2 Available at: http: //data. euro. whoint/hfadb 
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civilian and penitentiary sectors, leaving many TB patients undetected and untreated (Coker, 
Atun, and McKee, 2004b, Coker and others, 2003, Fry and others, 2005, Kimerling, 2000). 
HIV/AIDS 
The cumulative number of HIV-positive persons that were identified in the USSR (and later 
FSU) by 1994 reached around 1000 cases among 250 million citizens (Nabatov and others, 
2007). The USSR's initial response to HIV cases, which were detected primarily among 
foreign citizens, was legal and coercive measures (Medvedev, 1990a). All foreigners entering 
the USSR were required to undergo a mandatory HIV test, and if found positive were not 
allowed to enter the USSR or were required to depart if within the country (USSR law, 1987). 
`Knowingly putting at risk others' or `actual transmission' were criminal offenses (USSR law, 
1987), leading to 5 years and 8 years imprisonment, respectively. Such legislation gave 
authorities justification for the forced isolation of HIV-positive individuals in special 
institutions (Medvedev, 1990a, Medvedev, 1990b). 
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Figure 1.2 Registered HIV cases per 100 000 population, selected countries of the 
former Soviet Union, 1989-2009 
Source: European Health for All database, WHO Regional Office for Europe 
In 1994-1999, large outbreaks of HIV associated with IDUs were detected in several cities 
across the FSU (Can and others, 2005, Eyzaguirre and others, 2007, Latypov, 2008, Nabatov 
and others, 2002, Nabatov and others, 2007). It is currently understood that the FSU countries 
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have experienced a nascent pattern of HIV-1 virus transmission (independent and sporadic 
transmission) up until the middle of the 1990s, followed by large linked outbreaks among 
intravenous drug users (Nabatov and others, 2007). Since the middle of the 1990s, number of 
detected HIV cases has grown rapidly (Figure 1.2). This is understood as a fast growing HIV 
epidemic, which is likely concentrated among IDUs (Rhodes and others, 1999b). 
Both HIV/AIDS and IDU emerged as novel public health, legal and social challenges to the 
newly formed independent countries and their health systems. In the Soviet period, IDU along 
with prostitution and a bi- or homosexual lifestyle were illegal; thus the scope of these problems 
was unknown or unacknowledged. 
Stigma and discrimination against people who were substance drug abusers or sexual minorities 
were imprinted at the very core of communist ideology. Functions of specialised AIDS 
services, which were established in 1987-1988, were limited to provision of HIV-testing. 
Services provided by narcological services included treatment of narcotic drug dependency but 
were based on complete abstinence (complete withdrawal), which is not effective for treating 
dependence on opioids (Farrell and others, 2005 ). 
1.1.3. Health systems, communicable diseases and integration 
Empirical studies conducted in Russia concluded that the high fragmentation and specialisation 
of inherited Soviet health systems impeded effective responses to the changing TB and 
HIV/AIDS problems as well as other health problems (Atun and Coker, 2008, Atun and others, 
2005b, Axelsson and Bihari-Axelsson, 2005, Coker and others, 2003, Mosneaga and others, 
2008, Tkatchenko-Schmidt and others, 2008). Though the extent of fragmentation in the Soviet 
health system was rather exceptional (Axelsson and Bihari-Axelsson, 2005), in many other 
countries health systems have evolved with increased professional specialisation, equipped to 
deal with episodic and acute care rather than chronic, fluctuating and long-term health 
conditions (Nolte and Mckee, 2008). In several other settings, communicable disease control 
interventions have been delivered through specialised service providers (Gonzalez, 1965, Mills, 
1983, Raviglione and Pio, 2002, Sbarbaro, 2002). In such organisational settings, patients with 
multiple health problems have to attend several providers or specialists even within one 
organisation. Patients fall through the gaps within health systems, leading to inadequate 
treatment compliance, treatment failure, increased morbidity and mortality, the threat of drug 
resistance, and the potential for onward transmission (Coker, Atun, and McKee, 2008, 
Willenbring, 2005). 
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Clinical and epidemiological complexities associated with HIV/AIDS, TB and other chronic 
diseases led policy makers and health professionals in various settings to advocate approaches 
that can integrate diverse functions of health care and social support systems (Abdool-Karim 
and others, 2004, Andrews and others, 2007a, Edlin and others, 2005, Freeman and others, 
2005b, Kresina and others, 2005, Kuehn, 2008, Li and others, 2009, Matomora, Lamboray, and 
Laing, 1991, Soto, Bell, and Pillen, 2004, Sylla and others, 2007, Unger and others, 2006b). 
Whilst integration is intuitively appealing, there is still a paucity of evidence regarding whether 
integration of the elements of communicable disease management within health systems 
actually improves access to services, public health outputs (such as improved detection rates), 
clinical outcomes (such as deaths amenable to timely and effective health care) (Nolte and 
McKee, 2003), users' satisfaction with care and social support, or overall programmes' 
performance (effectiveness, efficiency, or equity) (Atun and others, 2010b, Briggs and Garner, 
2006, Church and Mayhew, 2009, Dehne, Snow, and O'Reilly, 2000, Wallace, Dietz, and 
Cairns, 2009). One of the impediments to empirical exploration of integration has been a lack 
of common conceptual understanding and agreement of what constitutes integration (Atun, 
Bennet, and Duran, 2008, Nolte and Mckee, 2008). 
1.1.4. Sustainability of disease control programmes in low- and middle-income countries 
Global Health Initiatives 
In low- and middle-income countries, international actors historically play a role in facilitating 
health system responses to communicable diseases (Mills, 1983, Mills, 2005). During the last 
decade, global development assistance has changed dramatically with the establishment of new 
governance, planning, financing and implementation mechanisms for addressing priority 
communicable diseases (Brugha, 2008, Samb and others, 2009). These novel mechanisms, 
which are referred to at present as global health initiatives (GHIs), are focused on supporting 
countries in concerted responses to disease epidemics. At the UN summit in 2000, reduction of 
the burden of TB, HIV/AIDS, malaria and other communicable diseases was included in the 
Millennium Development Goals. The UNGASS special session in 2001 declared HIV/AIDS as 
a development crisis (UNGASS 2001) in need of an emergency response. Under the auspices 
of the UN Secretary General, the Global Fund to Fight AIDS, TB and Malaria (GFATM) was 
created initially to respond to the HIV crisis in the African region, later to include TB and 
malaria. Several major global policy initiatives for the HIV response were initiated such the 
World Bank's Multicounty AIDS Programme, The President's Emergency Plan for AIDS Relief 
(PEPFAR), and the `3 by 5' initiative of the WHO. 
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TB was declared a global health emergency earlier in 1994 (WHO, 1994). After decades of 
neglect, political attention to TB re-emerged following the resurgence of TB in industrialised 
countries (Brudney and Dobkin, 1991, Frieden and others, 1995, Shiffman, Beer, and Wu, 
2002) and a considerable increase in TB mortality and morbidity in several regions attributable 
to maturing HIV/AIDS epidemics (Lienhardt and Ogden, 2004, Ogden, Walt, and Lush, 2003, 
Raviglione, Snider, and Kochi, 1995). WHO began intensive marketing of a TB control 
strategy branded Directly Observed Therapy, Short Course (DOTS), which was adopted by 
most countries by the end of the 1990s. The Stop TB partnership was launched in 1998. Policy 
makers set ambiguous objectives within Stop TB plans (WHO, 2001, WHO, 2006b) to rapidly 
expand quality DOTS, respond to the emerging challenges of HIV and MDRTB, improve TB 
diagnostics, and for prevention interventions. 
GHIs have been successful in gaining broad political support, appealing for funding, and 
advocating for the reduction of prices of antiretroviral drugs. Funding directed for priority 
communicable diseases grew substantially (McCoy, Chand, and Sridhar, 2009, Ravishankar and 
others, 2009). The increase in spending on HIV/AIDS has been unprecedented in the history of 
development assistance; annual spending grew from around US$300 million in the mid-1990s 
to US$10 billion in 2007 (Bonnel, 2009). This supportive financial environment allowed the 
introduction and rapid scale up of novel disease control interventions. These efforts also 
included provision to countries of considerable resource inputs for delivery of these 
interventions such as laboratory supplies and medicines. 
Sustainability concerns 
Rapid inflow of substantial assistance coincided with the proliferation of actors involved in 
assisting countries to achieve global disease control targets (Balabanova and others, 2010, 
McCoy, Chand, and Sridhar, 2009, Shiffman, 2008, Shitiman, Berlan, and Hafner, 2009). At 
country levels, this has created a complex operational environment, in which a growing number 
of stakeholders seek evidence that investments produce tangible benefits (Victora and others, 
2006). Along with searching for results, there have been notable concerns over long-term 
continuation of TB and HIV/AIDS interventions supported by donors (Bonnel, 2009, McCoy 
and others, 2005, Schneider and others, 2006). These concerns have lead to the revival of two 
long-standing and related debates in international development for health: one relates to the 
sustainability of donors' supported interventions (Bossert, 1990, Chen, 1997, LaFond, 1995b) 
and the other is a debate over the integration of priority health interventions and general health 
services (Atun, Bennet, and Duran, 2008, Gonzalez, 1965, Mills, 1983, Mills, 2005, Oliveira- 
Cruz, Kurowski, and Mills, 2003). 
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A key sustainability concern is related to the substantial reliance on external funding for 
implementing innovative interventions such as HIV prevention activities, ART or MDRTB 
management (David, 2009). Such dependence on donors for implementing innovative policies 
and interventions has raised questions of domestic ownership. Rapid and substantial inflow of 
foreign currency has implications for countries' monetary policies and inflationary pressures on 
the domestic economies (David, 2009, Lewis, 2005). It is clear that institutional capacity for 
transparent management of financial resources is lacking in many countries, and is 
compromised by wide-spread corruption (Garrett, 2007, Lewis, 2005). Health systems in many 
countries require resources and time for building and maintaining the overall health system 
capacity (e. g., human resources, wages, training, drugs, establishment and maintenance of 
laboratory capacity) that is necessary to deal with diseases such as HIV/AIDS and TB. These 
necessities go beyond donors' commitment and availability of international resources (David, 
2009). For example, ART scale up requires maintaining this level of provision including further 
scale up of other services in the general health system. Management of complex chronic 
conditions such as HIV is labour intensive, requiring qualified and well-trained staff capable of 
dealing with fluctuating patient needs (Buve, Kalibala, and McIntyre, 2003, McCoy and others, 
2005, Schneider and others, 2006, Van Damme and Kegels, 2006, Van Damme, Kober, and 
Kegels, 2008). 
GHIs have been criticised for focusing on measureable targets, establishing parallel `off budget' 
financial flows, and isolating donors' investments from domestic public health financial 
mechanisms. In their assistance efforts, donors have intensively used the non-governmental 
sector because of its ability to set up projects quickly (McCoy and others, 2005). Substantial 
funding for HIV/AIDS has been channelled through the non-governmental civil society sector 
(Bonnel, 2009, Garrett, 2007, Lewis, 2005), without establishing proper mechanisms of 
accountability for funds use. In some countries, this has created environments for brain drain of 
scare skilled personnel from the public health service (Garrett, 2007). Rapid scale up resulted in 
developing parallel systems of drug supply and delivery of specific interventions. Such 
approaches have been said to be contrary to solving fundamental weaknesses of public health 
systems (Ooms, Derderian, and Melody, 2006, Ooms and others, 2008). 
To avoid the abovementioned negative effects on health systems, advocacy for the integration of 
various functions of disease programs and broader health system has been renewed (Buvb, 
Kalibala, and McIntyre, 2003, Marchal, Cavalli, and Kegels, 2009, Yu and others, 2008). 
Proponents of integration historically argued that this would improve coverage, access, equity, 
and efficiency as well as the sustainability of disease control interventions (Atun, Bennet, and 
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Duran, 2008, Briggs and Garner, 2006, Feenstra and Visschedijk, 2002, Mosneaga and others, 
2008, Unger and others, 2006a, Unger, De Paepe, and Green, 2003, Visschedijk and others, 
2003, WHO, 1965). This perspective (referred to as horizontal) echoes views, originating in the 
Alma Ata Declaration (WHO, 1978), where population health is an overall goal and where 
universal access to basic health services is a human right (Lawn and others, 2008, WHO, 2003). 
By contrast, proponents of `a disease-centred' (or vertical) approach argued for a rapid response 
to epidemics through improving delivery of disease interventions, and evaluating benefits 
through improvements in disease-specific indicators and analyses of cost-effectiveness and 
efficiency (Lammie, Fenwick, and Utzinger, 2006, Lush and others, 1999, Raviglione and Pio, 
2002, Walsh and Warren, 1979). 
Neither the vertical nor the horizontal perspectives offer many insights into what integration 
implies, and have been counterproductive for decades (Farmer and Garrett, 2007 , 
Marchal, 
Cavalli, and Kegels, 2009, Ooms and others, 2008). There appears to be no consensus on what 
is meant by `sustainability `in health systems, and what is the relationship between these 
sustainability and integration concepts. 
1.2. AIMS, OBJECTIVES AND APPROACH TAKEN IN THIS RESEARCH 
1.2.1. Regional focus on central Asian countries of the former Soviet Union 
This research focuses on the central Asian region of the FSU. The region is represented by 5 
countries - Kazakhstan, Kyrgyzstan, Uzbekistan, Tajikistan and Turkmenistan. There are no 
empirical studies on health system responses to changing patterns of population health including 
to epidemics of TB and HIV/AIDS in this region. Overall, this region remains understudied 
including in terms of health system reform or patterns of health (McKee and Chenet, 2002, 
McKee, Figueras, and Chenet, 1998). 
1.2.2. Aims and objectives 
An overall aim of this thesis is to gain an understanding of the influence of integration on the 
sustainability of communicable disease control programmes within a health system. To achieve 
this aim the following study objectives were identified, that allowed the research questions 
posed in this thesis to be answered (research questions are listed thereafter). 
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Objectives: 
1. To examine existing conceptual definitions of sustainability in health systems and analytical 
approaches to sustainability; 
2. To assess conceptual definitions used to describe integration in health systems; 
3. To synthesise existing empirical evidence on the role of the integration of a programme 
with the broader health system in the programme's sustainability; 
4. To explore whether the TB control programme in Kyrgyzstan is sustainable; 
5. To explore whether the HIV/AIDS control programme in Kyrgyzstan is sustainable; 
6. In Kyrgyzstan, to explore interactions between: a) TB and HN/AIDS programmes; and b) 
each programme and general health services; 
7. To seek an understanding of the influence (and potential influence) of integration on the 
sustainability of TB and HIV/AIDS programmes in Kyrgyzstan. 
The research questions: 
1. How is the sustainability concept defined and how has sustainability in health systems been 
analyzed? 
2. What is meant by integration in a health system? How is the integration concept defined 
and how has it been analysed? 
3. How and whether integration of a health programme with the broader health system 
influences the sustainability of a programme? 
A case study in Kyrgyzstan asked the following research questions: 
4. Is the TB control programme sustainable? 
5. Is the HIV/AIDS programme sustainable? 
6. What is the nature of interactions between TB and HIV/AIDS control programmes at 
present? What is the nature of interactions between each programme, TB and HIV/AIDS, 
and general health services? 
7. What are the likely implications of the TB and HIV/AIDS programmes' integration for the 
sustainability of these programmes? 
1.2.3. Brief description of the research approach 
The research applied a case study approach (Yin, 1994). The key component in this research 
has been the development of a conceptual framework for the analysis of sustainability and 
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integration in the health system. Given the conceptual gaps outlined earlier, the study included 
conceptualisations of notions of sustainability and integration. I also aimed to clarify links 
between the concepts of integration and sustainability. For these purposes, I conducted a 
systematic literature review on concepts, definitions, analytical approaches and empirical 
studies on sustainability in health systems. In order to understand role of integration in 
sustainability, assessment of the literature included analysis and synthesis of factors that might 
influence the sustainability of a health programme (or an organisation). Additionally, I 
conducted a literature review on conceptual and/or analytical frameworks of integration (these 
included conceptual papers and empirical studies drawing on explicit conceptual frameworks), 
systematic reviews and meta-analysis of integration initiatives; and reviews (overviews) of 
conceptual or methodological approaches to integration. 
Drawing on a critical assessment of the published literature (Chapter 3), the sustainability of a 
programme is conceptualised as having five characteristics: leadership, capacity, interactions, 
flexibility (adaptability to changes in contextual environment or implementation of innovations) 
and performance. Assessment of the literature on integration (Chapter 4) led to the extension of 
existing frameworks of integration and health systems (Atun, Ohiri, and Adeyi, 2008), defining 
levels of integration between the system's components. These levels of integration were 
defined through the lens of interactions - no interactions, linkages, coordination and integration 
- between formal programmes' components (or other health system's components). In this 
research, programmes and health systems are viewed as complex adaptive systems (Atun and 
Menabde, 2008 -b). For analytical purposes, health systems are defined as having four key 
components, with each including structural and functional elements: governance, financing, 
services delivery and informational system (monitoring and evaluation). In developing a 
conceptual framework for the study analysis (Chapter 5), 1 draw on earlier work on systematic 
evaluation of complex health programmes and health systems by Atun and others (2004) and 
Coker, Atun and McKee (2004). These frameworks were extended to incorporate the 
abovementioned conceptual developments. 
The case study relied on review of published data (official statistical and epidemiological 
reports), documentary review and qualitative semi-structured interviews with key informants. 
Data were analysed using a framework approach by Ritchie and Spicer (1994). 
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1.3. STRUCTURE OF THE THESIS 
This opening chapter has presented the background to the research questions that this thesis is 
addressing and a brief outline of the research approach taken. The following three chapters 
present the detailed background to this research. Chapter 2 gives a historical perspective on 
health systems, TB and HIV/AIDS programmes in the FSU, particularly as existed during the 
Soviet period, and health systems' responses to TB and HIV/AIDS epidemics. This led to the 
formation of the research questions for this thesis. Chapter 3 presents a systematic review on 
sustainability in health systems, and chapter 4 outlines the results of the analysis of published 
literature on integration in health systems. In chapter 5I introduce the conceptual and analytical 
frameworks for this study. Chapter 6 details the methodology applied in the case study, 
outlining ethical considerations, data collection and the analysis process. Chapters 7,8 and 9 
present the results of the case study conducted in Kyrgyzstan. Chapter 7 presents an overview 
of political, socio-economic, and health system changes that have taken place in Kyrgyzstan 
since gaining independence. Chapter 8 provides an analysis of the sustainability of the TB 
programme, and the following chapter presents an analysis of the HIV/AIDS programme's 
sustainability. In chapter 10, I discuss the findings of this PhD study, outline the limitations of 
this research, and discuss the implications of this study for understanding the sustainability of 
communicable disease programmes and the role of integration in this. 
31 
CHAPTER 2 HEALTH SYSTEM RESPONSES TO 
TUBERCULOSIS AND HIV/AIDS EPIDEMICS IN THE FORMER 
SOVIET UNION 
INTRODUCTION 
This chapter provides an overview of research evidence on health systems responses to TB and 
HIV/AIDS epidemics in the former Soviet Union3. The chapter largely summarises the 
knowledge base at the inception of this thesis in 2007/2008. At that time, there had been no 
systemic research on health system responses to communicable disease epidemics in central 
Asia. Indeed, empirical studies on health systems and communicable disease control in the 
region had been conducted primarily in Russia in the early 2000s. These studies, referenced 
throughout this chapter, covered a time period prior to the entrance of the GFATM and a 
substantial increase of funding to address TB and HIV/AIDS epidemics. The studies in Russia 
concluded that programmatic responses to TB and HIV/AIDS epidemics have been to a 
considerable extent determined by the legacy of the Soviet health system and prevailing 
ideological, political, social and cultural factors. This chapter begins by providing a historical 
background of the Soviet health system, its achievements and failures. This is followed by two 
sections on the history of TB and HIV/AIDS control in the USSR. Then the chapter provides an 
overview of the health systems' responses to these epidemics after the disintegration of the 
Soviet state, as was documented by 2008. The knowledge presented in this chapter led to the 
formulation of the main research question for this thesis, that is to understand whether and how 
integration of a communicable disease programme with the broader health system influences the 
sustainability of the programme. 
2.1. HEALTH SYSTEMS IN TRANSITION 
2.1.1. Semashko health care system 
The Soviet health system is often referred to as the Semashko model, the name of the first 
Commissar of Health, Dr. Nikolay Semashko (appointed by Lenin in 1918), under whose 
leadership the principles of Soviet health care4 were laid out. Health care was declared a right 
of the citizenship. Public health and medical care services became a responsibility and a 
3 After the disintegration the Union of Soviet Socialist Republics (USSR), 15 new countries were formed: Armenia, 
Azerbaijan, Georgia, Latvia, Lithuania, Estonia, Moldova, Belaros, Russian Federation and Ukraine, Kazakhstan, 
Kyrgyz Republic, Tajikistan, Turkmenistan and Uzbekistan. 4 Referred in the Soviet literature as the Soviet socialized medicine. 
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function of the state. In theory, these public services were meant to be provided at no cost at the 
point of delivery (Field, 1990, Lisitsin, 1987). 
The ideas of the Soviet health care were influenced by thoughts of German social hygienists, 
who believed that population health largely depends on social and economic conditions rather 
than personal or medical care (Field, 1988). Soviet ideology postulated that socialism would 
get rid of illnesses and premature mortality by reducing poverty, eliminating exploitation of 
working class, creating better socio-economic conditions and constantly improving the material 
and moral well-being of the proletariat (Lisitsin, 1987). Health was seen as crucial to the 
socialist society, however the health of an individual as a personal benefit had less importance 
(Barr and Field, 1996). Health care was supposed to have balanced preventative, clinical and 
rehabilitation services, in which prevention was meant to take priority. However, in practice, 
prevention activities (called dispansarisation5) had a medical orientation, with a dominant role 
given to curative services delivered at hospitals. Prevention was limited to population screening 
and checkups for selected health conditions. Public health and health promotion never fully 
developed beyond the medical. 
Health system: structural and functional arrangements 
The health system was centralised, with hierarchical arrangements for governance, financing, 
service provision and informational systems. The Communist Party, through the USSR 
Ministry of Health in Moscow, had overall control over the entire health system. The all- 
republics Ministry exercised its power through the republics' Ministries of Health down to the 
lowest administrative health units. All health care organisations, irrespective of their place in 
the organisational hierarchy, had to be in compliance with the rules and norms made by the 
Ministries of Health, with limited participation in decision-making processes (Rowland and 
Telyukov, 1991). 
Approximately 80% of health system financing came from the government budget. The rest 
was financed by industrial enterprises for their respective health services (Rowland and 
Telyukov, 1991). The health system was conceived as an integral component of the overall 
socio-economic development of the USSR. Thus, planning was undertaken with an aim 
continuously to strengthen the material base of the health system (Lisitsin, 1987). Health care 
planning and budgeting were based on norms that determined type, number, and geographical 
distribution of health facilities, including numbers of beds and health personnel (Barr and Field, 
Derivative from `dispensary' 
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1996, Rowland and Telyukov, 1991). 80% of the health care budget was spent on hospital care 
(Rowland and Telyukov, 1991). By 1989, the USSR's health system had the largest number of 
facilities, beds and health personne16 in the world. Attention to quality of care and to meeting 
the changing population's health needs was limited. 
Several parallel sub-systems of health care services existed. Broadly, these were residential (or 
civilian) and occupational services. Occupational health services were established in 
penitentiary, military, oil and gas industry, railways, law enforcement sectors, and other large 
industrial plants. These occupational services were under their respective Ministerial 
jurisdictions. There was also a `closed' health service reserved for the Communist party elite, 
their relatives and high-ranking governmental servants (Field, 2002, Schultz and Rafferty, 
1990). Health care and social care services were operated separately under different Ministerial 
jurisdictions. 
Further, a number of parallel specialised services, each focusing on a single health condition or 
specialty (e. g. maternity, cardiology, oncology, neurology, narcology, infectious diseases, TB, 
STDs, mental health, emergency hospitals, and other), were established. Each specialised 
service network had a lead institution (or a department) at national and republic levels. 
Dominant structures were hospitals. Most facilities were divided into care for adults and 
children. Rehabilitation services (e. g., sanatoria, rest homes) were one of the essential curative 
services. 
Primary care services included a network of policlinics in urban settings and feldsher's offices 
in rural areas. Every citizen was assigned an outpatient polyclinic according to propiska (i. e. 
residency), with little or no choice of provider (Field, 2002). Normally urban policlinics were 
separated into adult and child policlinics; staffed by therapists, paediatricians, and specialist 
providers. Polyclinics played an important role in implementing screening activities (i. e. 
dispansarisation) and providing a first-line treatment of acute conditions and chronic diseases 
(Tragakes and Lessof, 2003). The coverage of primary services was high; however, primary 
care evolved to have more a referral function due to weak diagnostic capacities. Coordination 
of care among polyclinics, hospitals, specialised facilities and occupational networks was weak. 
Patients could self-refer themselves to specialised facilities or hospitals, avoiding primary care 
providers, but upon discharge from hospitals were left without continuity of care or follow up. 
6 23 711 inpatient treatment facilities with an overall capacity of 3.82 million beds, 132.9 per 10 000 population), 42 
816 ambulatories or polyclinics; 1.27 million physicians (44.4 per 10 000 population), and 3.38 million semi- 
professional personnel (117.7 per 10 000 population); in addition, 2323 sanatoria or rehabilitation facilities providing 
clinical services with an overall capacity of 608 000 beds (GosKomStat, 1990). 
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Leaders of the Communist Party proclaimed that the Soviet society would have a new 
proletariat type of medical doctors (Schecter, 1992). All health personnel were state employees. 
With the exception of the medical elite working in clinical research or academic medicine in 
large central institutions, doctors and mid-level health personnel were paid poorly (Field, 2002). 
The average salary rate of a Soviet physician was equivalent to that of an industrial worker; it 
was `on the low side even for the soviet society' (Barr and Field, 1996, Field, 1988). 
Soviet health system: achievements and collapse 
Historically, the Soviet health system made tremendous achievements. The USSR's 
government brought health care to its large population, part of which did not have even basic 
health care previously or lived in sparsely populated areas and under harsh climate conditions 
(Tragakes and Lessof, 2003). The Soviet health system at its inception focused on solving 
immediate health problems and needs. In this regard, the system was highly effective in 
comparison to conditions that existed in the pre-Soviet period. Health indicators were 
improving up until the 1960s. Major epidemics of communicable diseases had been controlled 
through massive efforts. Life expectancy nearly doubled and overall mortality had been 
reduced, particularly infant mortality (McKee and Shkolnikov, 2001, Mesle, Shkolnikov, and 
Vallin, 1992, Shkolnikov, Mesle, and Vallin, 1996a, Shkolnikov, Mesle, and Vallin, 1996b). 
However, in the middle of the 1960s, signs of a health crisis emerged, which continued through 
the 1990s and the 2000s (Andreev, McKee, and Shkolnikov, 2003, Shkolnikov and Leon, 2006). 
Spending on the health system decreased from 6.0-6.5% GDP in the early 1960s to 2-3% in 
1991 (Field, 2002, Tragakes and Lessof, 2003). Highly inefficient design and planning 
combined with chronic under-funding left the large network of health facilities outmoded (Field, 
2002, Rowland and Telyukov, 1991, Schultz and Rafferty, 1990). The limited health budget was 
distributed in a way that ensured that the health care sub-system serving the elite received 
increased funding. Disparities in resources allocation existed between republics, and urban and 
rural areas. Underpaid medical personnel often had to function without basic supplies, medicine 
and diagnostic equipment (Field, 2002, Rowland and Telyukov, 1991, Schultz and Rafferty, 
1990). Care was not free of charge. Under-the-table payments to providers were common 
(Ensor and Savelyeva, 1998). 
Health sciences suffered substantially from the USSR's isolation caused by the `cold war' and 
political ideology to establish the communist's science (McKee, 2007, Vlassov and 
Danishevskiy, 2008). Rather than applying internationally accepted approaches to judge the 
strength of scientific evidence such as randomised clinical trials to determine the efficacy of 
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interventions, selected experts decided on what health interventions to deliver. Application of 
outdated clinical interventions, or interventions with questionable efficacy (or effectiveness), 
was a common practice (Danishevski, McKee, and Balabanova, 2009). 
Historically, the USSR was the first nation in the world that made a constitutional pledge to 
provide free-of-charge and universal access to quality health care for all its citizens (Field, 1990, 
Field, 2002, Lisitsin, 1987). These early promises, which the Soviet government made to its 
people, were not realised (Field, 1990). 
2.1.2. Health system reforms 
Following the disintegration of the USSR, the FSU countries initiated reform of the financing, 
organisation and delivery of health care (Kulzhanov M., 2007, McKee, Figueras, and Chenet, 
1998, Rechel and McKee, 2009, Tragakes and Lessof, 2003). Among common objectives were 
diversification of funding sources, change of provider payment mechanism, reduction of the size 
of the hospital sector, strengthening primary care, decentralisation of health care governance 
and management, and improvement of quality of care (Ensor and Thompson, 1998, Field, 2002, 
Rechel and McKee, 2009). International organisations have played an important role in the 
health reform processes in a number of countries. The evidence on the effects of the reform 
undertaken in the last two decades on health care quality or health system efficiency is sparse 
(Rechel and McKee, 2009). Likewise, there were no comparative empirical studies on how and 
whether the reforms addressed the functioning of TB or HIV/AIDS services. 
2.2. TUBERCULOSIS CONTROL 
2.2.1. Tuberculosis control in the USSR 
As I mentioned in the introductory chapter, TB control has been always a high political priority 
for the Soviet government. A decree to set up a state committee on TB and the establishment of 
a dispensary system for TB prevention and care was signed in 1918 (Perelman, 2000). Soviet 
phthisiatry, under the leadership of the Russian school, put considerable efforts into establishing 
effective TB control measures. These measures were developed in isolation from the 
international scientific community. Russian phthisiatry takes pride in having developed 
approaches to TB control and their achievements in reducing the substantial TB burden prior to 
the 1980s (Sbarbaro, 2002). However, these very approaches, which were effective during the 
1960s, resulted in ineffective and inefficient measures when social, economic and 
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epidemiological conditions started to deteriorate during the Brezhnev era onwards (i. e. the 
1970s-1980s). I discuss this further. 
Soviet TB control was `comprehensive'. The cornerstone of control was prolonged inpatient 
treatment, repeated hospitalisations, post-treatment prophylaxis of relapses and rehabilitation in 
sanatoria. Some patients were hospitalised for more than 12 months. TB was framed as a 
disease with the potential for serious complications and sometimes disability (Mishin and 
others, 2006). Treatment was defined as a complex medico-social rehabilitation with an aim to 
achieve full clinical and psychological recovery, restoring the ability to work and return to usual 
social functions (Mishin and others, 2006, Perelman, 2000, Rabuhin, 1960). TB interventions 
also included repeated BCG vaccinations', preventative treatment with isoniazid, mass 
population fluorography screening, and screening of children for TB infection using Mantoux 
test (Coker and others, 2003, Drobniewski and others, 1996b, Kimerling, 2000, Mishin and 
others, 2006). Preventative treatment of TB disease with isoniazid was applied extensively8. 
This included preventative treatment among those diagnosed or suspected of TB infection9, and 
those who completed TB treatment in order to prevent relapse10. 
Clearly, the complex of interventions outlined above was designed to protect the public health 
of the Soviet citizens (Kimerling, 2000). Having TB was viewed as a risk to society, thus 
placing people in hospitals for extended periods was considered a major public health benefit. 
The cost to patients and their families associated with a long hospital stays (e. g., loss of a job) 
was of less importance (Kimerling and Banatvala, 2001c). Preventative measures, treatment 
and dispensary observation after completion of the treatment were mandated by the regulations 
(USSR Government, 1960). Though the regulatory framework guaranteed retaining 
workplaces for TB patients, and social support such as the provision of better housing 
(USSR Government, 1960), these were never been fully realised in practice. 
TB, services: organisational arrangements 
In line with the overall health system development, TB services (i. e. phthisiatry services) 
evolved as a large hierarchically organised network consisting of specialised TB dispensaries, 
7 Mandatory BCG vaccination at birth. Re-vaccination of children at the ages of 6-7 years old and 14-15 years old. 
Re-vaccination at age 30 has also been recommended if a person has been in frequent contact with TB patients. 8 Preventative treatment for 2-3 months, twice yearly (up to 2 years). 9 Children and adolescents who had positive conversion in a Mantoux test, or those who were from households of a 
TB patient with any type of disease. Any person (all ages) who was in close contact with patients (all ages) with 
active TB confirmed microbiologically or bacteriologically. 1°AII children and adolescents who previously had active TB. Adults who had residual changes in lungs upon 
completion of treatment, of those with co-morbidities (e. g. diabetes). 
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hospitals, sanatoria, and outpatient clinics. There was a separation of adult and paediatric TB 
specialties. The whole TB system was headed by the USSR Central TB research institute in 
Moscow. This institute was the main TB control policy body in the whole country (Mishin and 
others, 2006, Perelman, 2000). There were similar TB research institutions in each Soviet 
republic, and large oblasts. In each administrative unit, TB dispensaries had a central 
supervisory place in the hierarchy of TB services. TB services existed in occupational health 
sub-systems, including the penitentiary sector. Along with patients who had active TB disease, 
the dispensary system managed those suspected of TB infection or disease and those who 
completed treatment for TB (Coker and others, 2003, Mishin and others, 2006). TB 
dispensaries monitored all registered persons for years, some remained in the TB system for life 
(Atun and others, 2006b, Floyd and others, 2006, Mishin and others, 2006). 
Though outpatient TB ambulatories existed, treatment was primarily hospital-based. The venue 
of treatment (i. e. hospital or ambulatory) was decided based on several factors such as severity 
and extent of disease, housing and economic considerations, various local conditions (e. g., 
distance), social and psychological elements, and the patient's wishes (Perelman, 2000). 
General health services were involved only in implementing BCG vaccination and mass 
population screening activities. 
Soviet phthisiatry: TB treatment philosophy 
Broadly, there have been two principal features of the Soviet TB treatment philosophy. The 
first was an individualised approach to treatment. Though a standard combination therapy with 
first-line drugs was included into treatment protocols, TB physicians were encouraged to decide 
treatment regimens for each individual patient (e. g., doses, duration of therapy, or the 
introduction of second line anti-TB drugs). In theory, drug regimens were to be tailored 
depending on drug susceptibility patterns, pharmacokinetics of the drugs, tolerance to drugs and 
response to treatment, or concurrent illnesses (Mishin and others, 2006, Perelman, 2000, 
Rabuhin, 1960). In addition to TB chemotherapy, there was the use of pre-chemotherapy 
interventions such as surgical interventions and adjunct therapy" (Drobniewski and others, 
1996b, Mishin and others, 2006, Perelman, 2000, Rabuhin, 1960). 
Another feature of the Soviet phthisiatry has been over-reliance on chest x-ray for screening for 
TB, confirming TB diagnosis and determining treatment outcomes. According to the Soviet 
phthisiatry, TB diagnosis made based on bacteriology is a diagnosis made too late (Kimerling, 
11 Immunomodulators, aorticosteroids, vitamins and physiotherapy. 
38 
2000). Though multiple TB diagnostic strategies were used including microbiological and 
bacteriological investigation, their role became secondary, albeit unintentionally (Drobniewski 
and others, 1996a, Kimerling, 2000). Classification of TB cases was on clinical criteria based 
on localisation'2, extent and activity of pathological processes, excretion of mycobacteria, 
complications, and residual changes in affected organs (Mishin and others, 2006). History of 
previous treatment was not taken into the account. Thus, categories mixed new cases and 
patients who had previously received treatment (Coker and others, 2003, Drobniewski and 
others, 1996a, Drobniewski and others, 1996b, Kimerling, 2000). 
Fundamental issues of the Soviet approaches to TB treatment and care 
Approaches to TB control outlined in the previous section had taken shape by the late 1960s 
(Perelman, 2000). These hardly changed for decades. The tradition of mass population 
fluorography screening (Golub and others, 2005) and long treatment of TB patients in hospitals 
and sanatoria (Sbarbaro, 2002) had been commonly applied in industrialised countries up until 
the 1960s-1970s. Starting around the 1970s, however, a shift to outpatient treatment occurred in 
most countries globally after empirical studies demonstrated benefits of ambulatory treatment. 
Outpatient treatment had been shown to benefit to patients' morale and recovery (Wier, Taylor, 
and Fraser, 1957). Treatment in ambulatory settings was as effective as in specialised inpatient 
settings, and did not lead to any increase in TB transmission (Fox, Ellard, and Mitchison, 1999). 
With the deterioration of the health and social systems (which had began towards the end of the 
1960s), the very underlying principles of Soviet phthisiatry led to ineffective and inefficient 
approaches to control. The first principle problem relates to TB diagnosis and clinical 
management. The secondary role of bacteriological confirmation and the lack of considerations 
of previous treatments had not been taking into account the likelihood of drug resistance 
(Drobniewski and others, 1996a, Kimerling, 2000). Though in theory tailoring of TB treatment 
was based on drug susceptibility results, the Soviet TB system could not diagnose nor monitor 
drug susceptibility patterns. Years of under-investment had weakened the diagnostic capacity 
of clinical (including radiological and fluorography) and bacteriological laboratories. 
Misdiagnosis of TB had likely been taking place, missing patients with TB or putting persons 
without TB through additional tests and treatment in hospitals (Balabanova and others, 2005). 
Individualised treatment approaches combined with irregular drug supplies likely led to erratic 
treatment and, more important, the emergence of drug resistance. 
12 Three groupings: 1) TB intoxication in children and adolescents, 2) pulmonary TB and 3) extra-pulmonary TB. 
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Another principal issue of Soviet TB control has been inefficiencies rooted in the health 
system's structural arrangements. By 1989, the Soviet health system had at least 18 TB 
research institutions, 4756 TB facilities13 (of these 1068 were TB dispensaries) with an overall 
over-capacity of 205 900 beds. The system employed 22 461 TB physicians (GosKomStat, 
1990). These translated into one TB doctor per four new TB cases14 and two beds per one new 
TB case. Atun and others (2006), in their economic evaluation of costs associated with a 3-year 
follow up of TB patients in the Soviet TB system, showed that long-term management was not 
justified for either economic or clinical reasons. Around 60% of the total cost was accounted by 
hospital care, and nearly 40% of the total cost was incurred after 12 months of care. 
Furthermore, management of bacteriologically unconfirmed cases accounted for nearly half of 
total expenditure. TB inpatient facilities did not have instituted infection control precautions. 
Practices of prolonged and repeated hospitalisations have likely contributed to infecting those 
who did not have TB. 
Prolonged hospitalisation and associated public health laws contributed to making TB a 
stigmatised disease (Kimerling and Banatvala, 2001b). TB was seen by the public as a 
dangerous, infectious and threatening condition (Dimitrova and others, 2006). 
2.2.2. International TB control strategy in the FSU 
In the middle of the 1990s, a number of international organisations initiated pilot DOTS projects 
in civil and prison sectors in most FSU countries. The five components of the DOTS strategy 
are political commitment, detection of new TB cases using sputum smear microscopy and 
confirmation of diagnosis using bacteriological testing", uninterrupted supply of high quality 
anti-tuberculosis drugs, treatment of drug-susceptible TB using standardised fast-line drug 
regimens under direct supervision (DOT), and a standardised reporting and recording system 
including the evaluation of treatment outcomes for each patient (WHO, 1994). 
WHO recommendations for management of drug-susceptible TB are based on research 
evidence. Recommended treatment regimens16 can achieve high cure rates >90% within 6-8 
months of treatment (Dye and Floyd, 2006, Fox, Ellard, and Mitchison, 1999, Frieden and 
'3 Including TB dispensaries, hospitals, ambulatories. 14 In 1989, the USSR had documented 114 500 newly diagnosed TB patients, and a total of 582 400 cases in the TB 
registry (all under dispensary observation in the TB system). This makes a TB bed capacity of 1.8 TB beds per one 
new TB case. 15 An emphasis on bacteriological confirmation has been put in early 2000s. Initially, WHO has been promoting only 
sputum microscopy. 
6-8 months courses with isoniazid, rifampicin, ethambuthol and pyrazinamide are standardized short course (SSC) 
chemotherapy regimens recommended by WHO within DOTS strategy. 
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others, 2003). DOTS (i. e., sputum microscopy and standardised treatment) has also been shown 
to be a cost-effective intervention in various settings (Borgdorff, Floyd, and Broekmans, 2002, 
Dye and Floyd, 2006, Murray and others, 1991). However, there has been less evidence 
regarding the effectiveness of the DOT component (Zwarenstein and others, 1998) of the DOTS 
strategy. 
DOTS implementation in the FSU 
The introduction of DOTS in the FSU was an important TB control policy innovation. The 
intent was, through DOTS implementation, to improve the effectiveness of TB management and 
prevention of the development of MDRTB. Importantly, one intention was improvement in 
efficiency of TB control by decreasing unnecessary lengthy hospitalisations and long-term 
follow up of treated TB patients (Atun and Coker, 2008, Coker, 2001a, Floyd and others, 2006, 
Marx and others, 2007, Mosneaga and others, 2008). International recommendations also 
included shifting TB treatment to outpatient settings, establishing community-based TB care. 
Internationally, evidence consistently suggests that removal of structural barriers for access to 
care, and building health services around patients' lives, and not vice-versa, bring better care 
outcomes and reduces TB-associated stigma (Farmer, 1997, Harper, 2010, Noyes and Popay, 
2007). 
Several pilot projects in Russia and Ukraine have shown feasibility, high cure rates and cost- 
effectiveness of DOTS for drug-susceptible TB in FSU context (Atun and Olynik, 2008, 
Balabanova and others, 2006b, Bumburidi and others, 2006, Jacobs and others, 2002, 
Kherosheva and others, 2003, Mawer and others, 2001, Migliori and others, 1998, Mosneaga 
and others, 2008, Ruohonen and others, 2002, Vassall and others, 2009a). However, there has 
also been strong opposition from national stakeholders to dramatic changes in TB treatment 
philosophy (Atun and Olynik, 2008, Schwalbe, 2008). Nevertheless, by 2003, all FSU countries 
had declared their commitment to reach global targets of TB control, and adopted DOTS 
(Schwalbe, 2008). Substantial technical and financial assistance has been provided by the 
WHO and donors to establish nation-wide programmes based on the DOTS pillars. 
Research in Russia has demonstrated that large-scale reforms of the TB care system have not 
taken place, however. Despite scarce domestic resources for TB control in the FSU (Mosneaga 
and others, 2008), the introduction of DOTS was not leading to any noticeable reduction in TB 
beds (Marx and others, 2007). This is because financial mechanisms and regulations on clinical 
case management have encouraged the retaining of a large inpatient network for TB care (Atun 
and others, 2006b, Atun and others, 2005e, Floyd and others, 2006, Marx and others, 2007). 
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The health system's response in Russia was driven by incentives to ensure high TB bed 
occupancy rather than clinical need (Atun and Coker, 2008, Atun and others, 2005e, Floyd and 
others, 2006). TB patients continued to undergo lengthy and repeated hospital stays (Marx and 
others, 2007). TB hospitals shouldered the substantial burden of necessary social support for 
vulnerable population groups because of a lack of systemic reforms to ensure that social and 
medical care needs were met outside of TB hospitals (Atun and others, 2005c, Atun and others, 
2005d, Kimerling and Banatvala, 2001c). 
The fragmentation of elements of the vertical TB programmes and specialisation associated with 
this fragmentation has created substantial barriers for completion of TB treatment and 
management of concurrent conditions such as HIV or substances dependency (Schwalbe, 2008, 
Wolfe, 2007). Though primary care providers were involved in follow up of TB patients in 
demonstration sites, health reform efforts to' actively involve primary care within TB control 
have been limited. On a large scale, primary care providers were not prepared to take these new 
responsibilities (Mosneaga and others, 2008). 
DOTS plus or MDRTB management in the FSU 
Implementation of the pilot DOTS projects in the FSU has also demonstrated high rates of 
MDRTB. This was evident from the first trials conducted in Russia comparing DOTS and 
traditional TB management approaches. These demonstrated that the effectiveness of 
standardised short course therapy, as recommended by the WHO, was not substantially different 
than Russian's individualised approaches (Mawer and others, 2001). In several later studies, 
patients with resistant strains had poor treatment outcomes using DOTS regimens (Bonnet and 
others, 2005, Cox and Hargreaves, 2003, Cox and others, 2007, Cox and others, 2004, Espinal 
and others, 2000, Kimerling and others, 1999). In the early 2000s, international organisations 
began several pilot DOTS-Plus projects. Aside from these few pilots, the overall international 
messages of what to do with MDRTB and other so-called `chronic' cases were not clear and 
often confusing (Cox and Hargreaves, 2003). For years, international stakeholders working on 
the ground in the FSU were promoting a shift away from an individualised treatment approach 
to a simplified treatment approach. But MDRTB is, however, a complex disease to treat. 
Management of MDRTB, and other poly-resistant TB, requires an individualised approach 
tailored to drug-sensitivity patterns. Treatment of MDRTB lasts 18-24 months, is expensive 
and results in lower cure rates as compared with drug-susceptible TB (Coker, 2004, 
Drobniewski and Balabanova, 2002, Mukherjee and others, 2004). 
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MDRTB was not new in the FSU region when international organisations began their activities 
in the 1990s. Rates of MDRTB among previously treated cases in Russia in the period 1984- 
1994 ranged from 22% to 33% (Toungoussova, Bjune, and Caugant, 2006). MDRTB among 
new cases was also detected in the same period, suggesting on-going transmission. However, as 
of the end of the 2000s, the magnitude and changes over time were not fully known. 
The position of the WHO and international TB community regarding the response to MDRTB 
in low- and middle-income countries had been unclear up until 2006. The WHO had been 
recommending a careful approach to initiating treatment of MDRTB and making treatment of 
drug-susceptible TB a primary focus. A rationale for such recommendations was an assumption 
that well-performing DOTS would decrease the burden of MDRTB (Dye and others, 2002). 
Moreover, there were concerns that MDRTB would draw financial and human resources away 
from DOTS (Sterling, Lehmann, and Frieden, 2003). Concerns also were raised that irrational 
use of second-line drugs would lead to the emergence of completely resistant TB strains. Early 
international responses included forming the Green Line Committee (GLC) in 2000. The GLC 
is a GHI which was formed to provide technical assistance for pilot DOTS-plus sites, to ensure 
rational use of second-line drugs, and the purchasing of quality second-line anti-TB drugs at 
concessionary prices (Gupta and others, 2002). To be eligible to start pilots, countries had to 
meet criteria showing proper TB management within the DOTS programme. By the middle of 
the 2000s, however, it became clear that, with few exceptions, countries could not reach WHO 
targets for TB control (i. e. 75% case detection rate, and 85% treatment success). Even worse, 
TB mortality and morbidity was not falling as projected (Dye and others, 1998), including in 
those well-performing countries that achieved the set DOTS indicators. MDRTB and 
HIV/AIDS were understood to be key threats to successful TB control. The Global Plan to Stop 
TB 2006-2015 called national TB policy makers to address the challenges of MDRTB, 
HIV/AIDS and others (WHO, 2006a, WHO, 2006c). When an outbreak of XDRTB'7 was 
reported in South Africa, the WHO called for an emergency response to MDRTB and emerging 
XDRTB (WHO, 2007). Within this plan, targets were set to achieve universal access to 
MDRTB diagnosis and treatment by 2015. 
In addition to calls for an emergency response to MDRTB, there is renewed debate regarding 
human rights, legal and ethical questions relevant to imposing coercive measures on patients 
refusing treatment such as involuntary detention and isolation (Amon, Girard, and Keshavjee, 
2008, Boggio and others, 2008, Coker and others, 2007, London, 2009, Selgelid, Kelly, and 
17 XDRTB - extremely drug resistant TB, MDRTB and in addition resistant to any fluoroquinolone, and at least one 
of three injectable second-line drugs (capreomycin, kanamycin, or amikacin). 
43 
Sleigh, 2008). For example, a paper co-authored by staff members of the WHO (Boggio and 
others, 2008) argues for application of the Siracusa principles (UN, 1984) and justification of 
compulsory measures as a last resort when other measures of voluntary treatment have failed. 
In the FSU context, given the legacy of compulsory and punitive measures and the state's 
control over individual (especially marginalised groups), the result of this debate may add 
additional impediments to the development of community-based TB care. 
As discussed previously, aside from health system responses to TB in Russia in the early 2000s, 
further developments in health system responses to TB epidemics remain under-explored 
empirically. What is known is that with GFATM grants, several FSU countries, including those 
in central Asia, have been provided substantial resources for treatment of MDRTB patients 
(TheGlobalFund, 2009). 
2.3. HIV/AIDS PREVENTION AND CONTROL 
2.3.1. USSR's response to HIV/AIDS and substances dependency 
The potential of an HIV/AIDS epidemic had not been a serious concern for the Soviet 
Government or for the USSR's Ministry of Health (Feshbach, 2005, Medvedev, 1990a, 
Medvedev, 1990b). HIV/AIDS had been considered a `western' disease and confined to risk 
groups that officially were non-existent in the USSR. Illicit drugs use, prostitution and sexual 
minorities were illegal. Thus these problems were not acknowledged. The response of the 
USSR government to the first HIV/AIDS cases was denial. Soviet propaganda had been 
labelling HIV/AIDS as a microbiological weapon developed by the USA to attack the world 
(Feshbach, 2005, Seale and Medvedev, 1987). 
HIV/AIDS control 
In 1987, the USSR's government issued a decree that later was put into the law on prophylactic 
measures against HIV (TheUSSRLaw, 1990). This law embedded severe penalties, coercion 
and punitive actions against people living with HIV/AIDS. Liabilities for `knowingly putting at 
risk others' included 5 years, and `actual transmission' 8 years, imprisonment (TheUSSRLaw, 
1990). The human rights of people with HIV were not considered. In practice, those children 
infected with HIV/AIDS in large nosocomial outbreaks in Elista and Volgograd were isolated in 
a special hospital (Medvedev, 1990b). 
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Following this decree, specialised HIV/AIDS services were established in all Soviet republics 
and charged with conducting HIV testing. HIV policy included mandatory testing for all 
foreigners entering the USSR and Soviet citizens returning from international trips (those who 
spent a month or more in a foreign country). 
Such a legal environment generated stigma and discrimination against PLWHIV. The punitive 
policies created an environment of fear among the Soviet population, who were ignorant about 
the risk of HIV transmission, including among medical professionals and those at risk of HIV 
(Feshbach, 2005, Field, 2004). Those most at risk of acquiring HIV were viewed as `social ills' 
who have no place in the socialistic society (Feshbach, 2005). As in many other places, 
HIV/AIDS was seen by some as a punishment for a sinful way of life (Field, 2004). Such a 
climate prevented people from wishing to know their HIV status. 
Treatment of substance dependence 
The Soviet government had established specialised narcology services in 1976 for treatment of 
alcoholism and other substance dependency (any chemical dependency) (Mendelevich, 2006). 
The narcology services were established as a sub-division of specialised psychiatry services 
(Elovich and Drucker, 2008, Rhodes and others, 2006). Upon request, information about 
registered patients was provided to the law enforcement agencies. By 1989, these services 
evolved into a network consisting of narcology dispensaries, hospitals and outpatient rooms 
(GosKomStat, 1990). Up until 1990, treatment of substance dependency and chronic 
alcoholism were compulsory in narcology hospitals or dispensaries (Latypov, 2008). The 
approach to treatment was aimed at complete abstinence. Detoxification and psychotherapy 
were the main interventions. Though detoxification is an important initial step in opioid 
dependence treatment, it is not effective on its own in ensuring long-term abstinence because of 
high relapse rates (Degenhardt and others, 2010, Farrell and others, 2005 ). Psychotherapy was 
rooted in hypnoid-based therapy, when a patient is manipulated to believe if he drinks or uses 
drugs within a certain period, he will die (in Russian referred as kodirovka). These Soviet 
psychotherapy approaches had no evidence base, as Elovich and Drucker noted when they 
called them `therapy worthy of Rasputin' (Elovich and Drucker, 2008). 
2.3.2. HIV/AIDS prevention and control efforts in the FSU 
Soon after the collapse of the USSR the first signs of the HIV/AIDS epidemic started to emerge. 
In the middle of the 1990s, large outbreaks of HIV among IDUs were detected in several cities 
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in Ukraine, Russia, Moldova, and Kazakhstan (Carr and others, 2005, Eyzaguirre and others, 
2007, Latypov, 2008, Nabatov and others, 2002, Nabatov and others, 2007). Over the following 
decade, the number of detected HIV cases grew rapidly. Though the HIV/AIDS epidemic in the 
region is understood as the fastest growing IDU-driven epidemic in the world, the real 
magnitude is not known fully. HIV surveillance systems in the FSU region are generally weak 
and inadequate in identifying new patterns or reaching risk groups (Bernitz and Rechel, 2006). 
Both HIV and IDUs emerged as new and alien problems to post-Soviet states, given pre- 
existing policies and the social framing of both conditions. In the middle of the 1990s, several 
international agencies and NGOs had initiated their activities in area of HIV/AIDS control. 
UNDP set up a thematic group on HIV/AIDS. By the mid-1990s, all states developed national 
AIDS plans. At the same time, several international NGOs under the auspices of the Open 
Society Institute (OSI) initiated pilot harm-reduction projects, including needle-exchange and 
syringe programmes (NSP) and promotion of opioid substitution therapy (OST) (Sarang, 
Stuikyte, and Bykov, 2007). At this time, neither the WHO nor the World Bank (WB), both key 
international policy makers in the area of health at the time, had endorsed harm-reduction 
interventions (Schwalbe, 2008). Several other pilots on STD syndromic management and 
prevention, and health education, were also initiated to which national governments were 
receptive in general (Schwalbe, Lazarus, and Adeyi, 2008 ). 
The OSI's advocacy as early as the mid 1990s for harm reduction in the FSU, which had been 
facing an increasing use of opioids, was based on considerable research evidence. Injection 
(and sharing contaminated equipment) is one the most effective ways of transmitting the virus. 
Both, NSPs and OST have been shown to significantly reduce injecting risk behaviour (e. g., 
sharing injecting equipment) (Donoghoe, 2006, Gibson and others, 2002, Gibson, Flynn, and 
Perales, 2001, Tilson, 2006, Wodak and Cooney, 2006). OST has been associated with lower 
rates of HIV seroconversion (Farrell and others, 2005 , Gowing and others, 2004, Gowing and 
others, 2008, Sorensen and Copeland, 2000, Tilson, 2006), and decreases rates from illicit-drug- 
related overdose deaths (Caplehorn and others, 1996, Mattick and Degenhardt, 2003). OST has 
been shown to improve the chances of retaining drug users, who often face multiple co- 
morbidities, on any treatment, and to suppress heroin use in contrast to detoxification (Amato 
and others, 2005, Mattick and others, 2003). In fact, OST has offered an opportunity to retain 
HIV-infected IDUs on ART treatment and improve adherence (Donoghoe, 2006). Harm 
reduction (as a complex of interventions) among IDUs prevented larger HIV epidemics in 
western Europe (Donoghoe, 2006). 
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In 2001, all FSU states signed the 2001 UNGASS declaration on AIDS to implement extensive 
prevention and treatment measures, and the 2004 Dublin Declaration on Partnership to Fight 
HIV/AIDS in Europe and Central Asia (Schwalbe, 2008). 
It should also be noted that over the last decade, governments facing IDU-driven HIV/AIDS 
epidemics have been confronted with conflicting recommendations. On the one hand, there are 
signed UN conventions18 on narcotic drugs, psychotropic substances and precursors, which 
require the signatory nations to limit production, export, import, trade, manufacture and 
possession of drugs exclusively to medical and scientific purposes. The 1988 Convention 
Against Illicit Traffic in Narcotic Drugs and Psychotropic substances in particular requires 
countries to make criminal offenses, under the domestic, law, actions such as possession of 
drugs for personal consumption or publicly inciting or inducing others to use illicit drugs 
(Bewley-Taylor, 2004, Bewley-Taylor, 2005). On the other hand, there have been 
recommendations for public health approaches to drug control and promotion of harm reduction 
(Wolfe and Malinowska-Sempruch, 2004). These advocate reducing punishment for drug users, 
and reducing sanctions against possession of drugs. 
Implementation of international recommendations on HIV/AIDS prevention, treatment and care 
In fact one of the major impediments for implementation of HIV prevention, treatment and care 
among IDUs, an important risk group in the FSU, has been the legislative environment. The 
USSR, and consequently most FSU states, have historically been countries with strict `zero 
tolerance' policies on drug use. As was noted by Latypov (2009), the inherited legal system 
gives drug users basically three options -to get clean, go to prison, or hide in the `under-world' 
more often associated with criminal activities. In the FSU context, particularly as relates to the 
central Asian region, Russia has substantial influences on drug control policy. Russia has 
banned opioid substitution therapy. The legacy of the Soviet ideology of social exclusion and 
labelling persons with high risk behaviour as `asocial' and the `ills of the society' persists in 
post-Soviet times, contributing to persistent stigma and discrimination (Balabanova and others, 
2006a, Tkatchenko-Schmidt and others, 2008). 
In several sites in the FSU, effective models of integrated prevention, care and community 
support for IDUs, prisoners, and sex workers have been implemented within international 
18 The 1961 Single Convention on Narcotic Drugs, the 1971 Convention on Psychotropic substances, the 1988 
Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic substances. Under these UN conventions, 
countries may introduce strict, zero tolerance legislation. Among countries with zero tolerance policies are the USA, 
Japan, Sweden, and the FSU. 
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initiatives (Sarang, Stuikyte, and Bykov, 2007). These projects for HIV prevention among risk 
groups have been implemented by international agencies, to a large extent, through civil society 
organisations. There has been a position among international stakeholders that NGOs are better 
able to reach high-risk groups (Schwalbe, 2008). Despite these successes, piloted models have 
not been institutionalised into mainstream health and social support systems (Atun and others, 
2008). The coverage of harm reduction interventions for risk groups remains low, and likely 
has limited or no effect in reducing HIV transmission (Aceijas and others, 2007, Bobrova and 
others, 2007b, Matic and others, 2008, Sarang, Stuikyte, and Bykov, 2007). 
Political commitment for the scale up of harm reduction interventions has been inadequate 
(Atun and others, 2008, Godinho and others, 2005a). Financial resources for the HIV/AIDS 
response generally from domestic sources have been limited (Matic and others, 2008, 
Tkatchenko-Schmidt and others, 2008). Though civil society has been involved in the delivery 
of interventions and advocacy in many FSU sites, their involvement in policy and operational 
decisions has been limited (Sarang, Stuikyte, and Bykov, 2007). 
The legacy of the Soviet health and social systems, which were highly fragmented, has created 
barriers for addressing the multiple health and social problems facing PLWHIV or those at risk 
of HIV. Financial mechanisms, which were planned and allocated to each specific service 
separately, have not been taking into account the changed epidemiological context (Atun and 
others, 2008, Atun and others, 2008 ). Strict regulatory mechanisms governing delivery of 
interventions only within individual specialties has prevented the implementation of 
comprehensive HIV prevention and treatment programmes (Bobrova and others, 2007b, 
Tkatchenko-Schmidt and others, 2008, Wolfe, 2007). For example, in Ukraine prescription and 
management of opioid substitution therapy has been permitted only by narcology specialists, 
preventing the expansion of integrated harm reduction interventions (Bruce and others, 2007). 
Coverage of ART among IDUs has also been low (Aceijas and others, 2006b). An important 
impediment has been limited capacity of specialised AIDS centres. These specialised services 
have retained the exclusive right for HIV diagnosis and ART delivery (Bobrova and others, 
2007b, Wolfe, 2007). 
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CHAPTER SUMMARY 
In summary, empirical research and international policy makers have raised concerns over 
sustainability of historically vertical TB and HIV/AIDS control programmes, which have been 
unable to respond to new challenges such as MDRTB or IDU. TB control has been entrenched 
in traditional highly vertical models and a long history of powerful professional association, 
which has resulted in a resistance to respond to either new epidemiological challenges or 
evidence of marked inefficiencies. By contrast, public health responses to HIV control have 
been constrained by legal and social legacies that penalise those on the margins and thus limit 
models of control. Responses in the USSR to the public health challenges of TB and HIV, 
moreover, highlight a long neglect of evidence to inform policy and practice. 
Through GHIs, a number of evidence-based innovative TB and HIV/AIDS interventions have 
been introduced in the FSU region. However, most of these innovations have operated on a 
pilot basis, and their implementation was financially dependent on external support. Given 
considerable fragmentation of inherited health systems and the impediments this caused for 
implementing TB and HIV/AIDS control efforts, there has been growing advocacy for 
integrating vertical programmes into the broader health system. 
As I outlined in the introductory chapter, there are no agreements on what the notions of 
`sustainability' and `integration' entail, including as relates to communicable disease control 
programmes. The next two chapters (Chapter 3 and 4) provide an assessment of existing 
conceptual definitions and analytical approaches to sustainability, and integration and health 
system. 
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CHAPTER 3 SUSTAINABILITY 
INTRODUCTION 
This chapter presents a systematic literature review of peer-reviewed literature on concepts, 
definitions, analytical approaches and. empirical studies on sustainability in health systems. In 
order to understand role of integration in sustainability, the assessment of conceptual 
frameworks and empirical studies included a synthesis of factors that might influence the 
sustainability of a health programme (or an organisation). 
The literature review included conceptual and/or analytical frameworks, reviews (overviews) of 
conceptual or methodological approaches to sustainability, systematic reviews on sustainability 
in health systems, and empirical studies. The detailed methodology of the systematic literature 
review, search strategy, and the process of selecting papers and studies are presented in the 
Appendix 2 (sections A2.1 and A2.2. ). Briefly, the literature search included searches of 
Medline (from 1980), Embase (from 1980), and the Cochrane library (from 1980). The initial 
search was performed in October 2008 and updated in January 2011. The search was limited to 
the English language and papers accessible through the University of London library services. I 
also reviewed bibliographies of selected papers to identify further publications. The search 
strategy included key terms related to the concept of sustainability including `sustain*', 
resilience*', 'viability*', 'inistitutionalisation*', `routinisation*', `durability*', 'stability*', 
`persistence*', `continuation*'. The search was restricted to MeSH and EMTREE headings 
under 'health care', 'health services', and key terms `health program*', `health intervention*', 
`health system*'. A number of frameworks and empirical studies assessed are outlined in 
section 3.3. and section 3.4., respectively ('Conceptual frameworks', `Empirical studies on 
sustainability in health systems'). 
I begin this chapter by presenting an overview of the origins of the sustainability concept and 
theories that explain sustainability. I then present how sustainability is defined and understood 
as applied to health systems. Further, I provide the results of an analysis of conceptual 
frameworks and empirical studies. The findings outline the main characteristics of a sustainable 
health programme, including the role of integration in sustaining health programmes. The 
review presented in this chapter served as a basis for developing the conceptual framework 
applied in this thesis, which is presented later in Chapter 5. Further discussion and critique of 
existing conceptual frameworks is presented in Chapter 10, the Discussion. 
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3.1. THEORETICAL BACKGROUND 
3.1.1. Sustainability concept and its roots 
Sustainability is a neologism drawn from `sustain', which is defined in dictionaries as `to supply 
with sustenance', `nourish', `to make something to be kept up, prolonged or carried on' (Oxford 
English Dictionary). The notion of sustainability has a long history in intellectual thinking. Its 
roots may be found in the writings of the nineteenth's century economists19 who emphasised 
that the environment needs to be protected from unfettered economic growth in order to 
preserve human welfare (Goffman, 2005 , Goodland, 1995, Hueting and 
Reijnders, 1998). In 
the 1970s2o, these thoughts were further extended in environmental and economic literature 
(Goodland, 1995, Korten, 1981). The sustainability concept has emerged in systems theories as 
applied to ecological systems. The concept was originally used to express the state of an 
ecosystem, in which levels of harvest in agriculture, fishery, and forestry are maintained within 
the capacity of ecosystems, that is recoverable (Kajikawa, 2008). 
In their seminal work The Limits of Growth, Meadows et al. warned that future economic 
development is constrained by the world's population growth and depletion of natural resources 
(Meadows and others, 1972). Meadows at el. made a key conclusion, which built the basis for a 
modern understanding of sustainability: `it is possible to alter these growth trends and establish 
a condition of ecologic and economic stability that is sustainable into the future. ' This work has 
stimulated debates and concerns over the patterns of economic, social and environmental 
developments globally, in both industrialised and low-income states (Dovers, 1996, Goodland 
and Daly, 1996, Korten, 1981). The World Commission on Environment and Development, 
often referred to as `the Brundtland Report '2' (WCED, 1987), put these concerns onto the 
international policy arena in 1987, shaping a notion of sustainable development: 
`Sustainable development is development that meets the needs of the present without 
compromising the ability of future generations to meet their own needs' (WCED, 1987). 
The report has been met with political consensus on the urgent need for sustainability. The idea 
of sustainable development was endorsed by nearly all nations at the 1992 UN conference on 
Environment and Development in Rio de Janeiro, Brazil (UN, 1992). In 1997, the sustainable 
19 Thomas Malthus (1878), and JS Mill (1848) cited in Goodland (1995). 20 Modem neo-malthusianism: Daly, 1973, Ehrlich and Ehrlich, 1990s. 2 By the name of Gro Harlem Brundtland, a Chair of the World Commission on Environment and Development at 
the time. 
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development agenda was reaffirmed at the United Nations General Assembly session 
(UNGASS) (UNGASS, 1997 ). Brundland's report broadened the notion of sustainability to 
encompass a wide range of human values (Kajikawa, 2008). Sustainability is understood as 
simultaneous promotion of economic development, environmental protection and social well- 
beingu (Koehler and Hecht, 2006). Embedded within these pillars of sustainability are broad 
aspirations and values of humanity - entitlements to health, wealth, justice, peace and security 
(Kemp and Martens, 2007). 
Agreement on conceptual or operational definitions of sustainability has never been reached 
(Kemp and Martens, 2007). There is an emerging understanding that sustainability encompasses 
both spatial (i. e. intra-generational equity) and temporal perspectives (intergenerational equity, 
or a trade-off between short-term gains and long-term concerns) (Hueting and Reijnders, 1998, 
Kajikawa, 2008), interconnectedness and interdependence of multiple domains (i. e. economy, 
social, political, environmental systems) (Martens, 2006), and multiple interactions of actors 
within and across these domains (Kemp and Martens, 2007, Martens, 2006, McMichael, Butler, 
and Folke, 2003). 
Some authors have criticised the elusive character of sustainability. Others have accepted that 
sustainability is a complex, contested and ambiguous notion, which is impossible to put into a 
precise and all-encompassing definition. In principle, defining sustainability has a subjective 
character where human factors play a key role: 'defining sustainability is ultimately a societal 
choice about what to develop, what to sustain, and for how long' (Parris and Kates, 2003). 
Different ideas exist regarding sustainability for actors in various sectors (e. g., health, 
agriculture, education), cultures, contexts, and in different timeframes; thus sustainability may 
have a variety of objectives (e. g., environmental or social sustainability) and a variety of trend 
goals (e. g., equilibrium, growth, or reduction) (Kajikawa, 2008). 
3.1.2. Systems thinking and sustainability 
In the development literature, sustainability is often misinterpreted as an end goal, which is very 
long-term and thus elusive and abstract. As mentioned above, sustainability has its roots in 
ecological systems theories. By contrast, systems' thinking offers explanations of sustainability 
as a system's property or characteristic, rather than an end result (Fiksel, 2003). 
22 A most popular view on sustainability is represented by a set of three pillars, referring to the economy, the 
environment and society, or alternatively termed People, Planet, Profit (or 'P3'- People, Prosperity, Planet. 
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According to complex systems theories, a system's resilience is a critical characteristic of a 
system, which is essential for a system's sustainability (Dovers, 1996, Fiksel, 2006, Folke and 
others, 2002, Holling, 2001). There are two broad perspectives on resilience. The first, based 
on an understanding of nature and society as systems functioning near equilibrium (Holling, 
1973), is inspired by system dynamic and catastrophe theories (Forrester, 1961, Thom, 1975). 
In this discourse, resilience is understood as a degree and a speed of how a system can 
withstand threats, disturbances or catastrophic events, and return to a steady equilibrium or a 
stable state (Fiksel, 2003, Mayer, 2008). Based on this understanding of resilience, 
sustainability has been defined as (for example): `the ability of a natural, human or mixed 
systems to withstand or adapt to, over an indefinite time scale, endogenous or exogenous 
changes perceived as threatening' (Dovers, 1996). 
The other view of resilience, which builds on the theory of complex adaptive systems, 
emphasises adaptive capacity and possibilities of multiple equilibriums (Brand and Jax., 2007, 
Fiksel, 2006, Gunderson, 2000). In this case, the theory emphasises non-linear interactions 
among the system's agents under constantly changing conditions where uncertainty, shocks, and 
surprises are inevitable. In complex adaptive systems, resilience23 incorporates notions of 
adaptation, self-organisation and learning. It is focused on how to persist through continuous 
development in the face of change and how to innovate and transform into new and more 
desirable configurations (Fiksel, 2003, Fiksel, 2006, Folke, 2006, Folke and others, 2002). In 
this discourse, sustainability is viewed as a socially instituted process of adaptive change, in 
which innovation is a necessary element (Kemp, Parto, and Gibson, 2005). 
In theory, features of resilient systems include a strong resource base, diversity, cohesion, 
efficiency and adaptability (Fiksel, 2003, Fiksel, 2006, Fotke, 2006, Folke and others, 2002). 
Diversity implies seeking broadly comprehensible options in knowledge and learning rather 
than those dependent on of specialist expertise and the existence of multiple structural and 
functional components to protect against site-specific threats (Folke and others, 2002, Kemp 
and Martens, 2007, Kemp, Parto, and Gibson, 2005). Cohesion is referred to unifying forces, 
communication channels, interconnected and interrelated system components that support each 
other. Efficiency is key in sustainability discourse (thinking about needs of future generations), 
and is defined as functioning with modest consumption of resources. Adaptability implies 
flexibility in strategic, managerial, operational processes in response to new pressures, and the 
emergence of new knowledge and technologies (Fiksel, 2003). 
23 Vulnerability is the opposite of resilience (Folke at al. 2002) 
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3.2. DEFINITIONS AND PERSPECTIVES ON SUSTAINABILITY IN HEALTH 
SYSTEMS 
Attention to sustainability in health systems emerged in the early 1980s because of concerns 
over the continuation of interventions after the end of external funding. These concerns were 
related to interventions in industrialised countries (Altman, 1995, Bracht and others, 1994, 
O'Loughlin and others, 1998, Scheirer, 2005, Shediac-Rizkallah and Bone, 1998) as well as 
donor-initiated projects in low- and middle-income countries (Chen, 1997, Lafond, 1995a, 
Stefanini, 1992). 
My literature search identified several research areas that provided conceptualisations of 
sustainability in health systems. These areas include research in health promotion, community 
development, international development, diffusion of innovations, organisational studies 
(organisational learning, organisational sociology, organisational innovation and change), and 
studies of complex systems. Research from these various disciplines or stakeholders (e. g. 
international agencies) tend to have different views on sustainability (Greenhalgh and others, 
2005, Gruen and others, 2008, Hanson, Salmoni, and Volpe, 2009, Savaya, Spiro, and Elran- 
Barak, 2008, Shediac-Rizkallah and Bone, 1998). To define sustainability phenomena, various 
terms are used such as `routinisation', `institutionalisation', `integration', `maintenance', 
`viability', `longevity', `stability', `durability', `continuity', `adaptability' or `resilience' (Gruen 
and others, 2008, Savaya, Spiro, and Elran-Barak, 2008, Shediac-Rizkallah and Bone, 1998). 
The differences in definitions relate to two aspects. The first is a focus on what is being 
sustained (e. g., resources, or organisation or organisational goals). The second is what level(s) 
of a component of a health system is being considered, either a health intervention/innovation, a 
health service organisation (or a group, coalition), a system's functional or structural component 
(e. g. funds, or human resources) or the overall health system. Selected examples of definitions 
are presented in the Table 3.1. 
3.2.1. Sustainability of health interventions 
Definitions of the sustainability of interventions (often referred as projects or programmes) from 
a public health perspective emphasise maintenance of benefits to stakeholders over time 
(Hanson and others, 2005, Mancini, 2004, Pluye and others, 2004, Shediac-Rizkallah and Bone, 
1998, Swerissen and Crisp, 2004). These benefits (that is what is to be sustained) were defined 
as improvements in health (Hanson and others, 2005), continued control over a health problem 
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through maintaining sufficient level of effectiveness, accessibility, acceptability or coverage of 
interventions (Nelson and others, 2007, WHO, 2002 ). 
Similar definitions were found in international development discourse. Early definitions were 
focused on continuation of a project or benefits brought by the donor's project, with an 
emphasis on financial self-reliance (Bossert, 1990). This focus on a single investment, post- 
project financial mechanisms and overemphasis on quick results were said to `do little to 
promote it [sustainability] and may be well doing much to prevent it' (Brown, 1998, Lafond, 
1995a, Stefanini, 1992). Such narrow definitions were replaced with a focus on sustaining 
institutional capacity generated by the donor aid (Bossert, 1990, Stefanini, 1992). Similarly, 
research on community development takes a broader view, defining sustainability as community 
capacity building for addressing needs and health of community members (Hawe and others, 
1997). 
Diffusion of innovations theories are concerned with how to bring innovations into long-term 
viability within an organisation (Goodman and others, 1993, Greenhalgh, Kyriakidou, and 
Peacock, 2004, Yin, 1981). In this literature, continuation of innovations is defined as processes 
in organisational settings that lead to an innovation becoming a routine practice (Yin, 1981) or 
`an integral part of, the organisation in which it housed' (Goodman and others, 1993). These 
processes are termed as routinisation or inistutionalisation rather than sustainability 
(Greenhalgh, Kyriakidou, and Peacock, 2004, Johnson and others, 2004). 
Several researchers view the sustainability of a health intervention (or a programme) as a 
multidimensional concept, which includes several aspects of what to sustain outlined above: 
continuing benefits to stakeholders, institutionalisation of interventions within organisational 
settings, and maintaining capacity of implementing entity (e. g., a community or an organisation) 
(Cassidy, Leviton, and Hunter, 2006, Johnson and others, 2004, Nelson and others, 2007, 
Shediac-Rizkallah and Bone, 1998). 
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Table 3.1 Selected definitions of sustainability in health systems 
Health interventions 
(area of research or a focus) 
Diffusion of 'Routinization that is when new practices become a routine element in the 
innovations organization's activities and loses its distinct identity. ' (Yin, 1981) 
'Institutionalisation implies that the program becomes embodied within, an integral 
part of, the organization in which it housed. ' (Goodman and others, 1993) 
Development `Sustainability is the ability of a health project or programme to deliver health services 
assistance or sustain benefits after major technical, managerial and financial support has ceased. ' 
SAID, cited in Lafond, 1995a 
Health promotion 'Sustainable safety promotion programmes deliver lasting improvements in the health 
and public health status of individuals or the communities they target. ' (Hanson and others 2005) 
perspective 
`Sustainability is 'a process of ensuring an adaptive prevention system and a 
sustainable innovation that can be integrated into ongoing operations to benefit diverse 
stakeholders. ' (Johnson and others, 2004). 
Community-based 'Sustainability is the capacity of programs to continuously respond to community 
health interventions needs.... The key element of sustainability is providing continued benefits, regardless 
of particular activities delivered or the forma (institutionalization vs independence) in 
which they are delivered. ' (Mancini & Marek, 2004) 
'Maintaining adequate service coverage that will provide continuing control of a health 
problem, continuing to deliver benefits over a long period of time, becoming 
insititutionalised within an organization, and continuing to respond to community 
issues' (Nelson and others 2007) 
Health services/org 
Development `Program sustainability exists when elements essential to a program's effectiveness 
assistance continue to operate over time, within a stable organization, at stable or increased 
organizational and service capacity. ' (Cassidy, Leviton, and Hunter, 2006) 
'Sustainability of a health system is defined as a capacity of the health system to 
function effectively over time with minimum external input. ' (LaFond, 1995c 
Focus on capacity `Sustainability is defined as the maintenance of system of care over time, including the 
or performance services, infrastructure, goals and philosophy. ' (Stroul and Manteuffel, 2007) 
'A health service is sustainable when operated by an organizational system with the 
long-term ability to mobilise and allocate sufficient and appropriate resources 
(manpower, technology, information and finance) for activities that meet individual or 
public health needs/demands....... The system is sustainable when it has the capacity to 
initiate desired changes, or adapt to changes in demand or in environmental conditions 
while ensuring resources and desired outputs'. (Olsen, 1998) 
Focus on `Sustainability is 'the long term ability of a system to respond to external pressures, 
adaptability and to adapt to external constraints without detriment to its functioning' (Whittaker and 
others, 2004). 
`Sustainability is not only the long-term survival of project related changes, but also 
continued effectiveness and capacity to adapt or replace interventions or programmes 
within context that constantly char es. ' Bowman and others, 2008) 
Focus on 'The ability of a project to continue to function effectively, for the foreseeable future, 
interactions with high treatment coverage, integrated into available health care services, with strong 
community ownership using resources mobilised by the community and government. ' 
(WHO, 2002 
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3.2.2. Sustainabiiity of health organisations, services, or coalitions 
The what to sustain in definitions of sustainability of health organisations (or an institution, 
health service, coalitions) includes the organisation's longevity or viability (Cassidy, Leviton, 
and Hunter, 2006, Rog and others, 2004), maintenance of organisational capacity, goals and 
philosophy (Stroul and Manteuffel, 2007), bringing benefits to users of services or meeting 
population needs and demands (Alexander and others, 2003, Brinkerhoff, 1992, Humphreys and 
others, 2008, Knippenberg and others, 1997, LaPelle, Zapka, and Ockene, 2006, Olsen, 1998). 
Definitions from perspectives of organisational learning, organisational sociology and systems 
theories view an essence of sustainability as continuously meeting the changing needs of 
stakeholders or the ability to perform in a changing contextual environment. This perspective 
emphasises notions of adaptability or responsiveness to change (Greenhalgh and others, 2005, 
Olsen, 1998, Whittaker and others, 2004). Several authors do not separate the sustainability of a 
certain intervention from the organisation's sustainability (Cassidy, Leviton, and Hunter, 2006, 
Nilsen and others, 2005). In this view, the important thing is not to sustain an intervention 
indefinitely but the ideas, cultures, beliefs or principles underlying innovation or overall 
organisational goals (Virani and others, 2009, Weiss, Coffman, and Bohan-Baker, 2002). For 
example: `it is not only long-term survival of project-related changes but also continued 
effectiveness and capacity to adapt or replace interventions in the context that constantly 
changes' (Bowman and others, 2008). 
Relatively recently, there has been growing recognition of complexities surrounding 
sustainability in health systems, calling for system-based solutions (Alexander and others, 2003, 
Altman, 2009, Gruen and others, 2008, Humphreys, Wakerman, and Wells, 2006, Sarriot and 
others, 20(4, Sibthorpe, Glasgow, and Wells, 2005). Drawing on complex system theories and 
ecological sustainability perspectives, Gruen et al define a health programme (or health 
interventions) as a component of complex systems (Gruen and others, 2008). From this 
perspective, sustainability encompasses notions of alignment, connectivity, adaptation, and 
equilibrium. 
3.2.3. Sustainability of health systems 
There are limited conceptual developments related to sustainability of an overall health system. 
However, it is understood that the what of sustainability in any health system includes attaining 
the health system's goals, which are improved health status of the population, protection against 
health-related financial risks, responsiveness to needs and satisfaction of consumers' 
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expectations (Atzen and Menabde, 2008 -b, de Savigny and Adam, 2009, Frenk, 1994, Hsiao, 
2003, Murray and Frenk, 2000, Shakarishvili and others, 2010). It is also agreed by the authors 
of conceptual frameworks for health systems that among intermediate objectives are notions of 
effectiveness, efficiency and equity. 
In the context of low- and middle-income countries, sustainability of health systems is 
perceived to entail self-sufficiency that is functioning without external assistance. Thus, a 
capacity to mobilise, manage, allocate and use resources efficiently whilst retaining 
effectiveness of services are the key for sustaining health systems (Berman, 1995, Lafond, 
1995a). 
3.3. CONCEPTUAL FRAMEWORKS 
Through my literature review I identified 26 conceptual frameworks for analysis of 
sustainability in health systems (Appendix 2, A2.3). Seventeen were frameworks related to the 
sustainability of a health intervention (or a programme), six were aimed at analysis of 
sustainability of health organisations (e. g. health services or a coalition), and three were 
frameworks for the analysis of health system sustainability. 
Sustainability is difficult to conceptualise and evaluate, particularly because it concerns a future 
state. There is a need to consider a balance between meeting the short-term and the long-term 
needs of a population's health (Altman, 2009). As suggested by Alexandre et al. , one approach 
to analysing sustainability is by proxy fashion on the basis of observable qualities and 
characteristics, which are presumed to be precursors of sustainability (Alexandre and others, 
2007). In this review, identified frameworks were assessed asking the following questions: (i) 
what are common characteristics or capabilities which are assumed to be attributes of a 
sustainable health programme (or an organisation, not limited to a single intervention), and (ii) 
how are health systems and the broader context acknowledged? 
All frameworks (Appendix 2, A2.3) address the questions of what is being sustained and what 
factors determine sustainability. Among these factors, authors outlined the characteristics of an 
intervention (if this was a question of the framework), attributes of organisational settings and 
the broader contextual environment. In this analysis of the frameworks, these attributes of 
sustainability are grouped into five broad characteristics: 1) capability to govern, lead, and 
manage; 2) resources and capability to plan and implement activities; 3) ability to adapt to 
changing internal or contextual environment; 4) capability to build relationships and interactions 
58 
inside/outside programmes; and 5) ability to bring results or attain goals (relates to the what of 
sustainability). 
Capability to govern, lead and manage (I term this as `leadership) is conceptualised as one of 
the central capabilities and skills of stakeholders, which unites other aspects of sustainability. 
Included here are competencies such as vision and setting attainable organisational goals, 
strategic financial and organisational planning, resource mobilisation, community mobilisation, 
strategic use of monitoring and evaluation (Alexander and others, 2003, Bossert, 1990, 
Brinkerhoff, 1992, Gruen and others, 2008, Hanson and others, 2005, Knippenberg and others, 
1997, Mancini, 2004, Olsen, 1998). Leadership is also conceptualised as commitment, taking 
responsibility and ownership for actions, engaging others and handling conflicts (Alexander and 
others, 2003, Johnson and others, 2004, Olsen, 1998). Leaders also have a role in creating an 
environment for continuously supporting the development of the skills of those working in an 
organisation (Hanson and others, 2005, Mancini, 2004). 
Resources and capability to plan, implement, evaluate activities (capacity). All frameworks 
included capacity, however definitions of what capacity encompasses varied. In general, 
capacity included structures and processes (e. g., planning, execution, evaluation) related to 
financing, human resources (including managerial), medicines and technologies, physical 
infrastructure, and monitoring and evaluation capabilities (Bamberger, 1990, Humphreys and 
others, 2008, Johnson and others, 2004, Knippenberg and others, 1997, Nelson and others, 
2007, Olsen, 1998, Pluye, Potvin, and Denis, 2004, Shediac-Rizkallah and Bone, 1998, 
Stefanini, 1992). Funding was defined as essential for sustainability in several frameworks. 
This aspect of capacity included stakeholders' abilities to analyse funding needs, mobilise 
sufficient funds, evaluate and use funds efficiently (Krippenberg and others, 1997, Lafond, 
1995a, Mancini, 2004, Sarriot and others, 2004, Stefanini, 1992, Torpey and others, 2010). 
Ability to adapt, renew or be flexible (`flexibility/adaptability) is conceptualised as an attribute 
of the sustainability of development projects (Bamberger, 1990, Stefanini, 1992); innovations in 
health care settings (Greenhalgh, Kyriakidou, and Peacock, 2004); and organisations (Alexander 
and others, 2003, Humphreys and others, 2008, Olsen, 1998) (Bowman and others, 2008, Gruen 
and others, 2008, Hanson and others, 2005, Johnson and others, 2004, Mancini, 2004, Pluye, 
Potvin, and Denis, 2004). It was referred to in two aspects. The first is the ability to identify 
and recognise changes in contextual environment, organisational setting, in a health problem or 
its determinants, or in performance. Then in response, sustainable organisations possess a 
willingness and ability to change or modify strategy, priorities, or functioning whilst retaining 
overall organisational mission and performance (Alexander and others, 2003, Bamberger, 1990, 
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Gruen and others, 2008, Hanson and others, 2005, Humphreys and others, 2008, Mancini, 2004, 
Olsen, 1998, Pluye, Potvin, and Denis, 2004). The second aspect is the capability of 
stakeholders to value, learn, assimilate and apply new knowledge (Greenhalgh, Kyriakidou, and 
Peacock, 2004, Gruen and others, 2008, Johnson and others, 2004, Olsen, 1998, Pluye, Potvin, 
and Denis, 2004). 
Capability to build relationships and interactions inside and outside an organisation 
(`interactions) is included as a determinant of sustainability in several frameworks. Definitions 
of what these relationships imply differed and were often vague. For interventions, these 
relations were defined as their integration into domestic or routine administrative structures and 
functions (Bossert, 1990, Shediac-Rizkallah and Bone, 1998). Others defined interactions as 
building a broad political support base from the government or influential stakeholders 
(Alexander and others, 2003, Bamberger, 1990, Mancini, 2004). In community-based research, 
interactions were referred to as linkages and support from community members (Alexander and 
others, 2003, Bowman and others, 2008, Mancini, 2004, Nelson and others, 2007, Sarriot and 
others, 2004). Some authors outline how interactions likely influence sustainability. 
Coordination or collaboration with various stakeholders was defined as important for effective 
implementation of health interventions (Bossert, 1990, Greenhalgh, Kyriakidou, and Peacock, 
2004, Johnson and others, 2004, Mancini, 2004, Sarriot and others, 2004), ensuring efficient use 
of health system resources or resource inputs to an organisation (Gruen and others, 2008, 
Hanson and others, 2005, Humphreys and others, 2008, Olsen, 1998). 
Ability to bring results or attain goals (`performance') is included as an attribute of the 
sustainability of health programmes (Bowman and others, 2008, Brown, 1998, Johnson and 
others, 2004, Nelson and others, 2007, Pluye, Potvin, and Denis, 2004, Sarriot and others, 2004, 
Shediac-Rizkallah and Bone, 1998, Stefanini, 1992, Stephenson, Tsui, and Knight, 2004), 
institutions (Brinkerhoff, 1992), health services or organisations (Knippenberg and others, 1997, 
Mancini, 2004, Olsen, 1998), and health systems (Berman, 1995, LaFond, 1995c). This 
dimension of sustainability was defined as relating to the what of sustainability. For example, it 
was defined as either adequate service coverage (Nelson and others, 2007), adequate level of 
care quality, accessibility, acceptability (Olsen, 1998), or performance, which encompassed 
notions of effectiveness, equity and efficiency (Berman, 1995, Knippenberg and others, 1997, 
LaFond, 1995c, Olsen, 1998). 
Contextual factors as determinants of sustainability are included in most frameworks. Among 
components of contextual environments included in the frameworks are broad political, socio- 
cultural, and economic factors (Bossert, 1990, Greenhalgb, Kyriakidou, and Peacock, 2004, 
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Mancini, 2004, Olsen, 1998, Sarriot and others, 2004), including the concept of human 
development (Sarriot and others, 2004). I did not identify any frameworks for sustainability 
that build on on explicitly outlined health system framework. Only some authors included the 
prevailing health system's characteristics into their frameworks. These were, for example, 
financial resources available for health, or social and health care financial mechanisms (Hanson 
and others, 2005, Mancini, 2004, Olsen, 1998); regulatory and legislative base (Greenhalgh, 
Kyriakidou, and Peacock, 2004, Humphreys and others, 2008, Nelson and others, 2007); or 
organisational arrangements of the health system (Olsen, 1998). 
3.4. EMPIRICAL STUDIES ON SUSTAINABILITY IN HEALTH SYSTEMS 
92 empirical studies and 4 literature reviews met eligibility criteria and were accessible for the 
review. 58 studies were conducted in industrialised countries (the majority in the USA and 
Australia), 34 were in low-middle income countries (no particular regional priority). Most 
studies (n=55) focused on the assessment of sustainability of a health intervention or a project. 
36 explored sustainability of organisations (health services, coalitions/partnerships, or complex 
health programmes). I found one study by Lafond (1995a) which studied the sustainability of a 
health system. The majority of studies in both settings were concerned with the continuation of 
interventions, projects, health reform initiatives, or functioning of established organisations 
(e. g., community-based coalitions or NGOs) after the end of external funding, technical 
assistance or a research trial (Appendix 2, A2.4). 
A dominant focus of studies conducted in industrialised countries was prevention of chronic 
diseases and promotion of healthy behaviours (Table 3.2). Additionally, areas explored 
included clinical managements of chronic diseases, tobacco control and mental health. Most 
studies conducted in low- and middle-income countries were focused on prevention and control 
of communicable diseases, and maternal and child health (Table 3.2). Other areas explored in 
both settings were innovations or development of primary care services, and initiatives within 
broader health reform efforts. 
Table 3.2 presents a summary of study designs as defined by authors. Studies were case studies, 
descriptive narratives of experiences, evaluation studies (including economic evaluations), 
surveys and of quasi-experimental design (before and after intervention, or exposed and not 
exposed to an intervention). Several studies developed quantitative indicators or indices for 
measuring benefits or outcomes produced by the programme as a proxy for sustainability 
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(Amazigo and others, 2007, Glisson and others, 2008, Mancini, 2004, McDermott and others, 
2003, Sarriot and others, 2008, Stephenson, Tsui, and Knight, 2004). 
Table 3.2 Summary of reviewed empirical studies on sustainability in health systems 
Country setting All 
High 
mcome 
Low- and 
middle- 
income 
All studies reviewed 92 58 34 
Level of health system 
Interventions (projects) 55 39 16 
Health organisations (services, coalitions, 
complex programmes*) 
36 18 17 
Health system 1 0 1 
Health (research) area 
Health promotion in communities 24 24 0 
Chronic diseases management 8 8 0 
Tobacco control 3 3 0 
Mental health 5 5 0 
Communicable diseases control 20 1 19 
Maternal and child health 4 0 4 
Reproductive and family health 2 1 1 
Primary care services 11 8 3 
Other health system reform initiatives 8 2 6 
Other 5 4 1 
Study design 
Case study, single 12 9 3 
Case study, multiple 13 10 3 
Evaluation reports 19 13 6 
Multimethod evaluations 10 3 7 
Description (narrative) 8 2 6 
Survey (including cross-sectional) 12 11 1 
Quasi-experimental 
Before and after intervention 4 2 2 
Exposed and not exposed to 
intervention 
5 3 2 
Economic evaluation 5 1 4 
Factors determiningsustainability 
Assessment of empirical studies identified a number of factors that influenced sustainability of 
interventions or organisations. In this review, these factors are classified as in previous reviews 
(Gruen and others, 2008, Scheirer, 2005, Shediac-Rizkalla1 and Bone, 1998), which grouped 
factors as being related to an intervention, the organisational setting and a broader external 
environment. Additionally, factors in organisational settings are grouped into five 
characteristics of sustainability as identified in section 3.3, `Conceptual frameworks. ' 
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(i) Characteristics of interventions (in studies on health interventions sustainability) 
Attributes of interventions (innovations) which were found to influence sustainability are `fit' or 
compatibility with organisational strategies, objectives and practices (Bossert, 1990, Fuller and 
others, 2005), (Greenhalgh and others, 2005, Pluye and others, 2005, Pluye and others, 2004, 
Scheirer, 2005). Other factors outlined in empirical studies fall within factors presented in the 
next sub-section. 
(ii) Attributes of the organisational setting (implementing intervention) 
Leadership. The majority of empirical studies emphasised the importance of leadership. Some 
studies found that the presence of individual charismatic leaders ('champions') was important 
(Crone and others, 2006, Edwards and Roelofs, 2006, Goodson and others, 2001, Scheirer, 
2005). Other studies concluded that sustainability depends on the leadership's competencies as 
relates to collective efforts, norms and organisational culture. These competencies included 
managerial expertise in strategic and financial planning, fundraising, building trust and strategic 
relations outside the organisation, and generating political support (Baum and others, 2006, 
Bossert, 1990, Jana and others, 2004, Mancini, 2004, Nelson and others, 2007, Plochg and 
others, 2006, Savaya, Spiro, and Elran-Barak, 2008, Stevens and Peikes, 2006, Stroul and 
Manteuffel, 2007, Toledo Romani and others, 2007). Other traits of leadership found in the 
studies include a long-term vision for how to address a population's health problems (Alexander 
and others, 2003, Feinberg, Bontempo, and Greenberg, 2008); a vision on the value of 
innovations (Barnett and others, 2004, Bradley and others, 2005, Evashwick and Ory, 2003, 
Whittaker and others, 2004); the ability to avoid competing objectives, and to provide clarity in 
the roles and responsibilities of subordinate personnel/departments (Bailie and others, 2006, 
Wakerman and others, 2005). 
Capacity. The availability of adequate funding, infrastructure and commodities, qualified and 
trained staff were identified as factors influencing sustainability (Evashwick and Ory, 2003, 
Gruen, Weeramanthri, and Bailie, 2002, Hoelscher and others, 2004, McKenzie and others, 
2003, Mihalopoulos and others, 2005, Nilsen and others, 2005, Prasad and Costello, 1995, 
Scheirer, 2005, Wakerman and others, 2005). In both settings (high-income and low-/middle- 
income), authors concluded that the sustainability of health programs requires long-term 
funding (Bradley and others, 2005). Studies suggest that chances for sustainability are higher in 
those organisations that use available funds efficiently (Higgins, Naylor, and Day, 2008), 
regularly assess and plan present and future financial needs (Casey and others, 2009, Israel and 
others, 2006), and are capable of attaining diverse funding streams (not depending on one 
63 
source) (Bratt, Foreit, and de Vargas, 1998, Evashwick and Ory, 2003, Stevens and Peikes, 
2006). Diversified and sufficient funding in contrast to funding earmarked for a specific 
intervention was found to improve the chances of sustainability (Rog and others, 2004, Stroul 
and Manteuffel, 2007). 
Flexibility. Studies exploring the sustainability of interventions consistently found that the 
ability of stakeholders to adapt an intervention's design or implementation processes was a 
determinant of sustainability. This was related to the adaptability of an intervention to the 
changing needs of beneficiaries (Bracht and others, 1994, Bradley and others, 2005), or the 
modification of an intervention to fit the organisational culture and variations in patients 
population (Akogun and others, 2001, Goetz and others, 2009, Gurtler and others, 2007). 
Similarly, studies that explored the long-term viability of organisations concluded that 
continuous adaptation to societal changes, community needs, and population demands is a 
driving factor of sustainability (Nordqvist, Timpka, and Lindqvist, 2009, Wakerman and others, 
2005). Important for sustainability of organisations was the flexibility to change the 
organisation's strategy or operations in response to changes in the overarching health system's 
regulatory or fiscal environment (Bratt, Foreit, and de Vargas, 1998, Israel and others, 2006, 
Jana and others, 2004, Plochg and others, 2006, Singh and others, 2010, Wright, 2009). These 
included, for example in the case of funding cuts, redefining services and staffing patterns or 
changing strategies for creating demand for services (LaPelle, Zapka, and Ockene, 2006). 
Organisations with cultures open to new knowledge and with emphasis on a high level of 
proficiency were more likely to sustain innovations (Glisson and others, 2008). 
Interactions. Relationships within and with other organisations were found also to be a 
determinant of sustainability in all studies that included this component in the assessment 
(Appendix 2, A2.4). Interventions that were designed to run as vertical hierarchies were less 
likely to be sustained (Bossert, 1990, Stevens and Peikes, 2006). Pilots or innovations that were 
not integrated into domestic policy and legal frameworks, formal domestic health services, and 
on-going roles and responsibilities were at substantial risk of being discontinued at the end of 
external support (Amazigo and others, 2007, Fuller and others, 2005, Gruen, Weeramanthri, and 
Bailie, 2002, Harpham and Few, 2002, Milne and others, 2007). Though stand-alone projects 
enjoy independence, such interventions have limited options for funding and resources to draw 
upon when the project cycle ends (Stevens and Peikes, 2006). Collaboration, building alliances, 
gaining support and involvement of various stakeholders (both political and in the communities) 
were critical for sustainability in a number of studies (Bratt, Foreit, and de Vargas, 1998, 
Edwards and Roelofs, 2006, Eliason, 1999, Higgins, Naylor, and Day, 2008, Jacobs, Price, and 
Sam, 2007, Jana and others, 2004, Knippenberg and others, 1997, Minkler and others, 2006, 
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Nelson and others, 2007, Nilsen and others, 2005, Nordqvist, Timpka, and Lindqvist, 2009, 
Singh and others, 2010, Sivaram and Celentano, 2003, Wakerman and others, 2005, Wong, 
Chan, and Koh, 1998). Coordination in implementation between actors (e. g. government, 
NGOs, international actors) was found to be an important determinant for the sustainability of 
complex programmes such as HIV/AIDS (Greco and Simao, 2007, Le Loup and others, 2010, 
Rosenberg, Hartwig, and Merson, 2008, Torpey and others, 2010), family health (Mancini, 
2004), partnerships (Alexander and others, 2003, Israel and others, 2006), and community- 
based programmes (Gurtler and others, 2007, Nelson and others, 2007, Toledo Romani and 
others, 2007). 
Performance. Interventions that are culturally acceptable and demonstrate benefit, either 
observable or perceived, to communities or stakeholders had better prospects for sustainability 
(Amazigo and others, 2007, Bossert, 1990, Greenhalgh and others, 2005, Jacobs, Price, and 
Sam, 2007, Kachur and others, 1999, Rashed and others, 1997, Scheirer, 2005, Streefland, 1995, 
Toledo Romani and others, 2007, Wang, Gu, and Dupre, 2008). In low- and middle-income 
countries, projects that were viewed as an imposition from donors and not beneficial in the local 
context were not likely to be sustained (Amazigo and others, 2007, Israr and Islam, 2006, 
Jacobs, Price, and Sam, 2007, Rashed and others, 1997, Streefland, 1995, Toledo Romani and 
others, 2007). Achieving results or bringing benefits was referred to as an overarching attribute 
that determines the sustainability of an organisation. Authors noted a particular importance of 
the strategic use of monitoring and evaluations systems in planning, refining operations, and 
disseminating results (Alexander and others, 2003, Evashwick and Ory, 2003, Fuller and others, 
2005, Knippenberg and others, 1997, Milne and others, 2007, Minkler and others, 2006, Nelson 
and others, 2007, Stevens and Peikes, 2006, Stroul and Manteuffel, 2007, Torpey and others, 
2010). These studies concluded that achievement of organisational goals and results, and 
effective use of monitoring and evaluation systems are the foremost factors in building 
organisational credibility and reputation, gaining political and financial support, and creating 
demand for services provided. 
(iii) External contextual environment 
A number of empirical studies concluded that the overarching health system characteristics, 
economic conditions, political climate, policies of funding agencies and country's history may 
influence the sustainability of health interventions or organisations (Amazigo and others, 2002, 
Ashwell and Barclay, 2010, Atun and others, 2005e, Bossert, 1990, Dasgupta and Priya, 2002, 
Greenhalgh and others, 2005, Gruen and others, 2008, Higgins, Naylor, and Day, 2008, 
Humphreys and others, 2008, Israr and Islam, 2006, Jacobs, Price, and Sam, 2007, LaFond, 
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1995b, LaFond, 1995c, Le Loup and others, 2009, Le Loup and others, 2010, Nelson and others, 
2007, Nordqvist, Timpka, and Lindqvist, 2009, Rosenberg, Hartwig, and Merson, 2008, 
Sibthorpe, Glasgow, and Wells, 2005, Stroul and Manteuffel, 2007, Williams and others, 2007). 
Several authors highlighted the non-linear, interrelated and interdependent nature of influences 
on sustainability (Amazigo and others, 2007, Goodson and others, 2001, Gruen and others, 
2008, Humphreys, Wakerman, and Wells, 2006, Mancini, 2004). Authors concluded that there 
was a very human aspect to sustainability; role of leaders, social relations, and relationships 
among key decision-makers (LaFond, 1995c, Savaya, Spiro, and Elran-Barak, 2008, Sibthorpe, 
Glasgow, and Wells, 2005). For example, national political commitment for a certain 
programme does not guarantee on-going financing, and increased or solely national financing 
does not ensure sustainability (Bossen, 1990, Lafond, 1995a, Sibthorpe, Glasgow, and Wells, 
2005). 
Among external factors, several studies pointed out a key role of donors' investment policies. 
This was shown to be important in both high-income and low-/middle-income settings. In a 
low- and middle-income context, investment strategies that support vertical programmes and 
`value for money' draw attention away from a unified strategy for health sector development, 
thus compromising sustainability in health sector (Lafond, 1995a). In the USA, instability of 
short-term funding and high expectations from Panders created an impediment for developing 
comprehensive health promotion in the communities (Higgins, Naylor, and Day, 2008). 
Furthermore, uncertainty in funding negatively affects relations in complex organisations, 
creating tensions for sharing/competing for resources (Stroul and Manteuffel, 2007). In both 
settings, inflexibility in donors' funding and projects' implementation policies was found to be 
an impediment to sustainability (Ashwell and Barclay, 2010, Humphries, Gomez, and Hartwig, 
2010, Israel and others, 2006, Wakerman and others, 2005). 
CHAPTER SUMMARY 
Contemporary understanding of sustainability in health systems is as a complex, 
multidimensional phenomenon. Common themes found in definitions of sustainability include 
meeting current needs and a vision for the future as relates to the well-being and health of a 
population, benefits for people in the health system, continuing public health impact of health 
interventions, maintaining structural or functional components of a health system or the health 
system overall. It has been acknowledged and understood that sustainability is difficult to 
conceptualise and study. The reasons include the complexities surrounding the sustainability 
phenomenon outlined earlier in this Chapter and the nature of sustainability (e. g. looking ahead, 
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long term). An approach proposed by Alexandre et al is to analyse sustainability by proxy 
fashion on the basis of observable characteristics, which are presumed to be precursors of 
sustainability (Alexandre and others, 2007). The systematic review of conceptual frameworks 
and empirical studies presented here suggests that such observable characteristics might be 
leadership, capacity, adaptability/flexibility, interactions and performance. Research indicates 
that notions of integration are components of a sustainability characteristic which I termed here 
as `interactions'. A key finding, which was evident in this review, is that this notion has been 
defined differently. Next Chapter 4 provides an overview of the definitions and conceptual and 
analytical approaches to integration and health systems. 
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CHAPTER 4 INTEGRATION 
INTRODUCTION 
This chapter provides an overview of the definitions and conceptual approaches to the analysis 
of integration and health systems. I conducted an analysis of peer-reviewed literature on 
concepts, definitions, and analytical approaches to integration and health systems. The 
structured review included conceptual and/or analytical frameworks of integration (these 
included conceptual papers and empirical studies drawing on explicit conceptual frameworks), 
systematic reviews and meta-analysis of integration initiatives; and reviews (overviews) of 
conceptual or methodological approaches to integration. The detailed methodology of the 
literature review is presented in the Appendix 3 (A3.1, A3.2). Briefly, the literature search 
included searches of Medline [from 1980], Embase [from 1950] and the Cochrane library. The 
initial search was performed in December 2008 and updated in April 2010. The search was 
limited to the English language and papers accessible through the University of London library 
services. Bibliographies of selected papers were searched to identify further publications. The 
search strategy included key terms related to the concept of integration including `integrat*', 
`collaborat*', `coordinat*', `co-ordinat*', `link*'. The search was restricted to MeSH and 
EMTREE headings under `delivery of health care, integrated', `health services', and key terms 
`health program*', `health intervention*', `health system*'. The search was then limited further 
to include terms `measure*', `framework*' and `model*' 
The findings of this literature review have been published in a paper: Shigayeva A, Atun RA, 
McKee M, Coker R24 `Health systems, communicable diseases and integration", Health Policy 
and Planning, 2010,25, Supplement 1: i4-20. This chapter presents the findings of the literature 
review as they appeared in the mentioned publication with minor modifications. 
I begin this chapter with the theoretical background underlying the integration concept. I follow 
with an overview of definitions of integration in health systems and an analysis of conceptual 
frameworks identified in the literature search. I conclude the Chapter with a brief summary of 
the results of the identified systematic reviews on integration and health systems. 
24 Co-authors are Professor Richard Coker, PhD supervisor, and Professor Martin McKee, an advisory committee 
member. Professor Rifat Aran has been informal advisor who provided advice over the course of developing the 
conceptualization of integration applied in this thesis. 
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4.1. THEORETICAL BACKGROUND 
The word integrate is used to express the bringing together or merging of elements or 
components that were formerly separate (Kodner and Spreeuwenberg, 2002), or to `combine 
into a whole', `bring or come together into equal membership of society' and `complete by 
addition of parts' (Wilson, 2003 citing the Australian Oxford dictionary). 
4.1.1. Contingency theory 
The notion of integration has its roots in organisational theory, particularly in contingency 
theory (Galbraith, 1973, Lawrence and Lorsch, 1967a, Lawrence and Lorsch, 1967b), a subset 
of open systems theory (Scott, 2002). Complex organisational systems are composed of 
separate but interconnected elements, which, in a functioning system, play complementary roles 
in the conduct of tasks in the pursuit of common aims and goals (Pfeffer, 1982). However, as 
systems become more complex and their surrounding environment more uncertain and 
unpredictable, systems typically segment into subsystems. Organisations, in response to 
demands and uncertainties in the environment, adapt by allowing more flexible structures, 
division of labour and responsibilities, factors that consequently can lead to segmentation of 
professional norms, attitudes, behaviours and interests of the organisation's members (Lawrence 
and Lorsch, 1967b). This might result in loss of effectiveness in implementing common tasks 
or inefficiencies. Increased differentiation thus, it is argued, requires implementation of 
integration, which was defined by Lawrence and Lorsch as `the quality of the state of 
collaboration that exits among departments that are required to achieve unity of efforts by the 
demands of the environment. ' However, since differentiation also allows organisations to 
achieve their goals, according to these authors, most successful organisations are those that can 
effectively balance differentiation and integration. This challenge in finding a balance between 
differentiations in roles, occupations, and responsibilities, and a need for integration and 
coordination that encourages people to work together effectively and efficiently towards a larger 
organisational mission, highlights one of the fundamental tensions identified in organisational 
theory and practice (Jaffee, 2001). 
4.1.2. Inter-organisational relationships 
Similar tensions between integration and differentiation (or specialisation) have been described 
in the theoretical and empirical literature on inter-organisational relations (Jaffee, 2001). Inter- 
organisational relations have long been a topic of interest in a variety of disciplines including 
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organisational theory, organisational behaviour, strategic management, economics, sociology, 
and political sciences (Aldrich, 1979, Benson, 1975, Galaskiewicz, 1985, Oliver, 1990 , Smith, 
Carroll, and Ashford, 1995, Whetten, 1981). Research of inter-organisational relations is 
concerned with interactions, including factors determining these interactions, which occur 
among or between organisations, and the environment (Jaffee, 2001, Oliver, 1990 ). The 
theoretical developments are vast and have different facets. I did not aim for a detailed analysis 
of the literature on inter-organisational relations, limiting this to overviews in order to highlight 
how integration is understood in this literature. 
As a result of changes in the social division of labour, economic specialisation and 
differentiation (or with increased system's complexity), there is increasing interdependence 
among increasingly specialised organisations and the respective resources they control (Jaffee, 
2001). People in organisations typically pursue their own or their organisation's interests, 
which may or may not coincide. New demands, limitations in resources, competition, needs to 
control environmental uncertainty or increases in an organisation's influence or legitimacy 
create conditions for forming relations with other organisations (Galaskiewicz, 1985, Oliver, 
1990). 
Often formation and maintenance of inter-organisational relations are explained from theoretical 
perspectives of resources dependency (Aldrich, 1979, Pfeffer, 1982) and power-based theories 
(Benson, 1975, Pfeffer and Salancik, 1978 , Provan, Beyer, and 
Kruytbosch, 1980) that explain 
inter-organisational dependencies created by the need of all organisations to control and/or 
acquire scarce resources. Agency theory and institutional theory were applied to explain 
relational trust based on motives of mutual benefits rather than organisational individualism 
(Alter and Hage, 1993), or problems of joint working associated with resource sharing, political 
turf battles, or regulatory differences (Provan, Beyer, and Kruytbosch, 1980). 
Broadly, formation of inter-organisational relations can be mandated (through legal or 
regulatory mechanisms, or by means of organisational hierarchy), be driven by market forces, or 
based on mutual trust and reciprocity (Oliver, 1990 ). These forces are not mutually exclusive. 
Inter-organisational relationships have a potential to result in domination, overtly or covertly, of 
one organisation over another, or control by one organisation over anther's resources. An 
alternative relationship, based on reciprocity and trust, may result in inter-organisational 
relations that are characterised by cooperation, collaboration, and coordination (rather than 
domination, power, and control), working together towards common interests or mutually 
beneficial goals (Huxham and Vangen, 2000, Oliver, 1990 ). 
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Organisations are, however, abstract constructs; interactions between organisations `only 
emerge, grow and dissolve as a consequence of individual activities' (Ring and Ven, 1994). 
Even when inter-organisational relationships are formed based on trust, the longevity and 
success of collaborative efforts is largely determined by interactions between individuals, their 
individual roles, interests, and intentions (Hudson and others, 1999, Huxham and Vangen, 2000, 
Smith, Carroll, and Ashford, 1995). 
4.1.3. Health systems and inter-organisational relationships 
In contrast to the corporate sector, whose ultimate goal is to make a profit, the goals of the 
health system are more complex (Hsiao, 2003, Murray and Frenk, 2000). The strategic goals of 
health systems are often defined as balancing gains in population health, social and financial 
risk protection, and consumer or patient satisfaction (Atun and Menabde, 2008 -b, de Savigny 
and Adam, 2009, WHO, 2000) through intermediate goals of equitable access and coverage, 
choice, efficiency and effectiveness (Hsiao, 2000, McPake and Kutzin, 1997). 
Health systems are organisationally complex. Functions include, amongst others, planning, 
governance, administration, finance, and service delivery. Clinical care, public health and 
social services are provided by multiple actors, including state agencies, non-governmental 
organisations (including international), donor organisations, community groups and lay health 
workers, family members, and private enterprises (Atun and others, 2005b, Frenk, 1994). 
Moreover, health organisations, programmes, groups, and individuals within health systems are 
increasingly interdependent in their use of funds, human resources, knowledge, skills and 
technologies (Axelsson and Axelsson, 2006, Lasker, Weiss, and Miller, 2001). 
Although market forces are important in many health systems, connections between 
stakeholders (organisations or individuals) working on health issues are often characterised by 
consensus building, shared values and a shared philosophy concerning common problems rather 
than market imperatives. This consensual manner of working does not exclude competitive 
relations or power struggles, however (Alter and Hage, 1993, Axelsson and Axelsson, 2006, 
Contandriopoulus and others, 2003, Rodriguez and others, 2007). 
Thus, the concept of integration in public health systems is intrinsically related to notions of 
cooperation, collaboration, partnerships and coordination (Axelsson and Axelsson, 2006, 
Bolland and Wilson, 1994, Horwath and Morrison, 2007, Lasker, Weiss, and Miller, 2001, 
Lehman and others, 2009). In fact, the terms `coordination', `collaboration', `alignment', or 
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`networks' are often used interchangeably with the term `integration' in the health systems and 
health services research literature (Table 4.1). 
Given the complexity of contemporary health systems, they are increasingly being viewed as 
complex adaptive systems (Atun and Menabde, 2008 -b, de Savigny and Adam, 2009, Frenk, 
1994, Plsek and Greenhalgh, 2001) or complex socio-cultural-political systems (Atun and 
others, 2006a, Blaauw, 2003, McDaid and others, 2006). This view of systems acknowledges 
the social nature of organisations, that the goals, roles, interests, intentions, power-relations, and 
behaviours of actors within these systems are of critical importance, and so too are their 
interactions as individuals and the groups (whether formal or informal) they inhabit, be they 
individual health care workers, patients, policy-makers, donors, patients' groups, bureaucrats 
and administrators, or politicians (Blaauw, 2003, Frenk, 1994). Individual goals of patients and 
health care workers do not necessarily match aims of health policies. Underpaid and 
overworked staff often see health systems as means of their own survival, and are less likely to 
behave in the interest of overall organisational aims (Franco, Bennett, and Kanfer, 2002, 
McPake and others, 1999, Schneider and others, 2006). With the introduction of innovations or 
establishment of collaborative approaches, professionals are often reluctant to lose professional 
autonomy and independence, status, potentially income and respect from patients (Atun and 
others, 2005a, D'Amour and others, 2008). There is now recognition that for building successful 
collaborative and integrative approaches in health system; the local social and political culture, 
informal relations between providers and patients, providers, employers, and policy makers 
should be understood and addressed (Atkinson, 2002, Gilson, 2003, Horwath and Morrison, 
2007, Hudson, 2002, Johnson and others, 2003, Schneider and others, 2006, van Raak, Mur- 
Veeman, and Paulus, 1999). 
4.2. DEFINITIONS AND PERSPECTIVES 
The published literature reveals a wide range of concepts of integration in health systems (Atun, 
Bennet, and Duran, 2008, Axelsson and Axelsson, 2006, Kodner, 2009, Nolte and Mckee, 2008, 
Suter and others, 2007). Health systems differ in governance arrangements, regulatory norms, 
managerial rules and funding flows, professional skill-mix, political, institutional and 
professional structures, and cultural values. The notion of integration has been pursued in many 
ways in different health systems (Nolte and McKee, 2003). There is a wealth of terminology 
such as `integrated care', 'integrated services', `horizontal programmes', 'disease management', 
`case management', `continuity of care', `coordinated care', `managed care', `comprehensive 
care', and 'seamless care' to name a few (Atun, Bennet, and Duran, 2008, Kodner, 2009, Nolte 
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and Mckee, 2008). Table 4.1 highlights some of the definitional issues surrounding a few of 
these terms. 
This lack of a commonly adopted definition and the variety of approaches taken to analyse 
integration has been referred as an `academic quagmire of definitions and concepts analysis' 
(Howarth and Haigh, 2007). However, recent empirical studies reveal integration to be 
polymorphous by nature (Atun and others, 2010b, Nolte and Mckee, 2008). Those from 
different disciplines and professions understand the term differently. I present below three 
commonly used concepts identified in the integration literature, namely `integrated care', 
`disease management', and `continuity of care'. 
Integrated care 
Exploring the application of the 'integrated care' concept to health and social care in 
industrialised countries, Leichsenring (2004) distinguished discourses that evolved either from 
health care perspectives ('managed care' and `public health' discourses) or from social services 
perspectives that focused on broader whole system approaches ('person-centred' discourses). 
Complementing these perspectives, Leichsenring also explores `institutional discourse', which 
focuses on organisational strategies to realise integration and/or coordination of services 
(Leichsenring, 2004). For example (as noted by Leichsenring), the WHO European Regional 
Office defines integration from a health care perspective as: `a concept of bringing together 
inputs, delivery, management and organisation of services related to diagnosis, treatment, care, 
rehabilitation and health promotion. Integration is a means to improve services in relations to 
access, quality, user satisfaction and efficiency' (Grone and Garcia-Barbero, 2001). Definitions 
within a public health discourse (or `person-centred' view) put an emphasis on integration 
between primary and secondary care including social service delivery: `the goal of [integration] 
is to enhance quality of care and quality of life, consumer satisfaction and system efficiency for 
patients with complex, long term problems, cutting across multiple services, providers and 
settings' (Kodner and Spreeuwenberg, 2002). As noted by Nolte and McKee (2008), 
boundaries across these discourses are ambiguous, because of differences across industrialised 
countries in health systems arrangements and responsibilities for financing and health and social 
services delivery. 
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Table 4.1 Selected definitions of integration, and related concepts and terms 
Concept Definition (Authors) 
Integration `... a process where disease control activities are functionally merged or tightly 
coordinated with multifunctional health care delivery. ' (Unger, De Paepe, and 
Green, 2003) 
`.. a search to connect the health care system (acute, primary medical, and skilled) 
with other human service systems (long-term care, education, vocational and 
housing services) in order to improve outcomes (clinical, satisfaction, efficiency). 
(Leutz, 1999) 
`... a process that involved creating and maintaining, over time, a common structure 
between independent stakeholders (and organizations) for the purpose of 
coordinating their interdependence in order to enable them to work together on a 
collective ro'ect. ' (Contandriopoulus and others, 2003) 
Integrated care '... is a concept bringing together inputs, delivery, management and organization of 
services related to diagnosis, treatment, care, rehabilitation and health 
promotion.... is a means to improve the services in relation to access, quality, user 
satisfaction and efficiency. ' (Grone and Garcia-Barbero, 2001) 
Integrated 'A network of organizations that provides and arranges to provide a coordinated 
delivery networks continuum of services to a defined population and is willing to be held clinically 
and fiscally accountable for the outcomes and the health status of the population 
served. ' (Shortell, Gillies, and Anderson, 1994) 
Integrated health 'process of bringing together common functions within and between organizations 
services to solve common problems, developing a commitment to shared vision and goals 
and using common technologies and resources to achieve these goals. ' (WHO, 
1996) 
Disease '... is a systematic, population-based approach involving identification of people at 
management risk of a particular disease, intervention throughout the condition's life cycle, and 
the packaging and management of treatments and services across the entire care 
and disease spectrum in order to achieve better and more cost-effective health 
outcomes. ' (Kodner, 2009) 
'An approach to patient care that emphasises coordinated, comprehensive care 
along the continuum of disease and across health care delivery systems' (Ellrodt 
and others, 1997) 
Partnership '... encompass all types of collaboration (consortia, coalitions, alliances) that bring 
people and organizations together to improve health. ' (Lasker, Weiss, and Miller, 
2001) 
Continuity of 'is achieved by bridging discrete elements in the care pathway-whether different 
care episodes, interventions by different providers, or changes in illness status-as well 
(continuum of as by supporting aspects that endure intrinsically over time, such as patients' 
care) values, sustained relationships, and care plans. ' (Haggerty and others, 2003) 
Coordinated care '... system-wide efforts and/or specific policies to ensure that patients-particularly 
(case those with chronic conditions-receive services that are appropriate to their needs 
management) and coherent across care settings and over time. ' (Hofinarcher, Oxley, and 
Rusticelli, 2008 
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Disease management 
Another key concept related to integration is disease management, which concerns management 
of chronic conditions. Nolte and McKee (2008), in their analysis of relevant concepts, found 
that views on disease management evolved from focusing on a single chronic condition (focus 
on a disease) to a population-based approach with a focus on addressing multiple needs of 
patients with co-morbidities. The later views on disease management include notions of 
coordination, continuity and comprehensiveness, which in large extent overlap with the concept 
of integrated care (Nolte and Mckee, 2008). For example, Ellrodt et al define disease 
management as: 'an approach to patient care that emphasises coordinated, comprehensive care 
along the continuum of disease and across health care delivery systems' (Ellrodt and others, 
1997). 
Continuity of care 
Continuity of care (or continuum of care) is often used interchangeably with notions of 
integration. Defined differently, continuity of care in general relates processes by which 
patients experience cohesiveness and connectedness of the health system (Haggerty and others, 
2003). Continuity of care `is achieved by bridging discrete elements in the care pathway- 
whether different episodes, interventions by different providers, or changes in illness status-as 
well as by supporting aspects that endure intrinsically over time, such as patients' values, 
sustained relationships, and care plans' (Haggerty and others, 2003). Views on continuity of 
care encompass several aspects such as patient's experience in receiving care, provision of care 
over time, relationships with providers, relationships between different care levels, information 
and communications exchanges between providers and patients, and across providers (Haggerty 
and others, 2003, Kodner, 2009). 
4.3. CONCEPTUAL FRAMEWORKS FOR THE ANALYSIS OF INTEGRATION 
Reflecting the diversity of approaches to integration, there are a number of conceptual and 
analytical frameworks that have been developed specifically for a particular health care or 
contextual setting. The search identified 41 conceptual frameworks relating to integration and 
13 implementation frameworks offering roadmaps for the establishment of integrated 
programmes, services or system (Appendix 3, A3.3. ). I have not identified a unifying 
framework for analysis of integration initiatives, though frameworks exist to address specific 
research questions. 
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A variety of different typologies of integration in health systems exist (Armitage and others, 
2009, Atun and others, 201 Oa, Axelsson and Axelsson, 2006, Colombini, Mayhew, and Watts, 
2008, Delnoij, Klazinga, and Glasgow, 2002, Kodner, 2009, MacAdam, 2008, Nolte and 
Mckee, 2008, Simoens and Scott, 2005, Sobczak, 2002, WHO, 1996), including the concept of 
integration and communicable disease programmes (Grepin and Reich, 2008, Mills, 1983, Sylla 
and others, 2007, Unger, De Paepe, and Green, 2003, Wang and others, 2007). Existing 
typologies can be summarised in terms of how they address three questions: why integration is 
desirable, what structures and/or functions at different levels of the health system are affected 
by integration (or lack thereof), and how integration influences interactions between health 
system components or stakeholders. 
The `why' of integration asks about the driving forces or the purposes of integration. Ultimately, 
integration is a response to real or perceived fragmentation of functions and services for users, 
to gaps, duplication, inefficiencies, or to concerns about growing costs or changing population' 
demands and expectations (Grone and Garcia-Barbero, 2001, Kodner, 2009). 
The `what' of integration includes questions that relate to the structures and/or functions at 
different levels ranging from the overall health system, specific programmes and interventions, 
and individual and institutional stakeholders (Atun and others, 2010a, Contandriopoulus and 
others, 2003, Delnoij, Klazinga, and Glasgow, 2002, Grepin and Reich, 2008, Kodner, 2009, 
Kodner and Spreeuwenberg, 2002, Mills, 1983, Nolte and Mckee, 2008, Simoens and Scott, 
2005, WHO, 1996). The subjects of integration include structures and processes of governance, 
financing, policy, management and administration, service delivery, clinical care, demand 
generation, and information systems (Atun and others, 2010a, Kodner and Spreeuwenberg, 
2002). The what of integration also includes notions of convergence of institutional or 
professional cultures, norms, working methods, approaches and symbols adopted by various 
stakeholders, taking account of their power, interests and objectives (Fabbricotti, 2007). 
The 'how' of integration refers to the dynamic interactions between organisations, programmes, 
individual providers, and/or stakeholders (Atun and others, 2010a, Boon and others, 2004, 
Fletcher and others, 2009, Grepin and Reich, 2008, Horwath and Morrison, 2007, Kodner and 
Kyriacou, 2000, Leutz, 1999, Simoens and Scott, 2005, Sylla and others, 2007, Wang and 
others, 2007). These interactions include efforts to enhance joint working such as building 
strategic or contractual alliances, regulations, merging service delivery, establishing 
multidisciplinary teams, creating service networks, and developing coordination mechanisms. 
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Connections between organisations can occur within a geographical space, at international, 
national, regional/district, or local levels (Atun and others, 2010a, Grepin and Reich, 2008, 
Mills, 1983). Authors also discuss the breadth of integration. Horizontal integration involves 
integration of organisations or providers working at the same level of the hierarchy (for 
example, among hospitals), and vertical integration refers to integration across different levels 
of the service delivery hierarchy (for example, between hospitals and primary care facilities) 
(Axelsson and Axelsson, 2006, Kodner, 2009, MacAdam, 2008, Nolte and Mckee, 2008). 
There is an emerging acknowledgement that integration in health systems and the benefits that 
may accrue are, to a considerable extent, dependent upon the characteristics of different health 
systems and the wider context within which they are situated (Atun and others, 2010b, Atun and 
others, 2010c, Friedland, Harries, and Coetzee, 2007, Gyapong and others, 2010, Nolte and 
Mckee, 2008, Okot-Chono and others, 2009, Van Damme and Kegels, 2006). Particularly 
important are the role of key political stakeholders and decision-makers, and their commitment, 
support and willingness to work together to resolve conflicts and provide leadership in 
advocating, designing, implementing and maintaining integration initiatives (Atun and others, 
2005b, Mur-Veeman and others, 2003, van Raak and others, 2005, van Raak, Mur-Veeman, and 
Paulus, 1999). 
I reviewed these various frameworks, asking whether they reflect the questions of the why, 
what, and how of integration, as well as the extent to which they acknowledged health system 
characteristics, the wider contextual environment and the roles of key stakeholders. I did not 
find any one framework that explicitly addressed all of these parameters. Appendix 3 (A3.3. ) 
summarises selected frameworks. 
All the frameworks reviewed address questions associated with the what of integration. 
Publications exploring integration in high-income countries contributed disproportionately to 
conceptualising the dynamics of interactions (the how of integration) between previously 
separate components of the health system. Several authors conceptualised integration along a 
continuum of inter-organisational relationships, with increasing intensity in interactions, 
formalisation of governance arrangements, sharing of responsibilities, or pooling of resources. 
Integration is viewed by most as a transformative change that may lead to a complete merger of 
organisations or a formalised collaboration of systems of governance, accountability, or service 
delivery, often involving resource pooling (Axelsson and Axelsson, 2006, Boon and others, 
2004, Fleury, 2006, Konrad, 1996, Leutz, 1999, Messen, Kim, and Whetten, 2003, Sylla and 
others, 2007). Formal and structured interactions on such continuums are labelled as, for 
example, linkage, coordination, cooperation, or collaboration (though they may be defined 
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and/or ranked differently). Some authors argue that more complex, long-term or unstable and 
fluctuating problems requiring multiple complex interventions may benefit from greater 
integration (Fleury, 2006, Leutz, 1999, Messeri, Kim, and Whetten, 2003). Coordination is 
often viewed as involving some degree of managerial oversight (Axelsson and Axelsson, 2006), 
whilst collaboration, partnerships, and cooperation are more commonly understood to be built 
upon mutual agreements, with formalised arrangements following if common goals are agreed 
(Axelsson and Axelsson, 2006, de Rijk, van Raak, and van der Made, 2007, Konrad, 1996, 
Lasker, Weiss, and Miller, 2001, Weiss, Anderson, and Lasker, 2002). 
Several frameworks identified focus either on collaboration, partnerships, or cooperation as 
types of interactions within an overall rubric of health system or programme integration 
initiatives (Brazil and others, 2004, D'Amour and others, 2008, de Rijk, van Raak, and van der 
Made, 2007, Horwath and Morrison, 2007, Lasker, Weiss, and Miller, 2001, van Raak and 
others, 2005, van Raak, Mur-Veeman, and Paulus, 1999). These considered explicitly the role 
of key actors and stakeholders, their influences and interests, as well as factors in promoting and 
sustaining cooperation or collaboration. 
The review identified only one analytical framework (Atun and others, 2010) that builds on a 
clearly outlined conceptual framework of health systems and explicitly takes into account the 
role of key stakeholders, health system functions, and the broader context. In analysing the 
level, nature and extent of integration, the framework appropriately categorises integration of 
targeted programmes into health systems along a continuum from fully integrated to partially 
integrated and not integrated, but the question of 'how' partial integration occurs is not explored 
in detail. The majority of the conceptual papers reviewed outline the purpose of integration 
overall [the why of integration], but only a few analytical frameworks consider the intermediate 
and/or final outcomes or consequences of integration (Provan and Milward, 2001, Vazquez and 
others, 2009, Wan and Wang, 2003). 
4.4. SYSTEMATIC REVIEWS ON INTEGRATION IN HEALTH SYSTEMS 
I identified 16 systematic or structural reviews on integration in health systems, and examined 
the benefits of integration. These reviews examine integration in health systems in high-income 
countries (Bodenheimer, Wagner, and Grumbach, 2002, Butler and others, 2008, Hesse and 
others, 2007, Ouwens and others, 2009, Ouwens and others, 2005, Soto, Bell, and Pillen, 2004, 
Suter and others, 2007, Weingarten and others, 2002, Willenbring, 2005) or low- and middle- 
income countries (Atun and others, 2010b, Bhutta and others, 2008, Briggs and Garner, 2006, 
Church and Mayhew, 2009, Dehne, Snow, and O'Reilly, 2000, Lewin and others, 2008, 
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Wallace, Dietz, and Cairns, 2009), and identify a paucity of evidence that convincingly 
demonstrates that integration improves access to care, service quality, programme efficiency or 
effectiveness. There is no evidence to suggest a positive impact on equity of outcomes. This 
lack of evidence may be due to the complex nature of integration, which is clearly multifaceted 
and complex (Howarth and Haigh, 2007, Nolte and Mckee, 2008). 
CHAPTER SUMMARY 
In summary, despite the diversity of views and definitions, the review of the literature in my 
study suggests that, broadly, integration is viewed positively in relation to health systems. 
Common themes found in definitions are suggestions that integration reduces fragmentation or 
duplication of services, improves patient care outcomes and results in greater satisfaction with 
services, offers benefits to overall population health, and improves the performance of health 
systems, their programmes and services (Table 4.1). There is a diversity of analytical 
approaches to integration in different health systems. It appears that integration in a health 
system is a multidimensional notion, which can encompass at least three key questions: why 
integration is desirable, what structures and/or functions at different levels of the health system 
are affected by integration (or lack thereof), and how integration influence interactions between 
health system components or stakeholders. 
The review presented in this chapter served as a background for defining a concept of 
integration and health systems for this study. The next chapter presents the conceptual 
framework for analysis that was applied in this study. 
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CHAPTER 5 SUSTAINABILITY OF A COMMUNICABLE 
DISEASE PROGRAMME: A CONCEPTUAL 
FRAMEWORK FOR ANALYSIS 
INTRODUCTION 
This chapter presents a conceptual framework for the analysis of the sustainability of a 
communicable disease programme. In the development of this framework I draw on: 
(i) A conceptual framework for analysis of a communicable disease programme and a 
health system (Atun and others, 2004, Coker, Atun, and McKee, 2004a). Building upon 
Pawson and Tiley (1997), the authors proposed a conceptual and analytical approach to 
the analysis of a communicable disease programme and health system. Pawson and 
Tiley (1997) proposed that social regularities (e. g. outcomes, patterns, associations) are 
brought about by the actions of underlying mechanisms (e. g. choices that social actors 
make, resource capacity available to them) acting in a social context. According to 
Atun and others (2004), underlying mechanisms that can explain why a disease control 
programme works, for whom and in what circumstances lie within inter-dependent 
. programmatic and 
health system arrangements 25 
(ii) Theoretical perspectives on sustainability of complex adaptive systems (Fiksel, 2003, 
Fiksel, 2006, Folke, 2006, Kemp, Parto, and Gibson, 2005) and a systematic review of 
conceptual approaches to and empirical studies on sustainability in health systems 
(Chapter 3). Based on these, I propose a conceptualisation of the sustainability of a 
disease control programme. The concept is presented in section 5.1. `Sustainability of a 
communicable disease programme' of this chapter. 
(iii) Conceptualisation of integration in a health system26, which is a part of this PhD. I 
draw on the review of integration in health systems presented in Chapter 4.1 extended 
the conceptualisation of integration in health system that has been proposed previously 
by Atun, Ohir, and Adeyi (2008) in their conceptual framework for analysis of the 
integration of targeted interventions into health systems. 
25 The explanatory mechanisms, according to Atun and others (20(4) and Coker, Atun and McKee (20(4a), might 
include, for example, adoption of innovative policy by stakeholders, budget sharing between programmes, providers' 
ayment mechanisms and inceptives structure or organization of service delivery. 
Shigayeva A., Atun R., McKee M., Coker R., Health systems, communicable diseases and integration, Health 
policy and Planning, 2010, supplement November. 
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I begin the chapter by providing a brief background27, a normative definition of sustainability of 
a communicable disease programme and a proposed conceptualisation of sustainability. I then 
present a conceptual framework for analysis that has been developed and applied for exploring 
the sustainability of TB and HIV/AIDS programmes in the case in Kyrgyzstan. 
5.1. SUSTAINABILITY OF A DISEASE CONTROL PROGRAMME 
Disease control programmes, which are established with the purpose of controlling a 
communicable disease, are components of health systems. In this research, health systems are 
viewed as complex adaptive systems (Checkland, 1981, Plsek and Greenhalgh, 2001). This 
view of health systems emphasises the social nature of organisations, that the goals, roles, 
interests, intentions and behaviours of actors (individuals or groups), and their interactions, 
within systems are of critical importance (Frenk, 1994, Blaauw, 2003). Health systems are 
embedded within a broader context comprising a set of critical interacting functions that include 
governance, financing, planning, service delivery and evaluation, and which are designed to 
achieve specified objectives (Atun and Menabde, 2008 -b) Fundamental goals of the health 
system are increased health, protection from financial risk, and responsiveness to users (Frenk, 
1994, Hsiao, 2003, WHO, 2000), while intermediate goals include equity, efficiency, choice and 
effectiveness (Atun and Menabde, 2008 -b). 
Control of communicable diseases of public health importance requires long-term efforts, unless 
transmission in humans has been interrupted or a pathogen has been eliminated globally 
(Dowdle, 1998, Fine, Oblapenko, and Sutter, 2004, Heymann, 2006, Moss, 2009, Noordeen and 
others, 1996). Disease epidemics evolve as a result of complex relations among pathogens, 
social, ecological and broader economical and political systems. Complex adaptive systems 
constantly change and adapt in response to internal and external factors (Atun and Menabde, 
2008 -b, Plsek and Greenhalgh, 2001). These factors might include, for example, changes in a 
population's health, introduction of innovations, changes in a domestic political, or in global or 
national economic, environment. Systems operate in environments where uncertainty, risks and 
surprises are unavoidable. Propositions from complex systems theories suggest that a system's 
resilience is a system property, which is essential for the system's sustainability (Holling, 2001, 
Mayer, 2008). Resilience of complex adaptive systems is interpreted as an ability of a system to 
withstand disruptions or pressures whilst maintaining essential functions and performance; and 
to continuously renew, innovate and improve (Fiksel, 2003, Fiksel, 2006, Folke, 2006). 
27 Detailed background is presented in Chapters 3 and 4. 
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Drawing on the abovementioned theoretical propositions (Fiksel, 2003, Fiksel, 2006, Folke, 
2006), 1 define a sustainable communicable disease programme as continuously effective in 
reducing a disease problem, and responsive and adaptive to changes in the nature of disease 
epidemics (actual or perceived), population needs, or contextual environment. In this definition, 
the what of sustainability (i. e. what should be sustained) is a continued reduction of a 
communicable disease problem, which includes interruption of infection transmission and 
reduction of morbidity and mortality associated with an infection or a disease. 
Sustainability is inherently a multidimensional phenomenon (Greenhalgh, Kyriakidou, and 
Peacock, 2004, Gruen and others, 2008, Shediac-Rizkallah and Bone, 1998). This notion is 
difficult to conceptualise and explore empirically, particularly because it concerns a future state. 
In conceptualizing the sustainability of a programme, I follow an approach by Alexandre and 
others (2007). The authors suggested an analysis of sustainability by proxy on the basis of 
observable capabilities or characteristics, which are presumed to be precursors of sustainability. 
Drawing on the review of existing conceptualisations of sustainability of a health programme 
(or a health organisation) and empirical studies (Chapter 3), 1 propose five interrelated 
characteristics of a programme: (i) leadership, (ii) capacity, (iii) adaptability (or flexibility), (iv) 
interactions, and (v) performance, that are viewed in this research as precursors of programme 
sustainability. I extend the framework by Atun and others (2004), proposing that these five 
precursors of sustainability are underlying mechanisms that can explain why a disease control 
programme is likely be sustainable or not. 
In the following sub-sections, I provide definitions of each characteristic as has been viewed in 
this research. These are also summarised in Box 5.1. 
5.1.1. Leadership 
Leadership refers to the capability of a programme's actors to lead, govern, and manage. In a 
sense, these capabilities are a unifying force that energizes all other aspects of the programme's 
sustainability. Leadership is viewed as social processes occurring among individuals, groups 
and organisations, which are concerned with motivating and influencing people towards goal 
settings and achieving these goals (Hartley and Benington, 2010, Hartley and Hinksman, 2003). 
Leadership concerns the willingness and ability of actors to commit to disease control efforts; 
have a clear and long-term vision for disease control efforts, gain political and financial 
support, build a programme's credibility, build trust and engage with various stakeholders, 
mobilise resources and implementation efforts, taking ownership of reforms and innovations. 
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5.1.2. Capacity 
Capacity is defined as managerial, technical, financial, physical (organisational structures), 
communication and human resources capabilities, which enable a programme to function over 
time (LaFond, Brown, and Macintyre, 2002). These include both structures (resources) and 
processes involved in generating, allocating, maintaining and evaluating the use of resources. 
Important for sustainability is maintenance of resources over time and ability to operative 
effectively with modest consumption of resources (i. e. efficiency). As with other authors, I 
view financial resources as critical for a programme's sustainability (Lafond, 1995a, Mancini, 
2004). Stable and long-term funding is important for addressing complex or chronic health 
conditions (Nilsen and others, 2005, Stevens and Peikes, 2006), but of critical importance for 
sustainability is efficient use of funds and regular assessment of present and future financial 
needs (Higgins, Naylor, and Day, 2008, Knippenberg and others, 1997, LaFond, 1995b, 
Mancini, 2004, Torpey and others, 2010). 
5.1.3. Flexibility (adaptability) 
This characteristic of sustainability is defined as the willingness and ability of actors to adapt or 
change disease control strategy (strategic objectives and priorities), policy (strategy, legislation, 
regulations), or a programme's structures or functions (e. g., approaches to funds mobilisation, 
resource allocation mechanisms, service provision, re-training of personnel, reporting and 
evaluation approaches) in response to external pressures, changes in nature of a disease or 
introduction of innovations. This aspect of sustainability also refers to openness to innovations, 
and capabilities to incorporate innovations into routine programme practices, moving 
innovations beyond a pilot stage and expanding their implementation in order to improve the 
programme's performance. 
5.1.4. Interactions 
Interactions refer to ability and willingness of actors to establish and maintain key connections 
and relationships, both inside and outside the programme. This characteristic relates to the 
notion of integration as conceptualised in this PhD research. Drawing on theoretical 
perspectives on the sustainability of complex adaptive systems (Fiksel, 2003, Fiksel, 2006, 
Folke, 2006, Kemp, Parto, and Gibson, 2005), and assessment of conceptual and empirical 
literature on sustainability (Chapter 3) and integration (Chapter 4), I propose that integration, as 
a concept, is one of the characteristics (i. e. dimensions) of sustainability. In conceptualizing 
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integration in health systems, I extend a framework by Atun and others (2008) by drawing on 
literature on inter-organisational relations in social and health services (Kodner and Kyriacou, 
2000, Konrad, 1996, Leutz, 1999). 
In this research, integration (as a concept) is defined as the structures and functions (i. e. the 
what of integration) associated with establishing and sustaining a health system and its 
components in order to ensure effective, efficient and equitable use of resources (i. e. the why of 
integration). There is a range of functional (and structural) relationships across a continuum. In 
this study, these interactions (i. e. the how of integration) between programmes (or a programme 
and other health system component) range from no formal interactions, linkage, coordination 
and full integration. This characteristic relates to the presence of interactions with other actors 
and programmes in a system to avoid areas of vulnerability in resources, managerial or technical 
expertise, service delivery or information (Baum and others, 2006, Greco and Simao, 2007, 
Greenhalgh and others, 2005, Nelson and others, 2007, Scheirer, 2005). This notion relates to 
the evolvement of a programme as a coherent component of a health system, in which 
programmes contribute to achievement of the overall system's goals of effectiveness, efficiency, 
equity. 
5.1.5. Performance 
Performance refers to the capability of a programme to operate effectively, equitably and 
efficiently in order to increase the likelihood of reducing a disease problem. This aspect of 
sustainability relates to the what of sustainability (i. e outcomes), which is understood in this 
research as interruption of disease transmission and reduction of mortality and morbidity 
associated with infection/disease. Thus important for sustainability is the presence of 
monitoring and evaluation systems that can provide sound measurements of the programme's 
(or its intervention's) effectiveness, efficiency and equity. 
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5.2 A FRAMEWORK FOR ANALYSIS 
Empirical evidence suggests that the five characteristics of a programme outlined above are 
context-specific and emerge as a result of dynamic relations among several factors. Broadly, 
these factors are the nature of a communicable disease both actual and perceived, structural and 
functional arrangements of a communicable disease programme and a health system, individual 
and institutional roles of various stakeholders, and the political, economic and social contexts 
(Atun, Ohiri, and Adeyi, 2008, Atun and others, 2004, Atun and others, 2005b, Atun and others, 
2005e, Gruen and others, 2008, LaPelle, Zapka, and Ockene, 2006, Sibthorpe, Glasgow, and 
Wells, 2005). 
In this thesis I propose that several factors and inter-relationships among them enable or impede 
the existence and/or actions of the five programme characteristics (precursors for sustainability) 
on delivery of disease control interventions. The framework for the analysis of has the 
following key elements: 
"a communicable disease problem 
"a disease control programme 
" actors 
"a health system 
"a context. 
The framework comprises the following key relations and influences: 
9 interactions between health system components, 
" political economy (relations among actors and their influences on a programme), 
" input/output (influences of a programme on a disease problem). 
A schematic presentation of the framework as applied for the analysis of TB and HIV/AIDS 
programmes is presented in Figure 5.1. In the following narrative, I outline how sustainability 
characteristics relate analytically to the framework components (summarised in Box 5.1). 
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Box 5.1 Programme's characteristics for assessing sustainability 
Explanation/Indicators Elements of the analytical 
framework 
"A broad, clear, long term strategic vision for disease " Actors, political economy 
Leadership control efforts; "A disease control 
" Coherent disease control policy framework programme (governance 
(strategic objectives, legislation), lack of competing and organisational 
objectives and priorities; arrangements) 
" Ownership of innovations/reforms by domestic " Health system's 
actors; arrangements 
" Devolved and participatory decision making, " Context 
consensus building among various stakeholders 
involved in disease control efforts. 
Availability, planning, use and evaluation of "A disease control 
" Funding programme Capacity 
" Service infiustructure " 
Health system's 
" Human resources, drugs and medical technologic s arrangements 
" Informational system technologies and 
" Context 
infrastructure. 
In response to changing demands/needs, external 
pressures or introduction of innovations: " Actors, political economy 
Flexibility " Willingness and capabilities of actors to change "A disease control 
[adaptability] disease control strategy or priorities, or modify programme 
overall processes of resources planning and " Health system's 
allocation, organisation of service delivery, M&E arrangements 
system " Context 
" Openness to learning and orientation towards 
innovations 
Establishment and maintenance of relationships, both 
inside and outside the programme: " Interactions between 
Interactions " Interactions within the programme's institutions/ health system's 
organisations in order to maintain and efficiently use components 
the programme's resources and improve capabilities " Health system 
to perform arrangements 
" Interactions with actors and other health system " Context 
components to ensure effective efficient, and 
equitable use of resources 
Effectiveness: 
sufficient service (interventions) coverage; " Inputs - scope of TB 
Performance - accessible, available, timely and convenient to users epidemic, patients needs 
of services interventions; " Output - cost, quality, 
quality of care, efficacious and safe interventions; coverage, access 
Equity: " Disease surveillance, M&E 
- the same opportunities for access and quality of care evaluation system 
irrespective of social status, gender, or geographic 
location 
Efficiency- 
. Allocative efficiency - maximisation of health 
outcomes and least costly mix of interventions; 
Operational efficiency - maximum possible quantity 
of a specific output for a given level of expenditure 
(that is producing at lowest unit cost, or 
maximisation of health outcome at a given cost) 
5.2.1. A communicable disease problem 
A communicable disease problem refers to the nature of an infection or a disease caused by a 
pathogen, character of transmission, and scope and magnitude of an epidemic. A disease 
problem also relates to its changes such as the emergence of drug resistance or co-epidemics 
with other health conditions. In the framework, persons at risk of infection, infected or with 
disease28 are considered as inputs into a programme (Figure 5.1). The character of a disease 
problem informs necessary interventions, service coverage and resources, the need for 
introducing innovations (if/when available) or rapidity of response (in case of rapidly spreading 
new strain/disease). Whether and how a programme and the health system within which it is 
situated influences a disease problem, specifically whether they impact beneficially on 
improving coverage, access, quality, and reducing cost (outputs in Figure 5.1), and 
consequently reducing the disease problem (that is whether the programme is capable of 
performing effectively, equitably and efficiently), depend on many factors outlined below. 
5.2.2. A disease control programme 
Following Murray and Frenk in their definition of a health system (Murray and Frenk, 2000), I 
define a disease control programme as comprised of all organisations and individuals, whose 
purpose and activities are principally directed towards the prevention and control of a disease 
problem. For the purposes of this research, I conceive of a programme having four formal 
components outlined below. Each component has structural and functional elements (Table 
5.1). This view of a health programme echoes the conceptualisation provided by Atun and 
others (2004). Programme's components assessed in this research are: 
(i) Governance, that is overall oversight of a programme including disease control policy 
development, strategic and operational planning (decision making regarding the 
programme's resources, and implementation processes; needs assessment and priority 
settings), accountability, regulation, and performance management. In this research, I view 
this programme component as important for shaping the leadership of a communicable 
disease programme. 
(ii) Financing, that is the sources, collection, pooling, and allocation of funds (i. e. provider 
payment mechanisms) for the programme's activities and services. 
28 Depending on clinical manifestations of infection progression and their public health importance. 
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(iii) Service delivery relates to the structures and functions of a programme, which directly 
influence persons at risk/with disease. This function includes organisation and provision of 
disease control interventions (e. g. preventative, curative, rehabilitation and support 
interventions); development of human resources necessary for service provision (training, 
skills development), and procurement and distribution of drugs and medical technologies 
(including preventative commodities such as condoms). 
(iv) Monitoring and evaluation. Collection, analysis and dissemination of information related to 
disease epidemiology and programme activities (i. e. disease surveillance system), including 
monitoring and evaluation of the programme's activities and use of resources. 
Assessment of a programme's structural and functional components allow understanding of the 
programme's capacity, including capabilities for maintaining capacity over time. 
5.2.3. Actors 
In this research, programmes are viewed as socially established and sustained. Key roles are 
played by stakeholders, referred to here as the programme's actors (Figure 5.1), who may be 
fenders, policy makers, managers, community leaders, groups voicing the needs of patients and 
users' of services, providers of services, professional associations, religious authorities, civil 
society organisations and other groups who are directly or indirectly affected by a health 
problem (Atun and others, 2010a, Gruen and others, 2008). 
How actors define a problem is of considerable importance - its urgency, scope, socio- 
economic impact, and the social narrative surrounding a problem, the needs and demands of 
those at risk from and with disease (Atun and others, 2010a, Atun and others, 2008, Atun and 
others, 2005d, Oliver, 2006, Tkatchenko-Schmidt and others, 2008). Problem definition also 
often influences choice, and balance, of preventative and curative interventions; decisions about 
the adoption and continuation of polices and interventions. How programme actors view a 
specific disease problem or view changes in the problem (e. g., emergence of drug resistance, or 
HIV/ADS co-epidemics with IDUs) may influence decisions regarding the establishment of 
interactions with other health system components (i. e. interactions). For example, previous 
research from the FSU showed that the social narrative surrounding TB disease and perceptions 
of risk contributed to inhibiting the integration of TB clinical care into broader health system 
components (Atun and others, 2005a, Atun and others, 2005c, Atun and others, 2005d, Mathew 
and others, 2009a, Vassall and others, 2009b). 
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A programme's actors may positively or negatively inform and influence a programme's very 
existence, its resources, functioning, and relationships with other health system actors (Gruen 
and others, 2008). Relations among actors are referred to here as political economy, which is 
defined as actors' individual or institutional interests, influences (power), and positions in 
regards to a particular policy or organisational issue (Brugha and Varvasovszky, 2000, 
Varvasovszky and Brugha, 2000). These policy or organisational issues include, but are not 
limited to, decisions about resource mobilisation, allocation and evaluation (i. e. capacity). 
These also include decisions about the introduction and maintenance of innovative 
interventions, changes in disease control policies, strategic priorities or programme functions in 
response to changes in disease epidemics, introduction of innovations or other external 
pressures (i. e. flexibility - willingness of actors to change processes). Actors' roles, positions or 
authority to lead others shape the programme's leadership. Leadership is often determined by 
the health system's governance and organisational arrangements, ownership of resources, 
organisational culture or history (Hartley and Benington, 2010, Porter and McLaughlin, 2006). 
Actors are at the centre of the question of whether integration of communicable diseases with 
other health system components will be initiated, effectively implemented and maintained. 
Potential impediments include, but are not limited to, differences in philosophies and 
approaches to care and treatment (Heller, McCoy, and Cunningham, 2004), a lack of national 
and local leadership to dedicate resources, time and attention to those providing integrated 
services (Chaulet, 1998, Feenstra and Visschedijk, 2002, Mayhew and others, 2000), reluctance 
from specialists to lose professional autonomy (Dimitrova and others, 2006), and tensions over 
control of resources (Hill and Tan Eang, 2007). 
A programme's actors also interact with other health problems and health programmes, thus 
they are constrained (or supported) by health system, social, cultural, political, and economic 
environments (Gruen and others, 2008). 
5.2.4. Health system 
A programme's arrangements and resource capacity (i. e. capacity) are dependent upon the 
organisational characteristics of the health system and the context that is the broader political, 
legislative, economic, social and technological environments (Atun and others, 2004). Whether 
a programme is capable of responding to a disease problem, and to changes in the problem, 
effectively, equitably, and efficiently to a considerable extent depends on the health system's 
arrangements. The health system to a large extent determines the programme's flexibility 
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characteristics - whether, for example, with the introduction of an innovation a programme is 
capable of changing its structural or functional arrangements to support implementation of the 
innovation on a wider scale, both effectively and efficiently. For example, the prevailing health 
system financing mechanism in Russia created incentives for prolonged and repeated 
hospitalisations of TB patients, impeding the establishment of efficient approaches to TB 
control (Floyd and others, 2006). The prevailing health system's and programme's 
arrangements may determine the available options and feasibility for integration of 
communicable disease programmes with the broader health system (i. e. interactions) (Atun and 
Olynik, 2008, Atun and others, 2005e, Dimitrova and others, 2006, Floyd and others, 2006, 
Hasker and others, 2009, Marx and others, 2007, Tkatchenko-Schmidt and others, 2010, 
Tkatchenko-Schmidt and others, 2008, Wang and others, 2007). 
5.2.5. Integration as interactions between health system's components 
This framework element is focused on assessment of programme interactions. Integration, as a 
concept, is defined as the structures and functions (i. e. the what of integration) associated with 
establishing and sustaining a health system and its components in order to ensure effective, 
efficient, and equitable use of resources (i. e. the why of integration). Health systems and 
programmes have four key components with each including structural and functional elements: 
governance, financing, service delivery and information systems. These are outlined in Table 
5.1. Thus, integration may involve structural or functional elements of any of these 
components. In line with (Kodner and Kyriacou, 2000, Konrad, 1996, Leutz, 1999), there is a 
range of functional (and structural) relationships acting along a continuum. For this study, I 
define this continuum or levels of interactions (i. e. the how of integration) between programmes 
(or indeed a programme and other components of a health system) as: no formal interactions, 
linkage, coordination, and full integration (Table 5.2). Across this continuum of interactions 
there is increased formality in governance, sharing of responsibilities for joint activities, and 
pooling of resources. 
When no formal interactions exist, a communicable disease programme is structurally 
organised and functions in parallel with other health system components. An example of such 
programmes would be communicable disease control programmes as described in Chapter 2, in 
the Soviet Union (Atun and others, 2008 , 
Coker and others, 2003). Governance structures are 
separate; policy development, strategic and operational planning, and performance management 
are implemented exclusively by TB-dedicated institutions. Funds are planned and channelled 
separately, either through ear-marked budgets or parallel donors financing. TB detection, care 
and support is delivered only by specialised TB service providers. 
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Table 5.1 Programme's structural and functional elements 
Programme's components 
Governance Structures 
Organisational structures 
Disease control policy, regulations and laws 
Functions 
Strategic and operational planning 
Accountability 
Regulation 
Performance management 
Financing Structures 
Funds (sources) 
Functions 
Pooling of funds 
Provider payment mechanisms 
Service delivery Structures 
Facilities (infrastructure) 
Laboratories 
Drugs, medical technologies, medical supplies 
Human resources (including managerial) 
Functions 
Training and development of human resources, 
Procurement and distribution of drugs and medical supplies 
Care pathways/provision of interventions 
Information system Structures 
Informational technologies and infrastructure 
Functions 
Data management - collection, analysis, dissemination 
Monitoring and evaluation of programme's activities and impact 
Table 5.2 Levels of integration - examined through a lens of `interaction' 
No formal Linkage - Coordination - Full integration - 
interactions between 
programmes unstructured interactions such Goal oriented interactions Bringing two programmes 
as referrals and sharing of such as common together [merging]; 
information but not strategies/policies to address 
necessarily in a goal-oriented related health issues, sharing Or 
manner. information in a planned 
Cooperating agreement may 
be signed, or guidelines on 
who does what and when. 
Programmes objectives, 
structures/functions maintain 
separation. 
manner, implementing 
certain activities together 
including dedicating 
resources [funds, staff] to 
work together on these 
activities. 
Usually coordinating 
committee [or responsible 
staff member] is established. 
Programmes objectives, 
structures/functions maintain 
Bringing together 
programme's structures 
[funds, human resources, 
informational system], or 
functions [strategic 
planning, resource 
allocation, delivery of 
certain interventions]. 
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Linkage is defined as unstructured interactions between two programmes, such as when 
interactions occur in an ad hoc manner, information is exchanged upon request, or patients' 
referrals occur. 
Coordination represents goal-oriented activities enhanced by working together on joint 
activities, whilst a programme's distinctive structures and functions are retained. Coordinating 
structures or regulatory mechanisms should exist and be supportive of organised interactions 
(Contandriopoulus and others, 2003). Shared responsibilities would be defined in the 
arrangements for governance, planning of resources, implementation of joint activities or 
coordinated collection and analysis of information. 
Full integration involves changes in both programme structures and/or functions, leading either 
to establishing common formalised governance structures or uniting governance 
responsibilities, pooling of funding, merging service delivery, or unifying information systems. 
Integration also refers to a merging of two programmes across all functional areas. 
Detailed definitions for mapping interactions between TB and HIV/AIDS programmes and 
programmes with general health services are presented in Table 5.3. 
5.2.6. Context 
The context denotes economic, political, regulatory, social-cultural (including historical legacy), 
epidemiological, regulatory and technological environments (i. e. systems), within which a 
health system operates and interacts with (Atun and Menabde, 2008 -b, Atun and others, 2004). 
Empirical research on sustainability in health systems consistently shows that these contextual 
factors are important determinants of the sustainability of health programmes, potentially 
creating both impediments and opportunities (Chapter 3). Communicable diseases in particular 
have been a subject of political attention or neglect that affects resources dedicated for disease 
programmes. For example, GHIs have created an environment of global political attention to 
three major communicable diseases - TB, HIV/AIDS and malaria, including 
increased and 
substantial funding. Such international attention and funding, in some contexts, might create 
opportunities for improving the chances of disease control programmes' sustainability, through 
the introduction of evidence-based innovations (e. g. DOTS, ART, opioid substitution therapy) 
or improving domestic resource capacity. 
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CHAPTER SUMMARY 
This PhD research proposed analysis of a potential for sustainability based on a programme's 
capabilities or characteristics, which are presumed as precursors of a programme's 
sustainability. These precursors of sustainability are leadership, capacity, flexibility, 
interactions and performance. Throughout the thesis, I also refer to precursors of sustainability 
as a programme's characteristics. In my conception of sustainability, the notion of integration 
(referred to as `interactions') is one of the precursors of a programme's sustainability. 
The framework for analysis consists of several components that provide a guide to understand 
the existence and actions of these five precursors of a programme's sustainability and influences 
upon them. The overarching schematic presentation of the framework is outlined in Figure 5.1 
(Chapter 5). In particular, Figure 5.1 defines factors, and interrelationships among them, that 
potentially influence the five precursors of sustainability. These are a disease problem, health 
system and programme arrangements, actors, and the broader context. The five precursors of 
sustainability are not presented schematically in Figure 5.1 (with the exception of the 
assessment of formal interactions between programmes). Instead, the general understanding on 
the way in which the factors outlined in Figure 5.1 may relate to these five programme 
characteristics is presented in Box 5.1. Definitions used to assess formal interactions between 
programmes are presented in Table 5.3. 
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CHAPTER 6 METHODS 
INTRODUCTION 
The previous chapter presented the conceptual framework for analysis of the sustainability of a 
communicable disease programme. This chapter begins by stating the research questions for the 
case study followed by an overview of the methodological approach applied in this study. I 
then elaborate on methods applied in the case study in Kyrgyzstan, outlining data sources, and 
data collection and analysis. The procedural results are also presented (i. e. number of 
respondents interviewed, and data collected and used in the analysis). I discuss the limitations 
of the methodological approach in the concluding Chapter 10, `Discussion and conclusions', 
where I also reflect on challenges in studying sustainability in general. 
6.1. RESEARCH QUESTIONS FOR A CASE STUDY 
At the inception of this PhD thesis, the research questions for the case study in Kyrgyzstan were 
whether the TB and HIV/AIDS control programmes are sustainable, and how integration of the 
programmes with the broader health system influences sustainability (Chapter 1). Following the 
conceptualization of the sustainability of a programme (Chapter 5), these research questions 
were further detailed to understand five programme characteristics (i. e. leadership, capacity, 
flexibility, interactions and performance), and influences upon them. As I outlined in Chapter 
2, several policy innovations that are financed and supported by GHIs have been introduced in 
the FSU region. In this research, I focus on how Kyrgyzstan's health system arrangements 
support these innovations. Innovations that were considered in this research are DOTS and 
MDRTB management for TB control, and harn reduction interventions and ART for 
HIV/AIDS control. In the case study particular attention has been paid to issues pertaining to 
interactions of programmes with other health system components. Exploration of questions 
was focused on programmes at the national level. The research questions are as follows: 
Research question 1: Is the TB control programme sustainable? 
i. What is the nature of the TB epidemic in Kyrgyzstan? How is the TB problem defined by 
the programme's actors? 
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ii. Who are the key actors of the TB programme and what is their role? What is the character 
of the TB programme leadership? How and whether is leadership affected by the 
programme's governance and organizational arrangements? 
This question focuses on understanding the TB programme's leadership. This question establishes 
what actors are involved in developing the TB control strategy, policy and legal framework, planning 
and mobilizing resources. The inquiry also identifies how formal arrangements for the TB 
programme's governance affect leadership. 
iii. How are resources for the TB programme planned, allocated and evaluated? 
This question assesses the programme's capacity. Particular attention is paid to the availability of 
financial resources, their sources and allocation, and to evaluation of spending on TB control. 
iv. How and why have the TB programme's governance, financing, and service delivery 
changed, or have they not, with the introduction of policy innovations - DOTS and MDRTB 
management? 
This question explores the flexibility characteristic. DOTS was an important policy innovation in the 
FSU context, aimed at not only bringing evidence-based practices for TB treatment but also 
establishing efficient approaches to TB control (Atun and others, 2005e, Floyd and others, 2006). 
The question aims to understand how health system's arrangements for TB services financing and 
service delivery have changed, or have not, in response to the introduction of TB policy innovations. 
v. What are the interactions between TB services in the penitentiary and civilian sectors? 
What are the interactions between TB services and general health services? 
vi. How is the TB programme performance monitored and evaluated? How does the TB 
programme perform in terms of TB case detection, access to TB and MDRTB treatment, 
and treatment outcomes? 
Research question 2: Is the HIV/AIDS programme sustainable? 
i. What is the nature of the HIV/AIDS epidemics in Kyrgyzstan? How is the HIV/AIDS 
problem defined by the programme's actors? 
ii. Who are the key actors of the HN/AIDS programme and what is their role? What is the 
character of the HIV/AIDS programme leadership? How and whether is leadership affected 
by the programme's governance and organizational arrangements? 
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iii. How are resources for HIV/AIDS programme planned, allocated and evaluated? 
iv. How has the delivery of treatment of narcotic drug dependency changed with the 
introduction of interventions for harm reduction among IDUs? How and whether has 
specialized HIV/AIDS services delivery changed, or has it not, with introduction of ART? 
This question explores the flexibility characteristic. Harm reduction among IDUs, particularly 
treatment of opioid replacement therapy is an important policy innovation. During the Soviet period, 
drug dependency was traditionally delivered by vertical narcology services; opioid drugs use was 
criminalized. This the question aims to understand the why and how of the health system's 
arrangements for delivery of opioid substitution therapy. 
v. What are the interactions between specialized HIV/AIDS and narcology services with 
general health system? 
vii. How is HIV/AIDS programme performance monitored and evaluated? How does the 
HIV/AIDS programme perform in terms delivery of harm reduction interventions and ART? 
Research guestion 3: What is nature of interactions between TB and HIV/AIDS control 
programmes at present? 
Research question 4: What are the likely implications of TB and HIV/AIDS programmes' 
integration with the broader health system for the sustainability of these programmes? 
The four research questions also explored health system and broader context. 
6.2 METHODOLOGY OVERVIEW 
In exploring the potential for sustainability of the TB and HIV/AIDS programmes in this study, 
the extension of realistic evaluation by Pawson and Tilley (1997) as proposed by Atun and 
others (2004), is adopted29. The seminal work by Pawson and Tilley (1997) is derived from the 
critical realism30 tradition in the philosophy of science, particularly works by Bhaskar, Hesse, 
29 As has been presented earlier, Atun and others (2004) and Coker and others (2004a) build on Pawson and Tilley's 
(1997) realistic evaluation in their conceptual, analytical and methodological approaches to a study of health 
programmes and health systems. 30 This school of thought 'has sought to position itself as a model of scientific explanation which avoids traditional 
epistemological poles of positivism and relativism' (Pawson and Tilley, 1997). 
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and Harre (Bhaskar, 1975, Harre, 1986, Hesse, 1974). In critical realism's ontology there is one 
reality to discover, which exists and acts independently of scientists and their activities 
(Bhaskar, 1975). According to Bhaskar, social reality is stratified into three overlapping 
domains: the empirical (experiences or events that can be observed), the actual (events 
irrespective of whether observable or not), and the real (the causal structures and/or mechanisms 
that generate events). The core claim of realist ontology is that causal mechanisms do not work 
deterministically unless an experimental and closed system has been set up (Bhaskar, 1975, 
Olsen, 2010). In the realist's view, the real world is open and dynamic, where multiple 
explanations and causation are possible. The real is imperfectly and probabilistically 
comprehensible (Guba and Lincoln, 1994). The intent of a research is in improvement of 
interpretations and fostering a more complete understanding of the external reality rather than 
seeking a definitive truth (Blaikie, 2007, Downward, Finch, and Ramsay, 2002, McEvoy and 
Richards, 2003, Sobh and Perry, 2006). 
A realist's scientific inquiry starts with building a model (or a framework) of structures and/or 
mechanisms that are to provide better representations for phenomenon being studied (Bhaskar, 
1975, Blaikie, 2007, Healy and Perry, 2000, Olsen, 2010). Realistic evaluation is based on 
explanatory strategies, in which understanding of the context and causative mechanisms is the 
key in explaining why a health programme works, for whom and in what circumstances (Coker, 
Atun, and McKee, 2004a, Pawson and Tilley, 1997). The framework for analysis for this study 
has been presented in Chapter 5. As has been outlined in Chapter 5, I extended the work of 
Atun and others (2004) by proposing underlying mechanisms (i. e. the five programme 
characteristics, or precursors of sustainability) that can explain why a programme is likely to be 
sustainable or not. 
Qualitative and quantitative methods were used to understand the existence and actions of these 
five programme characteristics, and influences upon them. For my study, I adapted a toolkit 
developed by Atun and others (2004) (Appendix 1, A1.3)31, which incorporates methods 
allowing a systemic approach to understanding a programme and a health system, and allows 
assessment of historical and contemporary events. The toolkit consists of modules, each 
exploring a particular health system component (e. g. governance, financing, organization of 
service delivery). The toolkit is designed in a way to encompass a variety of perspectives, using 
both documentary sources and interviews with key informants representing different specialities 
(e. g. governance and administration, financing, M&E) and/or different levels of health system 
31 This is a validated tool, which has been applied for studying communicable disease control programmes and health 
systems in the FSU settings (Atun and Olynilc, 2008, Atun and others, 2005, Coker and others, 2003) and other I regions (Conseil and others 2010, Desai and others 2010, Mounier Jack and others 2010), 
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(e. g. national, regional, local). I adapted this toolkit by modifying a section to explore formal 
interactions between the programmes and by developing topic guides for interviews (Appendix 
1, Al. 4) to explore questions relevant to the five characteristics of a respective programme (TB 
or HIV/AIDS programme). 
Table 6.1 presents methods used in the research questions of the case study, and the respective 
chapter or section in a chapter where findings are presented. 
Table 6.1 Research questions of the case study, methods, and corresponding chapters 
Research question Methods used Chapter 
Questions 1-4 Review of published literature and documents, Chapter 7 
(context and health review of routinely collected data on socio-economic 
system) indicators, demographic and public health 
Questions 1&2. Chapter 8 
Sustainability of (TB programme), 
TB and HIV/AIDS 
programmes Chapter 9 
(HIV programme) 
(i) Problem Analysis of routinely collected epidemiological data; Chapter 8, section 8.1 
definition (TB documents and key informant interviews, thematic Chapter 9, section 9.1. 
or HIV/AIDS) analysis 
(ii) Leadership Analysis of domestic and international policy and Chapter 8, section 8.2 
regulatory documents and evaluation reports; key Chapter 9, section 9.2. 
informant interviews, thematic analysis 
(iii) Capacity Analysis of health system's and programme's Chapter 8, section 8.3 
financing, infrastructure and human resources (based Chapter 9, section 9.3. 
on documentary sources), key informant interviews, 
thematic analysis 
(iv) Flexibility Analysis of domestic and international policy Chapter 8, section 8.4 
documents and evaluation reports; key informant Chapter 9, section 9.4. 
interviews, thematic analysis 
(v) Interactions Analysis of domestic and international policy Chapter 8, section 8.5 
documents, regulatory documents and evaluation Chapter 9, section 9.5. 
reports; key informant interviews, thematic analysis 
(vi) Performance Analysis of health services provision and utilization Chapter 8, section 8.6 
data, analysis of domestic and international Chapter 9, section 9.6. 
evaluation reports, key informant interviews, 
thematic analysis 
Question 3 Analysis of domestic and international policy Chapter 8, section 8.5. 
documents, regulatory documents and evaluation 
reports; ke informant interviews, thematic analysis 
Question 4 Literature review, key informant interviews, thematic Chapter 10, section 
analysis 10.2 
loo 
In my research, quantitative methods included an analysis of secondary data - routinely 
collected data by national or international agencies. These included TB and HIV/AIDS 
epidemiological data, health system's financing, health services provision and utilization data, 
and socio-economic indicators. 
Qualitative methods comprised: 
" In-depth interviews with key informants, both using an interview's topic guide and 
unstructured discussions. All respondents were interviewed using interview topic guides 
(Appendix 1, Al. 4)32. Additionally, questions from the toolkit modules (Appendix, A1.3) 
that were relevant to a respondent speciality (e. g. financing, M&E) were included into an 
interview. 
9 Documentary analysis, with documents from the following three sources: 
- national (domestic) policy documents, which are defined in this research as strategic 
plans, legislation and regulatory documents, official country's reports to international 
agencies (e. g. UNAIDS country reports), 
- policy documents, and monitoring and evaluation reports of international agencies, 
- previously published and non-published studies and evaluations conducted in 
Kyrgyzstan in the areas of health system reform, TB and HIV/AIDS control; 
" Field observations, to support the above, during the 6 months presence in Kyrgyzstan, 
which included field notes and mass media outputs. 
A `framework approach', as outlined by Ritchie and Spencer (1994), was applied in the 
analyses. The analytical process was iterative. Data analysis was on-going and concurrent with 
the data collection process. A deductive inference approach guided the analysis within areas of 
interest identified in the toolkit (Appendix 1, A1.3) and interview guide with key informants 
(Appendix 1, A1.4). Collected data also were explored inductively using thematic content 
analysis (Green and Thorogood, 2009, Pope, Ziebland, and Mays, 2000, Ritchie and Spencer, 
1994) that generated emergent explanations. Additionally, I assessed emerging findings asking 
the question of `why things appear as they seem to be' (Olsen 2010) that is searching for a 
meaning within the context and within available empirical evidence (Atun and others, 2006). 
All steps of setting up a field work site, establishing cooperation with the study's counterparts, 
setting up appointments and conducting interviews, transcription of interviews, analysis and 
interpretation were performed by me. 
32 Two topic guides have been developed. The one was aimed for interviews with key informants representing the 
TB programme, and the other - with key informants of the HIV/AIDS programme. 
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6.3. DATA COLLECTION AND SOURCES 
6.3.1. Ethical considerations 
This study was approved by the Ethics Committee of the London School of Hygiene and 
Tropical Medicine (LSHTM), and the Committee of Bio-ethics at the Medical Academy of the 
Ministry of Health. In Kyrgyzstan, this is the only ethics committee for conducting research 
involving humans. Both committees approved an information sheet and a study participant 
consent form (Appendix 1, A1.2). During the consent for the study, the rationale of the study, 
and how information would be used were explained to potential respondents. All study 
participants were given options for an interview being `on record' or `off the record'. All 
participants signed the consent form. The consent form had an option of `off-record' interview 
Appendix 1, Al. 2). In `off the record' cases, a responded agreed to be interviewed but refused 
to be quoted or audio-recorded. Additionally, `off record' respondents requested that the 
information provided was not included in the thematic analysis. Interviewees agreed that their 
information would be used only to inform my understanding of research questions explored, and 
used to clarify data obtained from other sources. Those agreeing for the `on-record' interview 
were asked whether they would allow the interview to be audio-taped or only for notes to be 
taken (hand-recorded by me). Respondents also were asked whether they would allow their 
expressions to be quoted in the thesis or in any consequent publications. All respondents were 
given an option to remain anonymous. In accordance with requirements of both Ethics 
Committees, all personal identifiers of respondents have been kept strictly confidential. Names, 
contact information, and a job position are known only to me. Each respondent has been 
assigned a unique identifier. When quoting throughout the thesis, only the personal code 
assigned by me is given. When deemed necessary, general affiliations where given, and details 
of job affiliations and traceable job positions have been masked. Consent forms, all interview 
records, notes and audio tapes are accessible only to me. 
6.3.2. Field work 
Data generation included a desk study in London for 1 month and 6 months field work in 
Bishkek, Kyrgyzstan. Data collection also included a trip to Geneva, Switzerland, for 
interviews with key informants at the GFATM. At the initial stage, a desk study was 
undertaken with an aim to get a broad understanding of the historical, political, socio-economic, 
cultural and epidemiological contexts in Kyrgyzstan. The desk study included a review of 
published literature and grey literature on health system reforms, TB and HIV/AIDS control. 
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This stage allowed me to identify what data are available and what gaps exist, and to adapt an 
interview guide for key informants (Appendix 1, A1.3). 
The field work lasted from June 10,2009 to December 9,2009. During this period I lived and 
worked in Kyrgyzstan. Administratively, the field work was set up as collaboration between the 
research group of my supervisor, Professor Richard Coker, and the Health Policy Analysis 
Project (HPAP)33 at the Centre for Health Systems Development (CHSD), Bishkek city. This 
allowed filing an application to the Kyrgyzstan's ethics committee as the country does not have 
procedures for applications from a foreign research student. 
The host agency agreed to provide support for a Kyrgyzstan visa, filing an ethics application to 
the Committee of Bioethics of the Ministry of Health prior to my arrival to the country, and 
administrative support. Administrative support included providing advice on identifying key 
informants, contact information of Kyrgyzstani agencies and gaining access to national 
documents. A senior policy analyst at HPAP served as my counterpart, introducing me to some 
key stakeholders working in national and international agencies. 
Upon arrival in Kyrgyzstan, I took the formal steps that were necessary to conduct the study 
activities. These included introducing the study and seeking support from the Ministry of 
Health. A meeting with the deputy of the Minister of Health at the time resulted in overall 
support with advice to proceed further through respective head agencies responsible for TB and 
HIV/AIDS. These are the National Centre of Phthisiatry and the Republican AIDS centre. I 
conducted introductory meetings with head officials (or a deputy) of these agencies. At the 
introductory meeting, the Director of the National Centre of Phthisiatry gave his support and 
permitted the study activities. Upon initial contact, the director of the AIDS centre informed me 
that he did not approve the study activities. I managed to sort this issue in the next two months, 
which included several meetings with the deputy director and a research team at the AIDS 
centre. The two agencies appointed key points of contact for me; both were deputy directors at 
the respective institutions. 
It was explained to all potential respondents upon introduction that the study is a part of my 
PhD research, which is funded fully by the LSHTM. All information about my background 
and my research interests were explained to respondents. A reflection on how my background 
33 HPAP has been funded by the WHO/Euro and DFID. Whilst on field work, HPAP has disintegrated from the 
Centre for Health System Development formally becoming an NGO. 
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and values may have affected data collection, analysis and interpretation is presented in the 
section 6.5.2. 
6.3.3. Interviews 
Key informants were selected purposefully to encompass actors involved in each disease 
control programme on a national level. Key informants were selected based on their 
experience, knowledge and expertise in areas of TB or HIV/AIDS control. All attempts were 
made to have a sample of key informants representing different specialities. Though the focus 
of the research inquiry has been on the national level, respondents working at various levels of 
health system (e. g. national, oblast, rayon) have been included (Atun and others, 2004). A 
stakeholder analysis (Bryson, 2004, Varvasovszky and Brugha, 2000) was employed in order to 
identify actors involved in each programme, their role and influences. A preliminary list of 
actors was developed during a desk study and review of documents, consultations with my 
counterpart at the host agency and key contacts at the National Centre of Phthisiatry and the 
National AIDS centre. At this stage, I started to build a contact list of potential respondents. As 
the interview process proceeded, respondents suggested additional potential respondents. 
Actors' role and influences were further explored during the interviews. 
An initial contact with prospective respondents was sought through telephone, fax or an email. 
Potential respondents agreed to be interviewed after an initial contact, refused right away or 
required several attempts to secure an interview appointment. I had an introductory meeting 
with a number of respondents in order to recruit them into the study. Several potential 
respondents were unavailable despite numerous attempts. In two instances, representatives of 
the state's agencies working at the rayon level requested a formal approval from their respective 
state's administration (not ethical approval nor the MOH), which I could not obtain. In every 
instance, an alternative respondent was sought. One group not represented in this research is 
members of Parliament overseeing social and health sector. 
All interviews were face-to-face using a topic guide (Appendix 1, A1.4). All respondents were 
asked questions outlined in the respective topic guide, and were encouraged to discuss questions 
in length. Interviews were guided by probes (Appendix 1, Al. 4). Additionally questions 
relevant to their speciality (e. g. financing, or drugs management system) were asked using 
respective sections of the toolkit (Appendix 1, A1.3). Most interviews lasted on average for 1 
hour (ranged from 30 min to 2 hours). Interviews were conducted by me either in English or in 
Russian. All interviews, except for two, were conducted at the respondent's work place. These 
two interviews were conducted at the HPAP office. 
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6.3.4. Documents 
The documentary analysis served several purposes. First, documents facilitated understanding 
of how the health system's responses to TB and HN/AIDS epidemics had been evolving since 
Kyrgyzstan's independence. Documents facilitated understanding of formal positions, the role 
and aim of actors of the TB and HIV/AIDS programmes. Published quantitative data such as 
financial reports, epidemiological data, health services structural capacity (e. g. number of 
facilities, beds, medical personnel), and health care utilization data were considered 
documentary sources in this research. Documents analysis was one of the sources of 
information for verifying data provided during the interviews. Vice versa, information obtained 
from documents was verified during interviews with key informants. 
6.3.5. Field notes and observations 
I kept a diary of my field work, recording events such as making interview appointments, 
overall impressions during the interviews, observations of organizational settings (e. g. health 
care facilities), and information provided during informal discussions pre- or post-interview. 
These notes facilitated keeping a record of outstanding gaps in data, agreed follow-up meetings, 
obstacles encountered during the data collection. 
6.3.6. Procedural results 
41 key informants were interviewed individually by me. Seven of them were interviewed `off 
the record'. Table 6.2 summarizes the completed interviews with 41 informants. A list of 
organizations involved in the study and a time-line of interviews with individual respondents is 
included in Appendix 1, Al. 5. Of record interviews were not used in the thematic analysis. 
These off-record interviews informed the analysis by means of helping me to understand the 
issues explored in this PhD study, and to clarify information provided in some documentary 
sources. 
Only 34 on-record interviews were used in the thematic analysis. I conducted a follow up 
interview with 6 key informants 34 to clarify gaps and ask additional questions. Follow up 
meetings were unstructured discussions. Because `off-records' interviews were not 
systematically analysed, this thesis reports the results based on information provided during 
34 All 6 of them were 'on-record' interviews 
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interviewees with the 34 on-record interviewees. Out of 34 on-record interviews, 26 were 
audio-taped, and consents for quoting were given by 22 respondents. In cases where the 
interview was not audio-taped, I carefully transcribed notes taken during the interview 
immediately after the interview and recorded them in a Word document. All audio-taped 
interviews were transcribed verbatim by me. 
Table 6.2 Key informants interviewed in this study according to their programme 
affiliations 
TB 
programme 
HIV/AIDS 
programme 
All 
Domestic actors 15 16 25 
State 13 11 19 
NGOs 2 5 6 
National 9 7 12 
Oblast 3 7 10 
Rayon 3 2 3 
International actors 9 11 16 
All 24 27 41 
On record 21 24 34 
Off the record 3 4 7 
" 10 respondents were interviewed for both programmes 
I obtained regulatory documents such as strategic plans, laws and regulations governing health 
system functioning, including relevant documents related to the TB and HIV/AIDS programmes 
from my field work counterpart and key contacts at the National Centre of Phthisiatry and the 
National AIDS centre. From the same sources, I obtained official domestic reports on 
implementation of national plans or programmes. National health accounts of Kyrgyzstan's 
health system were obtained from my counterparts (HPAC, 2008, HPAC, 2009, HPAC, 2011). 
Epidemiological data and programme performance data were obtained from the Republican 
Medico-Informational Centre (this data are open access) and the National Centre of Phthisiatry 
and the National AIDS centre. 
I used open-access datasets routinely collected by international agencies. These included 
WHO/EURO health for all database (WHO/Euro, 2011), WHO Global TB reports (WHO, 
2010a), UNAIDS epidemiological updates, UNDP Human Development Indicators database 
(UNDP, 2010), World Bank World Development Indicators database (WB, 2010), and the 
OECD Official International Assistance database (OECD, 2010). 
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6.4. DATA ANALYSIS 
6.4.1. Data analysis using the realistic evaluation approach 
Data were analysed from a realist perspective, iteratively exploring whether postulated 
mechanisms (i. e. characteristics or precursors for sustainability) exist, how they act upon 
delivery of disease control interventions, and what factors influence these five characteristics. 
The aim of the analysis was not in finding direct causative relations, but in revealing multiple 
explanations and perceptions about the same reality (Olsen, 2010). In realism research, 
triangulation of different data sources, perspectives, or methods is applied to reveal a `family of 
answers' that cover several contingent contexts and different reflective participant, albeit 
imperfectly (Pawson and Tilley, 1997). 
During the analytical processes, I used findings from interviews and documents analysis looking 
for common and divergent opinions, comparing contrasting positions and contradictory 
information. I was interpreting opinions of respondents within the actor's organizational role 
and overall historical and health system context, aiming to determine how data are related, 
compiling ideas and key concepts and their relations, looking for relations between different 
accounts and events (Atun and others, 2006 ). I put emerging key findings within available 
research evidence on the role of health system's arrangements in shaping programme's 
characteristics (i. e. leadership, capacity, flexibility, connectivity and performance). I considered 
evidence such the historical role of institutions, influences of international actors on national 
policy-making and financial mechanisms for disease control, opportunities and challenges with 
integrating historically vertical programmes, and challenges with developing robust disease 
surveillance and M&E systems. 
6.4.2. Managing data 
As a guide to organising, managing and interpreting data, I used a framework approach (Ritchie 
and Spencer, 1994), which was defined by authors as `a content analysis method which involves 
summarizing and classifying data within a thematic framework'. Five interrelated steps of 
analysis were followed: familiarization, identifying a thematic framework, indexing, charting 
and interpretation. I also used guiding principles of thematic content analysis as outlined by 
(Green and Thorogood, 2009). 
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Familiarisation with qualitative data included review of collected documents and listening to 
interview recordings several times, making notes on emerging themes, remaining gaps or 
contradictions arising from different sources. I did not manage to transcribe all interviews 
concurrently during the data collection, however some were transcribed. All remaining 
transcriptions were made by me later upon return to London in January -February 2010. I 
returned to the original audio tapes during interpretation and further analysis to grasp any 
missed points on how respondents expressed their opinion. 
During the familiarisation step, a thematic framework for indexing the data was developed. I 
used NVivo 8 to organize the large amount of textual data (documents and interview transcripts, 
separate folders for each data source). Three separate folders were created in NVivo - `health 
system', `TB programme' and `HIV/AIDS programme' (the `health system' folder included 
components relevant to the general health system, and other health programmes as emerged 
during the data analysis process). On a broad level, all textual data were organised in NVivo 
into two overlapping categories (I refer to them here as `themes categories'). These themes 
categories were: (1) health system or programme components - governance, financing, service 
delivery, and monitoring and evaluation; and (2) sustainability characteristics - leadership, 
capacity, flexibility, connectivity and performance. Each `programme' folder also included a 
subfolder related to a `health problem'. Programme sustainability characteristics and 
programme components overlap, however given the large volume of textual data, organising the 
data in these two themes categories facilitated familiarisation with data. In a sense, such 
organisation of data allowed me to capture an overall picture of the collected data. 
The thematic framework was further developed within `sustainability characteristics' theme 
categories: (i) based on priori themes, which correspond to the questions within an analytical 
framework, and (ii) emergent themes arising from interviewees' responses and related to 
respondents perceptions, explanations or accounts. Table 6.3 presents a summary of the indexes 
and themes applied to the qualitative data. Interviewees were indexed systematically applying 
the codes. Documents were indexed using priori themes codes. 
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Table 6.3 Key themes explored in the data 
TB programme 
Themes Category Priori Themes Emergent themes 
1. TB Problem 1.1. Perception of TB epidemic 1.3. Stigma 
1.2. Perception of HIV/AIDS problem 1.4. MDRTB problem 
1.5. TB in marginalized groups 
2. Leadership 2.1. Formal governance arrangements 2.6. Perception of donors' role in 
2.2. TB control policy, legal framework TB control 
2.3. Decision making 2.7. Accounts of donors and 
2.4. Strategic vision and priorities national actors interactions 
2.5. Role and responsibilities of actors 2.10. Perception of programme's 
leadership 
3. Capacity 3.1. Funds, financial mechanisms 3.5. Perception long term availability 
3.2. Physical infrastructure, of funds 
organizational arrangements 3.7. Role of donors in funding TB 
3.2. Human resources control 
3.3. Drugs 3.6. Perception long term human 
resources needs 
4. Flexibility 4.1. DOTS introduction - policy 4.5. Willingness to change approach 
change to TB treatment delivery 
4.2. DOTS implementation, case 4.6. Capability to treat patients at 
detection primary care level 
4.3. DOTS implementation, TB 4.7. Perception of inpatient TB 
treatment treatment 
4.4. MDRTB management 
implementation 
5. Interactions 5.1. Coordination prisons and civilian 5.4. Willingness to interact with 
5.2. Interactions with HIV/AIDS HIV/AIDS services 
services 5.5. Perception of interactions with 
5.3. Interactions with primary care HIV/AIDS programme 
5.6. Perception of civilian and 
penitentiary sectors interactions 
5.7. Accounts interactions between 
TB services and primary care 
6. Performance 6.1. Monitoring and evaluation 6.2. Perception of effectiveness of 
mechanisms M&E system 
6.3. Perception of TB programme's 
achievements 
6.4. Perception of TB programme's 
barriers 
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Table 6.3 (continued). 
HIV/AIDS Programme 
Themes Category Priori Themes Emergent themes 
7. HIV/AIDS 7.1. Perception of HN/AIDS epidemic 17.2. Perception of IDU problem 
Problem 7.3. Stigma 
8. Leadership 8.1. Formal governance arrangements 
8.2. HIV/AIDS control policy 
8.3. Drug use reduction and drug 
control policy 
8.4. Decision making 
8.5. Strategic vision and priorities 
8.6. Role and responsibilities of actors 
9. Capacity 9.1. Funds, financial mechanism, 
9.2. Physical infrastructure, 
organizational arrangements 
9.3. Human resources 
9.4. Drugs 
10. Interactions 
11. 
10.1. Coordination prisons and civilian 
10.2. Interactions with TB services 
10.3. Interactions with primary care 
11.1. ART introduction - policy 
change 
11.2. ART- organization of service 
delivery 
11.3. Harm reduction - policy change 
11.4. Harm reduction - organization of 
delivery 
12. Performance I 12.1. Monitoring and evaluation 
mechanisms 
8.7. Perceptions of country 
multisectorial coordinating 
committee 
8.8. Perceptions of leadership role of 
NGOs 
8.9. Role of donors in HIV/AIDS 
policy formulation 
9.5. Role of donors's financing of 
HIV/AIDS response 
9.6. Perception long term availability 
of funds 
9.7. Resources mobilization 
9.8. Role of NGOs in delivery 
HIV/AIDS interventions 
9.9. Perceptions of long term 
sustainability of NGOs 
10.4 Willingness and capabilities to 
interact - NGO and state's 
organizations 
10.5. Accounts of interactions 
between HIV services and 
primary care. 
11.5. Willingness and capability to 
implement opioid substitution 
therapy 
11.6. Perception of service provision 
to IDUs 
11.7. Opinion, ART delivery at 
primary care 
12.2. Perception of M&E system 
12.3. Achievements and barriers 
I used NVivo for coding data using priori themes only (for both interviews and documents). 
Chunks of coded data within priori themes were extracted from NVivo and transferred to 
Microsoft Word to be re-arranged according to themes. For each programme (TB and 
HIV/AIDS) separately, interview data were further coded applying priori themes. To allow 
within-case and between-case (i. e. a respondent) comparison and analysis, interview data were 
organised in charts in a table format, in which columns represented themes and rows 
corresponded to each respondent. Similarly, for each programme, data from documents (e. g. 
evaluation reports, studies) were organised in charts with rows representing sources. 
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6.4.3. Presentation of findings 
I organize the presentation of the findings in four chapters. Chapter 7 presents an analysis of 
the broader political, socio-economic, regulatory context and health system based on the review 
of the literature and documentary sources. In Chapters 8 and 9, I present results of an analysis 
of TB and HIV/AIDS programmes respectively, focusing on the five programme characteristics, 
which as I proposed (Chapter 5) are precursors of the sustainability of these programmes. In 
presenting the findings, I aim to explain why and how health system changes have occurred, or 
have not, in Kyrgyzstan's context in response to evolving TB and HIV/AIDS epidemics and 
new challenges such as MDRTB. Throughout Chapters 8 and 9,1 elaborate on likely 
implications for sustainability of TB and HIV/AIDS control programmes. In the concluding 
Chapter 10, I bring together the results of the analysis presented in Chapters 8 and 9. I analyse 
and discus the differences and similarities between the two programmes in their potential for 
sustainability. Chapter 10 discusses the key findings of the study in the context of empirical 
studies in the FSU and broader knowledge on sustainability of health programmes. I also 
reiterate my conceptual developments and propose an empirically tested framework for analysis 
of sustainability. This concluding chapter also reflects on the conceptual and methodological 
limitations of the study. 
6.5. QUALITY 
There is an overall understanding that the quality of research can only be judged in terms 
specific to the paradigm under which a researcher is working (Bryman and Teevan, 2005, Healy 
and Perry, 2000, Mays and Pope, 2000, Porter, 2007). Nevertheless, commonly used criteria to 
judge the quality of qualitative research are broadly related to fundamental principles of ethics, 
relevance and importance of research, appropriateness and rigour of methods that include 
attention to validity (or credibility) and reliability (or verification)" as well as role of a 
researcher (Cohen and Crabtree, 2008, Mays and Pope, 2000). Earlier in this chapter I outlined 
the ethical principles applied in this PhD research. Additionally, the importance and relevance 
of this PhD research have been presented in the introductory Chapter 2. In this section, I focus 
on three aspects of judging research quality, namely criteria of validity, reliability and my role 
as a researcher. 
3S Criteria used to judge about validity and reliability in particular are defined and termed differently, with different 
meanings as compared to quantitative studies (Bryman and Teevan, 2005, Guba and Lincoln, 1994). For example, 
Guba and Lincoln, 1994 proposed criteria of truthfulness and authenticity. Truthfulness is made up of four elements 
- credibility and transferability (corresponding to validity), and dependability (corresponding to reliability), and 
confirmability (i. e. objectivity) (Bryman and Teevan, 2007). 
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6.5.1. Validity and reliability 
In the realism paradigm, a researcher aims to explain the one reality, which is in turn 
independent of a researcher and only imperfectly apprehensible (Guba and Lincoln, 1994, Healy 
and Perry, 2000, Pawson and Tilley, 1997). The commonly suggested criteria for assessing 
validity and reliability in the realism paradigm include the following: 
" One of the criteria of the internal validity. of a realist's inquiry include what Healy and Perry 
(2000) refer to as `contingent validity', which is the development of a priori theory about 
broad generative mechanisms and the contexts. 
" Internal validity is also judged based on how the research encompasses its reality's several 
contingent contexts and multiple perspectives about the single, complex and dynamic reality 
(Riege, 2003, Sobh and Perry, 2006). Triangulation in realist's research provides a more 
comprehensive analysis of different data sources, methods and participants' perspectives. 
" External validity, or analytic generalization (Healy and Perry, 2000), refers to theory 
building during the course of an empirical study and explores how findings relate to existing 
theories and empirical evidence. 
" Criteria of reliability in realist research are similar to Guba and Lincoln's (1994) criteria of 
dependability or consistency (Healy and Perry, 2000), which refer to the extent to which the 
research can be audited. 
Table 6.4 details the steps undertaken to ensure validity and reliability in this research. In 
summary, to improve internal validity, this study applied a validated tool that relies on multiple 
data sources and methods of data collection (documents, interviews, and routine datasets) (Atun 
and others, 2006). Respondents recruited for this study were of various backgrounds to ensure 
the capture of multiple perspectives (Atun and others, 2004). Data collected from these various 
sources was compared and corroborated. Over the course of data collection and initial analysis, 
I was comparing and cross-checking the data that was obtained from different sources (e. g. 
official national reports and previous evaluation reports implemented by international actor), 
information provided by different respondents, and results emerging from quantitative and 
qualitative analysis. Attention was also paid to contrasting and contradictory information, and 
opposing opinions in interviews (i. e. negative cases). 
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Table 6.4 Criteria of validity and reliability applied in this research 
Phase of the Steps undertaken 
research 
Validity criteria (reference) 
A priori theory about Design, data Entered the field with a priori 
generative mechanisms and collection and conceptualization of sustainability 
the context analysis Use of theoretical perspectives from complex 
(Healy and Perry, 2000) systems 
Literature review on sustainability and 
integration in health systems 
Keeping the journal dealing with the events, 
emerging facts and evidence 
Use multiple sources of evidence, including 
from other empirical studies 
Peer review 
Internal validity Data collection Explanation building through triangulation of 
(Healy and Perry, 2000, and analysis data sources, methods (i. e. quantitative and 
Riege, 2003) qualitative), sources of data and perceptions 
of interviewees 
Application of topic guide (Appendix 1. Al. 4) 
with open-ended questions to allow broad 
questions before probing 
Awareness of own values and their impact on 
data collection, keeping a detailed field notes 
to document how my own perspectives were 
evolving 
Peer and respondents review 
External validity or analytic Data analysis Evidence obtained in a case study is compared 
generalization and with extended literature (i. e. empirical studies 
(Healy and Perry, 2000, interpretation in the FSU, studies on sustainability and 
Riege, 2003) integration in health systems) 
Attention to, and interpretation of findings in 
the context 
Reliability criteria 
(reference) 
The extend by which research Data collection, Follow a study protocol Atun and others (2006) 
can be audited analysis and Use a systematic approach to data management, 
(Healy and Perry, 2000; interpretation coding, and analysis (the framework approach 
Riege, 2003, Lincoln and by Ritchie and Spencer, 1994) 
Guba, 1985) 
When there was divergent or contradictory information, I was seeking for explanations in order 
to understand the reasons why. I have discussed conceptual development and findings of the 
case study continuously with my supervisor and the advisory committee panel. I asked for 
feedbacks on the emerging facts and findings from several key informants during the follow up 
meetings. At the end of the field trip the preliminary findings were reviewed with two of the 
study's participants, my counterparts at the National Centre of Phthisiatry (NCPh) and the 
Republican AIDS centre. Such feedbacks were usefull to enrich or to adjust my interpretation 
of findings. To meet criteria of reliability, I followed systematically a methodological approach 
by Atun and others (2004). In addition, analysis of qualitative data using the framework 
approach by Ritchie and Spencer (1994) allows a researcher to demonstrate a systematic 
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approach and replication. I interpreted emerging findings in the context of available empirical 
evidence that allowed me to explain the relevance of the research findings to similar contextual 
settings and discuss how the findings add to existing body of knowledge (Chapter 10). 
6.5.2. Reflexivity: role of the researcher 
A realist is said to be value-aware, that is the realist accepts that there is one real world to 
discover through multiple perceptions of participants (Healy, and Perry, 2000). For these 
reasons, researcher's values and background, which affect a picture of external reality during 
the processes of collection, analysis and interpretation of data, are concerns in the realist's 
research (Cohen and Crabtree, 2008, Sobh and Perry, 2006). 
On reflection, there are two aspects of my background of which I was aware as potentially 
affecting the research processes. The first aspect relates to my prior educational and 
professional background. I came to study this PhD from a positivist background in infectious 
diseases epidemiology having received a MPH degree in the USA. Prior to the LSHTM, my 
experience in qualitative research was limited. The second aspect concerns my personal 
background. A native of Kazakhstan, I emigrated to Canada in 2001 (at the age of 30), where I 
worked for four years prior to starting PhD study at the LSHTM. It should be noted though, 
that I moved to Canada solely for professional reasons. I still consider myself belonging to 
Kazakhstan. In fact, this combination of professional background and personal values has 
driven me to further studies and shaped my interests in conducting research on communicable 
diseases control in central Asia. 
Thus, I came to the field work in Kyrgyzstan having a combination of both western and Soviet 
education and professional experiences. On one hand, as a researcher in Kyrgyzstan, I benefited 
from being a Russian-speaking native of Kazakhstan and understanding the Kyrgyz language36. 
I have a cumulative 7 years prior experience of working in the public health field on a national 
level in Kazakhstan, and in other the FSU countries as a consultant. This experience helped me 
to conduct the necessary formal steps and to establish working relations whilst in Kyrgyzstan. 
On the other hand, my origin is not of Kyrgyzstan. Kyrgyzstan, though one of historical 
Kazakh's neighbours, was a novel country and culture for me. These facts may have affected 
how respondents viewed me and consequently shared their information with me. Some 
respondents perhaps were hesitant to express their full accounts, as saw me as a representative 
36 Kazakh and Kyrgyz culture and languages are historically close. I am a native of Kazakhstan, ethnically Kazakh. 
114 
of a western society. The others, who viewed me as one who understand the FSU context, 
shared more insights. 
On reflection, the fact that I was not of Kyrgyz origin and a foreign PhD student may also have 
influenced the access to potential respondents. Indeed, this might be the reason why several 
interviewees have chosen to have an `off-record' interview. In my view, the process of 
establishing initial contacts, building working relations, and collecting the data has been 
challenging. Key informants in this study are senior level officials, either in international 
organizations, domestic state or non-governmental organizations. All have busy schedules, and 
getting an appointment often took several weeks, or even months in certain cases. There were 
instances when potential respondents were sceptical about my intensions and the purpose of my 
research. Nevertheless, my prior experience working with senior level officials in the region 
provided me with some of the advantages of an insider's status. During introductory meetings 
and discussions I attempted to find points of common experience or expertise, with an aim to 
gain trust and understanding of my research. With several respondents, including my 
counterparts at the NCPh and the National AIDS centre, I have met or conversed over the phone 
a number of times. On balance, I believe, working relations were established with key 
counterparts that were helpful in overall research process. 
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CHAPTER 7 KYRGYZSTAN: OVERVIEW OF HEALTH 
SYSTEM AND BROADER CONTEXT 
INTRODUCTION 
This chapter provides an overview of the health system, and the contextual environment within 
which the heath system functions. 
Kyrgyzstan was one of the poorest Soviet republics, relying on subsidies from Moscow. At the 
time of writing, the country remains classified as a low income country by the World Bank 
(WB). As of 2009, Gross National Income (GNI) per capita (Atlas methods, current US$) was 
US$ 870 (WB, 2010). The United Nations Development Programme (UNDP) Human 
Development Index (a composite measure of life expectancy, educational attainment and per 
capita GDP) ranks Kyrgyzstan 109t' among 169 countries worldwide (UNDP, 2010). This 
ranking is below all current FSU states, with the exception only of Tajikistan. As of 2007-2008, 
an estimated 40% of country's population lived in poverty (defined as consumption per capita) 
and approximately 9% were in extreme poverty (TheGovernmentKyrgyzstan, 2007b, 
TheGovernmentKyrgyzstan, 2009, WB, 2010). 
In the years following independence in 1991, Kyrgyzstan experienced substantial economic 
downfall and reversal in social indicators. By 1995, total public revenues as a share of gross 
domestic product (GDP) fell to 15% from an estimated 41% in the Soviet period of 1989 
(Cheasty, 1996, Kutzin and others, 2009, Promfret, 2002). As a result, the ability of the state to 
spend on health was reduced dramatically. By the beginning of the 2000s, public spending on 
health was reduced from an estimated 4.1% of GDP in 1991 to 1,9% in 2001 (Kutzin and 
Cashin, 2002). As per all countries in the FSU region, Kyrgyzstan embarked on a reform of the 
inherited, publicly funded Soviet health system (Rechel and McKee, 2009). The inherited 
health system had extensive physical infrastructure, and a high number of health care personnel. 
The system was financed in accordance with input-based norms (e. g., number of beds, 
personnel), with most of the health budget financing the large hospital infrastructure. 
The analysis presented in this chapter draws primarily from secondary sources. The chapter is 
structured to present key aspects of the following areas: 
"A brief historical background of the country; 
" Key political, socio-economic developments since the disintegration of the USSR; 
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" Major developments in the political environment; 
" The general demographic pattern and health status of the population; 
" Main features of the health system's components as known at the time of data collection. I 
provide an overview of the health system's governance, financing, service delivery, and 
informational systems, reflecting on changes that have been brought about by the health 
reform programme. 
7.1. HISTORICAL, POLITICAL AND SOCIO-ECONOMIC CONTEXT 
Kyrgyzstan is a relatively small37 mountainous country that borders Kazakhstan, Uzbekistan, 
Tajikistan and China (Figure 7.1). Its geopolitical location has determined not only its economic 
and social development throughout its history, but also the security and political interest of 
world's most powerful states such as Russia, the USA, and China. It is the only country in the 
world that hosts military bases of both the USA and Russia. Being at the crossroads of illicit 
drug trafficking from Afghanistan to Europe and Russia, Kyrgyzstan also hosts internationally 
connected criminal networks. The country has been referred to as a most liberal state in socio- 
economic and health system reforms in comparison with other central Asian FSU countries39 
(Kutzin, Jakab, and Cashin, 2010, Kutzin, Jakab, and Shishkin, 2009, Pomfret, 2007). On the 
other hand, the Transparency International ranks Kyrgyzstan 164th out of 178 countries in the 
corruption perception index (Transparencylnternational, 2010). In the following sub-sections, I 
review key aspects of socio-economic and political developments, highlighting key known 
factors that have been influencing these processes following the disintegration of the USSR. 
7.1.1. Historical background 
Kyrgyz nomads have more than 2000 years' history. Kyrgyz Qahanat, a type of nomads' 
statehood, existed at the time of Genghis Khan's rule in the 12th century (Tchoroev, 2002). 
Kyrgyzstan was previously the Kyrgyz Soviet Socialistic Republic. The republic was formed in 
1925 initially as an autonomous oblast, and was given `republic' status in 1936. 
The Soviet government defined the borders of the Soviet republics in central Asia based on a 
pragmatic approach, which tended to include ethnic and linguistic principles. Along with native 
Kyrgyz' lands in the Tian-Shan Mountains, the republic acquired historically native settlements 
of the Uzbeks around Fergana Valley (one of the most fertile valleys in central Asia) and 
Tadjiks, Kazakhs, Uyghur across the respective borders. At its foundation therefore Kyrgyzstan 
37 Size of overall territory - 198,500 km2. 38 Central Asian FSU countries are Kazakhstan, Kyrgyzstan, Uzbekistan, Tajikistan and Turlanenistan. 
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was a multinational republic. The ethnic structure has been changing during and after the Soviet 
period due to substantial immigration and emigration (Abazov, 1999a, Huskey, 1995, Schmidt 
and Sagynbekova, 2008). At all times, along with the titular nation, Uzbeks and Slavs 
(predominantly Russian) were the largest ethnic groups. As of 2008,65% were Kyrgyz, 14% 
were Uzbeks, 12.5% were Russian, and 8% were other ethnic minorities 
(TheGovemmentKyrgyzstan, 2009). 
Throughout Kyrgyzstan's history, its geography has been a determining factor in its economic 
and political developments. A mountainous country, only about 10% of its land is suitable for 
industrial, agricultural and urban development (Huskey, 2008). Most of the population live in 
rural areas. As of 2008,65.3% of its 5.250 million populations were rural. At present, the 
country is divided administratively into 7 oblasls, the capital Bishkck city and Osh city (Figure 
7.1). High mountains, which are impossible to cross most of the year, divide the country from 
north to south. The south comprises Osh, Jalalabad and Batken oblasts. The north includes the 
capital (Bishkek city), and Chui, Naryn, Talas, and Issyk-Kul oblasts. Industry developments 
have been concentrated largely in the north, primarily Chui oblast and Bishkek city. In the 
south agriculture is a major economic activity. 
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Figure 7.1 Administrative map of Kyrgyzstan 
During the Soviet period ethnic groups tended to divide along occupational lines, which was 
determined by their primary settlements and political factors (Huskey, 1995). Nomadic Kyrgyz 
lived mostly in the vast mountainous regions where sheep raising served a traditional livelihood. 
Uzbeks concentrated in agricultural lands in the fertile Fergana Valley in the south, and Slavs 
tended to dominate in the urban-based industrial sector in Bishkek and Osh, including in 
education and research (Huskey, 1995, Huskey, 2008). Post-Soviet transition deepened the 
socio-economic disparities among geographic regions, urban and rural populations, and these 
affected ethnic groups differently. Whilst agricultural settlements appeared more resilient, 
many Kyrgyz living in mountainous rural areas were forced to move to urban settlements in the 
search for jobs, largely to Bishkek and Osh cities. 
7.1.2. Macroeconomic context 
Kyrgyzstan does not possess substantial natural resources, with the exception of its hydro- 
electricity resources, small amount of gold and rare minerals. Upon disintegration of the USSR, 
left without any support from Moscow, Kyrgyzstan's government turned to the assistance of 
international agencies for economic and social systems reforms (Abazov, 1999b, Pr tric, 2005, 
Pomfret and Anderson, 2001, Promfret, 2002). The first President, Askar Akaev39, pronounced 
liberal and radical measures to move to a market-oriented economy. Kyrgyzstan was the first 
country in the FSU to sign an agreement with the International Monetary Fund (IMF) and 
cooperation with the World Bank (WB), in 1993, and to join the World Trade Organization 
(WTO), in 1998 (Pomfret and Anderson, 2001, TheGovernmentKyrgyzstan, 2007b). 
By the end of the 1990s, substantial external financial support from the IMF, WB and other 
individual states allowed Kyrgyzstan to achieve macroeconomic stabilisation, in terms of 
cutting inflation and slightly reducing the budget deficit (Abazov, I999b, Pomfret, 2007). 
However, international aid was provided about one-fifth in grants and four-fifths in loans, and 
eventually international assistance came at a high price in terms of external debt (Promfret, 
2007). In 2000 the external debt/GDP ratio exceeded 100% and Kyrgyzstan was forced to turn 
to the Paris Club for rescheduling in 2001. It was later rescheduled again on March 11,2005, 
following the IMF's approval of Kyrgyzstan's arrangement under the Poverty Reduction and 
Growth Facility (ParisClub, 2005). 
39 Askar Akaev, the 1" President of Kyrgyzstan, was in power in the period 1991-2005, and was removed by an 
infamous coup in March 2005. He lives in political exile in Moscow, Russia. 
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Since independence, the country has been continuously supported through the highest financial 
and technical assistance per capita in the central Asian region, averaging at 50-60 US$40 per 
person per year (OECD, 2010, Promfret, 2007). In the period from 2000 to 2008, Kyrgyzstan 
received a cumulative US$ 1.85 billion (OECD, 2010). Among multilateral external actors are 
the WB, European Union, and the Asian Development Bank. Among individual countries, key 
donors are the USA, followed by Germany, Japan, Switzerland, UK, Sweden, Norway (OECD, 
2010). Aside from international aid, direct international investments into the country's 
economy have been minimal. 
According to some authors, the overall performance of the economy is difficult to evaluate 
because of embedded corruption, growing shadow and criminal economy (Cummings and 
Norgaard, 2004, Pomfret, 2007). The country's economy is vulnerable to any external 
economic changes, particularly in Russia and Kazakhstan which are close trading partners and 
source of remittances. More than one-sixth of Kyrgyzstan's population, from 600 000 to 
1 million citizens, are seasonal or long-term labour migrants to Russian and Kazakhstan (Marat, 
2009, Schmidt and Sagynbekova, 2008). Labour migrants' remittances constitute a substantial 
part of Kyrgyzstan's economy. These were estimated, for example, as 27% of GDP in 2007 
(Marat, 2009). 
The country has a substantial and growing shadow economy, which in 2006 was estimated as 
equivalent to 53% of GDP (UNDP, 2006). Since the early 1990s, central Asian countries have 
become some of the key routes of illegal drugs trafficking from Afghanistan to Europe, Russia 
and China. Kyrgyzstan hosts influential central Asian criminal networks, whose key business 
involves illicit drug trafficking from Afghanistan to Europe and Russia (Kupatadze, 2008, Madi, 
2004, Marat, 2006 , Townsend, 2006). The underworld's criminal economy is substantial 
in 
regions where influence of central Government is weak (Kupatadze, 2008, Madi, 2004, Marat, 
2006 ). Krygyzstan has both a corrupt political environment (presented in the next section) and 
widespread poverty. 
7.1.3. Political context 
Kyrgyzstan is governed as a republic under the executive branch of the President and the Prime 
Minister. The elected parliament is the legislative branch of the government, and the Supreme 
Court is the judicial branch. The people of Kyrgyzstan have lived through two political crises; 
40 Source: Official Development Assistance, Organization for Economic Development and Cooperation (OECD). 
OECD databases, available at: http: //stats. oecd. org. 
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one in March 2005 and the other in April-June 2010. The country's only two ex-Presidents live 
in political exile. 
In the 1990s the country was referred to as an `island of democracy' in central Asia, largely 
because of the initial policy of the first President Akaev to open doors to international 
organisations, and to allow the proliferation of civil society organisations and NGOs, 
independent media and a vocal parliament (Anderson, 2000, Cummings, 2008). Despite 
relative (as compared to other central Asian republics) liberalism and declarations of 
democracy, Akaev's rule grew into an increasingly authoritative regime. Akaev's leadership 
manipulated the constitution, and promoted his family's economic and political interests 
(Cummings, 2008, Lewis, 2008). As elsewhere in central Asia, clans, tribal and regional 
affiliations based on ancestry historically play an important role in forming political, economic 
and social networks (Collins, 2004, Huskey, 1995). In the case of Kyrgyzstan, the north-south 
divide has always been profound, being a determining factor in political life throughout its 
history, even during the Soviet period (Cummings, 2008, Huskey, 1995, Madi, 2004, Marat, 
2008). During Akaev's regime, the country's political elite was engulfed in rivalries and 
tensions, in which the north-south divide played a key role. Corruption was wide-spread. In 
early March 2005, in response to manipulation of Parliamentary elections, violent clashes 
erupted initially in the southern oblasts, and eventually led to a popular uprising in Bishkek. 
These events, referred to as the `Tulip revolution', brought into power Kurmanbek Bakiev41, a 
southern politician, and once a Prime Minister of Akaev's government. 
Many hoped that the `Tulip revolution' would bring about democratic changes. However, under 
President Bakiev the country moved towards more centralisation of power and authoritarianism 
(Lewis, 2008). Corruption worsened, freedoms were limited, and political opposition was 
suppressed (Huskey, 2010). Bakiev applied the same approach as his predecessor, 
consolidating political and economic power in the hands of few, including his family 
(Kupatadze, 2008, Lewis, 2008, Marat, 2008). These few had control over parliament, law 
enforcement and national security, and key sectors of the country's economy, such as the hydro- 
energy sector, borders' and custom's control, and the banking system (Marat, 2008). 
On April 8,2010, the Bakiev regime was thrown out by a people's uprising, during which 
dozens of demonstrators were killed and hundreds injured. An interim government was formed 
and Parliament was dissolved. On June 11th, 2010, violent and ethnically motivated clashes 
between Kyrgyz and Uzbeks erupted in southern Osh and Jalal-abad oblasts. Hundreds were 
41 Kurmanbek Bakiev, the 2d President of Kyrgyzstan, was in power in the period 2005-2010. He was removed by 
an uprising in April 2010. He lives in exile in Belorussia at the time of writing. 
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murdered and thousands injured. Infrastructure of Osh city and Uzbeks villages was destroyed. 
The country once again underwent rapid political changes with election of a new parliament in 
October 2010. 
7.1.4. Civil society 
A main feature of the democratisation model that is promoted by international actors in the FSU 
region has been state transparency and accountability through involvement of civil society 
organisations. The establishment and support of the non-governmental sector in the FSU region 
was high on the donors' agenda. There was sizeable financial aid to realise this aim (Buxton, 
2009). Proliferation of NGOs in central Asia, including in Kyrgyzstan, and their financial 
dependence on donors have been at the centre of debate since the late 1990s (Anderson, 2000, 
Buxton, 2009, Paasiaro, 2009, P6tric, 2005, Shishkaraeva and others, 2006 , Ubysheva and 
Pogojev, 2006). Some researchers argue that donor-supported NGOs are advocates of western 
interests and a neo-liberal agenda with limited space for independent decisions even though they 
are not accountable to the state (Pbtric, 2005). The majority of well-established NGOs in 
Kyrgyzstan tend to concentrate in the capital Bishkek, and to a lesser degree in Osh city. NGOs 
are often led by former academic, scientific or state elite. It has being suggested that these 
organisations have very weak links to and common interests with the majority of rural poor. 
Others view Kyrgyzstan's NGO sector as vibrant and competitive with its own power balances 
and interests, which evolves on its own independent rules. The civil society sector is recognised 
as important, particularly in the context of political instability and rivalries. The majority of 
Kyrgyzstan's NGOs cover social, legal issues, gender issues, civic education, health services, 
ecology and other areas (Ubysheva and Pogojev, 2006). Several leading NGOs have become 
important actors in the political arena, bravely challenging and openly questioning agendas of 
the state or of international actors such as the IMF and WB (Marat, 2008, Paasiaro, 2009). 
7.2. PATTERNS OF HEALTH 
Patterns of health in central Asian countries and their determinants remain an understudied 
subject (McKee and Chenet, 2002). Available data are based on national vital statistics, which 
are routinely reportable to the WHO. Studies that have analysed these vital statistics suggested 
underreporting, problems with surveillance coverage and completeness (Aleshina and 
Redmond, 2005, McKee and Chenet, 2002, McKee, Figueras, and Chenet, 1998). Recording 
and reporting is particularly poor in rural areas (Guillot, 2007), where most of the population 
resides. A key issue for interpreting official vital statistics data is internal migration and 
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international labour migration, combined with weak capacity to properly register movement of 
the population. 
The trend in life expectancy at birth in Kyrgyzstan appears broadly similar to those observed in 
other central Asian countries (McKee and Chenet, 2002, McKee, Figueras, and Chenet, 1998). 
Life expectancy at birth improved throughout the Soviet period, and then fell during the 1990s, 
before levelling in the 2000s. According to the WHO/Euro Health for All database 
(WHO/Euro, 2011), the average life expectancy at birth (both sexes) has been 68.5 years in 
recent years. This is similar to the FSU average of 68 years and considerably lower than the EU 
figure of 79.6 years. Males have a lower life expectancy, with a gap of 8-9 years. 
According to empirical evaluations (Aleshina and Redmond, 2005, Guillot, 2007), infant and 
maternal mortality are likely considerably underreported. For example, the official infant 
mortality rate for 2002 was reported as 21 infant deaths per 1000 live births, whilst a multiple 
demographic cluster survey conducted by UNICEF and Demographic Health Surveys has given 
an infant mortality rate of 61 infant deaths per 1000 life birth (95% Cl 47-76) (Aleshina and 
Redmond, 2005). Recent estimates suggest that under-five child mortality in central Asia, 
including Kyrgyzstan, might have been decreasing (Rajaratnam and others, 2010). In 2010, 
under-five mortality was estimated at 42.5 deaths per 1000 (95% Cl 36.0-52.4). This health 
indicator appears higher in comparison, for example, with Russia which suggests a point 
estimate of 14.5 deaths per 1000 in the same study (Rajaratnam and others, 2010). Kyrgyzstan 
also has higher maternal mortality rates than several other FSU countries (Hogan and others, 
2010). In 2008 the maternal mortality rate was 69 deaths per 100 000 live births (95% Cl 58- 
82) as compared to a rate of 44 (95% CI 38-51) for Kazakhstan or 20 (95% CI 16-26) for low- 
income Moldovs (Hogan and others, 2010). 
Similar to other central Asian countries, Kyrgyzstan is likely facing a double burden of 
communicable and chronic non-communicable diseases (McKee and Chenet, 2002). 
According to existing health data (RMIC, 2008, )WHO/Euro, 2011), major causes of deaths are 
cardiovascular diseases (>40%), cancers, external causes such as injuries and poison, chronic 
diseases of the respiratory system, chronic liver diseases and cirrhosis. Kyrgyzstan shows high 
rates of preventable and manageable chronic diseases such as hypertension, endemic anaemia 
and endemic endocrine disorders including diabetes and thyroid dysfunctions (RMIC, 2008). 
The TB burden was historically substantial (presented in details in Chapter 8). Viral hepatitis 
including B and C is also a substantial problem. For example, the incidence of hepatitis B is 
10.4 cases per 100 000 population as compared to the European Union average of 2.7 or the 
FSU's average of 4.4 cases per 100 000 population (WHO/Euro, 2011). 
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Alcoholism and intravenous drug use are important determinants of premature mortality in the 
FSU region, including in Kyrgyzstan, and are shown to be associated with violent behaviour, 
poisoning, accidental injuries and cardiovascular diseases (McKee, Shkolnikov, and Leon, 
2001, Pomerleau and others, 2005, Pomerleau and others, 2008, Redmond and Spooner, 2009, 
Shkolnikov, McKee, and Leon, 2001). 
7.3. HEALTH SYSTEM 
The Kyrgyzstan's health system reform was initiated in 1996, upon the approval of the Manas 
health care reform programme (Meimanaliev and others, 2005). Among priority objectives of 
the health system reform were changes in financing, restructuring and downsizing hospital 
infrastructure and health personnel, and reforming primary care through introduction of family 
medicine (Atun, 2005 , Purvis and others, 2005 ). Financing reform included diversification of 
domestic sources of finances, centralizing pooling of funds, and moving away from input-based 
line-item providers' payment (Jakab and others, 2005, Kutzin, Jakab, and Cashin, 2010). 
Kyrgyzstan reportedly managed to move forward with this reform programme, achieving the 
abovementioned objectives, in spite of constrained financial capabilities and political instability 
during the last decade (Atun, 2005 , Falkingham, Akkazieva, and Baschieri, 2010, Jakab and 
others, 2005, Meimanaliev and others, 2005, Purvis and others, 2005 ). I highlight the health 
system's changes that have occurred as a result of the reform in the following sub-sections. 
The current health system reform programme, Manas Taalimi 2006-2010, aims to build on 
these achievements, moving forward to establish an integrated health care system 
(TheGovernmentKyrgyzstan, 2006b). The reform programme envisions an ambitious reform of 
sanitary epidemiological services to establish public health services that would integrate health 
promotion and prevention, surveillance and control of communicable and non-communicable 
diseases, and regulatory function. 
Donors' involvement in Kyrgyzstan's health reform in terms of financial assistance and 
technical advice has been considerable (McKee, Figueras, and Chenet, 1998, Meimanaliev and 
others, 2005, MOH, 2008a). Among key actors in Kyrgyzstan's reform were the Wold Bank 
(WB), United State Agency for International Development (USAID), World Health 
Organization (WHO), UK Department for International Development (DFID), Kreditanstalt für 
Wiederaufbau (KfW), German Technical Cooperation (GTZ) and Swiss Agency for 
Development and Cooperation (SDA) (Horowitz and Atun, 2006, WB, 2008). Kyrgyzstan 
124 
reportedly represents an exemplary case of donors' continuity of efforts, cooperation and 
coordination with national health system stakeholders (Borowitz and Atun, 2006, Falkingham, 
Akkazieva, and Baschieri, 2010, Kutzin and others, 2009). 
I present in the following sections the main features of the health system's components as were 
known at the time of data collection 
7.3.1. Governance 
Health care and public health services remain predominantly publicly owned. The private 
health sector remains limited. The notable exception is the pharmaceutical sector, which is 
nearly fully privatised (Meimanaliev and others, 2005). The state, through the MOH, develops 
and approves health policies, including the state health care benefit programme 
(TheGovernmentResoultion, 2006, TheLaw, 2004, TheLaw, 2005b). The MOH also carries 
regulatory functions in regards to health prevention, treatment and rehabilitation, licensing and 
attestation of health providers, and quality and safety assurance. The MOH's guidelines and 
regulations are compulsory for all health organisations irrespective of ownership. Parallel 
health services under other Ministries have been retained. 
Oversight of the health system is top-down. Some functions of the MOH have been delegated 
to its sub-ordinate organisations such as the Department of Sanitary and Epidemiological 
Services, and the Department of Pharmaceutics and medical technologies. Quasi-governmental 
entities have been established such as the Medical Accreditation Commission, the Association 
of Family Group Practices and the Hospital Association (Meimanaliev and others, 2005). 
Oversight at regional levels is provided through regional coordinating commissions on health42. 
The regional commission is chaired by the head of the regional state office (Meimanaliev and 
others, 2005, TheLaw, 2005b). The regional health commissions include the heads of main 
health organisations in the region, and representatives from other sectors such as education, 
social protection, and reportedly representatives of NGOs. 
42 Regional level extensions of the MOH were abolished in 2000 due to governance restructuring. 
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7.3.2. Financing 
Sources and financial flows 
There have been two principal changes in Kyrgyzstan's health system in generating revenue 
from domestic sources, namely the introduction of health insurance and formalisation of private 
out-of-pocket payments (OOP). The Mandatory Health Insurance Fund (MHIF) was established 
in 1996. The MHIF is based on earmarked 2% payroll tax contributions and a 5% health 
insurance contribution from the 5% land tax collected from farmers, the pensions fund, 
unemployment insurance fund, and social welfare recipients (Meimanaliev and others, 2005, 
TheGovernmentKyrgyzstan, 2006b). OOP include official co-payments, and in-cash payment 
made by households at the point of delivery for purchasing of pharmaceutical products, fees for 
non-medical services and for medical services not included in the state benefit package (latter 
referred to as `special means'). 
Exemptions from formal co-payments and entitlements are regulated by the State Guaranteed 
Benefit Package (SGBP) (TheGovernmentKyrgyzstan, 2007a). Under the SGBP, emergency 
services and basic primary care services for enrolled patients are free of charge. Co-payments 
are flat-fees payable to hospitals on admission, for certain additional outpatient services (e. g. 
diagnostic tests), for specialist's outpatient services, and for additional drug benefit to 
contracted pharmacies. Level of copayments and exemptions43 are defined annually by the 
MOH. Providers keep revenues collected from co-payments, and were mandated to use 80% of 
co-payments for supplies, food, and the purchase of medicines. 
Thus, health system revenue is collected from four sources: general taxes, earmarked taxes from 
payroll and social benefits, private (users' of services) and international funds (Figure 7.2). 
Revenues from all public sources are pooled at the national level (Kutzin and others, 2009). As 
of 2007, formation of the health budget is based on a programme approach (MOH, 2007 ). 
43 Based on (i) socio-economic status - veterans of World War II, disabled in army services, persons with disabilities, 
orphans, nursing home residents, military force personal; (ii) age - children under 5 years, pensioner 75 years and 
older, or (iii) health condition - those with socially-important diseases such as tuberculosis, diabetes, cancer, or highly-pathogenic diseases. 
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There are five programmes for budget purposes: 
(i) The State Guaranteed Benefit Package; 
(ii) Additional drugs benefit; 
(iii) Public health and health promotion, which includes services provided by sanitary- 
epidemiological stations, HIV/AIDS services, blood services, health promotion centres; 
(iv) Medico-social services - these include services provided by all organisations under 
republican jurisdiction, and specialised services such as tuberculosis, oncology, mental 
health, rehabilitation, and administration and medical education; 
(v) High-technology services. 
The MHIF manages SGBP and additional drugs benefits allocated from the state on behalf of 
the entire population. The MHIF purchases services from contracted providers. At present 
these include primary care providers and general hospitals. Services are reimbursed by the 
MHIF based on capitation for primary care providers, and on patient-based payment (i. e. 
hospitalised case) for inpatient facilities. The MHIF has allowed the introduction of new 
institutional arrangements for pooling of funds and purchasing of services within the SGBP, 
thus reportedly consolidating the purchaser-provider split (Falkingham, Akkazieva, and 
Baschieri, 2010, Kutzin and others, 2009, Kutzin, Jakab, and Shishkin, 2009). A so-called 
single payer system has been established. Such arrangements also have allowed a common 
informational system and new provider' payment mechanisms (Borowitz and Atun, 2006). 
The MOH pools the funds for the other three programmes. Each specialised health service has 
its own budget line. Funding for health services under other Ministries is channelled separately. 
External funding is either executed through the sector-wide approach (SWAp) or channelled 
`off budget' directly to service providers. SWAp actors in Kyrgyzstan include the WB, DFID), 
KfW, SDA and the Swedish International Development Cooperation agency (SIDA). 
Health expenditure trends 
As I mentioned earlier, public spending on health had reached its lowest level by 2000-2001 
when it was estimated at 2.1 % of GDP. During the last decade, state spending on health has 
increased, but not considerably (Figure 7.3). In nominal terms, total spending from all sources 
increased from 2900 million Kyrgyz Som (KS) in 2000 to 12,500 million KS in 2009 (HPAC, 
2008, HPAC, 2009, HPAC, 2011). This constitutes an increase in health spending from all 
sources from 4.8% of GDP in 2000 to 6.8% of GDP in 2009 (Figure 7.3). 
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Figure 7.3. Health expenditure as % of GDP, Kyrgyz Republic, 1995-2009. 
Source: WB Development Indicators database, HPAC 2008, HPAC 2009, HPAC 2010. 
*spending from the external sources is not shown on the Figure 7.3. Spending from external sources ranged from 
0.5% to <1.0% GDP in different years (HPAC 2008, HPAC 2009, HPAC 2010) 
Health spending per capita (PPP) increased steadily from US$ 66 in 2001 to US$ 152 in 2009 
(based on 2005 constant US$ prices) (WB, 2010). This is below the average per capita health 
spending among low- and middleincome states in Eastern Europe and central Asia, which was 
US$ 303, in current US$ (WB, 2010). 
Tax revenues remain a main source of public funds for the state, with the MHIF playing a 
complementary and relatively minor role in financial terms (HPAC, 2008, HPAC, 2009, HPAC, 
2011). Most health expenditure comes from the state budget and users' of services (Table 7.1). 
Nearly half of total health expenditure comes from the users' of services (Table 7.1, Figure 7.3). 
Data on donors spending on health were not collected systematically until 2006 (HPAC, 2008). 
This has generally fluctuated year-to-year and has been estimated to be as high as 9.5-12% of 
total health expenditure (HPAC, 2008, HPAC, 2009, HPAC, 2011, Meimanaliev and others, 
2005). 
Most public funds are spent on curative services. In this category, the amount spent on 
outpatient care has been growing over the last years. As of 2009, hospitals accounted for 45.7% 
and outpatient services for 29% of total public expenditure on curative services (HPAC, 2011). 
Public spending on public health and preventative services is not considerable, remaining at a 
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level of 5-7% (HPAC, 2008, HPAC, 2009, HPAC, 2011). Most of OOP are payments for 
medications at outpatinet level (HPAC, 2008, HPAC, 2009, HPAC, 2011). The National Health 
Acconts (NHA) estimate that more than 70% of OOP are spend in this category. 
Table 7.1 Health expenditure by source of funds as share (%) of total health spending, 
Kyrgyz Republic, 2000-2009 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Budget 43.4 40 38.2 35.1 34.5 36.4 34.3 32.5 37.6 38.6 
MHIF 3.7 3.6 3.7 4.5 6.5 4.3 6.6 7.7 4.6 5.5 
Private 52.9 56.5 58.2 60.4 59 59.2 55.5 48.2 46.9 42.9 
External, SWAp 3.6 5.8 4.0 7.6 
External parallel 5 7 6 9 5.5 financing . . 
Source: HPAC 2008, HPAC 2009, HPAC 2010, HPAC 2011. 
Systematic monitoring of external funding within NHA began in 2007. It is therefore difficult 
to infer trends over time in parallel and joint external financing for health. Thus far, detailed 
information on sub-accounts (e. g. TB) has been published only for 2008. In this year, the larger 
proportion of donors' financing was `parallel' financing (63%), and the rest was on budget 
support through a SWAp. Distribution of donors funding by health programmes indicated 
disproportionally high spending on TB and HIV/AIDS programmes. In 2008,42% of total 
donors funding went to the HIV/AIDS programme, 24% to the TB control programme, and the 
remaining 34% on other health programmes (HPAC, 2009) 
7.3.3. Organisation of service delivery 
In Kyrgyzstan most of the restructuring and downsizing of inpatients facilities was implemented 
in 1999-2003. Overall number of all hospital beds reduced from 83 beds per 10 000 population 
in 1997 to 50 beds per 10 000 in 2008 (RMIC, 2008). Hospitals' closures affected primarely 
rural hospitals. 78% of all closed hospitals were rural (Purvis and others, 2005 ). Regional 
large general hospitals with speciality departments were formed by merging, administratively 
and financially, pre-existing general and specialised hospitals (Meimanaliev and others, 2005, 
Purvis and others, 2005 ). The network of tertiary-level facilities and national hospitals has 
been retained. This network is clustered primarily in Bishkek city. Several specialised services 
such as dermatology-venerology and narcology have undergone considerable changes in the 
closure of all regional extensions, with the exception of national-level centres and Osh oblast. 
Other specialised services such as TB services underwent only closures of rayon extensions. 
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A primary care model based on family medicine has been introduced (Atun, 2005 , 
Hardison 
and others, 2007). This has included re-training of medical doctors as family practitioners, 
initially through short-term training courses (Hardison and others, 2007). Family medicine has 
been included into formal medical education programmes. An extensive network of outpatient 
service providers that existed in the Soviet times has been retained. Family medicine groups 
(FMG) have been formed based on pre-existing primary care providers (i. e. policlinics). Large 
urban specialised policlinics (e. g. adult and children, with a number of specialists) have been 
formed into Family Medicine Centres (FMC). In some instances, small hospitals were merged 
with FMCs as well. FMCs are the largest outpatient health facilities, located in cities and rayon 
centres. Outpatient services in rural areas are provided by feldsher ambulatory points (FAP). 
Administratively FAPs are supervised either by FMG or FMC. 
FMGs are the main providers of primary care, and population enrol only in family groups. 
They are staffed with at least one family doctor, paediatrician and gynaecologist (and therapist), 
2-5 nurses, and a manager. Most of the FMGs were established as affiliates of FMCs. FMCs 
provides administrative and financial management, and at the same time are providers of 
specialised outpatient care. Over time, the scope of services provided by family medicine 
doctors has increased (MOH, 2008a). Family doctors are responsible for managing STDs, 
family planning, prenatal and antenatal care, detection of TB cases and treatment follow up in 
the continuation phase, management of acute and chronic diseases, and management of mild 
mental disorders such as depression, health prevention and promotion. 
In addition to family doctors, FMC provide specialised services. Reform implementation has 
not fully addressed referral mechanisms from family doctors and specialists within FMCs and 
from primary care to hospitals (Atun, 2005 , Jakab and others, 2005). 
Human resources 
Following downsizing and restricting of health care services in the early 2000s, the numbers of 
medical doctors and mid-level personnel were reduced by approximately 30% (Purvis and 
others, 2005 ). The number of medical doctors decreased from a national average of 34.1 per 10 
000 population in 1991 to 23.8 per 10 000 in 2008, and mid-level personnel from 94.7 to 53.0 
per 10 000 respectively (Meimanaliev and others, 2005, RMIC, 2008). There is a noticeable 
divide in the availability of health personnel between urban and rural areas. On average, the 
availability of medical personnel (both medical doctors and mid-level) is 3-4 times higher in 
urban areas than in rural. For example, in 2008 the number of medical doctors in urban areas 
ranged from 27.1-46.6 per 10 000, and in rural areas from 7.9 to 16 per 10 000 (RMIC, 2008). 
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The health reform programme has not addressed problems with remuneration of health 
personnel. Low wages and lack of incentives for medical personnel has been a chronic problem 
since the Soviet period. There has been an increasing trend of outflow of health personnel from 
the health system (Kojokeev, Murzalieva, and Manjieva, 2008). Medical personnel either leave 
for jobs in other sectors, or migrate to regions with better job prospects, both internally to urban 
centres and externally to neighbouring countries such as Russia and Kazakhstan. In one study 
(Kojokeev, Murzalieva, and Manjieva, 2008), respondents identified low salaries, which do not 
match increasing responsibilities, and low prestige as the main reasons driving health workers in 
the search for other job opportunities outside the health sector. 
7.3.4. Information system 
Collection of health statistics (e. g., mortality, morbidity, health care utilisation, financing) 
follows a hierarchical principle in line with the hierarchical organisation of health system. The 
central unit for health information in Kyrgyzstan is the Republican Medico-Informational centre 
(RMIC), under the MOH. The MOH approves the health indicators to be collected. Depending 
on speciality, all health organisations from the lower level submit reports to their superior 
organisation. For example, TB hospitals submit the reports to their regional TB centre. 
Normally, reports are submitted monthly or quarterly (i. e. every three months) and annually. 
Respondents have noted that reporting requirements for FMC are considerable. As a result, 
family doctors spend a lot of time on administrative work. 
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CHAPTER SUMMARY 
In summary, a major focus of Kyrgyzstan's health reform has been changes in financing. In 
particular, these changes included the diversification of revenue collection, reduction of 
fragmentation of pooling and changes in payment mechanisms to general health providers 
(Kutzin and others, 2009). These new mechanisms are credited with reducing geographic 
disparities in resources allocation (Kutzin, Jakab, and Cashin, 2010). The introduction of 
official OOP has also been attributed to an improved transparency of financial transactions 
between patients and providers, given the high level of under-the-table payments to health 
providers that existed prior (Baschieri and Falkingham, 2006, Falkingham, Akkazieva, and 
Baschieri, 2010). Despite improvements, the burden of health care payments for the country's 
poor population remains considerable (Falkingham, Akkazieva, and Baschieri, 2010). 
However, the impact of financing reform on the performance of providers still has a limited 
evidence base (Moreno-Serra and Wagstaff, 2010, Rechel and McKee, 2009, Wagstaff, 2010, 
Wagstaff and Moreno-Serra, 2009), and has not been evaluated in Kyrgyzstan. Another major 
component of health system reform has been the introduction of family medicine as a model of 
primary care. Despite intentions (MOH, 2008a, TheGovernmentKyrgyzstan, 2006b), 
fragmentation of service delivery among providers of specialised services has not yet been 
addressed. 
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CHAPTER 8 SUSTAINABILITY OF TB CONTROL 
PROGRAMME 
INTRODUCTION 
Chapter 7 provided an overview of the health system and political, socio-economic, and 
epidemiological contexts within which the TB and HIV/AIDS control programmes function. 
This chapter aims to analyse the sustainability of the TB control programme in Kyrgyzstan. 
By the beginning of the 1990s, the status of TB services was critical. It was reported that there 
was a shortage of anti-TB drugs in the period from 1992-1996 (ICRC 2004). In response, 
WHO, WB, USAID, and KfW included the introduction of DOTS in their initial development 
assistance efforts. Kyrgyzstan piloted DOTS in 1996, being one the first countries in the FSU 
region to adopt the strategy as national policy in 1998 (MOH, 2006). The country was also 
among the first countries globally to have piloted WHO's Practical Approach to Lung Health 
(PAL) strategy in 2003 (MOH, 2006). Additionally, pilot projects to address TB/HIV and 
management of MDRTB were initiated in 2005. Considerable financial and technical assistance 
exclusively to the TB programme were provided most notably by WHO/Euro, WB, USAID, 
KfW, GFATM, International Committee of the Red Cross (ICRC), and M6decins Sans 
Frontibres (MSF). 
The chapter examines five characteristics of the TB programme: leadership, capacity, flexibility 
(adaptability), interactions, and performance (Chapter 5). In this research, disease control 
programme sustainability is assessed through analysis of observable programme characteristics. 
While these characteristics are intimately interconnected, for the sake of clarity, the chapter is 
structured to present an analysis of each. 
I begin the chapter by critically assessing TB data from surveillance sources with the purpose of 
showing whether TB surveillance likely reflects the reality of the TB epidemic in the country. 
This is followed by an examination of how the TB problem is perceived by study respondents. 
The 'Leadership' section aims to identify and characterise leadership. The section assesses the 
strategic aims of the TB control programme, how these are supported by the legislative 
framework, and what factors determine implementation of the defined strategic goals. The 
section presents results of the analysis regarding who the key actors of the programme are, their 
roles and influences, with a purpose to identify who leads the programme. I present an 
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assessment of the health system's arrangements for TB programme governance, organisational 
arrangements for the programme, and identify whether these arrangements influence the 
leadership of the programme. The section on `Capacity' outlines the results of the analysis of 
resources for the TB control programme. I assess the programme's financing, financial 
mechanisms, TB services infrastructure, focusing on changes in inpatient capacity. I also assess 
the availability and development of human resources for TB control; and availability, 
procurement and distribution of anti-TB drugs. 
In the `Flexibility/adaptability' section, I present an analysis related to how the health system's 
arrangements for TB programme functioning changed in response to the introduction of policy 
innovations. Two innovations are considered - DOTS and MDRTB management. In particular 
I focus on changes in clinical management of TB patients and organisation of service delivery, 
and providers' payment mechanism. As was discussed in Chapter two, these functions in 
particular were determinants of the ineffectiveness and inefficiencies of TB control during the 
Soviet period, including in the post-Soviet period as was shown in the research in Russia (Atun 
and others, 2005e, Floyd and others, 2006). The `Interactions' section summarises an analysis 
of interactions between TB services in civilian and penitentiary sectors, and interactions 
between TB services and HIV/AIDS services, and primary care services. I conclude the chapter 
with a section on `Performance'. Drawing on secondary data (national statistics and WHO TB 
data) and interviews, I explore whether the TB control programme is effective, efficient and 
equitable. 
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8.1. TUBERCULOSIS EPIDEMIC 
Tuberculosis has historically been a public health problem in central Asia, including in 
Kyrgyzstan. The scope of the TB problem prior to the Soviet period is unknown due to lack of 
surveillance activities. Epidemiological studies to directly or indirectly measure TB incidence, 
prevalence or mortality have never been conducted in the country. As was presented in Chapter 
2, there are, thus, substantial uncertainties in regards to the TB situation during the Soviet 
period. Reliance on fluorography for confirming TB diagnosis has likely resulted in 
misdiagnosis. In this section, I discuss available TB surveillance data4°, and analyse how TB is 
viewed by programme actors. This analysis is based on both interview data and definitions of 
the TB problem as outlined in official country documents. As I show further in this chapter, the 
perceptions presented here influence policy formulation by domestic policy makers. 
8.1.1. TB surveillance data 
During the Soviet period the central Asian countries showed higher TB notifications and deaths 
rates as compared to Russia and other USSR regions (Raviglione and others, 1994). According 
to the USSR surveillance data, the TB burden had been reduced by the middle 1970s. During 
the 1970s-1980s, Kyrgyzstan's TB notifications fluctuated at the level of 52-60 per 100 000 
population. TB death rates had been reported below 10 deaths per 100 000 (Raviglione and 
others, 1994). As elsewhere in the FSU region, notified TB cases and deaths grew rapidly 
during the 1990s, peaking in 2001-2002 (Figure 8.1. A, Figure 8.1. C). In the following years, 
the increase in TB cases and deaths was reportedly halted (Figure 8.1 . A, Figure 8.1. C). As of 
2008, national surveillance registered 106.3 TB cases per 100 000 population and 9.9 TB deaths 
per 100 000. 
Despite the abovementioned reduction in notified cases and deaths, assessment of TB 
surveillance data suggests weaknesses. For example, there are notable annual variations of 
registered new TB cases and deaths across oblasts (Figure 8.1. C, Figure 8.1. D). Though TB 
case notifications have seemingly improved (e. g. less annual variations) in the last five years, 
there are substantial intra-oblast (25-49%) and year-to-year variations in proportion of BK+ 
cases (BK+ is either smear and/or culture confirmed TB case)45. Annual variations in registered 
deaths in some oblasts are substantial. This suggests that TB case detection and diagnosis, 
including registration of TB-associated deaths, are likely subject to error. 
µ Despite attempts, the National Centre of Phthisiatry did not provide me with epidemiological surveillance datasets 
allowing an assessment of the accuracy and consistency of surveillance data. 
45 Data is not shown. Source - the the National Centre of Phthisiatry 
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Figure 8.1. A. Tuberculosis cases, notification rates per 100 000 population, Kyrgyz Republic 
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Figure 8.1. B. Tuberculosis cases, notification rates per 100 000 population, administartive regions 
Figure 8.1. TB case notification and death rates per 100 000 population, Kyrgyz Republic, 1991- 
2008 
Source: The National Phthsiatry Centre of Kyrgyz Republic, Republican Medico-Information Centre of 
Kyrgyz Republic, WHO (2010a). 
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Figure 8. I. D. TB death rates per 100 000 population, administrative regions 
Figure 8.1 (continued). TB case notification and death rates per 100 000 population, Kyrgyz 
Republic 1997-2008 
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Recent WHO estimates of TB incidence, prevalence and mortality (WHO, 2010a) also suggest 
potential underreporting of TB cases over the last decade. TB incidence was likely 143 TB 
cases (95% Cl, 114-171) per 100 000 population in 1995 and remained at a similar level of 159 
(95% Cl, 129-191) in 2008. TB prevalence has been reduced from a likely level of 180 (95% 
Cl, 89-290) TB cases per 100 000 in 1995 to 140 TB cases (95% Cl, 53-270) in 2008. TB 
mortality has not changed; it was an estimated 26 (95% Cl, 19-35) per 100 000 population in 
1995 and remained at 22 (95% CI, 15-32) in 2008. However, given the wide confidence 
intervals given by the WHO models, there are substantial uncertainties in the estimates 
provided. 
Table 8.1 Notified TB cases and registered TB deaths, 2008, Kyrgyz Republic 
Notified TB cases (all 
forms) 
TB death 
Population, N Rate per N (%) Rate per 
thousands (% total) 100 000 100 000 
Batken oblast 428.5 350 (6.3%) 81.7 14 (2.7%) 3.3 
...... Oshoblast .............. ......... 1081.3 1100(19.70/*) 97.9 ...... 84 (16.1 %) . 7.9 
ty 250.2 238 (4° .3 
/o) 9 95.1 20(3.8%) 8.0 
.. Jalalabad oblast .......: ........... ................ 987.1 ........ ......... 845(15.1%) 85.6 ....... 58 (11.1 %) 5.9 
Naryn oblast 
....... 
270.6 274(4.9%) 101.3 15(2.9%) 5.5 
Issyk-Kul Oblast 433.7 323 (5.8%) 65.7 18(3.4%) 4.2 
Talass Oblast 218.5 216 (3.8%) 98.9 23 (4.4%) 10.5 
Chul Oblast 761.2 
....... ..... 
1152 (20.6%) 
. 
151.3 113 (21.6%) 14.8 
Bishkek city 819.0 914 (16.4%) 111.6 139(26.6%) 17.0 
Penitentiary sector 10500* 250 (4.0%) 2439.0 38(7.3%) 370 
Kyrgyz Republic 5250.1 5583 106.3 522 9.9 
Source: Republican Medico-Information Centre, Kyrgyz Republic 
There are differences in notified TB cases and deaths across oblasts46 (Figure 8.1. B, Figure 
8.1. D, Table 8.1)). In the last five years, TB notifications were considerably higher in Chui 
oblast and Bishkek. Without sound epidemiological studies or a systematic assessment of 
surveillance, explaining the inter-regional differences in TB rates in Kyrgyzstan is difficult. 
Among possible causes, studies elsewhere indicate a strong socio-economic gradient in TB 
burden within countries and communities (Lonnroth and others, 2009, Lopez De Fede and 
others, 2008). According to these studies, urbanisation and rapid socio-economic changes 
create conditions in some urban clusters for higher TB transmission or higher risk of developing 
TB disease. However, empirical data on these phenomena in Kyrgyzstan are absent. 
46 Administrative regions. 
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TB notification and death rates in the penitentiary sector are 10-20 times higher than in the 
civilian sector (Bashmakova and others, 2009, ICRC, 2004). As of the end of 2008, new TB 
cases in the penitentiary sector comprised 4.5% of the country's notified cases, and 7% of TB 
deaths (Table 8.1). Because the factors contributing to higher rates of TB in Kyrgyzstani 
prisons have not been studied empirically, causes of these higher rates remain unclear. Higher 
rates of TB among prisoners than in the general population were found in other studies 
conducted in the FSU region (Drobniewski and others, 2005, Lobacheva, Asikainen, and 
Giesecke, 2007) and internationally (MacNeil, Lobato, and Moore, 2005). It has been 
suggested that prisons are a setting with increased risk of TB transmission due to higher contact 
rates (Jones and others, 1999, Stuckler and others, 2008) as well as an overall propensity of 
prison populations to have higher risks of developing TB disease (Drobniewski and others, 
2005, Lobacheva, Asikainen, and Giesecke, 2007). 
The number of detected TB cases, and TB notification rates (data is not shown) are higher in 
young adults aged 15-34 years (Figure 8.2). This pattern is suggestive of persistently high 
transmission (Rider, 1999). TB rates are higher in males (a common observation for TB). TB 
mortality is disproportionally higher among young males, which is 3 to 5 fold higher than in 
females (WHO/Euro, 2011). 
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Figure 8.2. Number of notified TB cases, by age and gender, 2007, Kyrgyz Republic 
Source: The National Phthsiatry Centre of Kyrgyz Republic 
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AMR TB data 
As elsewhere in the FSU region, the scope and trends of MDRTB in Kyrgyzstan are not fully 
known. There is no national MDRTB surveillance system in the country. Nationwide surveys 
have never been conducted. MDRTB surveys have been conducted in Kyrgyzstan twice47, in 
2002 and 2007. Both covered Bishkek city. The survey conducted in 2007 by Supra-national 
laboratory (Bristol, Germany) identified 24.8% MDRTB prevalence among new cases, and 
53.7% among previously treated cases (CMCC, 2009). MSF conducts MDRTB surveillance in 
one penitentiary facility, which showed 27.7% prevalence among new TB patients and 59% 
among previously treated (data for 2007). Modelling performed by the WHO suggests that in 
2008, MDRTB rates were 13% (95% Cl 0-25%) among new cases and 42% (95% Cl 12%- 
72%) among previously treated cases (WHO, 2010b). This has been interpreted to mean that in 
2008, the number of MDRTB cases in the country was somewhere between 350 and 2400 cases 
(WHO, 2010b). Substantial uncertainty thus surrounds the epidemiology of MDRTB in 
Kyrgyzstan. 
TB/HIV data 
TB and HIV/AIDS surveillance systems are not linked and the scope of TB/HIV problem is not 
clearly defined. Though all TB patients are required to undergo testing for HIV upon 
confirmation of TB diagnosis, TB services do not register HIV test results (HIV status is 
confidential and depends on voluntary disclosure by patients). Data on HIV/TB is currently 
collected by HIV/AIDS services. According to the AIDS services, as of July 1,2009 there were 
a cumulative 309 persons detected with TB/HIV co-infections, with a notable increase in recent 
years. WHO estimates also suggest that prevalence of HIV among incident TB cases has likely 
grown from 1.4% (95% CI, 0.52-2.1) in 1996 to 6.8% (95% CI, 5.1-9.0) in 2008 (WHO, 
2010a). 
8.1.2. Perceptions of programme actors' on the TB epidemic 
As I have shown in the preceding analysis, there are uncertainties with regards to the 
epidemiology of TB in Kyrgyzstan. It is likely that substantial reductions in TB incidence and 
mortality have not occurred in the last decade. TB surveillance lacks accuracy and 
completeness. The scope and any changes in MDRTB occurrence are not fully known. And the 
contribution of HIV to the TB public health challenge remains unclear but is probably 
47 WHO/IIJALTD in 2002 (Kyrgyz Republic, the sixth GFATM grant application, TB component), and supra- 
National Laboratory, Bristol, Germany in 2007 (Kyrgyz Republic, the ninth GFATM grant application, TB 
component). 
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underestimated. Nevertheless, detection of MDRTB in newly diagnosed cases clearly suggests 
ongoing transmission (Frieden and others, 1993, Rullan and others, 1996). A high proportion of 
MDRTB in previously treated cases is indicative of persistent weaknesses of clinical and 
organisational management patients (e. g. treatment interruptions) with TB (Post and others, 
2004) (Cox and others, 2007, Victor and others, 2007) 
This study finds that aggregate national TB notification and death rates are used by officials as 
indicators to report on TB progress. Changes in TB case notifications are often reported as 
changes in TB incidence. Reductions in both indicators are reported by official sources as one 
of the programme's achievements (MOH, 2008a). The majority of respondents view TB 
epidemics as having stabilised. However, the overarching perception is that TB remains a 
serious public health problem. Primarily, there is recognition that TB is, to a large extent, 
determined by socio-economic conditions: 
According to indicators the TB programme works well, TB mortality has been reduced 
as well, it is already below 10. However, the TB problem is a social problem - it will 
be acute till socio-economic conditions get improved. ' (Respondent TB10) 
TB in marginalised and vulnerable groups 
It has been noted by all respondents that TB in Kyrgyzstan disproportionally48 affects people of 
low socio-economic status such as the unemployed, homeless, poverty-stricken, old aged, 
labour migrants, and those with a history of detention. Empirical research elsewhere 
consistently demonstrates that those with low socio-economic status and marginalised groups 
are often at higher risk of acquiring TB infection or developing TB disease. Increased risk of 
TB infection has been found to be associated with poor and crowded living conditions 
(Lonnroth and others, 2009). Poor nutrition, unhealthy life styles, or a higher propensity for 
having underlying chronic conditions often contribute to an increased risk of progression to TB 
disease (Dye and Floyd, 2006, Frieden and others, 2003, Rieder, 1999). These population 
groups, for several reasons, are often subjected to stigmatisation, lack of information, delay or 
inability to access health services (Farmer, 1997, Grange and others, 2009, Jaramillo, 1999). 
Based on the analysis of interviews, there appear to be differences between domestic and 
international actors in how the TB problem is perceived. Domestic respondents appear to view 
the TB problem as one largely related to TB transmission associated with a lack of control over 
08 Official data on socio-demographic characteristics of TB patients has not been provided during the data collection. 
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groups that are difficult to trace, monitor or treat. On the other hand, international stakeholders 
perceive the problem in terms of TB stigma and weaknesses of TB service delivery processes. 
Domestic respondents in this study have consistently singled out internal migrants and ex- 
prisoners as groups driving the TB epidemic. These groups were cited as the ones contributing 
to higher TB notification and deaths rates in Bishkek city and Chui oblast (Table 8.1). 
Internal labour migrants often experience challenges with meeting the administrative 
requirement to register with local police following a move to an urban centre. This, in turn, 
prevents them from being registered with. primary care providers. Registration with primary 
care providers determines their eligibility for free primary care services. This lack of access to 
health services is, in the opinion of some key domestic respondents, viewed as a lack of control 
over a person and/or lack of responsibility on the part of an individual. This is shown in the 
following interview excerpt: 
`Because megalopolis has certain structures implementing law enforcement - these 
people of course settle down in suburbs, where strict control over a person is absent. 
Therefore, he is not getting registered, not getting propiska°9 in the passport office... 
they do not want go through prophylactic screening... even if sick, they visit their 
friends, market, funerals - certainly they represent a threat in terms of epidemiology.... ' 
(Respondent TB06) 
This points to the perception that migrants and migration present risks for TB transmission in 
the community. According to respondents and national reports, internal migrants still 
undergoing TB treatment often default. This is perceived by some domestic respondents as 
mainly a fault of the patient (i. e. lack of responsibility), but not as a failure of TB services to 
reach these population groups: 
'At the new site, they do not get on the dispensary registration (transfer of registration), 
not getting registered with police, for a long time... it is impossible thus to trace them. 
For example arrived from Naryn, got the intensive phase over there, and came to 
Bishkek to work in the bazaar. And how would we find him? ' (Respondent TB02) 
Ex-prisoners are also viewed by national respondents as a critical source of TB in the 
community. Chui oblast hosts two detention colonies, where penitentiary TB hospitals are 
49 In Russian - official residency registration with police. 
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located. Upon release, according to respondents, most former prisoners stay in the area. Ex- 
prisoners experience serious obstacles in obtaining passports, cannot (for various reasons) meet 
requirements of registration with police, and consequently cannot formally enrol into treatment 
entitlements with civilian health services. Those who are on TB treatment often do not continue 
treatment. The release of prisoners, who have undiagnosed TB or are still undergoing treatment, 
is sometimes viewed by providers as a fault of the prisons system: 
`They release people irrespective of whether treatment is completed or not. They say - 
human rights. What about the human rights of my residents? Here one has infected a 
teacher, and then she infected the whole school. Children... ' (Respondent TB07) 
A common theme that emerged in interviews with domestic respondents is the notion of 
`asocial' segments of society. The concept of `asocial members of society' has its roots in Soviet 
ideology, which considered certain segments of society as undesirable. These people are 
viewed as irresponsible (or `non-compliant'). For example, below is the opinion of a 
respondent who believes that ex prisoners practice `asocial' and sometimes illegal lifestyles, 
which lead them to hide from treatment: 
`They conduct an asocial lifestyle, or those who are involved in illegal activities. They 
not only hide from TB treatment, they live in their hidden world. ' (Respondent TB06). 
The existence of TB stigma has been noted by respondents representing international 
organisations. This issue did not emerge in interviews with domestic respondents. Ex-prisoners 
suffering from TB and/or with MDRTB are particularly stigmatised: 
'The civilian sector is very much stigmatised, TB patients and prisoners. If you are 
both, and undergoing MDRTB treatment - you are really at the end of the chain.... TB 
is not recognised as a real threat to public health... And, of course, not speaking for 
people who know, but in a broad society - they think it is a disease of the 
underprivileged of society like drinkers, homeless, prisoners ... and that it can never be a 
threat to public health. ' (Respondent TBOS) 
This negative perception is exemplified in the following interview excerpt from a representative 
of general health services: 
`and of course, a source of resistance are those from prisons - they spit out 
everywhere. ' (Respondent PHCO1). 
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Perceptions of TB programme actors about AMRTB 
MDRTB is recognised as a concern by all respondents. The lack of MDRTB surveillance and 
the limitations of available data are recognised, and it is acknowledged that the scope and extent 
of MDRTB is not defined: 
It is unknown what the pace is... how many new drug resistant patients are identified, 
or now exist, because there is no universal access to this test that defines the resistance 
pattern.... So it is unknown what is rate of creation of MDRTB. ' (Respondent TB 11) 
I found that national stakeholders often present the MDRTB problem as separate from TB. 
There is no explicit acknowledgement in national documents that MDRTB is caused by failures 
of TB providers to find and properly treat drug-susceptible TB. National stakeholders, 
particularly representatives of the National Centre for Phthisiatry (NCPh), frame the MDRTB 
problem as one related to a lack of control over people who are difficult to trace or treat. There 
is a tendency to link the problem to specific socio-economic groups: 
`The uncontrolled migration of population, and associated social problems... create 
challenges in detecting and registering TB patients. Their late presentation to TB 
services, and late initiation of therapy... impossibility of conducting direct observation 
of treatment are the main reasons for unsuccessful treatment outcomes and 
development of resistance. ' (MOH, 2008d) 
Along with an opinion that MDRTB is the fault of DOTS, we never had MDRTB before' 
(TBO1), MDRTB is perceived as a problem solely related to transmission control. Here for 
example, is how one key informant, who represents a decision-making institution in TB control, 
presented the issue: 
`Development of resistance is a natural process. Microorganisms are alive and are 
adapting - if one survives, it produces generations of resistant organisms. And we have 
resistant TB already circulating; we cannot interrupt its development... it is late to fight 
development of resistance, what we have to fight is transmission of resistant TB. This is 
why some of these patients have to be isolated. '(Respondent TB02) 
A similar perception of the MDRTB problem is expressed in an interview with another key 
informant. In this informant's view, the risk of MDRTB transmission is rather high thus 
necessitating isolation: 
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'MDRTB patients should, in principle, be in a certain closed environment - that is the 
patient is infectious and should be isolated from the society.... For example, we are 
located right on the highway; a patient can go to market, get on the bus, hang out all 
day then come back at night, and announce that by law he needs treatment and food.... ' 
(Respondent TB06) 
Perceptions of TB programme actors about TB/HIV 
The HIV/AIDS epidemic is viewed by all the TB programme's respondents as a potential threat 
to TB control. Nevertheless, the problem of TB/HIV co-infection is not yet considered as 
critically important by national TB stakeholders: 
`Of course it is a concern [HIV], because tuberculosis is a main opportunistic infection 
among the HIV infected, and not only an opportunistic infection, but also a cause of 
death. Really it is a potential problem, big problem for TB services. But yet the level of 
HIV infection in the republic is not so high. ' (Respondent TB02) 
7t [TB/HIV] is still ... number is not .... you know... we are not talking about Africa here. 
But it is coming, and it will grow. But most are not aware of it, not from the TB side 
[TB programme]. ' (Respondent TB05) 
In summary, the analysis presented in this section suggests that among some key TB 
programme actors, perceptions about the course of the TB epidemic are formed in the absence 
of robust surveillance and epidemiological studies. I found that views that existed during the 
Soviet period, which framed TB control measures as control over persons or patients, persist. 
Failures of the health system to properly treat patients and prevent the emergence of MDRTB 
often are not explicitly acknowledged, nor is the challenge posed by aligning HIV and TB 
control. Stigma is an important feature of the TB control system and informs its functioning. 
8.2. LEADERSHIP 
8.2.1. Policy responses to the TB epidemic 
I analysed leadership in TB control policy-making from the standpoint of whether a clear 
strategic vision for reforming TB control services is present, and what the vision is, and what 
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the processes of implementation are for the development of patient-centred TB care. I also 
examined what strategic steps are being planned for responding to emerged (or emerging) 
MDRTB. I present a more detailed analysis of the health system response to MDRTB in the 
section `Flexibility'. In analysing TB control policy I relied on two policy instruments. These 
are governmental programmes on TB control50, and the regulatory basis governing TB control. 
Strategic aims of the TB control programme 
Since the adoption of DOTS as a national strategy in 1998, national policy makers declared a 
commitment to implementing the TB control strategy based on international recommendations. 
The current TB control strategy is outlined in the governmental programme `Tuberculosis-III', 
2006-2010 and the health system reform programme `Manas Taalimi', 2006-20105' 
(TheGovernmentKyrgyzstan, 2006b, TheGovernmentKyrgyzstan, 2006 ). The strategy largely 
mirrors the objectives of the Global Plan to Stop TB, 2006-2015 (WHO, 2006b, WHO/Euro, 
2007). Kyrgyzstan declares commitment to the establishment of quality DOTS. Policy makers 
also aim to implement policy innovations such as MDRTB management, implementation of 
DOTS in prisons, collaboration between HIV and TB services, and contributing to health 
system strengthening through Practical Approach to Lung Health (PAL). 
The integration of vertical TB services with the general health system and public health services 
is one of the long-term objectives of health system reform (MOH, 2008a, MOH, 2008d, 
TheGovernmentKyrgyzstan, 2006b). As a priority, there are plans to integrate specialised TB 
and pulxnonology services at primary care level, thus allowing expansion of DOTS and PAL 
(MOH, 2007b, TheGovernmentKyrgyzstan, 2006b). Despite aiming at broader integration of 
the TB programme into the general health system, there is little detail and attention in strategic 
documents with regards to the mechanisms for strengthening community-based treatment and 
the social support system for TB patients. 
Furthermore, I have found that the policy framework in Kyrgyzstan has competing objectives. 
A case in point is an approved plan for TB services reform for the period 2008-2016, which has 
been developed by the MOH and the NCPh. The reform plan sets out an approach that 
emphasises hospitalisation as a key mode for TB treatment. This plan is formulated to retain 
J0 TB control measures in the country are implemented in accordance with a governmental programme, which is a 
state approved strategic policy document. This document outlines objectives, actions and implementation strategy, 
including expected outcomes. Since 1996, three governmental programmes on TB control were approved by the 
state and implemented ('Tuberculosis-I', 1996-2000; `Tuberculosis II', 2001-2005, and 'Tuberculosis-III', 2006- 
2010). 
61 TB control and prevention of respiratory diseases is a priority sub-programme within on-going health reform 
programme 'Maras Taalimi', 2005-2010. 
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TB service inpatient infrastructure52 with further differentiation of TB inpatient facilities. 
According to the approved document (MOH, 2008d), existing TB facilities/departments would 
be specialised into 4 types of inpatient facilities: (i) facilities for treating newly diagnosed and 
relapse TB cases, (ii) specialised facilities for treatment of MDRTB (or departments in tertiary- 
level TB facilities), (iii) specialised facilities for treating chronic cases (infectious cases and 
those with unfavourable course of treatment), and (iv) rehabilitation centres for patients on 
recovery and contacts (suspects of TB). 
Implementation of TB policy innovations 
This study finds that implementation of all policy innovations in TB control during the last 
decade have been dependent on technical, and to a large extent, financial, support from donor 
agencies. Examination of international assistance provided since the early 1990s identified that 
the assistance has been focused primarily on DOTS implementation (Table 8.2). The national 
expansion of DOTS has been implemented with assistance from the WHO, USAID/CDC and 
KfW (Table 8.2). Passive case detection using sputum microscopy and treatment observation 
during the continuation phase has been included in the functional responsibilities of primary 
care providers. Particular attention has been paid to the establishment of a network of 
microscopy laboratories at primary care level. Nearly all primary care providers and staff of TB 
services have been trained, laboratory equipment supplied, and DOTS has been included into 
formal medical education curricula. Centralised M&E and anti-TB drugs procurement and 
distribution systems have been set up. 
Fundamentally, donors have focused on changes in the clinical management of TB patients, 
with a move from individualised treatment of TB patients to strict adherence to the WHO 
recommended regimens. As I exemplify further in the analysis, in principle, structural reforms 
of TB services have been limited to closing down TB dispensaries at rayon level. Though the 
follow up of TB patients was included in the responsibilities of primary care providers early in 
the health reform process, interactions between TB services and primary care providers are 
limited to coordination of service delivery (the analysis of which is detailed in the section under 
`Adaptability'). International financial assistance for TB control has not been linked into SWAp 
mechanisms or linked with the aims of health reform processes. Structural reforms of TB 
services have not been encouraged by the targeted assistance for TB control. An exception has 
52 Downsizing of TB services infrastructure would involve 6 small TB departments at the territorial general hospitals. 
These together would account for closing 205 TB beds out of an existing 3520 beds over an 8 year period. At the 
same time, the MOH has requested, as a part of KfW assistance, to build a new TB hospital in Bishkek city, which is 
set to take place in 2010-2011, with an expected capacity of 175 beds. 
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been the World Bank that required, at the inception of piloting DOTS in 1996, inclusion of 
passive case detection and treatment follow-up into primary care (WB, 2008). 
Donors' initiatives have also determined the time of the inception, scope and speed of 
implementation efforts. With the exception of DOTS, innovations are being operated as pilots. 
Until 2005/2006 the strategic focus was primarily focused on drug-susceptible TB. Treatment 
of MDRTB patients became possible after GLC approval in 2005. The GFATM grant (round 2, 
2004-2009, and round 7,2007-2012) fully covers treatment of MDRTB patients. The DOTS- 
plus pilot initially included 50 MDRTB patients. Within the GFATM grant, MDRTB treatment 
is planned to be expanded to enrol 1180 MDRTB patients in the period 2007-2012 (CMCC, 
2009). With the exception of MSF (which operates in one TB facility in the penitentiary 
sector), there is no on-site and ongoing international assistance to domestic TB actors in relation 
to MDRTB management. 
The penitentiary sector started actual53 implementation of DOTS in 2004-2005, when ICRC and 
MSF (Table 8.2) began their assistance efforts to address the TB crisis in prisons. This was 
seven years after DOTS had been declared a national policy. Until then, there was reportedly 
limited attention to TB in prisons from the side of national stakeholders involved in piloting and 
expanding DOTS in the civilian sector (ICRC, 2004). The only exception has been the Soros 
Foundation and KfW, which were purchasing anti-TB drugs. 
53 Official country documents declare that DOTS was introduced in the penitentiary sector in 2000. 
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Table 8.2 International assistance to TB control, disbursed and approved funding, 
Kyrgyzstan, 1998-2010 
Agency Time period Focus Monetary value 
(sub-contractor/round) 
WHO 1994-present WHO TB control policy - technical appx 50 000 per 
support year 
KfW 1998-2005 (TB-1/2) I't line drugs, lab equipment and 5.12 million EURO 
supplies 
2006-2010 (TB-3/4) Construction of National Laboratory, 5.0 million EURO 
TB hospital 
World Bank 1996-2000, TB 1 line drugs, equipment, training , 1.6 million US$ 
component, Health piloting of DOTS 
System Reform Project 
-1 
USAID 1997-2000 DOTS pilot, Laboratory diagnostics, 
(CDC Central Asia) electronic surveillance (M&E) system 
2001-2009 DOTS implementation ( labs, training, 1.45 million US$' 
(Project Hope) M&E, integration with PHC) (approximately) 
2005-2009 TB/HIV pilot, Chui Oblast 
(Capacity ro'ect 
GFATM 2004-2009 (round 2) DOTS, DOTS-plus pilot, TB drugs, 2.8 million US$, 
etc 
2007-2012 (round 7) DOTS, DOTS-plus, TB drugs, etc 8.3 million US$ 
Round 9 (not signed) DOTS-plus, TB drugs, etc 7.8 million US$ 
(committed) 
ICRC 2004-2010 TB control in penitentiary sector, 500 000 US$ per 
colony 27 year (approximately) 
MSF 2005-2010 TB control in penitentiary, colony 31 600 000 US$ per 
(MDRTB management] year, 
(approximately) 
Government 2003-2007 Pilot WHO PAL strategy 2.2 million Euro 
of Finland 
2007-2010 WHO PAL strategy 200 000 - 500 000 
(implemented by Euro per year 
Finland's NGO) varied - AFEW 2005-2010 TB/HIV component 1 
1 
Amount is approximated for Kyrgyzstan, regional project for 5 countries total 5.8 million US$. 
USAID-funded project Capacity has implemented a pilot on a model of TB/HIV collaboration 
in Chui oblast in 2005-2009. The activities, though they were recognised by the domestic 
respondents as successful, were not expanded further reportedly because of lack of resources. 
At the time of data collection, interactions between two specialised services were limited to 
establishing collaboration at national level. National coordinators at the National Centre for 
Phtsiatry h and the republican AIDS Centre have been assigned as point contacts in regards to 
TB/HIV patients. A national clinical protocol on the management of TB/HIV based on WHO 
recommendations have been developed. At present, AIDS Foundation East-West (AFEW), 
international NGO, continues pilot TB/HIV collaboration in penitentiary sector. 
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Legislative and regulatory basis for TB control 
The legal and regulatory framework54 for the policy on TB prevention, diagnosis and treatment 
emphasises the state's responsibility for TB control. The regulatory framework prescribes 
centralised and hierarchical governance and organisational arrangements for TB services. The 
state pledges provision of TB control measures based on principles of free of charge, universal 
access and equal rights for all citizens and residents of Republic of Kyrgyzstan' (TheLaw, 
1998b). Guarantees include the organisation and delivery of `specific prophylactic, diagnostic, 
curative and rehabilitation measures', including the financing of these measures and social 
support for patients 55 and health care workers56 (TheLaw, 1998b). 
The legislative framework makes it clear that tuberculosis is a communicable disease, which 
poses a threat to public health. The law gives the state an authority to impose coercive 
measures. Persons are administratively liable (TheLaw, 1998b) in case of non-compliance with 
prophylactic and sanitary-epidemiological measures, failure to follow recommendations of a 
healthcare provider in regards to TB treatment or transfer of dispensary registration. Further, 
TB patients `who systematically avoid treatment upon the court's decision are objects of 
detention in special facilities for inpatient TB treatment' (TheLaw, 1998b). Those patients 
`with infectious forms of TB, who systematically avoid inpatient treatment, and who therefore 
pose a threat to the public are administratively and legally liable' (TheLaw, 1998b). The law, 
however, does not specify how to proceed if treatment is not available, for example in case of 
XDRTB or even MDRTB. As I present further in the analysis, MDRTB treatment is available 
only for those enrolled into pilot sites funded by the GFATM. 
The TB law outlines patients' rights for respectful and humane treatment, proper diagnosis and 
care, and social benefits9. There is very little said in the law or supporting regulations, however, 
regarding what constitutes proper treatment and how it should be delivered. 
8.2.2. Governance and organisational arrangements 
Over the last decade, increasing numbers of international actors have been associated with the 
TB programme, including involvement of primary care providers. Analysis indicates that, in 
54 TB legislation is outlined the Law of Kyrgyz Republic "On protection of population against tuberculosis". TB 
prevention measures are also governed by the Law `On sanitary-epidemiological well being of the population', and 
the Law 'On health protection of the citizens of the Kyrgyz Republic'. 
03 The state guarantees full coverage of sick leave, maintenance of employment, travel to the place of treatment, 
disability benefits, and treatment in specialized sanatoria. 16 Medical workers in specialized TB services are eligible to additional annual leave of 14 working days and 30% 
salary increase. 
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principle, governance and organisational arrangements of TB services remain centralised and 
organised hierarchically. The state, through the MOH, has a central authority in decision 
making and responsibility for all aspects of TB control. A core of the programme remains a 
large hierarchically organised network of specialised TB services, headed by the NCPh (Figure 
8.3), which is a subordinate agency of the MOH. Decisions made by the MOH and NCPh 'are 
obligatory for all health organisations irrespective of ownership or subordination' (TheLaw, 
1998b). There is a parallel specialised TB service in the penitentiary sector under the 
jurisdiction of the Ministry of Justice (MOJ). 
With the entry of donors, two parallel governance bodies related to TB control were established. 
The first is a High Level Working Group on TB (HLWG) also referred to as the Coordinating 
Committee for Tuberculosis. The HLWG is hosted at NCPh. It was set up as a part of the 
Project Hope/USAID efforts to establish better governance practices and political support at 
national level (Teitelbaum, Ibragimov, and Akchurin, 2006). This coordinating committee was 
meant to become an executed advisory body with participatory decision making from all 
interested parties involved in TB control. The committee formed 6 working groups focusing on 
the following priorities - MDRTB, TB/HIV, DOTS, drug management, laboratories, and 
prisons. The second body is the Country Multisectoral Coordinating Committees? (CMCC), 
which has been established as a response to a GFATM requirement. However, involvement of 
national TB actors in the CMCC is limited to reporting GFATM grants implementation. 
The TB service network consists of TB centres (formerly regional-level TB dispensaries), TB 
hospitals, dispensaries and rehabilitation centres (Figure 8.3). At each administrative level, 
there is a lead TB organisation, which oversees activities in a region. At rayon level, TB control 
activities are headed by a TB office at the rayon FMC or rayon territorial hospital (a main health 
facility at rayon level). Each FMC has a TB (phthisiatry) specialist, who oversees activities of 
family doctors. A TB specialist (TB cabinet) is a part of the FMC but works under 
organisational/methodological supervision of the TB service organisation. Sanitary 
Epidemiological Services (SES) have a regulatory role in overseeing implementation of 
preventative measures such as BCG vaccinations, selective screening for TB infection or 
disease. 
57 Analysis relevant to CMCC is presented in Chapter 9. 
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Involvement of community groups or non-governmental organisations in TB control is minimal. 
A majority of respondents mentioned that there are no strong groups that could represent the 
interests of TB patients. An exception is the Kyrgyz Red Crescent society58, which has a 
historical partnership with the national TB programme and the MOH. The Red Crescent is 
involved in providing social and psychological support to TB patients during their outpatient 
treatment. Assistance is focused on those from vulnerable groups - elderly retired, disabled, or 
poor. 
8.2.3. The National Centre for Phthisiatry as a formal leader of the TB control 
programme 
The analysis of the roles, responsibilities and positions of actors suggests that the TB 
programme's leadership has been formally assigned to the NCPh. I found that historically 
embedded formal governance and centralised authority, which is concentrated within the NCPh, 
create impediments for effective coordination of TB control efforts. Though HLWG was active 
sometime after its inception, it gradually has become a body associated with the NCPh and its 
decisions. Most respondents, outside of the institute, view the NCPh as not meeting their 
expectations on leadership. This is how one of the respondents elaborated on the issues of 
leadership and coordination: 
'[NCPh] a priori plays a leading role, however, as it relates to questions of 
coordination... they play more of a formal role than coordinate issues .... they need to be 
more active in their interactions with international partners.... This [area] is rather 
isolated, and civil society is practically absent here. We do not have any NGOs with 
open and strong position, which could present and protect interests of TB patients.... I 
think this highlights the weakness of the /TB] programme. '(Respondent TB 10) 
Formally the NCPh is open to and collaborative with international initiatives in TB control. The 
analysis revealed that the NCPh is perceived as isolated from the broader health system 
community including from donors and NGOs. The NCPh, by its mandate, is responsible for TB 
services and over the years has defended the interests of TB services. This is how a leader of 
primary care defines the NCPh leadership: 
38 Kyrgyzstan's NGO -a network of Red Crescent Society existed since early 1990s throughout FSU 
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`[national coordinator] is a leader. He defends the interests of his hospitals. When 
there are discussions going on about the budget - he defends hospitals. If money is left 
- only then to primary care. '(Respondent PHCO1) 
Neither the NCPh nor any other actors emerged as a leader that would have engaged and 
mobilised efforts of all interested parties: 
'[national coordinator] might be a leader in some segments, but unfortunately he does 
not pay the same interest to all segments. And penitentiary is not his piece of cake, 
definitely not..... there is no integrating leader figure, which would pay the same 
attention to all aspects, or to be there where attention is most needed, without taking 
into consideration his own interests - this kind of leader figure, we do not have. ' 
(Respondent TB05) 
Vertical governance of the TB programme in Kyrgyzstan has been indeed supported by the 
WHO and other TB partners. DOTS in principal encourages vertical managerial functions, drug 
procurement, and monitoring and evaluation (Raviglione and Pio, 2002). The WHO supports a 
strong central unit of the national TB programmes. In Kyrgyzstan, this role has been given to 
the NCPh. Technical and financial assistance has been largely channelled through the NCPh or 
specialised TB services. In the period from 2003-2010, the NCPh has been a principal recipient 
of GFATM grants. During data collection, concerns were expressed by some respondents that 
the NCPh has insufficient capacity in terms of grant management, particularly financial 
management. These concerns were expressed `off the record', thus I cannot present quotes in 
this thesis. However, an audit by the Office of the Investigator General of the GFATM 
conducted in December 2009 has revealed problems with financial and programmatic 
management (GFTAM, 2010a). At the time of writing, there was a transition that would 
include arrangements in which UNDP59 hosts the GFTAM grants implementation unit. 
59 UNDP is to become one unit for GFTAM grant management. 
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83. CAPACITY 
8.3.1. Financial resources 
Sources offunds and financial flow 
Funds for the programme come from the public (both the state budget and the social fund), 
private (users of services) and international sources. Financing of the TB programme is 
fragmented (Figure 7.2, Chapter 7). A network of TB facilities in the civilian sector is funded 
from the MOH budget as a separate budget line (`sub-programme') (MOH, 2007 , MOH, 
2008b). Primary care providers are funded by the MHIF The MOJ finances health services in 
the penitentiary sector from its own budget. International funding dedicated to TB control 
(Table 8.2) has been channelled as parallel `off budget' funding. Donors disburse funds to 
grants' recipients or serve as providers (e. g. training, etc). 
By law, treatment of all diagnosed TB patients is free at point of delivery on all levels of care 
(TheGovernmentKyrgyzstan, 2007a, TheLaw, 1998b). Official users' payments are charged 
only for x-rays and diagnostic services for non-TB patients. These official OOP are less than 
0.5% of total expenditure on TB control (Akkazieva and others, 2009 ). There have been no 
studies conducted to date to assess unofficial OOP incurred by TB patients. 
Expenditure on TB control 
This study finds that the monitoring and evaluation of spending on TB control is weak. The 
MOH budget on TB services is summarised within general spending categories. These include 
human resources (salaries and social insurance contributions), administration and planning, and 
'other services' (food for patients, maintenance and renovation of infrastructure, medicines and 
consumables). Expenditure on TB activities, which are provided by primary care providers, has 
never been monitored systematically. Similarly, donors' investments in TB control have not 
been monitored systematically. Information received from different sources on donor's annual 
disbursements is sometimes contradictory (Bashmakova and others, 2009). 
Based on previous evaluations (Akkazieva and others, 2009 , Bashmakova and others, 2009, 
Godinho and others, 2005b, WHO/Euro, 2004) and collected data, I reconstructed spending on 
the TB control programme. Total expenditure on TB control has been increasing steadily over 
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the last decade, from approximately 130.9 million Kyrgyz som60 (KS) in 2000 to 473.7 million 
KS in 2008 (Figure 8.4. ) This approximates to an increase from 2.8 million US$ in 2000 to 
10.4 million US$ in 2008. The state budget and donors' funding are the main sources of funds 
(Akkazieva and others, 2009 , 
Bashmakova and others, 2009, Godinho and others, 2005b, 
WHO/Euro, 2004). In nominal terms, spending from the state budget on specialised TB 
services (Figure 8.4) has increased from 80 million Kyrgyz som (KS) in 2000 to 290 million KS 
in 2008. Spending on TB services as a proportion of the MOH budget remained at the level of 
6.5-7% over the years (Figure 8.4). In different years, the proportion of donors' funding has 
been estimated to range from 30% to 50% of total spending on TB control (Akkazieva and 
others, 2009 , 
Bashmakova and others, 2009, Godinho and others, 2005b, WHO/Euro, 2004). 
Major donors, in terms of volume of financial support, have been USAID, KfW, and GFATM 
(Table 8.2). 
Figure 8.4 Expenditure on TB programme, 2000-2008. 
Source: National Centre for Phthisiatry, Akkazieva and others, 2009 , Bashmakova and others, 
2009, 
Godinho and others, 2005, WHO/Euro, 2004 
National Health Accounts 2007, TB sub-account 
According to NHA for 200761 (Akkazieva and others, 2009 ), 79.4% of programme funds was 
spent on specialised TB service providers in the civilian sector, 1.6% in the penitentiary sector 
and 4.1 % on primary care providers (Table 8.3). Functionally, spending on inpatient treatment 
60 1 US dollars = 46.7 KS current exchange rate as of 2010 61 Only one available study that systematically assessed funds allocation for the TB programme. 
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was 39.4%, outpatient treatment3.2%, diagnostics 10%, and public health and prevention 
activities 8.3% (Table 8.4). 
Table 8.3 Spending on TB control, by provider, National Health Accounts, Kyrgyz 
Republic, 2007 
Source 
By provider 
All sources (in Kyrgyz 
Som) 
Public 
(MOH and MHIF) 
External 
S ecialised TB services 342863.3 79.4% 270784.5 72078.8 
TB hospitals 58895.3 13.6% 58895.3 0 
TB centres 245026.8 56.8% 177437.9 67588.9 
NCPh 38941.2 9.0% 34451.3 4489.9 
TB hos hals, enitenti 6895.8 (1.6%) 6895.8 0 
TB departments, rayon 
territorial hospitals 6168.1 (1.4%) 6168.1 0 
FMG/FMC 17869.1 (4.1%) 17869.1 0 
International roviders 57792.4 13.4% 57792.4 
Total 431588.7 301717.5 129871.2* 
Source: Akkazieva and others, 2009 
*61 466 KS of donors' funds were channelled through the MOH, and were accounted as public expenditure (Akkazieva and others, 
2009) 
Table 8.4 Spending on TB control, by functional activity, National Health Accounts, 
Kyrgyz Republic, 2007 
Source 
by Function All sources (in 
Kyrgyz Som) 
Public (MOH and 
MHIF 
External 
Inpatient treatment 169 888,7 (39.4%) 120619,6 (40%) 49269,1 (37.9%) 
Outpatient treatment 
- - 
13 971,6 (3.2%) 507,6 (0.2%) 13464,0 (10.4%) 
Ancillary service- sr' -- 42 984,2 (10%) 33683,6 (11.2 %) - 9300,6 (7.2%) 
Prevention and public health 
activities 
35923,4 (8.3%) 25162,1 (8.3%) 10761,3 (5.6%) 
Administration and health insurance 
for TB activities; 
52586,2 (12.2%) 52586,2(17.4%) 0 
HC expenditure not specified 116234,5 (26.9%) 69158,3 (22.9%) 47076,2 (36.2%) 
TOTAL, KS (Kyrgyz Som), % of 
Grant Total 
301717.4 129871.2' 
GRANT TOTAL, all sources 431,588.7 
Source: Akkazieva and others, 2009 
' Includes diagnostics - culture, sputum microscopy, fluorography, PPD, and 'other'-unspecified; 3 Includes 1649,5 KS of estimated official OOP 
3 Other than DOTS management and administration. 
" 61 466 KS of donors' funds were channelled through the MOH, and were accounted as public expenditure (Akkazieva and others, 
2009). 
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International financing 
Since 1996, international funding covers implementation of all TB control innovations and key 
consumables. These include all quality anti-TB drugs (1" and 2°d line), equipment and recurrent 
supplies for functioning of laboratories, monitoring and evaluation activities (as per WHO), on- 
going training of health personnel, community health education activities, and social support 
packages for TB patients. According to the majority of respondents, the state will not be able to 
afford to fully finance TB control activities in the short-medium term. All domestic respondents 
perceive the state's funding for TB control activities as insufficient: 
`whenever there is a discussion about financing - we raise this issue constantly with the 
Ministry of Health, and on the level of the state that the plan for implementing TB 
control programme -this plan is already with 30-40% deficit. This means that we do 
not have funds to fully implement planned activities. ' (Respondent TB02) 
In this analysis, targeted donors' assistance, whilst improving capacity, is identified as impeding 
effective interactions. An example of this is the targeted assistance of ICRC and MSF to 
prisons. These efforts have resulted in substantial improvements in penitentiary TB hospitals' 
infrastructure, laboratory capacity and in delivery of TB interventions inside the penitentiary 
sector. However, such targeted assistance, coupled with fragmented domestic financial flows 
to TB provides and shortage of funding in the public sector, creates distrust. Representatives of 
the civilian TB service perceive patients who are released from prisons as an additional burden, 
which stretches already scarce resources in the civilian sector: 
`we understand that the GUIN62 is different 'state' with its own donors, but they act in 
a quite dishonourable manner in relation to civilian health services - they put problems 
on the shoulders of the civilian health system... They built those hospitals, show these 
hospitals to everyone - why did they build them? If they have given these resources to 
the civilian health sector.... just look and compare - in what dire conditions are our 
hospitals... ' (Respondent TB06) 
Representatives of primary care consider that they do not receive sufficient financial support, 
including from international agencies, to deliver either TB interventions or other disease 
interventions. Representatives of primary care express concerns that there are no mechanisms 
for on-going support to implement TB activities: 
62 GUIN is a Russian abbreviation of the Department of Execution and Punishment. 
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`This is a question, this is a big question - whether our health system will be able to 
afford what we were receiving from Project Hope. Question of financial 
sustainability... At present we have absolutely no financial support. I appreciate what 
Project Hope did - purchased microscopes, supplies, trained staff... Yes we integrated - 
integrated everything, but what about ongoing financial support... ?, 
(Respondent PHCO1) 
There has been a growing acknowledgement that parallel GFATM financing does not contribute 
to evolvement of community TB care. Funds do not reach patients effectively: 
`The money, which comes from the Global Fund has not yet smoothly found its way to 
the end users. So this is a channelling of the money and flow of funds - [they] do not 
reach yet the level of end users to an extent, which would be satisfying. ' 
(Respondent TB09) 
8.3.2. TB services infrastructure and laboratory network 
As has been discussed earlier, this study finds that structural reform of TB services has been 
limited to closing down TB dispensaries at rayon levels. In the period from 1997 to 2008, TB- 
bed capacity has been reduced63 from 9.4 to 6.7 TB beds per 10 000 population, respectively 
(RMIC, 2008). As a result of these changes, the network of inpatient TB facilities is being 
concentrated on national and oblast levels. The network includes secondary and tertiary level 
TB inpatient facilities with specialisation for adults and children. TB bed capacity differs across 
regions (Table 8.5). Out of the existing 3520 TB beds (in 2008), 1020 (28.9%) are dedicated for 
inpatient care for children; and 1140 (32.4%) beds are dedicated for tertiary care (and 
rehabilitation). The penitentiary sector hosts two TB hospitals with a total capacity of 240 TB 
beds (both hospitals are in Chui oblast's prisons). Kyrgyzstan has a well-established network of 
primary care (Table 8.6). 
The diagnostic network has a hierarchical structure headed by the National Reference laboratory 
(NRL) of the NCPh. At the time of data collection, it was reported that drug susceptibility 
testing is done only at the NRL. A network of microscopy laboratories has been expanded to 
primary care providers (Tables 8.5 and 8.6). Bacteriological culture is performed in 13 
63 Most of reduction of bed capacity has been implemented in 2001-2003. 
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laboratories (including NRL), which are located in oblast TB centres or TB facilities under 
republican jurisdiction. 
Table 8.5 TB services capacity, Kyrgyz Republic, 2008 
Region 
Population, 
'00Os 
No. 
Inpatient 
TB 
facilities' 
Bed 
capacity 
(all facilities 
in the 
region) 
TB beds per 
10 000 
population 
Laboratories 
performing 
bacteriology 
Laboratories 
performing 
only 
microscopy 
Batken oblast 428.5 4 190 4.4 1 3 
Osh oblast 1081.3 6 570 5.5 1 4 
Osh city 250.2 1 100 2 
Jalalabad oblast 987.1 7 584 6.5 1 3 
Naryn oblast 270.6 1 65 2.4 1 1 
Issyk-Kul oblast 433.7 1 60 1.4 1 
Talass oblast 218.5 2 120 5.5 1 1 
Chui oblast* 761.2 4 321 3.8 2 1 
Bishkek city, capital 819.0 3 370 4.5 1 1 
Republican 
jurisdiction (n=6)** 
1140 3 3 
Kyrgyz Republic 5250.1 31 3520 13 17 
Source: Republican Medico-Information Centre, Kyrgyz Republic 
' Four tertiary-level facilities (including NCPh), 25 secondary level facilities" (9 Oblast/city TB Centres, 11 TB hospitals at 
city/rayon levels and 5 TB dispensaries on rayon level), and 2 rehabilitation centres (republican jurisdiction) for TB patients. Five 
out of 11 TB hospitals and one of rehabilitation centres are dedicated for children care. 
2 The laboratories also have microscopy 
3 National Reference Laboratory is included into the count 
4 Included in the preceding count 
"" Republican level facilities and NCPh, tertiary level facilities 
Table 8.6 PHC providers Involved in delivery of TB control interventions, Kyrgyz 
Republic. 2008 
Family 
Medicine 
Centres 
FMG 
(affiliates of 
FMC) 
FMG 
(independent 
organisations) 
Centres of 
General 
Practice 
Laboratories 
performing only 
microscopy 
Batken oblast 7 83 - 2 9 
Osh oblast 9 112 13 
Osh city 7 40 3 
Jalalabad oblast 11 138 1 5 14 
Naryn oblast 6 45 1 6 
issyk-Kul oblast 7 41 13 2 8 
Talass oblast 4 34 2 1 6 
Chui oblast 9 86 5 1 10 
Bishkek city, capital 19 99 - - 18 
Kyrgyz Republic 79 678 21 12 90, 
Source: Republican Medico-Information Centre, Kyrgyz Republic 
1 There are 3 microscopy labs in Bishkek in 3 specialised polyclinics. 
64 At the time of data collection, there also were 6 TB departments at the rayon territorial hospitals (general health 
services). These would be closed down as per TB services reform concept MOH (2008c). 
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Respondents noted that TB inpatient facilities are old (many were built in the 1960s-1970s) and 
in poor condition. The relative exceptions are a few facilities renovated with financial support 
from donors65. In economically underdeveloped regions, some facilities have interruptions of 
electricity and water supplies. In several hospitals, patients are being treated in wards up to 6 
persons with poor ventilation. Lack of infection control in TB hospitals, as well as in health 
care facilities in general, has been mentioned as a key challenge for TB control. There are no 
funds for infection control equipment for staff such as proper respiratory protection. 
8.3.3. Anti-TB drugs 
The TB programme has a centralised system of anti-TB drugs procurement and distribution. 
The first-line anti-TB drugs are distributed in line with the hierarchical organisation of the 
programme (Figure 8.3). High quality first-line anti-TB drugs are being purchased through the 
Global Drug Facility (financed at present by GFTAM, previously by KfW). The county 
reportedly keeps 6 months stock at the national level. The drugs are then distributed to the 
Oblast TB centres, which have a quarterly stock for all patients on treatment in the oblast (3 
months supply). A rayon TB coordinator takes a supply of drugs for each patient discharged 
from a hospital, a supply necessary to complete treatment in an outpatient setting. 
A key problem noted by some respondents is that anti-TB drugs such as isoniazid, rifampicin, 
and some antibiotics used in treatment of MDRTB are available in some private pharmacies. 
Representatives of the NCPh noted that despite their efforts to ban the selling of anti-TB drugs, 
especially isoniazid and rifampicin, these were not successful. The NCPh pointed that without 
effective regulatory mechanisms it is challenging to prevent all private pharmacies from selling 
anti-TB drugs without prescriptions. 
8.3.4. Human resources 
According to official sources, in 2008 Kyrgyzstan's health system employed 241 TB doctors 
and 1857 family doctors (with 5333 new TB cases in 2008 that is 4.5 TB doctors per 100 new 
TB patients; or 0.5 TB doctors per 10 000 population). Only TB specialists have the right to 
confirm TB diagnosis, prescribe treatment and make decisions about treatment outcomes. 
65 Penitentiary TB facilities funded by ICRC, and facilities for MDRTB treatment funded by GFATM in Bishkek city 
and under NCPh jurisdiction. 
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Most respondents perceive this human resources situation as a crisis. As has been discussed in 
Chapter 7, human resources challenges in Kyrgyzstan's health system include concentration in 
urban settlements and shortage in rural areas, low salaries, high work load, lack of incentives 
and overall often low motivation. According to respondents in this study, the medical 
profession, and particularly phthisiatry, is not considered prestigious: 
`Phthsiatrist, especially on level of FMC, is not a prestigious job, nobody pays attention 
to our problems. Everything is on us. The TB problem is right at the end, and the 
general assumption is that we work only with ex prisoners and risk groups. ' 
(Respondent TB07) 
There has been a notable outflow of personnel from the health system either because of change 
of occupation or labour migration to Russia and Kazakhstan. As relates to the TB programme, 
respondents reported that many qualified, experienced or trained personnel leave their jobs. 
Donors invest considerably through training of health personnel in new skills (e. g. sputum 
microscopy, M&E). Ironically, training that is provided by international donors (with issued 
certificate) is often used to get employment elsewhere: 
`We conduct annually 3-4 trainings for laboratory personnel. Substantial money is 
spent, substantial, all donors' funding. Give certificates - CDC s, GFATM's trainings 
- and with these certificates they leave. Therefore, training is very good, we prepare 
them well. We are given money for this - we teach them, train them - but... they do not 
have the motivation to stay. '(Respondent TBO 1) 
8.4. FLEXIBILITY (ADAPTABILITY) 
This section presents my analysis of how and why health system arrangements for the TB 
programme have changed, or not, in support of the introduction of the policy innovations, 
DOTS and MDRTB management. I focus on changes in the providers' payment mechanism, 
clinical management of TB patients and organisation of service delivery. 
As highlighted previously, in general the country is committed to implementing WHO- 
recommended policy for TB control. Indeed, some domestic respondents hold the WHO's 
expertise in high regard: 
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'WHO developed standards of treatment based on evidence... and if the whole world 
follows this approach - why should not we? .... DOTS is a very good programme; it is 
just not everyone understands it right. Many think it is only about the last letter Y, but 
the first three letters - this is a cornerstone of everything - directly observed treatment. ' 
(Respondent TB06) 
The NCPh, the main TB control policy institution, however, emphasises that the country is 
adopting internationally-recommended approaches whilst at the same time taking into account 
historical approaches, scientific experience and feasibility (MOH, 2006, MOH, 2009). These 
may, at times, be contradictory. 
8.4.1. Resource allocation and payment mechanisms for TB providers 
Previous empirical research conducted in Russia showed that providers' payment mechanisms 
have important implications for the efficiency of the TB programme in the FSU context. Input- 
based payment, either based on number of registered TB patients or number of beds, creates 
perverse incentives to retain inpatient TB facilities and continue unnecessary hospitalisations 
(Atun and others, 2005e, Floyd and others, 2006). 
Kyrgyzstan initiated changes in financing of inpatient TB facilities in 2008 (MOH, 2008a, 
TheGovernmentKyrgyzstan, 2006b). This was 10 years after adoption of DOTS. Until then the 
budget formulation and payment to TB services was based on historical fixed line-items per 
facility. At the time of data collection, the TB services were on their second year of financing 
reform. Thus, it was early to identify any impact on efficiency. Nevertheless, an analysis of 
financial changes identified several barriers impeding a shift towards community-based, 
efficient, patient-oriented TB care. 
Changes in fmancing are input oriented. Each TB hospital is paid (i. e., receives an annual 
budget) based on number of expected hospitalised cases and average reimbursement rate per 
case. Expected number of cases is estimated based on historical data from the number of 
admissions for the previous year. Average reimbursement rate is adjusted for case group, 
geography (mountainous area, remote cities, rural, urban), hospital type (national, oblast, rayon, 
and adult/children's), and expenses for the ambulatory-diagnostic department (MOH, 2008b). 
In 2009, there were 5 reimbursement case groups based on treatment category (cost of drug 
regimen) and deemed maximum length of stay. These categories were (from lower 
reimbursement rate to a higher): (i) a person with a differential diagnosis (i. e. a suspect of TB), 
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(ii) a newly diagnosed TB case, (iii) a previously treated case, (iv) a chronic case requiring 
surgery, and (v) a MDRTB or a poly-resistant TB. 
Consequently, hospitals that treat more patients, diagnose and manage more clinically 
complicated patients, or have more admissions receive larger funding. Such payment 
mechanisms also create perverse incentives to keep large republican-level tertiary facilities and 
oblast level hospitals. According to the regulation (MOH, 2008b), TB hospitals are given 
financial autonomy within the allocated budget and may reinvest any savings (e. g. retention of 
personnel through salary's incentives, etc). However, respondents noted that possibilities to 
save the funds are limited as the allocated state budget is in deficit: 
'These are the same money, there is no increase in funds... the same budget with deficit 
already.... ust redistributed...... those hospitals that treat more, receive more funds. 
Perhaps there is some flexibility, but how would one save money. ... and increase 
salaries so to retain staff if electricity, food and other expenses are going up... ' 
(Respondent TB02) 
An oversight over allocation of resources, according to regulations, remains within interested 
parties - the MOH and the NCPh. These agencies are given the main responsibility for 
monitoring hospitalisation and performing cost analysis (MOH, 2008b). 
The health system's financial mechanism does not address a lack of linkage or coordination in 
resources planning and allocation among inpatient TB facilities, primary care providers or TB 
services in penitentiary sector. Primary care providers are paid per capita, based on number of 
enrolled population (presented in the Chapter 7). There is no performance-based element in 
payment to primary care providers as relates to TB care despite that fact that they oversee TB 
treatment after patients are discharged from hospital. 
8.4.2. DOTS implementation: changes in TB service delivery 
The study finds that partial changes in clinical management of drug-susceptible TB have taken 
place. According to representatives of TB services, WHO-recommended standardised treatment 
regimens for drug-susceptible TB are strictly followed. However, application of pathogenic 
therapy and surgical interventions as treatment modality continues. Capacity to conduct passive 
case detection at primary care level has been improved. Kyrgyzstan continues to conduct 
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selective fluorography screening among risk groups66. Screening of children for TB infection 
using the Mantoux test and preventative treatment using isoniazid continue. Kyrgyzstan has 
adapted the TB registration system67 to incorporate WHO recommendations for classifying TB 
cases based on epidemiological criteria (sputum positive or negative) and history of previous 
treatment. 
A network of specialised TB facilities has been retained, with increased centralisation of 
inpatient care at secondary/tertiary care. My analysis finds that there is persistent overreliance 
on specialised TB services for TB diagnosis, treatment, rehabilitation and social support. 
Nearly all newly diagnosed and relapse adult TB cases, irrespective of sputum-positivity, are 
admitted to hospitals during an intensive phase of treatment (2-3 months). Treatment of 
children and adolescents with confirmed TB disease or infection (prophylactic treatment) is 
being delivered, as a preference, in hospital settings. Though regulations require hospitalisation 
for TB treatment only during the intensive phase (except of MDRTB), there are no clear 
guidelines with regards to repeated hospitalisations. Decisions about hospitalisation are made 
on an individual basis: 
`We decide depending on the situation. If it is better to complete treatment in the 
hospital - then we keep a patient in the hospital. For example, if the patient has a big 
family, no normal living conditions in the place of residence. But, there are also cases 
when the patient cannot or does not want to be treated in the hospital even if it is 
prescribed. ' (Respondent TB07) 
Hospitals serve as social-support institutions: `considering the socio-economic situation of some 
contingents ofpatients (poor, homeless, those with many children, etc), the national coordinator 
recommends conducting treatment in the intensive phase as well as in the continuation phase in 
an inpatient setting' (MOH, 2006, MOH, 2009). 
Inclusion of passive case detection and treatment observation by primary care providers (i. e. 
family doctors) are viewed as an important achievement of the health system reform and TB 
programme. Recognised benefits of integration include improved access to TB services for 
patients, and acceptance in the communities: 
66 The risk groups include: all health care workers, HN-positive persons, all persons with underlying chronic 
diseases (i. e. diabetes, lung diseases), migrants, those who have completed TB treatment and have residual changes in 
the lungs, or contacts with persons who diagnosed with active TB. 67 TB dispensary registration system. 
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'services became closer to people, to communities - instead of [travelling] to other 
rayon to TB hospital or dispensary, patients are close to their family, to communities.... 
Integration with primary care is necessary, and should be strengthened further. ' 
(Respondent TB07) 
Detailed analysis in this study reveals that interactions between TB services and primary care 
providers are limited to coordination of service delivery. Confirmation of TB diagnosis or any 
other decisions about TB treatment are made exclusively by a TB specialist. Even if a person is 
found sputum-positive by a primary care provider, sputum microscopy and other clinical 
investigations are repeated upon referral to TB services. Functions of family doctors are limited 
to observation of treatment and timely referral to a TB specialist. Family doctors make no 
decisions about TB treatment (e. g. prescription of anti-TB drugs). 
Several respondents reported that primary care performs well in implementing passive case 
detection. However, they also state that overall, primary care has a weak capacity to implement 
treatment observation accordingly. Representatives of TB services stated that DOT is not 
necessarily followed and drugs are being given for several days ahead. Along with delivering 
TB interventions, family doctors carry out responsibilities for other vertical programmes (e. g., 
STDs, mental health). Every programme has different reporting and M&E requirements. 
Family doctors, and all staff at primary care, are overworked; often having to spend 
considerable time on administrative paperwork. One respondent explains the situation: 
'On the stage of case detection, it works well. Regarding treatment follow-up, primary 
care certainly does not have resources for observing each patient directly. This is 
understandable, as primary care implements many programmes not only anti- 
tuberculosis... This is a question of workload, or as we can say, rational allocation of 
tasks which primary care can implement effectively. ' (Respondent TB 10) 
8.4.3. Health system response to MDRTB 
The study finds that the health system's response to MDRTB has been slow and fragmented. 
There is no universal access to MDRTB diagnosis and treatment. Access to treatment is limited 
to those patients enrolled into GFTAM-funded pilot sites. There is a plan to treat 1180 MDRTB 
patients over the course of 5 years (GFATM round 6 grant, 2007-2012) (CMCC, 2009). By the 
end of 2009,550 patients have been enrolled into the treatment (GFTAM, 2010a). At the same 
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time, the country reported 785 confirmed MDRTB cases (WHO, 2010a, WHO, 2010b). The 
destiny of detected MDRTB patients, who are not enrolled in DOTS-plus, is not clearly 
communicated, and thus is unknown. Treatment of MDRTB is centralised and decisions on 
patient's enrolment into the treatment programme are made by the NCPh. The criteria on what 
basis patients are being selected for MDRTB treatment are not clearly defined nor 
communicated. 
Several factors played a role in this response. Implementation of MDRTB management solely 
depends on approval from international donors (e. g. GLC regulations), followed by the 
disbursements from GFATM. The country does not have independent capabilities to expand 
capacity for MDRTB diagnosis and treatment (e. g. purchase 2°d line drugs). Treatment of 
MDRTB is centralised (through a national coordinator at the NCPh). Pilot sites are organised at 
NCPh, Jalal-Abad and Osh oblast TB centres. MDRTB patients are treated in hospitals over the 
whole course of treatment (18-24 months). 
The strategic focus for responding to MDRTB has been on highly specialised care. As I 
presented earlier, the NCPh and the MOH envision further specialisation of existing TB 
inpatient facilities. According to some respondents, particularly domestic, specialist hospitals 
are necessitated by the extent of the TB epidemic68, lack of infection control capacity in all 
inpatient facilities in the country, and a lack of financial and other resources to rapidly 
strengthen capacity for MDRTB treatment. The perceived threat from MDRTB patients is cited 
as one of the reasons for further specialising TB hospitals. Here is how an official country 
policy document articulates the issue: 
`In the current structure, in hospitals patients with different types of TB receive 
treatment (in one hospital) - newly diagnosed, MDRTB, chronic cases. Hospitals are 
located in places with high population density (e. g. Bishkek city, Osh city, Naryn, and 
other oblast and rayon centres); very often patients move freely, and as a result can 
infect environment and population. ' (MOH, 2008d) 
68 Respondents and documents often referred to only when level of TB incidence will be below the level of 50 cases 
per 100 000 population integration of anti-tuberculosis services with general system on all levels be possible.. Some 
respondents explained that this level is a WHO definition of TB epidemic. 
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Further, key national policy makers consider isolation as one approach for MDRTB control: 
`...... isolation of chronic cases and MIDRTB is a solution. We lobby this question on a 
higher level, there is support. Otherwise, where should we put these patients? 
Primarily socially vulnerable. Now some departments are already being changed to 
caring for chronic cases.... if we want to conquer TB, it is perhaps the time to undertake 
radical measures. They will be isolated whilst infectious, whilst they are a source of 
infection... yes the issue of human rights exists, but I am not saying to lock them -I am 
saying to create acceptable living conditions in such institutions, as they did in 
Estonia. ' (Respondent TB02) 
Options of ambulatory treatment of MDRTB were not being considered at the time of data 
collection. Concerns about the slow response to MDRTB, and the focus on centralised and 
highly specialised care, were expressed by a respondent who represents an international agency 
working in Kyrgyzstan on MDRTB management: 
Disaster might come later, especially TB/HIV, MDRTB/HIV. The speed by which the 
response is given is very crucial. It is not a solution to have a plan - this patient will be 
treated in 5 years. All depend on skills, capacity of the National Centre of Phthisiatry... 
they keep them in the hospital for 2 years... once a patient has become non-infectious 
they could be treated in an ambulatory setting... But it is not done although it is 
recommended by international standards... There is a need to accelerate the 
decentralisation of MDRTB treatment' (Respondent TB 11) 
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8.5. INTERACTIONS 
`What the WHO was saying in 1998 about multisectorial approach, in this area things 
did not quite work out yet.... a multisectorial approach to TB treatment should actually 
be multisectorial. But what we have - we doctors struggle on our own. To some extent 
social services also express interest. The Ministry of Justice also does something on its 
level... But a unifying, clear and effective strategy, which all would follow, for some 
reason, we do not have it. '(Respondent TB06) 
In this section I present my results and analysis of the TB programme's interactions with other 
health system components (Table 8.7). In summary, the TB control programme in Kyrgyzstan 
remains predominantly comprised of specialised TB services. TB services are centralised and 
separately financed, planned, delivered and evaluated with limited interactions with specialised 
HIV services, and the general health system. Formal coordination with the primary care 
programme, and between civilian and penitentiary sectors (including pre-detention or remand 
prisons) have been established and reportedly improved as compared to the Soviet period. 
These improvements have been, to some extent, attributable to donors' projects. I earlier 
reported that a major impediment for further improvement of interactions between services 
analysed in this study is the lack of coordination in planning, and allocation and evaluation of 
financial resources. Several aspects of interactions, particularly as relates to interactions 
between TB services and primary care, have been presented earlier. I provide additional 
findings below. 
TB services in penitentiary and civilian sectors 
There is formal coordination between civilian and penitentiary TB services in governance, 
service delivery and monitoring and evaluation of DOTS. The policy and regulatory framework 
explicitly outlines (TheGovernmentKyrgyzstan, 2006 ) roles and responsibilities of the MoH 
and the MOJ, and coordination of efforts. There is a formal national coordinator appointed in 
each Ministry and guidelines on release of prisoners who are still on treatment to civilian TB 
services. It was mentioned by all respondents that coordination in governance on a national 
level between two Ministries has improved in recent years. Efforts have been put forward by 
international actors such as, for example, establishing HLWG on TB control by the Project 
Hope. 
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A representative of an international agency explains changes in interactions: 
`Retrospectively, certainly coordination of efforts between the penitentiary and civilian 
sectors has improved, because there were times when it was difficult to sit at one 
negotiation table representatives of the penitentiary system and the Ministry of Health, 
in particular of phthisiatry services. At present this issue is being solved. ' 
(Respondent TB 10) 
However, improvements in coordination of transition of ex-prisoners to the civilian sector are 
largely supported by donor agencies. ICRC and MSF provide on-site facilitation with the 
implementation of DOTS, and management of MDRTB, including management of co- 
morbidities such as malnutrition and HIV/AIDS. Success stories related to the transition of ex- 
prisoners and their adaptation back to communities are implemented within donors' pilot 
projects by HIV-service NGOs (presented in details in `HIV/AIDS' chapter). ICRC and MSF 
also facilitate transition of released prisoners, who are still on TB treatment, to the civilian 
sector. 
Aside from donors' supported projects, in practice, critical problems with transition of ex- 
prisoners back to civilian communities have not been solved. These problems relate to 
registration of prisoners with civilian organisations (e. g. police), access to health and social 
care, and default in TB treatment among ex-prisoners persists. Sometimes, representatives of 
TB service providers blame donors, the penitentiary sector overall and the behaviour of ex- 
prisoners: 
`This is all the fault of international donors - renovated their hospitals according to 
'Euro standards, these prisoners are getting released and they then do not want to get 
treated in our conditions. ' (Respondent TB07) 
Stigmatisation of ex-prisoners has been mentioned as an impediment for their transition back to 
civilian life. According to representatives of international organisations (e. g. ICRC, MSF), 
there is overall negative attitude towards ex-prisoners even from providers of TB services in the 
civilian sector: 
'Ex-detainees tell us they are not treated well and this is why they go away. And this is 
not only their fault; it is lack of education in a system which does not really support 
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them. And whenever we have an ex prisoner whom we want to send to Vorontsovka69, 
the TB coordinator would tell us `if I take him -I would not be able to take a child in 
his place... '- they [TB specialists] feel that they actually do not deserve it [treatment] 
or do not appreciate it. ' (Respondent TBO5) 
TB and HIV/AIDS services 
As has been noted earlier, there have been considerable efforts within GHI, led by USAID, to 
establish a foundation for linkages between these services in governance, service delivery and 
information system. My analysis in this study indicates that these interactions (as existed at the 
time of data collection) are limited to the national level. Where local coordination of service 
delivery exists it is limited to activities within donors' projects. A thematic group on TB/HIV 
(High Level Working Group at the NCPh) was set up in 2006. National coordinators at the 
NCPh and Republican AIDS Centre have been assigned as point contacts with regard to 
TB/HIV patients. There is exchange of information through meetings and conferences. 
National clinical protocols on management of TB/HIV based on WHO recommendations have 
been developed. 
These services in principle remain separate as relates to financing, service provision and M&E. 
Interactions in service delivery are limited to HIV testing at TB facilities upon diagnosis. 
Isoniazid prophylaxis among HIV-positive persons, if prescribed, is administrated by HIV 
services. Similarly, if a patient requires both TB and ART treatment, he/she attends each 
service separately to receive treatment. In terms of GFATM funding, separate principle grants 
recipients (e. g., the NCPh for TB programme and Republican AIDS centre for HIV/AIDS 
programme) do not contribute to closer interactions. Information between services is shared 
only on request. Analyses in this study indicate that lack of robust M&E systems, and linkages 
between, in both programmes potentially might impede further evolvement of interactions: 
'Programmes in principal are still vertical. For TB - it is TB/HIV, - for HIV - it is 
HIV/TB. Thus, there is tension - yours'- 'ours'. Of course they clearly need to see 
evidence - but what do they see? There are not too many cases. '(Respondent HS03) 
Several respondents reported that the HIV/AIDS programme is more concerned about 
interaction, particularly its HIV service NGOs (though also supported through donors' projects): 
69 Vorontskovka - department of NCPh, where MDRTB patients receive treatment. 
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'HIV community is much more concerned. They are very much aware, but not the other 
way around. Not the TB community. Now HIV services, HIV institutions - they try to 
attract attention from TB services, from TB facilities - because they have some 
percentage of HIV, 'TB patients, and of course they have some problems with screening 
for TB, diagnosing TB, and treating TB.... ' (Respondent TB05) 
8.6. PERFORMANCE 
8.6.1. Effectiveness 
Based on available secondary data and weaknesses of TB surveillance, it was difficult to judge 
the TB programme's performance. Kyrgyzstan reports a universal access to DOTS. There has 
been 100% DOTS coverage in the civilian sector since 1999, and in the penitentiary sector since 
2005. TB case detection of sputum-positive pulmonary cases has varied over the years, 
indicating a trend towards improvement. The 'most recent WHO report estimates 65% case 
detection rates in the last five years (WHO, 2010a). The proportion of BK+ TB cases70 grew 
from 26% in 1998 to 45.7% in 2008. However, there is substantial year-to-year variability 
across regions (Figure 8.2. C). Treatment success among sputum-positive pulmonary cases has 
been reported consistently above 82-84% since 1998 (MOH, 2006, MOH, 2009, WHO, 2010a). 
Among the successful outcomes, 80-81% are reported as cured and 4-5% as completed 
treatment ()WHO, 2010a). 
Coverage and access to MDRTB diagnosis and treatment is limited. According to official 
sources, around 20% of notified new cases as well as previously treated are being tested for 
drug susceptibility (WHO, 2010). National stakeholders reported during the interviews that 
they do not monitor development of MDRTB during the course of TB treatment. Development 
of MDRTB during TB treatment is arguably one of the key indicators of quality of treatment. 
As of the end of 2009,550 MDRTB patients out of 785 identified patients were undergoing 
treatment. Treatment outcomes for MDRTB have not been officially reported. 
70 BK+ are either sputum positive or bacteriologically confirmed TB cases, or both. 
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8.6.2. Efficiency 
Average length of hospital (ALOS) stay in 2008 for adults with TB was 60.1 days (ranging 45.8 
to 75.2 days across regions), and for children 87.2 days (range 63.3 - 118.4 days) (Table 8.8). 
The earliest data on ALOS that were accessible during the data collection were for 2002, and 
these indicators have not changed (RMIC, 2002, RMIC, 2008). Data on ALOS for years prior 
to DOTS adoption were not accessible. Judging from research conducted in Russia where 
ALOS was 86 days for adults prior to DOTS (Marx and others, 2007), length of adult's hospital 
stay for TB treatment in Kyrgyzstan has likely been shortened as compared to practices existing 
during the Soviet period. 
Nevertheless, inpatient TB treatment for 2-3 months for all patients including sputum-negative 
patients is an extended hospital stay. There is empirical evidence that once treatment of drug- 
susceptible TB patients with effective anti-TB drugs is started, the infectiousness of a patient 
might be minimal within around 2 weeks (Harries, Maher, and Nunn, 1997, Riley and others, 
1962). Even though there is variability in response to treatment, when there is clinical evidence 
that a patient clearly responds to treatment he/she can be treated on an outpatient basis. 
In 2008, TB beds were occupied on average 335 days (ranging across regions 282-377 days), 
which equates to 92.6% bed occupancy for the year (across regions - from 77.2% to 103% of 
the year) (Table 8.8). Number of hospital admissions per bed per year was 4.2 nationally, 
ranging from 1.7 to 6.3 across the regions. Nationally, there were nearly 3 times more hospital 
admissions than number of newly notified TB cases (admission/new case ratio varied from 0.95 
to 2.8 across the regions) (Table 8.8). This is suggestive of inefficiencies of TB services. These 
findings echo findings of studies conducted in Russia (Floyd and others, 2006) that have shown 
inefficiencies associated with overcapacity of TB beds and unnecessary hospital admissions. 
There is a perceived shortage of human resources in the TB programme (presented in the 
section `Human resources'). Though I have not assessed workload of medical personnel, there 
might be potential inefficiencies related to the number and functional responsibilities of TB 
doctors. As has been presented earlier, there are 241 TB doctors currently working in the 
system. On average, there are 5500-6000 new TB cases notified each year, whose treatment is 
6-8 months. Each doctor therefore should be caring, on average, for approximately 10-15 TB 
patients at any one time, which is not a high number of patients. 
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8.6.3. Equity 
As was discussed earlier in this Chapter, TB stigma exists particularly as relates to patients who 
represent marginalised groups (i. e. ex-prisoners). I was not able to assess in this study whether 
the quality of TB care for these groups of patients differs from other patients. Other authors 
found that TB stigma contributes to less attention to their needs from health care providers in 
general health services or communities (Dodor and Kelly, 2009, Dodor, Kelly, and Neal, 2009). 
Overall, efforts to systematically conduct health education in communities and reduce stigma in 
Kyrgyzstan have been limited: 
'Overall, there is a serious stigmatisation of the problem, up till now, in my opinion, 
there is overall belief that TB is an untreatable contagious disease. Even if the patient 
is coughing more than two weeks... he does not go to health services.... afraid.... There 
is a need to strengthen the work with communities, more actively conduct explanation 
activities. ' (Respondent TB 10) 
SUMMARY FINDINGS 
In conclusion, this chapter revealed several impediments to the sustainability of the TB 
programme in Kyrgyzstan. 
The Government of Kyrgyzstan declares political commitment to implementing internationally 
recommended approaches to TB control. Despite these political declarations, the establishment 
of community-based care of TB patients is hampered by prevailing reliance on, and retention of, 
hospital-based TB services. This contradicts the public health objective to establish efficient 
approaches to TB control. Furthermore, the response to the potentially serious MDRTB 
problem is being framed as having only one option; to continue practices of specialised 
hospitalised TB care. Given the country's limited resources, such a strategic approach may 
contribute to an inability to meet the financial cost of MDRTB management, in addition to 
perpetuating inefficiencies. The programme's leadership is characterised by centralised and 
formal authority, dominated by one institution - the NCPh. This has been determined by the 
health system's arrangements for the TB programme's governance and organisational 
arrangements. Verticality was supported by donors, most notably in the way funds were 
channelled. Participatory decision making and involvement of other actors is limited to donor- 
supported projects, otherwise decision making is dominated by the NCPh. 
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Political commitment to TB control is supported partially by governmental funding. The state's 
guarantees for all TB interventions are firmly embedded in the country's legislation and state 
funding streams (i. e. into the state's budget). Implementation of DOTS and MDRTB 
management to a considerable degree depends on international funding. Domestic resources 
(managerial capabilities, funds, human resources) are concentrated in inpatient facilities located 
at national and oblast levels. 
Financial mechanisms for the TB programme pose critical impediments to sustainability. 
Domestic financial mechanisms (planning, allocation) are fragmented; needs of patients facing 
multiple comorbidities are not being taken into account. Fragmentation in financing and 
vertical financing (both domestic and international) emerged as a key factor impeding further 
evolvement of interactions between TB services and other health system components. 
Effective mechanisms for evaluating investments in TB control have not been established. 
Declaratively, domestic TB actors are willing to implement innovative approaches in TB 
control. However, implementation of innovations depends on external financial assistance. 
Overall the programme's domestic actors demonstrate limited flexibility in changing the 
delivery of TB care. Despite implementing DOTS for over a decade, a shift to community- 
based TB care and support has not occurred. Hospitalisations remain a dominant approach to 
TB care. Social support and the response to MDRTB are framed as relying on specialised 
inpatient care. 
Overall, the TB programme, which is comprised primarily of specialised TB services, has 
limited interactions with the broader health system. 
Performance of the programme appears to be sub-optimal, however full assessment of 
performance was not possible in this study because of weaknesses in TB surveillance and lack 
of robust monitoring of MDRTB and TB/HIV problems. This study finds that inefficiencies in 
TB service delivery likely persist. 
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CHAPTER 9 SUSTAINABILITY OF HIV/AIDS CONTROL 
PROGRAMME 
INTRODUCTION 
`Certainly, investments of such substantial amount of funds resulted in very dynamic 
developments, and introduction and even scaling up delivery of interventions in 
general. How effective are these interventions or projects? This question has emerged 
only because here are substantial money channelled to HIV/AIDS. We started to think 
about that. Iffinancing would been only from the state's budget, we would be worrying 
and thinking more about mobilizing resources instead of effectiveness of 
investments..... ' (Respondent HIV04) 
This chapter aims to explore sustainability of HIV/AIDS programme. Similar to other FSU 
countries, 11V has emerged as a novel public health problem to a newly formed state (Chapter 
2). Prior to 2000, most HIV cases in Kyrgyzstan were assumed to be imported from abroad as 
cases were detected primarily among foreign citizens. In the period from 1987-2000, the 
Kyrgyzstan health system detected 14 HIV cases among its citizens (Table 9.1). A notable 
outbreak of HIV among IDUs in Osh city was reportedly detected in 2001 (Osmonaliev, 2005). 
Since 2001, the number of detected 11V cases has been increasing rapidly (Table 9.1). 
UNAIDS defines the epidemic in Kyrgyzstan as a low prevalence (<0.1% in adult population) 
or concentrated epidemic among IDUs (UNAIDS, 2010 ). Over the last 15 years, the 
HIV/AIDS control programme has been evolving with substantial technical and financial 
assistance from international organisations. As has been discussed in the Chapter 7, in the 
middle of 1990s Kyrgyzstan's political climate was marked by openness to western 
international organisations and ideas, a proliferation of NGOs and relatively free mass media. 
A UNDP thematic group on HIV/AIDS was set up in 1996, with the aim to mobilise response 
and advocacy in preventing HIV/AIDS epidemics". Even though there were only a few 
detected HIV/AIDS cases, national policy makers declared their political commitment72 to a 
multisectorial response in preventing HIV/AIDS epidemics. Needle and syringe exchange 
projects were piloted73 in 1999 in the civilian sector, and in 2000 in penitentiary sector. 
" UNDP and the Government signed an agreement to conduct a joint project on 'Prevention of STDs/HIV, 1997- 
2001'. Within framework of this collaboration, a first governmental programme 'On prevention of STD/HIV/AIDS, 
1997-2001' (ret) has been approved by the State. 72 Including commitment to signed international declarations, treaties and conventions on HIV/AIDS control and 
revention and human rights. 
Two Pilots in Bishkek and Osh city. UNDP and Soros Foundation/the Open Society Institute . 
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Kyrgyzstan has been a pioneer in the FSU region to pilot methadone replacement therapy, first 
in the civilian sector in 2002, and in prisons in 200874. ART is delivered since 2005 and fully 
funded by the GFATM grant. 
In my research, I assess a programme's sustainability by analysing five programme 
characteristics: leadership, capacity, flexibility (adaptability), interactions, and performance 
(Chapter 5). This chapter is structured similarly to the previous chapter (Chapter 8), by 
presenting these characteristics in separate sections I begin the chapter by presenting an 
analysis of HIV/AIDS surveillance data and how the HIV/AIDS epidemic is perceived by 
programme actors. The `Leadership' section assesses leadership of the HIV/AIDS programme. 
This section analyses the strategic aims of the UV/AIDS control programme and how the 
strategy is supported by a legislative framework for HN/AIDS control and illicit drug use 
reduction. I then identify key programme actors, explore their role in HIV/AIDS control efforts, 
and analyse formal governance and organisational arrangements for HIV/AIDS control 
programme to identify whether these influence the programme leadership. 
The `Capacity' section assesses financial resources for the programme, their sources and overall 
expenditure on HIV/AIDS control over time. This section also analyses available infrastructure 
(services) available for delivering HIV/AIDS interventions. I also assess in this section the 
availability and development of human resources, availability, procurement and distribution of 
ART drugs and other medicines, commodities for preventative interventions, available 
information and communication technologies. 
The `Flexibility/adaptability' section presents an analysis related to how health system's 
arrangements for specialised narcology (that traditionally deliver treatment of substance 
dependency) and AIDS services changed to support implementation of innovations. I explore 
in this study two innovations - (i) opioid substitution therapy, and (ii) ART. In the 
`Interactions' section I analyse the interactions between specialised HIV services and primary 
care services, narcology and primary care services, and overall between is of integration 
between state services and HIV-services NGOs. Details of these interactions were also 
presented throughout the other sections. In section the `Performance', drawing on secondary 
data (national statistics and UNAIDS reports), I assess performance of the HIV/AIDS 
programme (e. g. effectiveness, efficiency, and equity). 
74 There are only few countries in industrialized countries, or otherwise, that implement harm reduction in prisons 
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9.1. HIV/AIDS EPIDEMICS IN KYRGYZSTAN 
9.1.1. HIV/AIDS surveil lance data 
As of the end of 2009, the national HIV surveillance had reported a cumulative number of 2561 
detected HIV cases (Table 9.1). This year, the majority of cases (67.4%) were among IDUs. 
During the last several years, Kyrgyzstan also detected HIV cases infected through heterosexual 
contact. As was reported by the study respondents most are identified as sexual contacts of 
IDUs (Figure 9.1). A large outbreak of paediatric HIV cases in a rural town Nookat, Osh oblast 
was detected in 2007, among children below 5 years old who were infected either through blood 
transfusions, other hospital-based invasive procedure, or unknown causes (in later years this 
number grew to 147 children). By the end of 2009, Kyrgyzstan had also identified 52 babies 
who were infected through vertical transmission. Among registered HIV cases, majority were 
young males aged 24-39 years old. Male to female ratio is 3 to 1 (75%/25%). 
Table 9.1 Registered HIV and AIDS cases, 2000-2009. Kyrgyz Republic 
Year 2000' 2001 2002 2003 2004 2005 2006 2007 2008 2009 
New HIV cases 53 149 160 132 161 171 244 409 552 687 
New HIV cases 
(Kyngyzgtan' citizens 
14 134 146 125 153 165 233 388 532 671 
HIV cases, cumulative 14 148 294 419 572 737 970 1358 1890 2561 
IRV cases 
per 100 000 population 
0.3 3.0 3.2 2.6 3.1 3.3 4.6 7.7 10.1 12.8 
AIDS diagnosis, 
cumulative 
1 10 20 34 54 82 108 145 214 
Died (all causes) 
14 8 17 16 31 37 57 55 
from AIDS 10 48 72 124 
TB/NW cumulative 49 112 
270 345 
bourse: Kepubucan AIDS Centre, Kyrgyz Republic 
1cases registered up to 2000. 
According to the recent UNAIDS data, as of the end of 2009 a point estimate of the number of 
HIV infected people living in Kyrgyzstan was 9800, with confidence interval (95%) ranging 
between 6500 and 16000 cases (UNAIDS, 2010 ). The difference between officially registered 
HIV cases and UNAIDS estimates (which, in tum, have wide confidence intervals) is 
considerable. Clearly, there are considerable uncertainties in available data. Problems with 
data are also exemplified with HIV or AIDS associated deaths that are also estimated to be high 
-a cumulative 2600 (1400 - 6500) by the end of 2009 (UNAIDS, 2010 ). Official registration 
system has detected 332 deaths among HIV positive persons. 
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Figure 9.1 Cumulative registered HIV cases, by route of transmission, 2000-2009. 
Kyrgyz Republic. 
Source: Republican AIDS Centre, Kyrgyz Republic. 
Cases by the transmission route(if known) as of 2009: IDUs-1726 (67.4%); heterosexual contact -633 (24.7%), 
paediatric HIV (nosocomial transmission 147 (5.76%), paediatric HIV (mother to child) - 52 (2%). 
As I discussed in Chapter 2, the magnitude and the trends of HIV/AIDS epidemic in the FSU, 
including Kyrgyzstan, are not fully known. The region lacks accurate and reliable data on 
HIV/AIDS and persons at risk (Bernitz and Rechel, 2006). Uncertainties in estimates are 
particularly profound in countries with weak surveillance systems such as most FSU countries 
(Bernitz and Rechel, 2006, Lyerla, Gouws, and Garcia-Calleja, 2008, Walker and others, 2004). 
UNAIDS produces its estimates based on available data from national sources (UNAIDS, 2010 
). At present, HIV/AIDS data in Kyrgyzstan come from the HIV case registry and sentinel 
surveillance among risk groups. The current HIV testing policy includes mandatory testing 
among blood donors, selected occupational groups and migrants from selected countries 
(TheLaw, 2005a). The MOH also recommends routine testing all pregnant women, and patients 
with TB (MOH, 2007a, MOH, 2008c). 
Weaknesses of routine HIV surveillance are well-recognised by some respondents in this study: 
`We have around 2500 cases detected. But according to WHO - this number should be 
multiplied by 4. Our epidemiological department forecasts around 6500 cases.... How 
do we detect them? Those who need a certificate to work abroad, migrants. Women - 
when pregnant, TB patients.... But majority - we cannot reach or find ' 
(Respondent HIV08) 
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In 2004, sentinel surveillance among risk groups75 for HIV infection and their behaviours was 
introduced into functional responsibilities of the Republican AIDS centre. 76 The most recent 
results (Table 9.2) indicate the highest proportion of HIV positive individuals among tested 
IDUs (14%), and prisoners (7%). MSM (4% in 2007), and sex workers (1.6% in 2009) had 
lower rates. Compared to previous years rates of HIV among IDUs and prisoners nearly 
doubled in 2009. However, these results require cautious interpretations, as these are non- 
representative of populations at risk and likely bear considerable uncertainties. A major 
problem, as I illustrate in the following section, is that a size of populations at risk and their 
changes in Kyrgyzstan are unclear. A second issue is that sentinel surveillance among risk 
groups even if implemented with methodological rigour have considerable likelihood of biases 
and errors. These errors might include, but are not limited to, selection biases, incompleteness 
of sampling frame, poor definition of populations at risk, misunderstanding of context and 
behaviour of risk groups that affects ability to reach sufficient representation, and non-response 
biases (Magnani and others, 2005, Malekinejad and others, 2008, Simic and others, 2006). 
Table 9.2 Results of HIV sentinel surveillance among risk groups, 2004-2009, 
Kyrgyz Republic 
Risk group 2004 2005 2006 2007 2009 
IDUs 6.4% 8% 7.4% 7.7% 14.3% 
Prisoners 2.7% 0.4% 3.5% 4% 7% 
SW 1.7% 1.1% 1.4% 1.3% 1.6% 
MSM 0 0 3.5% 4% 
Pregnant Women 0 0.1 0 0.1% 
Patients with STD 0.5% 0.1% 0 0.1% 
Source: Republican AIDS Centre, Kyrgyz Republic 
During my fieldwork and data collection, representatives of RO SPID were not able to provide 
me with detailed information on applied methodology and changes to it. Sampling was 
snowballing or clusters sampling techniques in earlier years, and in 2009 a respondent driven 
sampling (Heckathorn, 1997) has been applied. Sentinel surveillance activities had initially 
included Bishkek city and Osh city only, then, starting 2007, were expanded to include cities 
in Jalal-Abad, Batken and Chui oblasts. 
n IDUs, prisoners, sex workers, MSM, pregnant women and persons with STD. 76 In KYrgYzst, designed and implemented with donors' technical and financial assistance CDC/USAIDS, 2004- 
2006, than CAAP project in 2007 -2009. 
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9.1.2. Population groups at risk of H1V - limitations of available data 
In Kyrgyzstan, reliable data on size of population groups at risk of HIV such as IDUs, sex 
workers and MSM is lacking. Changes in a number or behavioural patterns among these groups 
over time are largely unknown. Kyrgyzstan is not unique in this matter. Globally data on 
prevalence of IDUs in populations is limited or fragmented due to methodological challenges 
with estimating or measuring the size of these marginalised groups (Aceijas and others, 2006a, 
Mathers, Cook, and Degenhardt, 2010, Mathers and others, 2008, ReflGroupUn, 2010). 
UNODC have produced estimates of IDUs twice. In 2001, the estimated number ranged 80 000 
-100 000 (Bashmakova and others, 2009), in 2006 a point estimate was 25 000 IDUs 
(Bashmakova and others, 2009, UNODC, 2008 ). CDC conducted a study in 2007 and provided 
a point estimate at 35 000 (respondent HIV06). WB assessment in 2003 estimated that there 
were around 70 000 IDUs (Godinho and others, 2005a). At present, UNDOC 2006 figures 
suggesting that there are around 25 000 IDUs are used by national stakeholders as a best 
available estimate of IDUs population in the country. UNDOC produces its estimates based on 
assumptions extrapolated from official registration data that captures populations in urban 
settings (or known IDUs `hubs') with rest being imputed (Mathers and others, 2008). 
Estimates of MSM and sex workers also suggest substantial uncertainty. According to national 
sources, number of sex workers might range from 7000 to 10500 (mid- point 4000), and number 
of MSM was estimated from around 5000 to as high as 18000-36000 (CMCC, 2011). 
Illicit drug trafficking and detected HIV cases 
Despite substantial limitations of available HIV/AIDS data in Kyrgyzstan, IDU likely was, and 
remains, an important driver of HIV/AIDS epidemics. Relationships between illicit drug 
trafficking, heroin availability, needle sharing behaviours spread of HIV has been well- 
documented in the FSU (Beyrer and others, 2009, Nabatov and others, 2002, Nabatov and 
others, 2007) other regions (Beyrer and others, 2000, Crofts, Reid, and Deany, 1998). Since 
the early 1990s, central Asian countries are host to key opiates trafficking routes from 
Afghanistan en-route to Russia, Europe and increasingly to China (Madi, 2004, Townsend, 
2006). Kyrgyzstan has experienced continuous increase of new registered opioid (primarily 
heroin). According to national sources the number of registered opioid users (mostly heroin) 
increased from 3261 IDUs in 2000 to 6573 in 2008 (RMIC, 2008). 
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Known major drug trafficking routes through Kyrgyzstan cross Fergana Valley, which hosts 
Osh and Jalal-Abad oblasts, Bishkek city, and several sites in Chui oblast (Townsend, 2006, 
UNODC, 2008 ). The trajectory (temporal and geographical) of HIV/AIDS epidemic appears to 
mirror the pattern of the IDU epidemic in Kyrgyzstan. Geographically, HIV-cases are 
predominantly being detected in four regions, which are located along known drug trafficking 
route (Figure 9.2). It should be noted however that known drug trafficking routes are those 
which are defined by the UNODC based on reports from national law enforcement agencies. 
There are potentially drug trafficking routes which are not known to the law enforcement. 
Based on molecular epidemiology studies on HIV-1 subtypes prevalence and distribution in the 
central Asian region (including Afghanistan) the HIV epidemic likely started through linked 
outbreaks among IDUs and trafficking of drugs to Kazakhstan and Russia. The country likely 
has experienced a nascent pattern (sporadic transmissions with no relations to each other) up 
until middle 1990s. Similar to other central Asian countries, this was followed by linked 
outbreaks among IDUs that led to a larger but concentrated epidemic (on-going transmission but 
limited to this risk group and their sexual contacts) (Beyrer and others, 2009, Carr and others, 
2005, Nabatov and others, 2007, Sanders-Buell and others, 2007). 
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Figure 9.2 Cumulative number of registered HIV cases, by administrative regions, Kyrgyz 
Republic, 2001-2009. 
Out of a cumulative number registered HIV cases (total =2561) in 2009,44% (n= l 128) were in Osh oblast (including 
Osh city), 27% (n=687) in Chui oblast, 14% (n=364) in Bishkek city, and 11% (n=282) in Jalal Abad oblast. 
Source: Republican AIDS Centre, Kyrgyz Republic 
9.13. HIV/AIDS problem definition -perceptions of programme's actors 
In summary of the previous section, there are substantial uncertainties in terms of magnitude 
and geographic areas affected by HIV/AIDS epidemic in Kyrgyzstan. Available data indicates 
nevertheless that IDU is the likely a main driver of the epidemic. I found in this research that 
available data leads sometimes to divergent interpretations about the course of epidemics or 
HIV/AIDS control efforts. Most respondents expressed a view that HIV/AIDS problem is a 
serious socio and health problem. There is overall understanding that HIV/AIDS epidemic is in 
principle driven by IDUs: 
'The driving force of the epidemic remains and continues to be IDUs. Though there is 
transmission to general population, but through close contacts of IDUs... There are 
cases through blood transfusion. Not through donors' blood actually- there are only 
few cases, there is primarily hospital transmission.... (Respondent HIVO6) 
Transmission of HIV in hospital settings is viewed by some respondents as rather 
uncontrollable. Additionally, transmission cases among MSM are viewed as a serious and an 
unacknowledged problem. Below is how these issues had been summarised by one respondent: 
`Among critical moment, we see uncontrolled HIV transmission in clinics. Not only 
here, but also in Uzbekistan, Kazakhstan and Tajikistan, in all countries - nosocomial 
transmission. This is perhaps is most important aspect. We also see that despite an 
overall general trend of feminisation of the epidemic, the epidemic remains 
concentrated among intravenous drug users. We also see hidden infections, infections 
about which nobody likes to talk is among MSM. ' (Respondent HIVO2) 
Lack of transmission in the general population is viewed by other respondents as effective and 
successful efforts with preventing HIV/AIDS. This is how a respondent, with years of 
experience working on HIV/AIDS prevention present the situation: 
`We never had problems with surveillance. Never this question was not an issue in 
Kyrgyzstan.... we practically managed to contain transmission in within risk groups. 
Only recently, we observe growth of heterosexual transmission. In my opinion, we have 
very good prevention programmes. Of course, we had an outbreak in Nookat.... but 
programmes are indeed excellent, and this is recognised and it is obvious. This is 
because of these prevention interventions, we managed for a long time to prevent 
heterosexual transmission in general population' (Respondent HIVO1) 
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Respondents who work closely on issue of drug use reduction also noted changes, albeit slow, 
in overall view on drug use problem among policy makers: 
`In the last 3-4 years, there is emerging understanding, more-less, that drug use is not 
necessarily legally liable. And people started to understand, especially among policy 
makers - those who make decisions, that drug use is a disease for which people should 
not be always incarcerated. This is a health condition, which should be considered 
from medical as well as social standpoints. ' (Respondent HIVO4) 
However, other study participants noted fragility of attention to IDUs. During the Soviet 
period, drug use has been historically considered as one of society's `ills' (ref). Drug use was 
criminalised. A respondent who worked on substance dependence treatment for decades noted 
that it is only because of an increased political attention to HIV/AIDS that there is now some 
attention to IDUs problem: 
`We have 70-80% of HIV cases among IDUs. This is why there is an increased 
attention to IDUs. Prior to HIV - there was only criminalisation of drug users. ' 
(Respondent HIV03) 
All respondents identified stigma and discrimination against persons with HIV/AIDS, IDUs, 
prisoners, sex workers, and MSM as a fundamental problem for HN/AIDS prevention and 
control efforts. Study participants noted that stigma exists in the general population. Notably, 
stigma from the side of health care providers was identified as considerable. A quote below 
perhaps profoundly exemplifies this perception (quote of a representative of a primary care): 
'We agreed to have methadone centre here . But prior to really 
having experience of 
interacting with them [IDUs], we did not know what problems we might encounter. 
Some of them are really are not manageable, really doomed people. I think some of 
them - it is just complete degradation. No rehabilitation would help them. I think, their 
cognition is permanently damaged from long-term use [of drugs]. ' 
(Respondent PHC02) 
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9.2. LEADERSHIP 
9.2.1. Policy responses to HIV/AIDS and IDUs epidemics 
Leadership and political commitment to HIV/AIDS prevention and control in the FSU context 
are represented when seen in the context what strategic goals are being formulated, and how 
legislative base has been made aligned with these strategic goals. Studies in Russia (Chapter 2) 
demonstrated that legacy of the Soviet legislation with punitive measures against marginalised 
populations including PLHN impeded effective response to epidemic. In the analysis presented 
in this section, I considered two policy instruments: i) the state's approved programmes, 
referred here as governmental programmes, which are strategic policy documents; and ii) 
legislation - law and regulations governing HIV/AIDS control and narcotic drugs use. Among 
other indicator of leadership is what has been implemented. These are explored further in this 
chapter. 
Strategic aims of HIV/AIDS prevention and control response 
Analysis of strategic documents endorsed in the last decade indicates that Kyrgyzstan has been 
following international recommendations in setting strategic aims for HIV/AIDS efforts. At the 
beginning of the 2000s, strategic goals on HIV/AIDS control were framed within an overall 
international discourse on HIV/AIDS, embedded in UNGASS 2001 session on HIV/AIDS and 
the 2004 Dublin declaration. As one the MDG, addressing HIV/AIDS is included as priority 
area in Poverty reduction strategy, Country development strategy, and health system 
reform(TheGovemmentKyrgyzstan, 2006b). 
In the early 2000s, HIV/AIDS epidemics in the FSU was defined as a potential threat to 
countries' development: `the HIV/AIDS epidemic threatens to become a crisis of unprecedented 
proportions in our region, undermining public health, development, social cohesion, national 
security and political stability in many of our countries, as was formulated, for example, in the 
Dublin declaration in 2004 (DublinDeclaration, 2004). 
The current national HIV/AIDS control efforts in Kyrgyzstan were formulated as preventing a 
generalised epidemics and averting potentially an associated socio-economic crisis 
(TheGovernmentKyrgyzstan, 2006a). Kyrgyzstan's policy makers declare a commitment to a 
comprehensive and multisectorial response to HIV/AIDS epidemics. Kyrgyzstan aims to 
achieve universal access to prevention and treatment, scaling up targeted interventions such as 
risk reduction among youth, IDUs, migrants, and sexual workers. Strategic documents 
(TheGovemmentKyrgyzstan, 2006a, TheGovernmeentKyrgyzstan, 2009) state the authorities' 
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intentions to change the legislative framework to protect vulnerable groups from stigma and 
discrimination, to ensure medical, legal and social support for persons living with HIV, /AIDS, 
and their families. Among goals are also capacity development of community groups, which 
represent interests and needs of PLHIV. 
As elsewhere in central Asian region (Latypov, 2009), Kyrgyzstan's national strategy on illicit 
drugs control and drugs misuse declares a balanced approach (TheGovernmentKyrgyzstan, 
2004). Among key policy objectives, are law enforcement measures against drugs trafficking 
and counter criminal activities as well as objectives of prevention and reduction illicit drugs use. 
The country states intentions to establish modern approaches to treatment and rehabilitation of 
persons with illicit drug dependency. This policy document also explicitly states links drug 
control efforts with measures against HIV/AIDS epidemics, development of regulatory 
mechanisms for supporting HIV/AIDS prevention including implementation of harm reduction 
programmes. 
Legal framework for HIVIAIDS control and illicit drugs use 
Despite endorsing a comprehensive response to HIV/AIDS epidemic, achievements of these are 
not supported by existing legislation. Since independence Kyrgyzstan has passed laws on 
HIV/AIDS twice, in 1996 and then in 2005 (TheLaw, 2005a). As compared to USSR's law on 
HIV/AIDS, Kyrgyzstan includes several important provisions. The law guarantees persons 
living with HIV/AIDS(PLHIV) provision of high quality medical care, humane and fair 
treatment, social and psychological support, legal assistance and representation, free expression 
of sexual and reproductive rights, and free choice of health care provider (TheLaw, 2005a). 
HIV status is confidential, and unauthorised disclosure without consent is a criminal offense 
(TheLaw, 2005a, TheLaw, 2005b). Discrimination and stigma against people living with and 
affected by HIV/AIDS are prohibited (TheLaw, 2005a). However, the regulatory mechanisms 
have not been developed or implemented fully to ensure confidentiality of PLHIV or to reduce 
stigma and discrimination against them. This is how one respondent explained: 
`The confidentiality principle is being broken all the time. There are many cases, the 
legal clinic Adilet has a full portfolio of cases on that. But system does not change. 
The Ministry of Health is a system, and this system must develop normative acts and 
executive mechanism to ensure implementation of the HIV law. This does not exist yet. ' 
(Respondent HIV02) 
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Criminal and administrative liabilities against sexual minorities and sex workers were removed 
from the criminal code in 1997. At the same time, Kyrgyzstan retained the Soviet Union's 
provision in the criminal code which specifically focuses on HIV and STD transmission 
(TheLaw, 1997). Infecting other persons, when knowing about own HIV/STDs status is 
administrative or criminal offenses. There is also a liability for HIV transmission which results 
from `improper implementation of job responsibilities' by a health worker. In 2008, 
Kyrgyzstan's court sentenced nine health care workers of causing the HIV outbreak among 
children infected in hospitals in Osh oblast to 3 to 5 years imprisonment (Utyasheva, 2008). 
The existing legal framework (TheLaw, 1997, TheLaw, 1998a) does not address the needs of 
individuals suffering from drug dependence, protection of their rights or protecting them from 
discrimination. The existing legislation is focused on control of drug use (UNODC, 2010). 
There has been partial decriminalisation of drug possession". The legislative framework 
nevertheless remains very restrictive. Acquiring, possession, mailing or transporting a small 
quantity of illicit drugs for personal use even without intentions to sell are administrative or 
criminal liabilities. Notably, implementation of harm reduction interventions is not written into 
the existing legislative framework. These interventions, in both civilian and penitentiary sectors, 
are run based on Ministry of Health and Ministry of Justice prikazes (MOH, 2001, MOH, 2002, 
MOH and MOJ, 2007) allowing implementation of pilots. (These will be further explored in the 
section under `Adaptability'. ) 
Implementation of HIV/AIDS policy innovations 
Since 1997, implementation of all HIV/AIDS innovative interventions, including opioid 
substitution therapy and ART, and innovative models of integrated prevention and care delivery 
for marginalised groups has been under way with technical and financial assistance from 
international actors. UN-agencies, KfW and the Open Society Institute (OSI) in partnership 
with the Soros foundation continuously provide support since that time (Table 9.3). It is with 
the assistance of the OSI and UNDP, that needle and syringe exchanges (NSP) were piloted in 
1999 and methadone replacement therapy piloted in 2002. KfW provides ongoing assistance 
for strengthening diagnostic laboratories. In the middle of 2000s, a number of international 
actors have grown. WB, DFID, and USAID started large multimillion dollars regional 
HIV/AIDS projects. Kyrgyzstan's has been successful in obtaining GFTAM funding through 
round 2 (17 million US$), and round 7 (27 million US$). Within GFATM grant ART has been 
77 A minimal residual quantity of narcotic substance was defined as 1 ml. 
190 
initiated in 2005, and reportedly continuously being scaled up. OST and NSP are also being 
expanded within GFATM grant. 
Broadly, the provided international assistance has been focused on three areas. The first is 
strengthening the country's capability to develop ' The Three Ones' - one unified HIV/AIDS 
policy, one coordination body, and one M&E system (UNAIDS, 2004). The second is 
development of capacity of local organisations in implementing HIV/AIDS interventions. Most 
interventions have been those of HIV prevention - risk reduction. A major focus has been on 
developing capabilities of non-governmental organisations. Attention to strengthening 
capacities of the state's health care providers has been limited. Capacity building is usually 
understood as being developed through training programmes. These in turn were often 
fragmented, each international actor having their own priorities. Trainings on skills such as 
financial management, economic evaluation or principles of epidemiology and public health 
were limited. The third is provision of medicines, consumables and supplies necessary for 
implementing HIV/AIDS prevention and treatment. 
The situation has evolved in the way that priorities of what is being implemented are driven by 
what is being funded by donors. Domestic respondents noted a lack of coordination in the 
priorities setting with those who implement HIV/AIDS interventions on the ground. 
'From one hand, donors are trying to coordinate.... we have the following process here 
- we know that each organisation [NGO] has two-three donors supporting, and we of 
course are trying to find out -what activities current grant is covering. This is from 
one hand. From another hand, duplication is taking the place nevertheless because 
each donor has own interest. And these interests may not intersect and sometimes it is 
difficult to reach agreement' (Respondent HIVO1). 
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Table 9.3 International assistance to HIV/AIDS control, Kyrgyz Republic, 1996-2010 
Agency Time Project or grant Focus Monetary 
period round value 
UNDP 1996- UN Joint Strengthening `Three ones' - technical 39.000- 
present programme for assistance to CMCC, national strategy, M&E. 50.000 US$ 
UNAIDS78 HIV/AIDS per year 
UNODC 2006- Central Asia Prevention of HIV in prisons, treatment of 866.000 
2009 Regional Project drug dependency, rehabilitation of drug users US$79 
UNFPA Pi Sexual reproductive health, youth nt 
UNICEF PMCTC, VCT in health care, youth 
WHO 1992- Technical assistance to CMCC, national 
resent strategy, M&E. 
2005- Central Asian Aids Supportive policy environment, strategic World 
BankEO 2010 Control Programme 
planning, sentinel surveillance, HIV 
i k i li fH V 
5.5 million 
(CARP) prevent on r s groups; qua ty o I US$ 
services 
2000- BOMCA82 Boarder control strengthening, counter-drug EU 2008 CADAP83 crime and drug control measures, drug (extended) control 
2004- HIV prevention among risk groups, PLHIV t million 17 
2009 Round 2 grant treatment and care. All consumables and . US$ 
_Medicines. 
M&E 
GFATM 11.8 million 
2009- HIV prevention among risk groups, PLHIV US$ approved 
2011- Round 7 grant treatment and care All consumables and 25 million 
medicine. M&E US$ 
committed 
2001- CDC/Central Asia Sentinel HIV surveillance, blood safety, 2004 diagnostic laboratories 
Civil society mobilisation, education and 
2004- 
Capacity project 
empowerment of vulnerable groups, technical 1.2 million 
USAID 2009 assistance to the CMCC, TB/HIV integration US$ 
model (Chui oblast), VCT 
IIIV and TB prevention among risk groups, 
2009- Health outreach capacity 
building opf NGOs and state 3.75 million 
2014 agencies to reach and improve access to USS" 
services 
2004- Harm reduction among IDUs, development of 5 million 1 DFID 
2012 
ss CARHAP quality services and M&E system, . GPB 
strengthening enablin environment 
KlW 2005- Diagnostic laboratories, procurement of 3.6 million 2010 equipment and consumables, VCT Euro 
GTZ 2009- 
HIV/AIDS and 
preventing addiction 
Health promotion and education with a focus 
2018 in central Asia on preventing 
drug use among youth 
1997- Harm reduction. Implementation partner of Soros/OSI 
2009 CARHAP in Kyrgyzstan 
AFEW 2005- 
2010 Social support, prisons, IDUs, TB/HIV 
71 Kyrgyzstan's UNAIDS country coordinator was appointed in 2010, prior - under UNAIDS/central Asia region 
coordinator. 
79 Amount is approximated for Kyrgyzstan, total regional 5,212 million US$. 80 Co-financed with DFID. 61 Amount is approximated for Kyrgyzstan, total regional 25 million US$ from WB, and 1 million GBP from DFID. 62 Boarder Management Central Asia 
"Central Asia Drug Control Action Programme 84 Amount is approximated for Kyrgyzstan. Regional project for 4 countries, 15 million US$. as Central Asia Regional HIV/AIDS Programme 
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9.2.2. Governance and organisational arrangements 
In line with the commitment to multisectorial response to HIV/AIDS, Kyrgyzstan's government 
has formed its first high level HIV/AIDS coordinating committee in 1997. Over the last decade, 
a high level national coordinating body has undergone a number of changes (Figure 9.3), caused 
by political changes in Kyrgyzstan's government and international initiatives such as the UN's 
`Three Ones' principles and the introduction of the GFTAM country's coordinating mechanism 
(Murzalieva and others, 2009, Murzalieva and others, 2008, Spicer and others, 2010). At all 
times, the CMCC or its equivalent has been chaired by the high level governmental official. 
At the time of the data collection, a national coordinating body was referred as the Country's 
Multisectoral Coordinating Committee (CMCC) on communicable diseases of social 
importance and high pathogenicity (Figure 9.3). This structure was formed in 2007 by merging 
the state Republican Epidemiological Commission (REAL) and the Country Multisectorial 
Coordinating Committee on HIV, TB and malaria. One of the changes has also involved a 
physical relocation of the coordinating unit (referred to as the executive secretariat) from the 
Vice Prime Minister's office to the MOH. 
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Figure 9.3 HIV/AIDS coordination structures, Kyrgyz Republic, 1996-2009 
Adapted from Murzalivea et al, 2008, and the MOH, 2008. 
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Previous studies conducted in Kyrgyzstan have shown that CMCC as was formed in 2007 had 
weak coordination capabilities, unbalanced membership composition (i. e. majority members are 
state's representatives), and had lost its authority in decision making as compared with the 
previous structure (Murzalieva and others, 2009, Spicer and others, 2010). All respondents in 
my study noted similar challenges including weak leadership capabilities of the CMCC: 
`There are many players in HIV/AIDS, but leadership, which would unite all sectors, 
does not exist. The situation evolved in the way that CMCC, in its form today, is very a 
weak structure..... ' (Respondent HIV 10). 
In this analysis, several factors emerged as creating important barriers for effective coordination 
of HIV/AIDS efforts, irrespective of location of coordinating unit or membership composition 
of the CMCC. These factors consequently affect the forming of an unifying domestic 
leadership. These factors are: 
" Prevailing governance and organisational arrangements of the health system and other 
sectors. Separate planning, decision making and accountability lines within health system's 
programmes (e. g. AIDS services, narcology), between sectors (e. g. health, social services, 
financing, penitentiary), and between the state and non-governmental organisations. 
" Limited interactions between the CMCC and country's existing coordination mechanisms 
(e. g. state's governance coordinating mechanisms, health system coordination, SWAP), and 
lack of clear regulatory framework for the CCMC functioning. 
"A parallel channelling of substantial amount of funds (e. g. GFATM) in the environment of 
weak country's' economic conditions. Weak domestic capacity for financial management, 
planning and resources allocation for HIV/AIDS in accordance with epidemiological 
evidence. The latter issue is compounded by lack of a robust HIV/AIDS surveillance 
system. These all combined contributes to creating tensions and competitions for funds 
from limited sources and prevents strengthening collaboration among programme actors. 
These findings are detailed hereafter in the following subsections. 
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Organisational arrangements 
The state has an overall responsibility for social and public health challenges related to 
HIV/AIDS epidemics. There is a parliamentary commission on social and health care and 
public health issues that oversees implementation and formally coordinates any governmental 
programme". Similar formal state offices and commissions are established at all regional 
levels. These formal government commissions at all levels have a coordinating role in planning 
and implementing any governmental programme endorsed by the state (e. g. TB, mental health). 
The HIV/AIDS programme is complex comprising of public health service organisations, 
NGOs and international organisations (Figure 9.4). Among the state's institutions, the Ministry 
of Health and the Ministry of Justice (including its Agency for Drug Control) oversee the state's 
organisations involved in delivery for HIV/AIDS interventions. 
The Ministry of Health is, in principle the main policy making body and main decision making 
institution as relates to planning, delivery and evaluation of H1V/AIDS preventative, curative 
and rehabilitation interventions as well prevention and treatment of narcotic drug dependency. 
The Ministry of Health oversees specialised health services, which are responsible for delivery 
of HIV/AIDS interventions (Table 9.4, Figure 9.4). Functional responsibilities of these services 
are presented in Table 9.4. The MOH delegates formal responsibilities for HIV/AIDS to the 
AIDS services and for drug dependency to the Narcology services. Specialised services are 
headed by Republican level institution (referred as a Centre or Institute) with regional 
extensions to the oblast level. Delivery of services such as STD and narcology is integrated 
with general services. There are specialised outpatient rooms at Family Medicine Centres 
(FMC) or departments at general hospitals. 
The Ministry of Justice and its Agency for drugs control are policy making entities as relates to 
drug control, including drug use control. All decisions regarding health services in the 
penitentiary sector also have to be approved by this Ministry. 
NGOs are providers of HIV-services (Table 9.4). Most services provided by the NGOs are 
nearly fully those supported financially by international organisations. Donors operate in 
Kyrgyzstan based on bilateral country's agreements or treaties with multilateral agencies (e. g. 
86 Governmental programmes are state's approved strategic policy documents, outlining efforts for a certain period 
of time, usually 5 years period 
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UN). For implementing any project, donors have to agree with and get approval from 
respective Ministry or regional administration. 
Accountability lines and effective communication between NGOs implementing donor- 
supported projects and the MOH (or other Ministries) have not established. A key factor 
impeding effective coordination is a lack of formal interactions in financing. These lead to 
overall to misunderstandings and confusions because donors tend to implement their projects 
through NGOs and these in turn are reportable to donors. These tensions were articulated by 
one respondent, a representative of international organisation and previously a member of 
CMCC: 
'Many representatives of the state argue - The Ministry of Health is responsible at the end. 
NGO receives funds, and they are not accountable for anything; the state is being left on 
the side... Donors argue - sorry, the money are given to the country; thus, the country 
should establish effective mechanisms of monitoring, evaluation and coordination to be 
able to control what is happening in the country. ' (Respondent HIVO5) 
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Table 9.4 Services and organisations Involved in delivery of HIV/AIDS prevention 
Interventions 
Main functions related to HIV/AIDS prevention, treatment, care or support 
AIDS services Policy on diagnosis, treatment and care for PLHIV; 
Development of clinical protocols and guidelines 
HIV testing and counselling 
Confirmation of HIV/AIDS diagnosis; 
Clinical monitoring and management of PLHIV; 
Provision of ART; 
Supervision and coordination of treatment and care for PLHIV when treated 
with any provider; 
Surveillance, including sentinel HIV surveillance (planning, organisation, 
implementation); 
Health education 
Narcology services Policy on diagnosis, treatment and care for people with drug dependency 
Development of clinical protocols and guidelines 
HIV testing and counselling 
Treatment of drug dependence 
Opioid substitution therapy 
Needles exchange, condoms distribution; 
I Health education 
Drug dependency surveillance 
NGOs HIV counselling; 
Friendly clinics (STDs treatment); 
Legal services; 
Support (social, legal, food vouchers, various counselling on health care, ) for 
PLHIV, drug users, sex workers, ex-prisoners; Peer-to-peer counselling 
Referrals to AIDS centres, TB services, other treatment (IDUs are often 
accompanied by social worker) 
Syringe and Needles exchange, 
Rehabilitation centres (IDUs, ex-prisoners), drop in centres 
Health promotion 
General health HIV testing and counselling 
services PMCT 
Primary health care providers: (Observation of PLHIV) 
STD services Organisational and methodological work (development of clinical protocols, 
guidelines) ; 
HIV testing and consulting; 
STDs testing, consulting, treatment; 
STDs/HIV prevention (health education and promotion); 
STD surveillance 
TB services HIV testing and counselling 
Treatment of PLHIV, who developed active TB (do not deliver ART) 
Penitentiary health HIV testing and counselling 
services Testing for STDs, TB, Hepatitis B and C 
ART provision; 
Drug-dependency treatment; 
TB treatment; 
Opioid substitution therapy; 
Needles exchange, condoms distribution, health education; 
SES Regulatory function on implementation of prevention activities 
Surveillance of communicable diseases 
Blood services Screening of blood for HIV, Hepatitis C other blood-borne pathogens 
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9.2.3. The Country multisectorial coordinating committee: interactions with other 
coordination mechanisms 
The CMCC emerged in this analysis as having weak formal interactions with existing national 
and regional governance structures and mechanisms, which in turn are charged with 
coordination of efforts in their constituencies as relate to health and social development. The 
CMCC functioning has not been institutionalised into existing domestic organisational structure. 
In fact, functioning of the CMCC secretariat is funded from GFTAM grant (Bashmakova and 
others, 2009). In 2004-2009, UNDP and USAID/Capacity project provided technical 
assistance. The existing regulatory framework does not provide the CMCC with an authority in 
making decisions regarding planning and implementing HIV/AIDS interventions, particularly 
on regional levels. This often resulted in duplication of lines of command, and sometimes 
confusion over roles and responsibilities within country's pre-existing governance functioning. 
Membership in existing committees and national and oblast extensions often overlapped. Given 
frequent turn around in the government on all levels, several respondents expressed a need to 
integrate the CMCC into existing permanent structure such as the AIDS centre or the MOH. 
This is how one respondent, who used to work at high level position at the MOH and now holds 
post in an international agency, pointed issues with CMCC: 
`One of the rationale to unite existing Committee (RCHPK) and CMCC against 
HIV/AIDS, TB, malaria was to reduce duplication in membership (time as well) 
particularly where it is needed - on oblast and rayon levels. And within existing 
governance structures and existing regulatory framework to allow implementation. In 
a sense, the government was thinking about sustainability of coordinating functions, to 
limit duplications and confusions. ' (Respondent HS02) 
There are also parallel working groups and coordinating bodies, in which HIV/AIDS is one of 
the sections (Fig 9.3). There are overall weak linkages between the CMCC and SWAP 
mechanisms. This is despite that HIV/AIDS is one of the sub-programme in the health system 
reform programme, which aims at integration of HIV/AIDS interventions with primary care 
(TheGovernmentKyrgyzstan, 2006b). 
Capabilities to mobilise, evaluate use of resources for HIV/AIDS programme 
Most domestic respondents perceive the main role of the CMCC as mobilisation of resources, 
more specifically in ensuring proper processes for applying for GFTAM grants. One of the 
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indicators of a country's leadership in HIV/AIDS control is having domestic oversight over 
investments in HIV/AIDS, and not only as relates to the GFATM. Several respondents pointed 
out that at present neither CMCC nor other domestic entity can negotiate with the higher level 
decisions makers on priorities and allocation of resources, for example with donors' agencies. 
Donors in fact are viewed by some domestic respondents as actors who dominate HIV/AIDS 
policy implementation processes. 
`It is difficult to say about any uniting or coordinating entity. Such entity would help. 
One which would keep everyone together; would have a lobbying function - even as 
relates to donors. When they come with their projects proposals, such entity would 
lobby interests of national stakeholders. Each donor has own policy here in 
Kyrgyzstan.... Kyrgyzstani stakeholders should have a say - today we need money for 
harm reduction but tomorrow we would need funds for HIV prevention among sex 
workers. Unfortunately, donors dictate. '(Respondent HIVO 1) 
Another indicator of HIV/AIDS programme governance and leadership is capabilities to 
monitor investments and evaluate the programme's performance. Analysis indicates that there 
is still (i. e. evidence based public health and policy development were limited during the Soviet 
period) weak capabilities for economic evaluation, and planning and resources allocation in 
accordance with epidemiological evidence. Given weaknesses of HIV surveillance outlined 
earlier, decisions are sometimes made without rigorous evaluations: 
'My major concern is that some of our politicians, those who make decisions, do not 
fully understand why we are trying to direct money to this group (IDUs). There are 
opinions already - since transmission is occurring in general population, there is no 
need to prioritise IDUs... But we have to think about effectiveness of measures whilst 
epidemic is still concentrated. ' (Respondent HIVO6) 
Key impediment for CMCC functioning, as perceived by respondents, has been tensions and 
conflicts associated with competition for scarce resources: 
`.... political games have resulted in Kyrgyzstans losing 9th round [GFJ. A close friend 
of a Vice Minister at the time, leader of NGO 'Women's Congress, which never worked 
in the area of HIV/AIDS has been put as co-recipient from civil society .... 
If such things 
would continue, we are at risk to lose substantial investments. '(Respondent HIV 10) 
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9.2.4. Role of NGOs in HIV/AIDS response 
Domestic NGOs emerged in the analysis as important actors of HIV/AIDS programme. 
According to all respondents, particular important role of NGOs is provision of services (Table 
9.4). A common perception among respondents was that NGOs are more effective in reaching 
marginalised group than the public services, and provide services that the state organisations are 
not providing effectively such as social and legal support. Several civil society leaders took an 
active part in facilitating the state in formulation of HIV/AIDS strategic documents 
(TheGovernmentKyrgyzstan, 2006a). Some leaders played a role in advocacy for legislation 
change87. Otherwise, role of NGOs in HIV/AIDS programme governance and decision making 
is limited. NGO's reported challenges with getting their interests activities approved through 
the CMCC' mechanisms: 
`Because there is a majority of the state's representatives, but we are minority. Therefore, 
we beforehand are destined to lose because any decision is being approved by the majority 
of votes. '(Respondent HN06) 
Most respondents have noted improved interactions between NGOs leaders and the state actors, 
particularly with the entrance of the GFATM. However, overall the perception is that there is 
much do to in building trust between the state and NGOs: 
`We always were trying to work and were saying, that non governmental sector is not 
here to replace, its purpose is to add to and to expand capabilities to the state. ... but, 
the state does not always understand. Attitude to us is nevertheless as to a younger' 
brother - 'what you can possibly do? ' and so on. ... Effective partnership should 
be 
based on trust - that we are professionals in our areas and they are in their field. But 
we do not have it yet. ' (Respondent HIVO6) 
Despite the growing role of NGOs in HIV service delivery, formal interactions with the state in 
financing have not been established. For most, the only source of funds is international donors. 
Several respondents pointed that NGOs in Kyrgyzstan have evolved as proactive actors, who 
take an active role in resources mobilisation for the country, though often for their own 
interests: 
87 Example - the lobby in changing administrative and criminal code for possession of drugs. 
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`We have very strong civil sector. Civil sector has own interest, because financing is 
primarily from donor sources. This is why civil sector organisations always put 
question about funds mobilisation .... civil organisations are aware of all mechanisms to 
ensure implementation of Global Fund requirements during an application 
preparation .... Civil sector has grown during the 
last several years, know its rights, and 
use all mechanisms to defend such. ' (Respondent HIV05) 
NGOs have become important partners for implementing a number of international projects. 
They often do not have decision making capacity or involvement in determining design of these 
projects and how the allocated funds could be spend. : 
'NGOs depend on policy from where money comes from. From donors. In any 
circumstances, [NGOsJ have to align with donors' programmes... the only distinctive 
characteristic of our Kyrgyzstan is that we have 'green light' to all [donors J projects... The 
distinctive limitation however - any project that is started has own priorities - what money 
are given for, and what are not. '(Respondent HIVO3) 
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9.3. CAPACITY 
9.3.1. Financial resources 
Sources of funds and financial flows 
HIV/AIDS programme is funded from public (i. e. the state budget and the social fund), private 
(i. e. users of services) and external sources. Financing is fragmented (Figure 9.5). The MOH 
purchase services from providers of specialised services - AIDS, narcology, health promotion, 
STD dispensaries, TB, blood services and SES. Each specialised service has a separate budget 
line within the MOH programme (i. e. `programme' for financial purposes), which is planned 
and allocated separately. MHIF purchases services from general services, as well as social 
assistance channelled for PLHN. The MOJ has its own pool of funds, which is planned for and 
allocated to health services in the penitentiary sector. Financial planning and payment 
mechanisms to providers of HIV/AIDS interventions are linked. 
Assessment of out-pocket payments (OOP) of PLHIV or persons at risk of HIV have not been 
assessed. At present treatment and care after PLHIV are being funded from the GFTAM grant. 
Only HIV infected children below 5 years old are fully covered by the state's benefits. 
Treatment of people suffering from narcotic drug dependency is not covered by the state. In 
general, as was presented in the Chapter 7, OOP constitutes around 50% of health expenditure 
(HPAC, 2008, HPAC, 2009). 
Funds from external sources for HIVJAIDS programme are channelled as `parallel', off-budget 
funding. Each donor channels funds separately either directly to providers of services (as to 
grant recipients), or act as service providers (e. g. provision of trainings). The republican AIDS 
agency has been a principal recipient of GFTAM grants until principal's recipient from 2004 
until 2010. At the time of writing, there was a transition, in which UNDP would be a principal 
receptinet of all Kyrgyzstan's GFATM grants (GFTAM, 2010b). Funding for NGOs for 
delivery of HIV/AIDS interventions come from international sources. 
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Expenditure on HIV/AIDS prevention and control 
This study finds that up until recently 2006-2007, there has not been on-going monitoring of 
spending on HIV/AIDS. With the exception of the GFATM and KfW, historical information on 
external funding, which was obtained from different sources, is sometimes contradictory 
(Bashmakova and others, 2009). National reports prior to 2008 on domestic spending on 
HIV/AIDS tend to include only expenditure on specialised AIDS services, without taking into 
account state's spending on HIV/AIDS prevention interventions delivered by other services. I 
managed to reconstruct spending on HIV/AIDS over time based on previous studies 
(Bashmakova and others, 2009, CARHAP, 2008, Murzalieva and others, 2008) and recent 
national reports (UNAIDS, 2010). 
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Figure 9.6 Expenditure on HIV/AIDS programme, 1998-2009 
Sources: Bashmakova and others, 2009; CAR HAP, 2008; Murzalieva et al, 2008, UNAIDS 2010 
*Notes: for 1998,2000,2002,2003 - data on donors' spending were not available. Data for all years from national sources includes different inclusion criteria: all years with expetion of 2008-2009, spending only on HIV/AIDS services. ). 
In financial terms, international financing and the state's budget constitute major sources of 
funding. Documentary sources and interviews indicated that starting 2004-2005 there has been 
substantial inflow of international financial assistance channelled specifically for HIV/AIDS 
(Figure 9.6). Total spending on HIV/AIDS has increased 10 folds in the period from 2001 to 
2009, from approximately 44.5 million Kyrgyz Som (KS) in 2001 to 428 million KS in 2009. 
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In US dollars, the increase is approximately from 0.95 million US$ in 2001 to 10 million US$88 
in 2009. During this period, spending on HIV/AIDS from domestic sources has fluctuated at 
the level of 8-18% of total spending, whilst the rest came from donors. Domestic spending on 
specialised AIDS services, as proportion of the state's spending, has been 0.6-0.7% over the 
years. International investments in HIV/AIDS have been disproportionally high. In 2007, 
international spending on HIV/AIDS constituted 28% of total international investment on 
health in Kyrgyzstan (Murzalieva and others, 2009). Since 2005, GFTAM funding accounted 
for 50% -70% of international funding for HIV/AIDS (Bashmakova and others, 2009, 
Murzalieva and others, 2009). GFTAM is not linked to SWAP mechanisms. A respondent, 
who represents one of the development partners working on health system reform, expressed a 
frequently mentioned concern: 
`There is an urgent need to align GFATM funding with health system development. 
Funds for HIV/AIDS are enormous comparing to overall donors' assistance for health 
system. Roughly, for example. SWAp - total donors contribution is 60 million [US$] 
for 5 years, GFATM has spend and committed some 45 million for a comparable 
period. ' (Respondent HS02) 
Data on funds allocations by type of HIV/AIDS prevention, treatment and care has not been 
collected systematically over the years. The relatively detailed data on HIV/AIDS spending 
was compiled by the country in its UNGASS 2008 report (UNAIDS, 2008). This data indicates, 
for example, that in 2006,81.7% of funds were spent on prevention activities (with nearly half 
in this category not specified what activities), 10.7% on care and treatment and 5.9% on 
management. 
Intern ational funding for HIV/AIDS response 
The programme depends on external funding for medicines (antiretroviral drugs and other 
medications), condoms, syringes, functioning of laboratories (e. g. laboratory supplies and 
reagents), implementation of HIV sentinel surveillance and so on. An overarching problem 
indentified by all respondents is that the state cannot fund HIV/AIDS interventions because of 
country's economic situation. All respondents singled out dependence on donors' financing and 
lack of secure long term funding as a risk for functioning of HIV/AIDS programme: 
86 1 US dollar = 46.7 KS current exchange rate as of 2010. 
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`Unfortunately... if international funding would stop -for example, tomorrow they would 
leave Kyrgyzstan - all programmes on harm reduction, prevention of HIV infection and so 
on - these simply stop. Nothing would be implemented. We all know this very clearly. ' 
(Respondent HIVO 1) 
All domestic respondents identified dependence on donors for almost all aspects of clinical 
monitoring of HIV positive persons, ART and treatment of opportunistic infections. For 
example, even though the state guarantees all medical care for PLHIV free of charge by law 
(TheLaw, 2005a), at present, all treatment of PLHIV is covered fully from GFTAM grant. If 
donors pull out, neither the state nor most PLHIV would not afford ART: 
`We wish they [donors] continue to support us. With our groups - they would not 
afford ART is not yet included into the state's guarantees. Only children below 5 
years old... ' (Respondent HIV08) 
It appears that by the end of 2010, the GFATM might be a main source of funding for 
HIV/AIDS programme. Some donors (e. g. DFID) have undertaken strategy to assist in 
GFATM application processes and to ensure inclusion of their activities into GFATM grant 
application. Other donors cannot guarantee continuity of funding. There is a perception, that 
each donor's has been concerned only with own investments: 
'Every (donor] is interested about own funding and how their projects work... first of all. 
Global Fund is somehow.... it just provides funds. It is just interesting for everyone -how 
necessary is to continue their presence if Global Fund provides grants. Only in this 
respect. ' (Respondent HIVO5) 
The dependence on few donors also creates competition for funding, sometimes opposition and 
prevents coordination within NGOs community. Below is how a recognised NGO leader 
defined interactions within NGO community: 
`There is practically no coordination among civil sector organisations, there is a 
competition for funds. But, in this regard, it is necessary to note role of the Global Fund's 
Principal recipient - they are trying to keep things in order... In my opinion, it is currently 
only force that coordinates anything. Accordingly, they coordinate only in own interests, 
and it is interest of the Ministry of Health because it is Ministry's structure. What relates 
to internal processes within civil sector -I do not see any coordination. ' 
(Respondent HIV02) 
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9.3.2. Capacity of HIV-service NGOs 
There has been reportedly a proliferation of HIV-service NGOs since the beginning of 2000s 
(Shishkaraeva and others, 2006 , Ubysheva and Pogojev, 2006). There are reportedly nearly 
100 NGOs, whose portfolio involve HIV-related activities operating in Kyrgyzstan (Ubysheva 
and Pogojev, 2006). The long term viability of NGOs as organisations is perceived as a major 
problem by all respondents. Many NGOs do not have their own infrastructure (e. g. offices), 
they rent their facilities and pay salaries to staff solely from grant funds. 
`They are not sustainable - civil sector organisations. If donors leave, they would not 
be able to support the staff, they would not be able to... As soon as there be no 
financing - they simply would be forced to close down, and then - simply, all this 
network of services would stop functioning. ' (Respondent HIVO5) 
Several respondents noted that civil society sector is still evolving. Established NGOs tend to 
be located in Bishkek city, Osh city and urban settings in Jalal Abad. and Chui oblasts. For most 
NGOs, future survival is fragile. There are NGOs which have been established only for 
implementing a certain project; others are created based on a public organisation (e. g. an AIDS 
centre also have own NGOs, in which employees of AIDS centre also members of NGOs). 
Below is how one respondent has explained the status of the NGO community: 
'If you look closer... there are not too many strong NGOs indeed. UN, Soros brought 
them up (developed). In reality -yes, we also were thinking 'too many NGOs'... But in 
reality, only few, the ones which would work when there be less funds. Here I think 
quantity will grow into quality, eventually. ' (Respondent HIVO7) 
NGOs do not have predictable, secure and long term sources of funding either from the state or 
from donors. Previous studies in Kyrgyzstan demonstrated that interruptions in GFATM 
disbursements resulted in interruptions of HIV services provided (Murzalieva and others, 2008). 
Several respondents in this study pointed out a similar issue. This concerns not only NGOs but 
also the public organisations. Though NGOs, according to domestic legislation, are eligible to 
conduct commercial activities, this is not possible for most HIV-service NGOs that provide 
services to vulnerable population groups: 
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'There are a lot of questions about sustainability of NGOs, about financing. I honestly 
cannot imagine how service NGOs would do any commercial activity. Our clients are 
vulnerable people, without any funds or other means for living. This is why I do not see 
how we may offer any fees for our services. ' (Respondent HIVO3) 
Donors' granting mechanisms to NGOs do not allow their growth as organisations. Existing 
mechanisms of giving 'seed' funds also do not allow implementation of comprehensive 
programmes. According to respondents, donors prefer a small and short term granting 
mechanism (normally one year funding) disbursed across a number of NGOs rather than longer 
term agreement with established organisations. An NGO leader explains the challenges: 
`They have such system - you are already established [NGO], and getting funds for a 
long time, we also have to give grants to other'... and at the end - they give a little here 
and a little there... For example, UNDOC given us a grant to establish rehabilitation 
programme [for IDUs] for one year. But who can establish a comprehensive 
rehabilitation in one year? We needs to learn lessons, have time to improve in order to 
have any impact. It is not possible in one year. ' (Respondent HIVO6). 
9.33. Available public services for delivery of ART and narcotic drug dependency 
treatment 
Main functional responsibilities for delivery of diagnostic services for HIV, treatment and care 
after PLHIV remain within specialised health services (Table 9.5). Formally, interventions such 
as HIV test counselling, collection of blood for testing is delivered at any health care facility in 
the country. Specialised AIDS services have an exclusive right for confirming HIV diagnosis, 
prescription of ART or treatment of other opportunistic infections. These specialised services 
are located in the capital and oblast's urban centres (Table X). Each AIDS centre has a 
diagnostic laboratory; however, capabilities to perform Western Blot (for confirming HIV virus) 
are limited to the National Reference laboratory and a laboratory in Osh AIDS centre. 
Monitoring of CD4 count, and monitoring of viral load in HIV-positive persons (PCR 
technique), is possible only at the National laboratory. Narcology facilities for delivery of 
treatment of narcotic drug dependency including OST are also concentrated in urban settlements 
(Table 9.5). 
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Table 9.5 State services structures providing specialised HIV/AIDS testing and 
treatment, and drug dependency treatment and care 
Region 
Population, 
thousands 
AIDS centres Narcology' OST 
Batken oblast 428.5 1 
Osh oblast 1081.3 1 1 5 
Osh city 250.2 1 
Jalalabad oblast 987.1 1 1 
Naryn Oblast 270.6 1 
Issyk-Kul oblast 433.7 1 
Talass oblast 218.5 1 
Chui oblast 761.2 1 7 
Bishkek city, capital 819.0 1 4 
Republican jurisdiction 1 2 
Penitentiary sector 1 2 
Kyrgyz Republic 5250.1 9 6 18 
Source: Republican AIDS Centre, Kyrgyz Republic 
'Narcology dispensaries or departments at mental hospitals. Specialised narcology dispensaries are only in Bishkek 
city and Osh city. There are narcology offices in 39 Family Medicine Centres in the country 
9.3.4. Antiretroviral drugs and other medicines and commodities 
As has been mentioned earlier, donors' fully finance procurement of antiretroviral drugs, 
methadone other drugs for treating opportunistic infections, syringes, and condoms. I did not 
manage to conduct detailed assessment of procurement and distribution system. An officer who 
oversees procurement and distribution of commodities through GFTAM grant refused an 
interview. Other respondents noted that procurement of these products is organised in 
compliance with donors' requirements. Kyrgyzstan either receives medical products directly 
from a supplier contracted by an international agency or purchases pharmaceutical products in 
compliance with donors' recommendations to ensure quality of pharmaceutical products. 
Distribution of medical products is centralised through GFATM principal recipient, at the time 
of data collection it was the Republican AIDS Centre. 
9.3.5. Human resources 
Respondents representing HIV/AIDS programme have mentioned the same problems with 
human resources such was presented in Chapters 7 and 8. Common themes were low pay rates, 
and shortage of personnel on rayon levels. According to respondents there is a shortage of 
personnel on management of substance drug dependency or infectious diseases in general. The 
Republican AIDS centre reported that there are 83 medical doctors and 51 middle-level medical 
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personnel working in the specialised AIDS centres. However, all are working on national or 
oblast levels. 
9.4. FLEXIBILIY (ADAPTABILITY) 
This section presents an analysis of the flexibility characteristic of HIV/AIDS programme. I 
analysed changes in service delivery arrangements that had occurred, or are occurring, with the 
introduction of two evidence-based interventions - opioid substitution therapy (OST) and ART. 
Historically, treatment of substance dependence has been delivered through vertically organised 
narcology services (discussed in Chapter2). Any interventions related to HIV/AIDS were the 
exclusive function of specialised AIDS services (Chapter 2). Previous research has 
demonstrated that such health system arrangements impede effective implementation of both 
interventions (Bobrova and others, 2007b, Tkatchenko-Schmidt and others, 2008). As has been 
discussed, delivery and scale up OST and ART have been included into the country's strategic 
plans 
Overall, this study finds an openness and willingness to implement to innovations. Despite such 
willingness, respondents identified two overarching barriers. One is the lack of domestic 
resources to continue or to expand geographic coverage of interventions. The other is slow 
changes or even resistance to change in supporting regulatory mechanisms. Donors' pilots are 
often allowed, but when a question of expanding arises, the regulatory system is constraining: 
`.... what is obvious that in Kyrgyzstan a new practice is being introduced first, then 
proper regulatory mechanisms Meaning that many innovations are being conducted as 
pilots, but when question of expanding of a pilot arise then it is becoming obvious that 
activities are not in line with existing legislation and regulations. In other countries, it 
is vice versa-first a legislative base is being prepared'. (Respondent HIVO5) 
9.4.1. Legal environment as a barrier for implementing and scaling up harm reduction 
interventions 
This study finds that implementation of OST in Kyrgyzstan is vulnerable to changes in the 
domestic political climate. Kyrgyzstan's legislation remains restrictive and is focused on drug 
control. Harm reduction interventions operate as pilots without clear and explicit regulatory 
framework. Implementation of these interventions is based on Ministerial decrees that approve 
implementation of pilots. Activities of outreach workers and NGOs that implement harm 
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reduction activities (e. g. needles and syringes exchanges) are not regulated by the law or any 
other domestic regulatory mechanisms; there are no standards or rules governing their activities 
(UNODC, 2010). Existing provisions in the administrative and criminal codes potentially put 
them at risk of legal liability for distributing syringes or other equipment (e. g. for `inducing 
consumption or `organisation and maintenance' of sites) (UNODC, 2010). 
The introduction of a legislative base for drug dependence treatment and harm reduction has 
been in strategic plans since 2004. The law `On narcological services and prevention of narcotic 
drug dependence' has been drafted and public hearings conducted. The law was drafted to 
clarify rights of drug users, and regulate service provision and standards of drug dependence 
treatments and harm reduction interventions. However, according to study participants, there 
has been a strong resistance from some legislators, parliamentarians and representatives of some 
public services: 
`What we have met is resistance to methadone therapy. On the level of 
parliamentarians. One parliamentarian has initiated the process to legalise harm 
reduction programmes. We have only prikaz to implement pilot projects. But no 
legislation. Thus, [we] wanted to legalise methadone therapy, and syringe exchange, 
and our projects. And a barrier became methadone therapy. Some parliament 
members raised an issue that Russia has prohibited methadone therapy... thus, the 
question of legislation got suck, and still is not solved ' (Respondent HIVO3) 
Inclusion into the law obliges the state to ensure provision of interventions. Thus far, the state 
has been reluctant to take responsibility: 
'For example, the Law on Narcology services - during hearings certainly a question 
was put - `so we approve this law but in 5 years the Global Fund would end its 
activities -from where will we get money to cover interventions which are proposed 
in the legislation? ' The proposed law obliges the state to ensure provision of these 
interventions to drug-dependent persons. ' (Respondent HIVO4) 
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9.4.2. Delivery of illicit drugs dependence treatment 
Opioid substitution therapy has been piloted in civilian sector in 2002, and then in penitentiary 
sector in 2008. Methadone is included into national essential list of medicines. Naloxone, a 
drug for opioid overdose management is also allowed in Kyrgyzstan (UNODC, 2010). 
Currently treatment of drug dependency is carried out by the state's narcology services 
(dispensaries or departments at mental hospitals, rooms at primary care) and private providers. 
Those who receive treatment at the state narcology services are being registered. Respondents, 
who work with IDUs, noted that despite the law on confidentiality of patients' information 
(TheLaw, 2005b), information is being shared with law enforcement is such requests are made. 
Along with traditional approach of inpatient detoxification practiced during the Soviet period, 
public narcology services reportedly apply psychotherapy and rehabilitation, and opioid 
substitution therapy. IDUs are not covered by the state's benefits. Even traditional 
detoxification treatment is not affordable for majority of IDUs. According to respondents, IDUs 
prefer to avoid state's narcology services, or disclose this problem to any state's health provider. 
IDUs prefer to get treatment either at NGOs (e. g. rehabilitation or physiological counselling), or 
be treated at private clinics. Treatment in the latter is expensive and unaffordable for most. 
Opioid substitution therapy is provided exclusively by public narcology services under 
supervision of the republican narcology centre (there were 18 OST sites at the time of data 
collection). Several sites have been co-located with FMC and AIDS centres. Co-location is 
viewed as an achievement by many national and international actors. However, co-location 
without formal interactions in financing or management of delivery creates lack of interest. 
This is exemplified by a quote from an interview with a head of the family medicine centre: 
`Methadone centre brings us many problems....! do not like this centre. This is a 
Global Fund project..... They just physically located here. In my opinion, there should 
be a separate facility. Perhaps - let them be, but separately from us.... in reality - they 
should not be in general health system. They are not our employees, and are under 
complete supervision of the Narcology Centre........ I would better have opened there an 
outpatient clinic for the elderly... we have no financial flow from [this methadone 
centre].. They use our infrastructure'. (Respondent PHCO2) 
One of the major impediments for delivery and expansion of OST are weak formal linkages in 
financing and service delivery among narcology, mental health, general health system, social 
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services, and other specialised services such as TB and HIV/AIDS. As one the leader of a harm 
reduction NGO explained, only methadone replacement without addressing co-occurring health, 
social and legal problems would not likely be effective: 
`.... An issue that they want substantially scale up the coverage. But, there should be 
joint efforts of physiologists as well, and social problems have to be addressed. ... All 
should be considered and addressed in a comprehensive way. But not -just distribute 
methadone. Meaning addressing one problem, other also should be taken into account 
- and medical problems, and legal, and social - only then it be possible to achieve 
anything....... when we are solving only one problem - it does not work' 
(Respondent HIV03) 
Analysis shows that gaps in services provision for IDUs caused by fragmentation and 
specialisation of health services are often covered by NGOs. There are several integrated 
models provided by NGOs, which include social workers, narcology specialist, and 
psychotherapists. These models also provide referral support for IDUs and other clients. 
`Services for risk groups, particularly for IDUs is developing quite dynamical... around 
60-70% of services are provided primarily by NGOs. Non-governmental organisations 
are more flexible. Responses to changes in demand, which are determined with 
contextual changes or clients' needs, are more timely then response of the public 
organisations. Public organisations usually require more time. ' (Respondent HIVO4). 
However, as was discussed earlier these models of integrated service delivery are limited to 
donors' supported projects. The scope and scale of implementing harm reduction innovations 
depends on donors' policies and within limits of external funds. 
9.4.3. Delivery of ART 
Delivery of ART started in 2005 with financial support of GFTAM. At present, diagnosis and 
clinical monitoring of HIV-positive person is centralised and performed only by AIDS centres: 
Clinical management decisions are made only by national consultants in Bishkek city and Osh 
city. According to MOH regulations, health care for PLHIV is to be provided in any health care 
organisation. There are now 2 hospices (10 beds each) for end-stage AIDS patients. Formally, 
there is coordination of delivery of some HN/AIDS interventions. As was presented, primary 
care providers perform VCT (including collect blood and sending to AIDS centres' labs) and 
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observe registered PLHIV. The role of FMC is limited to conducting clinical tests and 
providing AIDS centres with updates on clinical status (e. g. send lab results). PLHWIH have to 
attend AIDS services to collect antiretroviral drugs usually 2 weeks to 1 months supply. At the 
time of data collection, ART reportedly has been s delivered via FMC only in Osh oblast, again 
under close supervision of AIDS centres. 
Antiretroviral drugs and all other medications for treating opportunistic infections, are 
purchased from GFATM grant. According to regulations (ref), HIV-positive persons are 
registered (under dispensary observation) for life at the AIDS centres and at the primary care 
provider. Representatives of AIDS services recognise that the services do not have sufficient 
capacity to deliver ART. These respondents highlighted a major problem with ensuring 
adherence to ART therapy among IDUs, but not with other PLHIV: 
`With therapy - it is primarily a problem with IDUs. Very difficult to work with them. 
They often agree with everything, but in practice many disappear and do not keep 
appointments, check-ins or to pickup drugs. '(Respondent HN13) 
This gap in service provision is often covered by NGOs through their social work and referrals. 
They bring their clients to the AIDS services, TB services or other health care organisations. 
NGOs also were mentioned as the ones closing the gaps between AIDS services and primary 
care providers: 
`As opposed to collaboration with AIDS services, the work with NGOs is set very well, 
with TaisPlus, `Positive Initiative. They bring us their clients - we provide them 
services, performing tests. Very good interactions, we conduct round tables, and are 
involved in their activities'. (Respondent PHCO3) 
9.4.4. Plans for Integrating HIV Interventions Into primary care 
Integration of delivery of biomedical HIV interventions (e. g. diagnosis, treatment) with general 
health system is one of the aims of health system reform (TheGovernmentKyrgyzstan, 2006b). 
Respondents expressed an opinion that integration is a promising prospect, given that 
specialised services cannot handle growing number of detected HIV/AIDS cases. However, 
there are no clear plans or mechanisms on how integration will take place: 
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'... important aspect of integration - this requires investments. For example, Manas 
Talimi puts integration as a priority ... however, there is no defined financial resources 
for integrating preventative interventions into primary care.... There is no clear 
mechanisms how integration will take place.... there is a need to think about financial 
mechanisms so to ensure effectiveness would not hampered. (Respondent HIVO4) 
Furthermore, primary care providers perceive their involvement in HIV/AIDS as not clearly 
defined. Though trainings on HIV/AIDS of FMC personnel have been conducted, some 
providers appear not to know what is required from their side: 
`Regarding HIV/AIDS -..... Not clear what is required from us, and what is done overall 
throughout the country to address HIV/AIDS. We have regulatory base, staff is trained, 
we have infectionist office here. We have HIV patients under observation. But 
collaboration with AIDS services is only in its inception stage ... we 
have more 
questions than answers. AIDS services act as regulatory agency. Here is no 
coordination, no collaboration. ' (Respondent PHCO3) 
Key informant representing primary care noted that their services are not ready to deal with HIV 
problem properly. Over the last decade attention of AIDS services and donors has been on high 
risk groups and support for NGOs, On balance, efforts to strengthen general health system were 
minimal: 
`AIDS centre started with risk groups. To a less extent things were done to train 
medical personnel on all levels -primary care, hospitals.... And as result we have what 
we got in Osh - doctors do not use precautions. If they would start with training as 
National TB centre. And attitude to HIV problem would be different, and there would 
be some caution. And perhaps we would have avoided the outbreak in Osh. They've put 
everything on risk groups - prostitutes, prisons ... But health care workers were 
left 
behind... yes of course they issued clinical protocols and guidelines. But to distribute 
guidelines is one thing. Health care workers need to be trained to implement new 
protocols and monitored how they implement it... ' (Respondent PHCO 1) 
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Another barrier for effective integration of HIV interventions (biomedical) into general health 
system is a broader problem of stigma and discrimination against PLHIV, which persists 
including among health care providers: 
`In regards to [HIV] service delivery at primary care, stigma creates serious barriers. 
People living with HIV are not attending general health services and will not - unless 
problem ofstigmatisation and discrimination from health providers would be solved' 
(Respondent HIV02) 
9.5. INTERACTIONS 
This section summarises interactions of HIV/AIDS programme (Table 9.6). HIV/AIDS 
programme is complex and fragmented. In this study, I assessed interactions between 
specialised HIV services and primary care services, narcology services and primary care 
services, and HIV-service NGOs and state services (i. e. narcology, HIV services or primary 
care). Several aspects of programme's interactions have been presented earlier throughout this 
chapter. 
Specialised services involved in delivery of HIV interventions (i. e. AIDS, narcology) have 
separate governance, financing, and service delivery. These specialised services in turn have 
limited interactions with primary care services in governance. These interactions are limited to 
health system's regulatory framework and disease control policy (i. e. state regulations are the 
same for all state agencies). There are no formal interactions between specialised services and 
primary care in financing, including in mobilizing international funds. There is a formal 
coordination in service delivery, however as was outlined these are not effective. Gaps in 
service provision caused by lack of interactions among specialised TB, HIV/AIDS and 
narcoogy services are being covered by HIV-service NGOs. 
These NGOs functions are however limited to donor-supported initiatives. Formal interactions 
between the state's organisations and NGOs in terms of financing, service delivery and 
information exchange have not been established. Coordination between the state and NGOs 
exits only as relates to mobilisation of funds and implementation of projects, more specifically 
as relates to GFATM grants. 
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9.6. PERFORMANCE 
Judging HIV/AIDS programme performance in this study has been challenging because of 
weaknesses of HIV/AIDS surveillance presented earlier in this chapter. There are substantial 
uncertainties with regard the scope of the epidemic. A unified M&E system has not been 
applied at the time of data collection, though reportedly has been developed nearly three years 
ago. The M&E system has not been approved by the relevant Ministries. For GFATM grants 
application and UNGASS reporting, HIV/AIDS programme actors report indicators as defined 
by the UNAIDS (UNAIDS, 2010). 
Each major donor or project has its own indicators systems, data management requirements 
(e. g. computer data bases), and reporting requirements. Though respondents have noted that 
some indicators are similar, reporting requirements add an unnecessary administrative burden. 
According to respondents, there are a number of M&E indicator systems used by donor 
agencies to monitor implementation of their grants. Through there has been a tendency in 
recent years to harmonise the M&E systems. For example, a M&E system developed within 
Central Asian Harm Reduction Project (CARHAP) project has been adapted by the principal 
recipient of the GFATM, and Central Asian AIDS control programme (CAAP). A major issue, 
from the perspective of domestic respondents, ' is rather, a preoccupation on the side of 
international projects with reaching indicators rather than focusing on how things may be done 
in response to fast changing local demands or realities. 
`.... each donor has own policy, and donors are not very flexible. For example, Global 
Fund - it has monitoring system and evaluation; indicators are being discussed and 
agreed upon in advance on stage of grant signing. Global Fund does not have 
flexibility in terms of how things may be done. ' (Respondent HIVO6). 
Quality of services provided by NGOs to their clients (e. g. IDUs, sex workers, other groups) has 
not been systematically defined, assessed or collected routinely. 
9.6.1. Effectiveness 
By the end of 2009, Kyrgyzstan reported 231 PLHIV receiving ART, nearly half of whom 
(n=101) were children. At that time, Kyrgyzstan reported 450 PLHIV, among those who were 
registered and needed ART. UNAIDS estimates number of persons who needs ART - <1000 
(95% Cl, 1900-2700). This might translate into 12% (95 Cl 9%-24%) coverage of those HIV- 
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positive who needs treatment according to WHO criteria (UNAIDS, 2010 ). There are 
substantial uncertainties whether current efforts have any impact on reduction of HIV 
transmission or survival of PLHN. Given a very low ART coverage and problems of 
adherence to therapy mentioned by the respondents, current efforts are likely have no or 
minimal impact. 
As was mentioned OST is delivered in 18 locations, and there are reportedly 990 IDUs who 
were enrolled into OST programme. Kyrgyzstan reports 17000 IDUs are reached by any HIV 
prevention intervention, including needle and syringe exchanges89 (NSP). 
`So we say we reached quantity... but quantity does not mean effectiveness. The ways 
the system works - we [NGOs or other service providers] do not know yet whether we 
duplicate each other, weather the same client is registered in different organisations. 
Main challenge at present relates to quality of services provided and to quality of 
monitoring system. '(Respondent HIVO6) 
Thus far, coverage of interventions provided by NGOs is concentrated in the regions understood 
as most affected by IDUs epidemic: 
`As relates to geographic coverage, particularly remote areas, for example we do not have 
any syringe exchange points in Naryn or Issyk-Kul oblasts...... epidemiological situation 
with HIV and drug use problem is more serious in Bishkek city, Osh and Jalal-Abad. 
Therefore, the response is being organised based on priorities. ' (Respondent HIVO4) 
Given uncertainties with the size and changes over time in regards to IDUs population outlined 
in the earlier section, it is also difficult to conclude whether current harm reduction measures 
have any impact on public health. 
9.6.2. Efficiency 
Assessment of efficiency was not possible in this study. Cost-effectiveness analysis of any 
HIV/AIDS interventions has never been conducted in Kyrgyzstan. Cost-effectiveness analysis 
was beyond the scope of this study. I discuss overall challenges with HIV/AIDS interventions 
efficiency analysis in Chapter 10 `Discussion and conclusions'. 
89There were reportedly 46 Needle and Syringe exchange (37 in public services including 14 in penitentiary sector, 
and 9 in NGOs). Source: Republican AIDS Centre. 
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9.6.3. Equity 
Respondents noted that stigma and discrimination against marginalised groups such as ex- 
prisoners, IDUs and sex workers persists. Studies conducted by the Open Society Institute and 
Soros Foundation/Kyrgyzstan (OSUSoros, 2008 -a, OSI/Soros, 2008 -b) demonstrated that 
health care providers often discriminate these population groups. Care provided to these 
population groups is often inadequate; and their rights of marginalised for fair and equal 
treatment are often violated. 
SUMMARY FINDINGS 
This study fords several factors that might potentially create impediments for sustainability of 
HIV/AIDS programme. 
The Government of Kyrgyzstan declaratively demonstrates political commitment to the 
HIV/AIDS problem, including addressing the IDUs problem. The Government has formulated 
comprehensive strategies for HIV/AIDS control as well as prevention and treatment of illicit 
drug dependency. These strategies are in line with international recommendations. However, 
the comprehensive and multisectorial response is not supported either by regulatory or financial 
environment. Despite progressive provisions explicitly stating protection of PLHIV from 
discrimination, stigma, and protection of their confidentiality, regulatory mechanisms to 
implement these statues have not been developed or are not being enacted effectively. 
Legislation is focused on drugs control and criminalises IDUs. Such regulatory environment 
contributes to persistence of discrimination and stigma against PLHIV, IDUs and other 
marginalised groups, and creates barriers for their access to prevention and care. 
Formally, the CMCC governs and coordinate HIV/AIDS response. However, CMCC has 
limited interactions with other country governance mechanisms, including SWAP/health sector 
development. Regulatory framework is not clearly defined. The HIV/AIDS programme 
operates without a clearly defined performance framework to monitor, evaluate and prioritise 
allocation of resources. Accountability lines among key domestic actors (i. e. state organisations 
and NGOs) are not developed. Programme's financing mechanisms (both domestic and 
international) affects establishment of effective multi-sectorial coordination. In absence of 
robust M&E system, combined with weak CMCC oversight, donors funding often influences 
what is being implemented (vs. Local needs or epidemiological evidence). Similarly, the same 
factors often contribute to tensions between, and within, the state and NGOs actors. These all 
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combined consequently negatively affect the formation of a unifying and collaborative domestic 
leadership of the programme. 
Implementation of developed comprehensive HIV/AIDS response is financed (i. e. up to 80%) 
by international organisations, This financial assistance is channelled as parallel targeted 
assistance for HIV/AIDS. HIV/AIDS programme has a weak domestic capacity for 
implementing HIV/AIDS interventions. Infrastructures and human capacity are concentrated in 
large urban centres. These relates to funds, development of human resources (e. g training on 
innovative approaches, new skills), and key commodities such as medicine, syringes, and 
condoms. Financial mechanisms for HIV/AIDS programme pose challenges for the 
programme's sustainability. Domestic financial mechanisms are fragmented. Planning of 
interventions implemented by variety of public services does not address needs of patients. 
Donor funding for HIV/AIDS has not been integrated into overall health system financial 
mechanisms. 
NGOs emerged as important providers of HIV-services covering the service delivery gaps 
caused by overall health system fragmentation (i. e. a number of specialised services). HIV- 
service NGOs substantially depend on donor funds. NGOs have weak formal interactions with 
health and social welfare systems (e. g. there is no financial mechanisms), thus posing questions 
of their long term viability as organisations. 
Overall the HIV/AIDS programme's actors demonstrate considerable flexibility. Programme's 
actors are willing to implement innovative approaches in HIV/AIDS control. Capabilities to 
implement and expand innovations are limited by weak resources capacity. OST operate as 
pilots without clearly defined regulatory mechanisms, and remain vulnerable to changes in the 
political environment. 
Delivery of ART and OST remain centralised within exclusive jurisdiction of corresponding 
specialised services, with limited capabilities to ensue coverage, access and quality of services 
to marginalised groups or population groups residing in rural areas. General health system is 
not sufficiently prepared to undertake tasks of managing HIV/AIDS patients or people with 
narcotic drug dependency. 
HIV/AIDS programme is complex and fragmented, with limited interactions with general health 
system. Where models of comprehensive service deliver exist, these are facilitated by NGOs 
and limited to donor-supported initiative. 
222 
Performance of HIV/AIDS programme is overall sub-optimal. Main issues relate to weak 
performance in terms of reaching populations at risk, identifying HIV-positive patients, and 
importantly effectively providing ART treatment (problems of adherence to ART are largely not 
solved). Similarly, the programme (and health system) does not effectively address the problem 
of narcotic drug dependency, fully assess performance of HIV/AIDS programme, or extrapolate 
on programme's impact on HIV incidence and associated mortality is not possible. This is 
because of a lack of a robust HIV surveillance system and gaps in data on population at risk of 
HIV infection. 
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CHAPTER 10 DISCUSSION AND CONCLUSION 
INTRODUCTION 
This study sought to understand whether and how integration of a communicable disease 
programme with other health system components influences the sustainability of the 
programme. Applying a case study approach, this overarching question has been addressed 
through development of a novel conceptual framework for the sustainability of a communicable 
disease programme. A case study exploring the sustainability of TB and HIV/AIDS 
programmes has been conducted in Kyrgyzstan, a central Asian country of the FSU. 
The aim of this chapter is to review and discuss the conceptual developments, analytical 
approach taken, and empirical findings of this PhD research. The discussion is organised into 
five sections. The first section discusses the development of the conceptual framework for 
analysis applied in this PhD research. As was presented earlier, the development of the 
conceptual framework was based on the results of the literature reviews on sustainability and 
integration (Chapters 3 and 4, respectively). I begin this section with a brief summary on 
contemporary conceptual understandings of sustainability and integration90. Then I continue 
with the discussion of the theories that explain conceptual relations between these two notions 
(sub-section 10.1.2). This is followed by the assessment of strengths and limitations in 
identified frameworks for studying sustainability and integration in health systems (sub-section 
10.1.3). I discuss the conceptual framework applied in this PhD study (sub-section 10.1.4) by 
highlighting how this study's analytical approach addresses the gaps identified in previous 
conceptual developments to understand sustainability and integration in health systems. 
Additionally, this section reiterates on bow previous approaches, upon which I draw, have been 
extended in the development of the analytical approach for this thesis. 
The second section discusses the empirical findings of this research. The empirical findings of 
a case study in Kyrgyzstan were presented in Chapters 7,8 and 9. In chapter 7, I reviewed the 
health system and the broader contextual environment within which the TB and HIV/AIDS 
programmes operate. Chapters 8 and 9 presented the analysis of the TB and HIV/AIDS 
programmes' characteristics. In section 10.2, I bring these findings together by discussing the 
similarities and differences in the potential for sustainability of these two programmes. The 
discussion of the empirical findings is provided in the context of existing studies in the FSU and 
90 The objectives of the study to review and clarify contemporary understanding and analytical approaches to 
sustainability and integration (Chapter 1). 
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beyond, and broader knowledge on factors determining the sustainability of health programmes 
in a health system. 
Throughout the discussion I identify the contribution of this research to knowledge, both 
theoretical and empirical. This is summarised in the third section, 10.3. In this section, I also 
revise the representation of the framework for analysis applied in this study (Chapter 5, Figure 
5.1) and offer an empirically tested framework drawing on the implemented research and 
reflections on limitations. The limitations of this PhD research are defined and discussed in the 
fourth section. Recommendations to the government and donors working in Kyrgyzstan, and to 
central Asian governments more generally are made in the fifth section. 
10.1. SUSTAINABILITY AND INTEGRATION 
10.1.1. Conceptual definitions 
The theoretical and conceptual developments related to sustainability evolved in the research on 
the behaviour of ecological and socio-economic systems, an interdisciplinary research area 
referred to as sustainability sciences. The concept is inherently complex and contested, and 
difficult to put into an all-encompassing definition (Kaiikawa, 2008). Inherent to sustainability 
is a focus on the future needs and co-evolution of systems with mutual benefits across 
environmental and socio-economic systems (Kemp, Parto, and Gibson, 2005). There is therefore 
a fundamental tension between short-term gains and long-term needs. Because the future is a 
concern, efficiency is the key for sustaining systems. 
Contemporary views of sustainability in the health system echo, to some extent, those of 
sustainability sciences. Common themes in definitions of sustainability are meeting current and 
future needs of population in terms of improving well-being and health, continued public health 
impact of health interventions, maintenance or viability of structural or functional health 
system's components or of the health system overall. Sustainability in health systems is 
understood as a complex and multidimensional phenomenon influenced by multiple, often 
interrelated, contextual factors (Greenhalgh, Kyriakidou, and Peacock, 2004, Gruen and others, 
2008, Humphreys and others, 2008, Sibthorpe, Glasgow, and Wells, 2005). 
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In my assessment and synthesis of attributes or dimensions of sustainability in health systems 
(Chapter 3), 1 identified at least five broad attributes: 
" Capability of stakeholders to lead, govern, and manage 
" Availability of resources and ability to plan, implement and evaluate activities 
" Capability to build and maintain relationships and interactions inside and outside an 
organisation 
9 Capability to learn, adapt, renew or be flexible 
9 Ability to perform, bring results or attain goals. 
Among these attributes of sustainability is the notion of integration. In my literature review 
(Chapter 4) on integration and health systems, I found that integration is defined, understood 
and pursued differently in different settings. Through assessing and summarising various 
typologies of integration, I identified at least three broad dimensions: 
" Aim and/or rationale for integration (the why of integration). 
" Structures and/or functions at different levels of the health system that are affected by 
integration, or the lack thereof (the what of integration). These include, but are not limited 
to, health system components such as governance, financing, planning, service delivery, 
monitoring and evaluation as well as integration of ideas or professional goals. 
" Interactions between health system's components or stakeholders (the how of integration). 
There is a range of interactions, ranging from collaboration, cooperation, coordination, 
linkage, integration, mergers. 
10.1.2. Sustainability and integration: theoretical link 
As has been mentioned, the review of conceptual approaches to sustainability in health systems 
revealed that integration (though defined differently) is viewed as one of the attributes or 
determining factors for sustainability. However, these views on sustainability and integration 
have not provided theoretical insights to explain what the link between these two concepts is. 
The findings of the literature reviews on sustainability (Chapter 3) and integration (Chapter 4) 
suggest that both notions have their roots in theories of complex systems (Kajikawa, 2008, 
Kodner and Spreeuwenberg, 2002, Nolte and Mckee, 2008). The integration concept is central 
to system theory (Checldand, 1981, Scott, 2002). Systems are composed of multiple, 
interacting and interdependent agents (e. g. individuals, organisations). Inter-relationships and 
connections among agents are the necessary conditions for forming and maintaining systems. 
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Theories rooted in systems perspectives provide conceptual insights on the role of integration in 
sustaining systems. In social research, some explanations of the potential influence of 
integration on sustainability of organisational systems were found within organisational 
theories, particularly within open system perspectives. I review these perspectives below. 
Perspectives, from organisational theory 
Though the term `sustainability' is not commonly used by organisational theorists, an 
organisation's viability, survival, adaptation and performance are among the central questions. 
These notions in turn are viewed as central aspects of sustainability in sustainability research 
(Chapter 3, Table 3.1). The central argument proposed by the open system model is that all 
organisations depend on exchanges with other systems (Jaffee, 2001, Scott, 1987). The 
environment is an ultimate source of resources, support, energy and information, all of which is 
vital for the existence and continuation of the organisational system (Scott, 1987). A more 
complex and uncertain environment drives organisations to adapt and change their arrangements 
for the purposes of survival (i. e. performance, viability, legitimacy). One of the strategies that 
organisations undertake in adapting is to build integrative relations, both within an organisation 
and with other entities. 
The contingency theory (Galbraith, 1973, Lawrence and Lorsch, 1967b) and resource 
dependency theory (Aldrich, 1979, Pfeffer and Salancik, 1978 ) argue that organisations 
generally strive for performance. Therefore, they often build integrative relations with other 
organisations (or modify internal structure) in the interest of effectiveness and efficiency. In the 
view of institutional theory (Meyer and Rowan, 1977), organisational survival depends on two 
potentially contradictory conditions that may conflict. These are legitimacy and productive 
efficiency. Decisions to build linkages (or not) with other organisations may be also driven by 
social pressures to conform to conventional beliefs or institutional rules that produce support in 
obtaining resources or legitimacy (Jaffee, 2001). However, conformity to the institutional rules 
or conventional beliefs may be in conflict with efficient realisation of organisational objectives. 
The abovementioned theoretical perspectives argue that organisations are capable of acting 
effectively in determining their arrangements. In an alternative perspective, population ecology 
theorists (Hannan and Freeman, 1984) view organisations as structurally inert in response to 
changing environmental demands. According to this view organisational survival is dependent 
on selection by the environmental forces. Those organisations that `fit' with the environment 
(including their interactions with other organisations) are favourably selected. Success requires 
the establishment of predictable routines that produce consistent results over time, which often 
227 
locks organisations into established and fixed procedures (Jaffee, 2001). This works well in a 
stable environment, but becomes an issue for organisational survival when the context becomes 
complex and uncertain. 
The theoretical perspectives reviewed here identify that integration (e. g. coordination, 
collaboration, mergers) is important for an organisation's adaptation to the constraints and 
opportunities posed by the external environment. There are tensions in organisational 
theorizing (Jaffee, 2001), as maintaining independence and autonomy is also related to 
organisational survival and viability. Additionally, integration may have negative effects on 
organisational viability. It was argued, for example, that in some contexts tighter systematic 
integration may reduce adaptive potential, or extensive coordination may reduce the quality of 
services of the overall system/network, and hinder innovativeness (Whetten, 1981). 
Organisational theorists generally view the environment as external to an organisation, and 
evolving separately (Begun and Zimmerman, 2003). Ultimately, the best way to organise 
depends on the environment within which an organisation operates, thus the influence of 
integration initiatives on sustainability is highly context specific. 
Perspectives from complex systems theories 
Complexity theories represent multidisciplinary ideas and theories to address the non-linearity 
and dynamics of the real world systems, often known as complex adaptive systems (Holling, 
2001, Plsek and Greenhalgh, 2001, Sturmberg and Martin, 2009). Within this discourse, 
systems operate in a constantly changing environment in which uncertainty, risks and surprises 
are unavoidable, thus the essence of a system's sustainability is increasingly understood as the 
system's resilience9' (Folke and others, 2002, Gunderson, 2000). 
Among key characteristics of a resilient system is the notion of integration, which is referred to 
as interconnectedness or connectivity (Fiksel, 2003). The role of connectivity in a system's 
sustainability relates to several properties of complex adaptive systems (Box 10.1). In complex 
systems, the numerous and diverse interacting agents are typically organised as hierarchical 
nested networks (e. g. a sub-system nested in a larger system). Structured this way, agents 
interact in a dynamic and non-linear manner, and are capable of relatively autonomous 
functioning without external control (i. e. locally controlled). Because of such properties, 
"One of the definitions of resilience on which I build, has been provided by the cited authors (Folke and others, 
2002). Resilience is defined as an ability to adapt to internal and external pressures yet retain functioning and 
performance, and initiate changes through innovations in order to continuously improve performance 
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systems are potentially capable of self-organisation, which is forming a collective behaviour 
(Box 10.1). 
Both the absolute number of connections and the strength of these connections (i. e. frequency) 
have consequential roles in a system's functioning and adaptations (Eidelson, 1997). In a sense, 
a system's connectivity relates to internal controllability, a measure that reflects flexibility or 
rigidity of internal control (Holling, 2001). It determines the degree to which a system can 
control its own destiny, and adapt to internal and external changes (Holling, 2001). Inadequate 
connections can make it difficult for a system to coordinate an adaptive response. On the other 
hand, excessive connections can also endanger a system. In the latter case, the system's agents' 
may be unable to devise an adaptive response when faced with an overload of conflicting 
influences. 
Box 10.1 Properties of complex adaptive systems 
" Composed of multiple agents and components, these agents are interacting and 
interdependent. 
" Structured as hierarchical nested networks. Connection close to a focal point or a hub is 
stronger than with neighbouring components; in turn connections with neighbouring 
components are stronger than with the distant ones. 
" Open to the environment, the system's agents continuously interact with and co-evolve with 
its environment. 
" Interactions are non-linear and dynamic; some sequences of interactions involve feedback 
loops, both positive and negative. Small changes in the environment or within a system may 
lead to massive system change and vice versa. 
" Capable of self-organising, a pattern of behaviour emerges iteratively through dynamic and 
non-linear interactions among the system's components. As a result the organised behaviour 
of a system is larger and more complex than the sum of its parts. 
" Path-dependent, non-reversible processes have similar starting points yet lead to different 
outcomes, even if they follow the same rules. Outcomes are sensitive not only to initial 
conditions, but also to choices made along the way. 
Paine and Peters, 2011, and Sturmberg and Martin, 2007 
Along with connectivity, insights from theories of complex systems provide somewhat 
competing explanations suggesting that multiple factors may determine a system's 
sustainability. Independence and diversity of system's agents (both structural and functional) 
are also necessary for a system's resilience. Diversity provides opportunities for innovations 
and development as it is a source of learning and a resource base for adaptation and 
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reorganisation (Kay and others, 1999, Kemp, Parto, and Gibson, 2005). Complexity theorists 
emphasise that each complex system is unique (Begun and Zimmerman, 2003). Systems evolve 
in a way that multiple outcomes are possible depending on history (i. e, path-dependence, Box 
10.1), choices made along the way and influences over time. 
10.1.3. Analytical approaches to sustainability and integration in health systems 
Frameworks for analysis of sustainability 
I found that theoretical and analytical developments related to sustainability in health systems 
are evolving and less advanced as compared to sustainability sciences. Additionally, my 
assessment of the conceptual literature also identified the lack of theory-based conceptions of 
sustainability of communicable disease programmes. The traditionally applied view of a 
disease control programme has been as a set of disease control interventions (e. g. biomedical, 
structural, health promotion) without indications of the health system's arrangements for 
delivery of these interventions. 
Identified frameworks92 for analysis of sustainability in health systems were focused on three 
areas: i) sustainability of a health innovation or intervention, conceptualised as 
institutionalisation of the intervention into routine organisational settings; ii) sustainability of 
international initiatives (e. g. interventions or health reforms) proposed within the international 
development discourse; and iii) sustainability of complex programmes or services (Table 10.1). 
Frameworks which I grouped in i) and ii) (Table 10.1) build upon theoretical propositions, or 
researchers' experiences, that do not fully provide explanations to capture the multiple 
dimensions of sustainability, interrelated factors that influence it, or the issue of time. These 
frameworks and approaches tend to be deterministic in nature where sustainability is an end 
goal, assuming linear and predictable processes. 
For example, frameworks that conceptualise the sustainability of an intervention as its 
institutionalisation into routine organisational settings build on propositions from diffusion of 
92 1 identified 26 frameworks that were proposed or applied in exploring the sustainability of health interventions, 
organizations, services or a health system (Appendix 3). Seventeen of the identified 26 frameworks were frameworks 
for assessing sustainability of a health intervention or a programme, six were developed for sustainability of a health 
organization, and three aimed at the assessment of a health system. Sixteen papers explicitly draw on theoretical 
perspectives. The rest were based upon researchers' experience and/or literature review. 
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innovation theor? 3 (Rogers, 1995). The underlying assumption in these frameworks is that the 
new intervention should be sustained indefinitely, thus there is potential resistance to further 
innovation and development (Greenhalgh, Kyriakidou, and Peacock, 2004). Sustainability as 
institutionalisation does not provide insights on whether activities are achieving effective 
outcomes (Scheirer, 2005). 
Table 10.1 Frameworks for analysis of sustainability in health systems 
Frameworks Theoretical underpinnings or References 
background 
(i) Sustainability of Diffusion of innovations theory Bowman and others, 2008, Goodman 
interventions as (Rogers, 1995) and others, 1993, Pluye, Potvin, and 
institutionalisation Denis, 2004, Shediac-Rizkallah and 
in routine Bone, 1998, Virani and others, 2009, 
organisation Johnson and others, 2004 
settings 
Organisational learning theory Virani and others, 2009, Pluye, Potvin, 
(Argyris, 1993, Argyris and Schön, and Denis, 2004 
1978) 
Institutional theory (Powell and Pluye, Potvin, and Denis, 2004 
DiMa io 1991) 
(ii) Sustainability of Institutional theory, strategic Brinkerhoff, 1992 
interventions or management 
health services Bossert, 1990; Bamberger and 
within Guides or experiences with Cheema, 1990, Knippenberg and 
international implementing international others, 1997, LaFond, 1995b, Sarriot 
development development initiatives (e. g. USAID, and others, 2004, Stephenson, Tsui, 
initiatives UNAIDS, WB) and Knight, 2004, Torpey and others, 
2010 
Freak, 1994, and concept of 
sustainable development Bernuran 1995 
(iii) Sustainability of Organisational theory, open systems Olsen, 1998 
complex perspective (Katz and Kahn, 1978) 
programmes or 
services Ecological systems theory Gruen and others, 2008 ; Hanson and 
Hanson, 2005 
Complex organisational networks Nelson and ohers, 2007 
(Nohria and Eccles, 1992) 
Mancini and Marek, 2004. 
Researchers' experiences Humphries, 2008 
Organizational theory, formation of Rog and others, 2004, Alexandre and 
interorganisational relationships others, 2007. 
Diffusion of innovation theories, Greenhalgh and others, 2004 
theories of organizational change and 
innovation 
" Classical diffusion innovations theory, set out by Everett Rogers in 1995, draws on a simple law of natural growth 
in a closed system, postulating that adoption of innovations by individuals follows a predictable linear pattern. 
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In international assistance discourse, conceptual frameworks make a particular focus on the 
operational and/or financial self-sufficiency of local organisations or institutions after the 
withdrawal of international assistance. With few exceptions (Berman, 1995, Brinkerhoff, 
1992), these frameworks are guided by a theory. Most encompass the views of international 
actors (e. g. WB, USAID). Though resources are important for sustainability, it is unclear how 
long after the withdrawal of funding an organisation should remain self-sufficient to qualify as 
being sustainable. 
It has been acknowledged in research on sustainability in health systems that sustainability is 
difficult to predict, conceptualise or explain. Authors (Greenhalgh, Kyriakidou, and Peacock, 
2004, Gruen and others, 2008, Humphreys and others, 2008, Nelson and others, 2007, Olsen, 
1998) have proposed utilizing systems' theories, or apply a `whole system' approach to analysis 
(grouped in (iii), Table 10.1). These frameworks aimed to explain and understand complexities 
surrounding the sustainability of health interventions, programmes or organisations. The 
proposals emphasise, in various extents, the need to maintain resource capacity, the importance 
of interactions and interdependence among the system's structural and functional components, 
the role of individual actors, adaptability, and performance. A main limitation of all identified 
frameworks for the analysis of sustainability and integration is the lack of an explicitly outlined 
conception of a health system. Though the context is acknowledged, sustainability of health 
interventions or programmes tends to be analysed in isolation from the overall health system. 
Consequently, the offered frameworks cannot fully provide explanations on what role the 
different health system's functions, including integration of programmes with the health 
system's components, may play in sustainability of interventions or programmes. 
A number of frameworks for analysis of sustainability of health programmes or services have 
included notions of integration as one of the determinants, or a dimension, of sustainability 
(Alexander and others, 2003, Bossert, 1990, Gruen and others, 2008, Hanson and others, 2005, 
Humphreys and others, 2008, Mancini, 2004, Olsen, 1998, Sarriot and others, 2004, Shediac- 
Rizkallah and Bone, 1998). In these frameworks, definitions of what integration entails differed 
(e. g. collaboration, coordination, supporting relationships, alignment). With few exceptions 
(Berman, 1995, Knippenberg and others, 1997, Olsen, 1998), identified, frameworks address 
questions of efficiency, which is a cornerstone in sustainability discourse. 
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Frameworks for assessment of integration in health systems 
According to my assessment (Chapter 4), the most conceptual and analytical approaches to 
integration in health systems originate from research in high-income countries90 (Appendix 3, 
section A3.3). All identified frameworks were focused on integration of structural and/or 
functional components of a health system. Theoretical perspectives applied95 in the proposed 
frameworks include theories explaining the formation and maintenance of inter-organisational 
relationships, namely contingency theory, resource dependency, institutional theory, agency 
theory. The underlying assumption in most frameworks is that integration plays a positive role 
in a health system. Authors stated a need for integration (i. e. why of integration96) as a necessity 
to reduce a health system's fragmentation and/or duplication of services, reduce health care 
cost, or improve the overall performance of services (Appendix 3, section A3.3). I did not find 
any frameworks for assessment of integration in the health system that aimed at exploring the 
influences of integration on sustainability. A main limitation of all frameworks, similar to 
frameworks for the analysis of sustainability, is the lack of an explicitly defined conception of a 
health system. There was only one exception in my analysis, which is the framework proposed 
by Atun and others (2008), which conceptualised integration based on the explicitly outlined 
conceptualisation of a health system. 
Synthesis of empirical studies: influence of integration on sustainability 
With few exceptions (Le Loup and others, 2010), my research finds that empirical studies did 
not aim to explore explicitly the influence of integration on sustainability. One of the main 
findings of the assessment of empirical studies on sustainability (Chapter 3) is that integration is 
one of the determining factors97 for sustainability of interventions or health organisations. As 
was presented in the Chapter 3, relationships (e. g. coordination, partnerships) within and with 
other organisations were found as a determinant in all studies that included this component into 
the assessment. However, notions of integration and sustainability were viewed differently in 
the assessed studies, what prevented me from forming any additional conclusions. 
"9 out of 41 identified frameworks (Chapter 4) were proposed for exploring integration in low middle income 
countries; the rest- high income countries (Appendix 3, section A3.3). 95 22 frameworks build on explicitly outlined theoretical perspectives; the rest draw on researchers' experiences or 
literature reviews, 
96 Frameworks for integration in health systems were assessed from the point of how they reflect on three questions - i. e. what, why and how of integration (Chapter 4). 97 In empirical studies (Chapter 3), I found at least five determining factors, broadly grouped as leadership, capacity, flexibility, integration (notion of integration is defined differently) and performance. 
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10.1.4. Conceptual framework for sustainability applied in this study 
In the development of the conceptual framework for analysis in this PhD study, I took into 
account the following considerations: 
" The main limitation in the previous frameworks for sustainability and integration was the 
lack of an explicitly outlined conception of a health system. 
" To build a framework on theoretical and analytical approaches that can provide plausible 
explanations of sustainability, a phenomenon that is multidimensional, dynamic and 
influenced by multiple and interrelated factors. 
I took the work by Atun and others (2004) and Coker, Atun and McKee (2004a) as a starting 
point for the developing the conceptual approach in this study. I began with defining what 
constitutes a communicable disease programme. Drawing upon Pawson and Tilley's 'realistic 
evaluation' (Pawson and Tilley, 1997), Atun and others (2004) proposed conceptual and 
analytical frameworks for understanding the functioning of a communicable disease programme 
within a health system. Their developments explicitly outline a conception of, and analytical 
approach to, a health system and a communicable disease programme. 
Because of its underlying ontological perspectives within the philosophical school of critical 
realism9B, 'realistic evaluation' (Pawson and Tiley, 1997) appeared to be a promising analytical 
approach for studying a complex phenomenon such as sustainability of a health programme. 
Several authors (Byrne, 1998, McPake, Blaauw, and Sheaff, 2006, Reed and Harvey, 1992) 
argued that critical realism ontology provides a relevant philosophical perspective for 
understanding and explaining complex social phenomena. Both critical realism and complexity 
sciences view the reality as open, dynamic and non-linear, where multiple explanations and 
causations are possible. A realist's conception of causality is generative. The explanation of 
outcomes and observations can be traced back to generative mechanisms which are triggered or 
not depending on the context. Realists contend that causative mechanisms that explain a 
phenomena can be known by first constructing ideas about these mechanisms (Olsen, 2010, 
Pawson and Tilley, 1997). Based on the conception of sustainability developed in this PhD 
research, I extended the work of Atun and others (2004) by proposing mechanisms that can 
explain why a programme is likely sustainable or why not. I explain my contribution bellow. 
98 Pawson and Tiley, 1997 draw on critical realism tradition in the philosophy of science, particularly works Bhsskar, 
1975, Harr6,1986, Hesse, 1974 
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In this research, a programme's sustainability is defined as being continuously effective in 
reducing a disease problem, responsive and adaptive to changes in the nature of disease 
epidemics, population needs or contextual environment. I build on theoretical insights of 
complex adaptive systems which view a system's resilience as an essence of sustainability 
(Fiksel, 2003, Fiksel, 2006, Folke, 2006, Kemp, Parto, and Gibson, 2005). This view accepts 
the uncertainty of sustainability phenomena, which is difficult to measure empirically 
(Alexander and others, 2003, Altman, 2009). What is possible is to identify a potential for 
sustainability through an analysis of sustainability by proxy fashion on the basis of observable 
capabilities or characteristics, which are hypothesised precursors of sustainability. In my 
conception of sustainability, the precursors of a programme's sustainability include leadership, 
capacity, interactions, flexibility and performance" (also labelled throughout the thesis 
interchangeably as a programme's characteristics, in Chapters 8 and 9). These precursors for 
sustainability are the underlying mechanisms which, as proposed in my research, can explain a 
potential for sustainability. Figure 10.1 represents a schematic presentation of the conceptual 
framework by Atun and others (2004) with mechanisms as assumed in this research. 
The notion of integration (which I have chosen to call `interactions') is one of the precursors for 
a programme's sustainability. In defining integration, I extended the conceptual approach to 
integration and health systems developed by Atun and others (2008) (whose work also builds 
upon Atun and others 2004), who conceptualised a health system as a complex adaptive system 
(Atun and Menabde, 2008 -a). Integration is viewed as occurring at any of the health system's 
structural or functional components (i. e. what of integration), including governance, financing, 
service delivery, and monitoring and evaluation (Chapter 5, Table 5.1). My contribution 
includes bringing the insights from propositions of the literature on inter-organisational relations 
(Kodner and Kyriacou, 2000, Konrad, 1996, Leutz, 1999) defining interactions (i. e. how of 
integration) between programmes (or a programme and other health system component). These 
are viewed as ranging from no formal interactions to linkage, coordination and full integration 
(Chapter 5, Table 5.2). 
"The definitions are presented in the Chapter 5. 
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Figure 10.1 The schematic representation of conceptual framework for communicable 
disease programmes by Atun and others (2004), using the example of a T13 programme 
Source: Presented with permission from Coker and others (2004a). The framework is extended through 
defining mechanisms (shown in italics) for sustainability of a programme. 
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Whether proposed precursors (i. e. mechanisms) for a programme's sustainability exist, act and 
affect the delivery of interventions and consequently contribute to the reduction of a disease 
problem depend on several factors, including the inter-relationships among them. In the 
analytical framework (Chapter 5), 1 follow Atun and others (2008)100 as outlined previously, and 
Gruen and others (2008)101. These authors draw on the theories of complex systems and 
relevant empirical evidence. The mentioned analytical frameworks emphasise a key role of 
stakeholders and relations among them in establishing, changing and sustaining health 
programmes. In my analytical framework, factors (and interdependence among them) that 
potentially act upon precursors of sustainability (i. e. mechanisms) are the nature of the disease 
problem, actors, the health system's and programme's arrangements (both structural and 
functional), and the broader context. Based on the application of the framework for analysis 
(Chapter 5) in the case study, I propose a modified framework in section 10.3.2. 
10° Atun and others (2008) developed a conceptual framework for analysis of integration and health system. 101 Gruen and others (2008) proposed an integrated framework for exploring the sustainability of a health programme. 
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10.2. SUSTAINABILITY OF TB AND HIV PROGRAMMES IN KYRGYZSTAN: 
DISCUSSION OF FINDINGS 
As was outlined in the preceding section, the potential for the sustainability of a disease control 
programme in this study has been analysed through assessing the existence of and actions of the 
precursors of programme sustainability in the delivery of disease control interventions. The 
analysis also included identification of key enabling and constraining factors that influence 
these five precursors of sustainability. 
10.2.1. Overview of main findings 
Over the last two decades, Kyrgyzstan has witnessed a worsening TB epidemic and emerging 
IDU-driven HIV/AIDS epidemic. The country had inherited approaches that were not effective 
in controlling the expanding epidemics. By the middle of the 1990s, Kyrgyzstan's government 
had declared a political commitment to achieving global targets of TB and HIV/AIDS control. 
In the next decade (the 2000s), several potentially effective innovative interventions were 
introduced to central Asian countries, including Kyrgyzstan, through GHIs and other efforts of 
international organisations. Among these novel approaches were DOTS and MDRTB 
management for TB control, and harm reduction interventions among IDUs and ART for 
HIV/AIDS control. As was presented in Chapter 6 on `Methods', these interventions were at 
the centre of my analysis. 
Precursors for sustainability of TB and HIV/AIDS programmes 
My analysis of the five precursors of sustainability of TB and HIV/AIDS programmes suggests 
that the programmes have differences and similarities in their potential for sustainability. The 
programmes had differences in terms of leadership style, available domestic resource capacity, 
and flexibility. The programmes appeared to face similar challenges as relates to the 
development of interactions with other health systems components and performance. 
" The TB programme is predominantly represented by the specialised TB services. The 
leadership of the TB programme is characterised by centralised and formal authority 
dominated by one institution, the NCPh. Political commitment is partially supported by 
dedicated domestic resources for maintenance and functioning of specialised TB services. 
Since 2000, the government allocates an estimated 50-70% of total spending on TB 
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control102. Implementation of innovations and key consumables are funded externally. A 
main impediment to sustainability of the TB programme is inherent inefficiencies caused by 
overcapacity of specialised TB services and concentration of the programme's resources in 
these. The TB programme is characterised by limited adaptability (flexibility) and limited 
formal interactions with other health system components. Despite nearly 10 years of 
implementing DOTS, no major shift in the financing and organisation of TB care has taken 
place. Over-reliance on hospitalisations for treating TB and social care persists. The 
response to MDRTB is structural and reliant on hospitalisations. It was not possible to fully 
assess the programme's performance in this study because of weaknesses of disease 
surveillance and M&E systems. Analysis of available data suggests that the TB programme 
likely remains ineffective in reducing TB transmission and associated mortality and 
morbidity, including the emergence and transmission of MDRTB. 
" The HWIAIDS programme is complex, involving the state, civil sector and international 
actors. The programme's leadership is evolving with an intention to establish multisectorial 
coordination among many actors. A main obstacle to sustainability for the HIV/AIDS 
programme is nearly full reliance on external financial resources for implementing a 
comprehensive HIV response strategy. During the last decade, the government allocates 
less than 20% out of total expenditure on HlV/AIDS programme103. Domestic actors 
demonstrate adaptability and openness to innovations, as was evident from changes in HIV 
legislation, piloting of harm reduction including in prisons, and involvement of NGOs. 
Novel interventions and governance approaches such as the CMCC are not integrated into 
mainstream regulatory, social and health systems. The scale up of interventions is 
potentially impeded because of limited formal interactions between specialised services 
involved in the HIV/AIDS programme, and between NGOs and the state organisations. 
Data on programme performance are nearly absent. Available M&E indicators are not 
informative of whether the programme contributes to the reduction of HIV transmission 
among risk groups or reduces risky behaviours. Existing data suggest that the HIV/AIDS 
programme is likely not effective in reaching risk groups and preventing HIV transmission. 
102 The estimates for the years 2000-2008, Chapter 8, Figure 8.4 103 The estimates for the years 1998-2009, Chapter 9, Figure 9.6. 
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Factors acting upon the five precursors for sustainability 
Several interrelated factors emerged in the analysis as enabling or constraining factors 
influencing the five precursors of sustainability of both programmes: 
The distinct histories of TB and HIV/AIDS as public health problems, including in the 
contemporary period, have led to differences in the programmes' potential for 
sustainability. The TB and HIV/AIDS programmes have evolved along different historical 
trajectories in the health system. The TB control programme has historically established 
Soviet era institutions with professionally embedded approaches to TB care. The 
HIV/AIDS programme, addressing a new communicable disease and its drivers such as 
IDU, is an innovation on its own in the health system. These factors, among others, 
emerged as determinants of the programmes' differences in terms of leadership, flexibility 
and available domestic resources. 
" Political and institutional interests and priorities of both domestic and international actors 
determined how health system resources are allocated and utilised to deliver innovative 
interventions. Institutional interests of domestic actors were profound in the case of the TB 
programme, impeding development of patient-centred care. In the case of the HIV/AIDS 
programme, international actors emerged as having a substantial influence on 
implementing control strategies and distribution of resources. 
" Prevailing health system arrangements, including the Soviet legacy upon which they are 
founded, impedes the development of interactions between the two programmes, and 
between the programmes and general health system. Delivery of interventions is affected 
by historically embedded social and regulatory control of persons with communicable 
diseases and other risk factors such as IDU. Delivery of interventions for diagnosis, care 
and support for people with TB, HIV/AIDS and narcotic drug dependency remain 
centralised with strict control over clinical management. Historically fragmented 
governance and financial mechanisms (both domestic and international), combined with 
such domestic traditions of management of patients within single speciality services, limit 
the programmes' adaptability. The health system fragmentation creates impediments to 
changes in the organisation of the delivery of disease control interventions, and 
consequently impedes the scale up of interventions and effectiveness of innovative 
interventions. 
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0 Weak TB and HIV/AIDS surveillance systems create barriers for developing disease 
control policy and planning of resources. Capabilities for planning, evaluating and using 
scarce resources efficiently are weak. Effective M&E systems for evaluation of the impact 
of innovative control interventions (such as DOTS for TB and harm reduction initiatives 
for HIV) on public health have not been put into operation. Consequently, this poses one 
of the key obstacles for assessing performance of disease control programmes in 
Kyrgyzstan. A central question for sustainability, that is efficiency, is not addressed in the 
M&E systems of both programmes. 
" Providing development assistance to countries with weak health systems and difficult 
socio-economic conditions presents challenges. The study reveals tensions between the 
need to promptly deliver necessary interventions to save lives and the necessity of overall 
capacity building of local organisations for the long-term impact. Limited financial 
resources capabilities in the health system create vulnerabilities in terms of long-term, 
secure and sufficient funding for both programmes. On one hand, an increased global 
attention to TB and HIV/AIDS provided Kyrgyzstan opportunities for implementing 
control efforts, particularly initiating innovative interventions. On the other hand, 
international actors focusing on each disease separately have often been acting in parallel 
with broad health system reform processes. Opportunities for establishing efficient and 
integrated approaches for planning and delivery of disease control interventions, which 
were created by the health system reform programme, have not been fully utilised by actors 
of the respective programmes. 
Further in the discussion, I reflect on the central challenges for sustainability of TB and 
HIV/AIDS programmes as identified in this research. I first focus on the differences between 
the programmes in their prospects for sustainability. In discussing the sustainability of the TB 
programme in the next sub-section, I explore the main reasons that contribute to the persistence 
of inefficient practices of TB care, and interrelated consequences. This is followed by a 
discussion of the key obstacle to the sustainability of the HIV/AIDS programme, namely 
dependence on donors, including potential consequences for sustainability. Then, I focus the 
discussion on three main factors that potentially affect the sustainability of both programmes. 
These are interactions of the programmes with the broader health system, disease surveillance 
systems, and challenges with providing international assistance for TB and HIV/AIDS in 
Kyrgyzstan. 
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10.2.2. Tuberculosis control programme: the legacy of the Soviet phthisiatry 
My study concludes that a key impediment to the sustainability of the TB programme in 
Kyrgyzstan is inherent inefficiencies rooted in the legacy of Soviet practices of overreliance on 
hospitalisations for TB care. From the standpoint of sustainability, given considerable TB 
burden and potentially increasing number of MDRTB cases, the overreliance on hospitalisations 
raises questions as to whether the health system could afford expensive inpatient TB care in the 
long run. In addition to inefficiencies, overreliance on hospitalisations may have negative 
consequences for programme sustainability for reasons of effectiveness. Lastly, the Soviet 
legacy of social and regulatory control of patients with TB likely negatively affects the equity of 
TB care. 
This thesis adds to the empirical studies on TB control in the FSU region, highlighting that 
history (i. e. the legacy of the Soviet phthisiatry) is a profound factor shaping policies and 
practices of contemporary TB control in the region. In contrast to the inefficiencies of the 
Soviet-style in-patient care mode, international agencies favour models of out-patient based 
care, especially for drug-sensitive cases of TB through the DOTS programme. Despite 
considerable international investments, these latter models of care have not been fully realised 
in Kyrgyzstan. Though treatment of TB patients using the WHO-recommended standardised 
treatment protocol has been adopted, inefficient clinical care of TB patients in specialised TB 
hospitals persists. Additionally, it appears that, in the absence of state provision of social care 
to TB patients, TB medical services in Kyrgyzstan continue to fulfil this role, as was reported 
from Russia (Atun and others, 2005c, Atun and others, 2005d). Emerging studies in the FSU 
region demonstrate that even though treatment in hospitals mitigates social care for some low 
income patients, long-term hospitalisation indeed is one the key reasons for defaults among 
patients. Considerable defaults among hospitalised patients were reported from Ukraine 
(Vassall and others, 2009a), Russian hospitals (Belilovsky and others, 2010), and Uzbekistan 
(Hasker and others, 2010, Hasker and others, 2008). There is also emerging evidence from the 
demonstration projects on the feasibility of community-based MDRTB treatment, including in 
Russia (Keshavjee and others, 2008, Mitnick and others, 2003, Shin and others, 2004). 
The findings of my study echo the previous studies on health system responses to the TB 
epidemic, which were conducted in the early 2000s at the inception of DOTS in the FSU region 
(Atun and Olynik, 2008, Atun and others, 2005e). This similarity is an important finding on its 
own. This may suggest that in the context of the FSU, irrespective of resource availability, the 
TB system is reluctant to change despite important changes in TB epidemiology (i. e. emergence 
of MDRTB), health system reform and broader changes in global TB policies. Three broad 
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factors appear to have supported the interests of specialised TB services and contributed to their 
reluctance for a systematic change of structural and functional arrangements. These are 
legitimacy of regulatory control over patients with TB, tensions between a need to establish 
comprehensive and patient-centred TB care and lack of capacity to do so, and financial 
mechanisms of the TB system. 
Social and regulatory control ofpatients with TB 
The legacy of the Soviet approaches has been evident in the analysis of perceptions of people at 
risk of TB or with TB disease. As has been presented in Chapter 2, the Soviet health system put 
a strong emphasis on the interests of the public and the state (Field, 2002, Kimerling and 
Banatvala, 2001 a). TB was seen as a threat to the public. Coercive measures were applied to 
those who were perceived as difficult to treat or who did not comply with ordered measures or 
prescriptions (USSR Government, 1960). My analysis of interviews shows that there is a 
tendency, on the side of domestic respondents working in the TB system, to single out 
marginalised groups such as ex-prisoners and internal migrants, label them as difficult to find, 
and perceive that they are likely not to comply with treatment. As existed during the Soviet 
period, perceptions that weaknesses in TB control are often determined by faults of patients' 
persist in Kyrgyzstan. 
MDRTB is shaped by domestic actors as a threat, as a problem pertinent largely to TB 
transmission and the lack of control over persons who are difficult to treat or follow-up. 
Isolation of patients refusing treatment was voiced by domestic respondents as an intervention. 
Administrative and legal liabilities for refusing compliance with TB control interventions are 
written into the law (TheLaw, 1998b). In the context of weak capabilities to diagnose and treat 
MDRTB, traditions of social control of TB patients might have several consequences related to 
the equity and effectiveness of TB control measures. Involuntary detention or other coercive 
measures have no evidence base (Coker, 2001 b, Coker and others, 2007, Coker, 2003). There is 
empirical evidence however that hospitalisation in special hospitals, physical separation of TB 
departments, isolation or any coercive measures contribute to TB stigma (Dodor and Kelly, 
2010, Kelly, 1999). Other studies have also shown that TB stigma in turn prevents patients 
from seeking health care or creates barriers to completion of TB treatment (Courtwright and 
Turner, 2010, Woith and Larson, 2008). 
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Barriers for the development of comprehensive TB care in Kyrgyzstan 
My study contributes to the understanding of health system challenges in the establishment of 
comprehensive patient-centred TB care in a setting with potentially high rates of MDRTB. 
An important barrier is the false dichotomy between TB and MDRTB that has been created by 
the global policies on TB control (Keshavjee and Farmer, 2010, Keshavjee and Seung, 2009). 
Over the last decade the international response to MDRTB has been unclear. Countries have 
received fragmented assistance, which was centralised and controlled by the GLC. As was 
presented in the introductory Chapter 2, for a long time countries were advised to focus on drug- 
susceptible TB. As a result, Kyrgyzstan's response has been slow and largely structural. The 
domestic policy makers envision further specialisation of TB hospital care, and justify this 
because of the increase in MDRTB rates. At the time of the research, MDRTB patients in 
Kyrgyzstan were treated in a hospital setting for 18-24 months. 
Another barrier is the unpreparedness of the general health system to manage patients with 
communicable diseases. There is an absence of infection control in hospitals which creates a 
risk of TB transmission. Clinical management of MDRTB is complex and often requires 
specialised inpatient care and advanced medical skills. There is no capacity in Kyrgyzstan's 
health system to properly diagnose resistant forms of TB, with the exception of a few donor- 
supported pilot sites. Lastly, there is no capacity yet to establish effective community-based TB 
care. Primary care services are still weak. In contrast to the HIV/AIDS programme, there is a 
near absence of NGOs or community support groups addressing the needs of TB patients. 
Critical role of financing in changing approaches to TB treatment 
This study confirms previous finding of studies in Russia (Floyd and others, 2006, Marx and 
others, 2007) that in the FSU context a shift to patient-centred TB care is not likely without 
changes in financial mechanisms and regulations of TB services. I highlighted in Chapter 8 that 
despite health reform efforts to restructure and downsise inpatient infrastructure, TB services 
retained a substantial TB bed capacity. This continues to encourage unnecessary 
hospitalisations104. It appears that Roemer's law of `beds exist, beds occupied' (Roemer, 1961) 
stands in Kyrgyzstan similar to other settings (Kroneman and Siegers, 2004, Marx and others, 
2007). 
104 In 2008, there were 5333 new TB cases notified and the country reported 14 727 admissions for TB treatment 
nationally (Table 8.8, Chapter 8). This is equivalent to 2.7 admissions per each new TB case. Review of historical 
data indicated a similar, or higher, ratio of number of new cases to number of admissions. 
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The budget formation for TB services changed1°5 in 2008. However, financing of TB services 
in Kyrgyzstan remains input-based (i. e. per hospitalised case), keeping incentives for retaining 
specialised TB beds and/or potentially increasing the number of admissions. In general, policy 
makers, representing both the state and international actors, viewed the changes as timely and a 
step forward. There were tensions however. Positions on the rationale for financing reform of 
TB services differed. International actors viewed changes in financial mechanisms as a way to 
reduce unnecessary hospitalisations. Domestic policy makers in TB control viewed the changes 
as a way to retain the funds for the specialised TB services 106 
The lack of linkages in resources planning and allocation between TB services and primary care 
providers arguably impedes further development of outpatient TB care. Generally, TB case 
detection and observation in the ambulatory phase by primary care providers is viewed as an 
achievement, by both international actors and representatives of TB services. However, this has 
not been supported in the way funds for the TB programme are allocated. Spending on TB 
activities at primary care level is low. For example, in 2007107 primary care providers spent 
4.1% of the total programme budget (from all sources), versus 79% allocated to specialised TB 
services (Table 8.3, Chapter 8) (Akkazieva and others, 2009 ). In this regard, this study finds 
tensions between the TB services and primary care providers. Whilst TB service representatives 
argue that primary care has sufficient resources to conduct TB activities, the representatives of 
primary care interviewed in this study insisted that allocated resources are not sufficient to 
implement TB activities effectively. Indeed, most respondents generally agree that primary care 
providers, whilst capable of detecting TB cases, are not effective in providing DOT. 
There is emerging evidence from other settings that providers' incentives and mechanisms such 
as pay-for-performance may improve outcomes of TB care (Beith, Eichler, and Weil, 2009, Li 
and others, 2010, Tsai and others, 2010). In Kyrgyzstan, providers' payment mechanisms are 
not linked to considerations of performance. 
ms During the Soviet period and up to 2008, the formation of the budget for TB services was based on number of 
beds and personnel. At the time of data collection, the budget formation for TB services was based on historical data 
on number of treated patients in the previous year (Chapter 8, section 8.4). 106 In the past, allocated budget was to be returned to the state if not used/appropriated in accordance with the budget 
line. 
107 This is the only review of TB programme expenditure (National Health Accounts) that has been conducted in 
Kyrgyzstan at the time of data collection. 
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10.2.3. HIV/AIDS control programme: a novel programme in the health system 
This study emphasises the challenges facing the novel HIV/AIDS programme. The evolvement 
of the HIV/AIDS programme in Kyrgyzstan over the last decade has been shaped by 
international HIV/AIDS initiatives. The contribution of this study is in demonstrating that the 
potential for sustainability of the HIV/AIDS programme in Kyrgyzstan mirrors, to a 
considerable extent, the opportunities and challenges of international assistance for HIV/AIDS 
in low income countries. Increased international commitment to HIV/AIDS combined with 
substantial funding for the HIV/AIDS response have turned the political attention of domestic 
actors to the problems of people with HIV/AIDS, of IDUs, and other marginalised groups. 
NGOs became important actors in delivering HIV interventions, including in policy making 
processes. Piloting of OST, other harm reduction interventions and actual involvement of the 
civil sector in the HIV response are achievements on their own in the context of the FSU. In 
spite of these opportunities, the health system response has not yet gone beyond implementation 
of pilots. As was stated earlier, novel governance approaches (i. e. CMCC) and control 
interventions are not institutionalised into the mainstream health, social and regulatory systems. 
In addition to challenges to sustainability created by resource vulnerability, the HIV/AIDS 
programme is affected by the legacy of the Soviet system. In the following discussion, I further 
explore this issue. Then I return the discussion to three main challenges related to sustainability 
of the HIV/AIDS programme. These are the governance of the HIV/AIDS response, financial 
mechanisms particularly allocation of resources, and the role of NGOs. 
Social and regulatory control, stigma ofpeople at risk of HIV and PLHIV 
This study illustrates that changes in the legal system and in public perception about 
marginalised groups are slow and challenging. In Kyrgyzstan, stigma and discrimination 
against drug users persists. The respondents in this study, particularly domestic actors, noted 
that aside from international projects, domestically-supported attention to IDUs health care and 
social needs remains limited. The restrictive legal framework, which criminalises drug users, 
and the weak regulatory base to prevent stigma and discrimination were commonly identified by 
respondents as contradicting the country's strategic aims for HIV/AIDS control. According to 
respondents, the legal and regulatory environment, if not changed, will continue posing 
fundamental barriers for implementing HN/AIDS prevention and treatment interventions 
among IDUs. 
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Health system responses to HIV/AIDS and IDUs epidemics interact with geopolitical influences 
and the social milieu surrounding the HIV/AIDS epidemic concentrated among IDUs. This 
finding echoes empirical studies conducted in the central Asian region (Latypov, 2008, Latypov, 
2009, Latypov, 2010) and other states with a history of strict state and social control over IDUs 
and other marginalised groups (Herington, 2010). In such states, IDUs, sex workers and other 
risk groups such as prisoners were viewed as `social evils' or `badly behaving' persons 
(Herington, 2010, Tkatchenko-Schmidt and others, 2010). Evidence from elsewhere 
consistently illustrates that fear of stigma and coercion prevents IDUs from accessing health 
services and impedes timely diagnosis and treatment, if sick (Beyrer and others, 2010, Bobrova 
and others, 2007a, Bobrova and others, 2008, Bobrova and others, 2007b, Jurgens and others, 
2010, Sarang and others, 2010). 
Another key factor that potentially impedes implementation of drug-use reduction policies in 
the central Asian region, including in Kyrgyzstan, is geopolitical influences from historically 
important allies such as Russia (Latypov, 2009). Since September 11,2001, drug control 
policies in the region have been framed as global security concerns and a `fight' against 
terrorism (Latypov, 2009). Kyrgyzstan is a member of regional initiatives on drug control led 
by Russia. Russia promotes initiatives to harmonise drug control laws regionally, including the 
adoption of legislation based on the Russian template (Utyasheva and Elliott, 2009). Russia has 
a zero tolerance policy on drug use and forcefully opposes OST (i. e. opioid substitution 
therapy). The decision of Russia to prohibit OST has been often mentioned in my interviews 
with domestic actors (both NGOs and the government) as an important factor that potentially 
might influence decisions of Kyrgyzstan's government and lawmakers to prohibit this 
intervention. 
Coordination of the HIV/AIDS response 
This case study adds to previous reports on challenges in establishing one coordination body for 
the HIV/AIDS response (Spicer and others, 2010). In Kyrgyzstan, as in many public health 
systems, multisectorality, involving private and non-state actors, and fairness in decision 
making among many actors, are new (Caceres and others, 2010, Tkatchenko, McKee, and 
Tsouros, 2000). Putzel (2004) has noted that prioritizing HIV/AIDS and ensuring cooperation 
and coordination in managing substantial financial resources is a political question rather than 
technical. I find similar traits in Kyrgyzstan. The amount of external assistance for HIV in 
Kyrgyzstan is considerable. As was pointed out by a respondent, one of the SWAp partners, the 
amount disbursed and committed for HIV/AIDS has been US$ 45 million for 2005-2010 
compared to US$ 60 million that is planned to be spent by the SWAp for health system 
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development in the same period. Domestic respondents noted that there were attempts in the 
past, from the side of high level political elite, to put interested groups as principal recipients of 
the GFATM grant for HIV/AIDS. 
Other researchers have raised concerns about requiring countries to establish a stand-alone 
coordination body for HIV/AIDS, in addition to existing governance mechanisms, as a 
condition for obtaining financial support (Godwin and others, 2006, Putzei, 2004). Though 
Kyrgyzstan followed international recommendations with setting up the CMCC, the CMCC was 
not integrated into existing governance and regulatory systems. As a result, similar to many 
other countries (Caceres and others, 2010, Spicer and others, 2010), the CMCC has been given 
'responsibility to coordinate without authority to control and ensure coordination' (Godwin and 
others, 2006). 
International funding as a determinant of the HIV/AIDS response 
Domestic oversight over financial resources is a key pre-requisite for ownership of innovations. 
However, this study suggests that country-level actors have limited influence over decisions 
regarding international spending on HIV/AIDS. There was a common opinion among domestic 
actors interviewed in this study that they have little influence in decisions on what and how HIV 
projects are to be conducted in Kyrgyzstan. International actors, on the other hand, ensured that 
they are operating under agreements with the Government of Kyrgyzstan, and their activities 
fall within the current state strategy for HIV response. Development partners also pointed out 
that the country set priorities for international funds allocation through the GFATM grant 
application processes. However, as one of the domestic actors elaborated, given the weaknesses 
of the CMCC and M&E system, priorities for the GFATM grant often have been set based on 
recommendations of international actors working in Kyrgyzstan. 
Additionally, the main issue for sustainability, I argue, is the lack of efficiency considerations in 
decisions of international actors. Lack of assessment of whether resources for HIV/AIDS are 
allocated and used effectively and efficiently is not unique for Kyrgyzstan. Overall, there have 
been limited studies on optimal resources allocation for HIV/AIDS in the context of health 
systems in the FSU (Alistar, 2010). This situation mirrors overall problems that have been 
encountered internationally. Recent assessments indicate that many countries did not allocate 
HIV/AIDS funds in a way that is most effective or efficient (Bautista-Arredondo and others, 
2008, Forsythe, Stover, and Bollinger, 2009). Identified factors include lack of robust 
epidemiological data, perceived overemphasises on multisectorial response, poor planning and 
evaluation capabilities, general inefficiencies in use of resources, and lack of domestic control 
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over resources (Bonnel, 2009, Forsythe, Stover, and Bollinger, 2009). Often resource allocation 
decisions are influenced by political factors such as international and regional priorities 
identified by international actors rather than epidemiological or economic evaluations (Lasry, 
Carter, and Zaric, 2011, Poku, 2006, Sridhar and Gomez, 2011). Broader analysis conducted by 
other authors suggests that global or regional priorities remain drivers of aid allocation in many 
low- and middle-income countries (Piva and Dodd, 2009). 
NGOs 
There has been a key expectation from GHIs that civil society organisations would provide the 
backbone of the response to HIV/AIDS. In Kyrgyzstan, as in several other settings, donors' 
development assistance has resulted in a proliferation of HIV-service NGOs (Kelly and Birdsall, 
2010, Rau, 2006). NGOs have become recipients of the funding; on balance the state has not 
benefited to the same extent (Bonnel, 2009). As has been reported from other countries 
(Bonnel, 2009), what has been evident in Kyrgyzstan is a lack of overall oversight, quality 
assurance and indeed coordination of HIV-prevention efforts implemented by NGOs. NGOs 
report principally to donors and follow guides dictated in the grants. Whilst the role of NGOs is 
undeniably important in Kyrgyzstan's context, one of the unintended spill-over effects of 
donors' policies to work directly with NGOs is that such an approach creates barriers for 
building trust between the State and NGOs. In the long run, this may impede the development 
of effective and long-term partnerships between the state and NGOs. This conclusion is 
supported by others (Rosenberg, Hartwig, and Merson, 2008) who showed that sustainability of 
donor-supported projects implemented by NGOs depends substantially on interactions between 
the state and NGOs. 
10.2.4. Interactions between TB and HIV/AIDS programmes, and between programmes 
and the general health system: potential implications for sustainability 
One of the contributions of this PhD research is empirical exploration of how integration'08 of a 
communicable disease programme with other health system components influences the 
sustainability of communicable disease programmes. I find that health system fragmentation 
impedes programmes' adaptability'09, another dimension of sustainability, limiting options for 
108 Integration in this research is defined as occurring at any health system component (i. e. governance, financing, 
service delivery, M&E) and to a different degree of interactions - no formal interactions, linkages, coordination, Ml integration (Chapter 5y) 
109 I define flexibilitin Chapter 5. Flexibility (adaptability) is defined as willingness and ability of actors to adapt 
or change disease control strategy (strategic objectives and priorities), policy (strategy, legislation, regulations), or a 
programme's structures or functions (e. g., approaches to funds mobilization, resources allocation mechanisms, 
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effective implementation and scaling up of innovative interventions. In particular, fragmentation 
of governance and financing prevents the development of effective interactions at service 
delivery between TB and HIV/AIDS programmes, and between these programmes and primary 
care. Similar challenges were found as relates to the establishment of long-term interactions 
between the HIV-service NGOs and the state organisations (i. e. state specialised services). In 
turn, I find that the limited formal interactions at service delivery have important implications 
for sustainability of both programmes for reasons of effectiveness and efficiency. It has been 
long recognised, and shown empirically, that health system fragmentation in the FSU context 
creates barriers for effective delivery of disease control interventions such as ART, OST and TB 
treatment (Bobrova and others, 2007b, Tkatchenko-Schmidt and others, 2010, Wolfe, 2007). 
Similar accounts were expressed in my study (Chapter 8 and 9). On the other hand, this study 
reveals tensions around the feasibility of integrating disease control interventions (e. g. ART, 
OST) with the general health system because of its limited capabilities. These latter services 
operate with limited financial and human resources and diagnostic capabilities to manage 
patients with TB, HIV/AIDS or narcotic drug dependency. 
Interactions at the governance and financing levels 
It is recognised that the establishment of inter-organisational relations often depends on factors 
that broadly can be grouped into two intervening factors, namely money and authority (Benson, 
1975). The extent by which authority and resources are concentrated or disbursed in the 
organisation's environment influences an organisation's traits or options in interacting with 
other organisations (Benson, 1975, Pfeffer and Salancik, 1978 ). In Kyrgyzstan, parallel 
domestic governance structures and separate financial streams are service-oriented and not 
focused on patients' needs. Each communicable disease service (including narcology services) 
operates within its own separate budget. There is neither room for diversification of funding 
streams nor flexibility in resources allocation (for example, shifting of allocated resources to 
where most needs are). Each service is dependable on allocated funds, which are often very 
tight. Such arrangements create disincentives for establishing a unified implementation 
strategy, joint resources planning and allocation among health care organisations that deliver 
disease control interventions to overlapping population groups (Atun and others, 2008 ). 
The important contribution of this study is adding to the literature on the impact of international 
financial mechanisms on health systems' development. My study suggests that in the context of 
the FSU, parallel and targeted donors' financing for each disease prevents integration initiatives, 
service provision, re-training of personnel, reporting and evaluation approaches) in response to external pressures, 
changes in nature of a disease or introduction of innovations. 
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albeit unintentionally. Indeed, most international actors working in Kyrgyzstan put 
improvement of coordination between organisations as one of their strategic objectives. Several 
models of integrated and comprehensive care have been implemented within donors' initiatives, 
reportedly successfully' 10. Yet, according to several domestic respondents, most such 
partnership efforts stop functioning well after the withdrawal of funding. I find that one of the 
spill-over effects of targeted international funding streams and their limited time horizons (e. g. 5 
years grant cycles) is creating the tensions between domestic actors competing for resources. 
Uncertainties in funding ultimately negatively affect coordination and/or development of 
partnerships and collaboration. Additionally, domestic respondents noted inflexibility of 
donors' funding and the project's implementation policies as an impediment to their 
responsiveness to the changing needs of their clients or contextual conditions (e. g. changes in 
local regulatory framework). 
Previous studies on sustainability appear to support the findings of this thesis, though these were 
conducted in different health system contexts. Earmarked funding streams targeted to a specific 
intervention or dependence on one or few funding sources emerged as a factor impeding 
sustainability of health initiatives or programmes in a number of studies (Bossert, 1990, Bratt, 
Foreit, and de Vargas, 1998, LaFond, 1995b, Rog and others, 2004, Stevens and Peikes, 2006, 
Stroul and Manteuffel, 2007). Inflexibility of donors' policies on implementation of grants was 
a factor limiting chances for sustainability in studies in the international assistance context 
(Ashwell and Barclay, 2010, Humphries, Gomez, and Hartwig, 2010) as well as in 
industrialised countries (Israel and others, 2006, Wakerman and others, 2005). 
Is integration of TB and HIV/AIDS programmes with primary care a solution for the 
programmes ' sustainabil ity? 
Historically, international policy discourse on integration of priority health programmes has 
been focused on integration at the service delivery level, particularly with primary care 
(Mosneaga and others, 2008, Unger and others, 2006b). A similar approach has been 
recommended by international actors to Kyrgyzstan's policy makers (WB, 2008). The TB and 
HIV/AIDS programmes included into their strategic objectives integration of delivery of 
interventions with primary health care. As has been presented in Chapters 8 and 9, it was 
evident from the study findings that specialised services on their own are not likely to achieve 
effective coverage of interventions. However, my analysis of the domestic documents 
suggested that there is a lack of clear implementation strategy, required resources, or clarity on 
what is meant by integration. Additionally, I find that primary care in Kyrgyzstan is not 
110 For example, the Capacity project funded by USAID; MSF programme in prisons which applies an integrated 
model of management patients in prisons; several successful international projects implemented by domestic NGOs. 
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sufficiently prepared to undertake communicable diseases management responsibilities, 
including management of narcotic drug dependency. Challenges included management of 
potentially infectious patients (in the case of TB patients) in the context of lack of infection 
control in health care settings, weak diagnostic capabilities, and negative attitudes towards 
patients with TB and HIV/AIDS including stigma. Indeed, domestic respondents representing 
the HIV programme in my study highlighted that stigma against marginalised groups is notable 
in the general health system settings. 
In summary, findings of this case study support previous propositions that effective interactions 
of disease control programmes with the broader health system are likely factors that would 
improve the prospect of a programme's sustainability (Mosneaga and others, 2008, Unger, De 
Paepe, and Green, 2003, Visschedijk and others, 2003). The study highlights however that the 
decisions in choosing integration strategies, including their timing, need to be based on 
considerations of whether integration is feasible, possible and opportune (Criel, Kegels, and 
Van der Stuyft, 2004). I agree with arguments of several authors (Atun and others, 2010b, 
Yang, Farmer, and McGahan, 2010) that a `horizontal' versus `vertical' divide is an over- 
simplified view of the complex processes occurring in health systems. There is an emerging 
evidence that options and feasibility for integration of disease control programmes with other 
health system components differ in different health systems (Desai and others, 2010, 
Hanvoravongchai, Warakaniin, and Coker, 2010, Mounier-Jack and others, 2010, Rudge and 
others, 2010). This PhD study adds to this emerging research. 
10.2.5. Importance of disease surveillance for studying sustainability of programmes 
This study emphasises critical challenges in measuring the impact of TB and HIV/AIDS 
interventions on public health in settings with weak health systems (Bennett, Boerma, and 
Brugha, 2006, Boerma and Stansfield, 2007, Cox, Ford, and Reeder, 2009, Murray, 2007, 
Murray and Frenk, 2008). Despite substantial efforts from all actors involved and financial 
assistance provided to Kyrgyzstan for the development of M&E systems for both programmes, 
it is not possible to conclude whether TB or HIV/AIDS incidence or associated mortality have 
declined. Answers to the simple question of whether implemented interventions improve public 
health outcomes were not found in this PhD research. Additionally, as was discussed earlier, 
this study highlights that both programmes have not addressed a key question for their 
sustainability, namely efficiency. 
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This study illustrates that the lack of robust communicable disease surveillance systems, and 
limited capabilities to apply epidemiological and analytical techniques, sometimes leads to 
misinterpretations of available data and divergent opinions about the course of TB and 
HIV/AIDS epidemics. Crude national statistics are often used by domestic actors to judge the 
occurrence of TB or HIV/AIDS and are communicated to the public. Available data are also 
used to formulate policy objectives, apply for grants, and judge programme performance. 
Similar to previous reports, the study respondents representing domestic HIV/AIDS services 
and some local NGOs suggested that having several M&E platforms adds to the administrative 
cost, and has been viewed as being designed to meet donors' interests (AbouZahr and Boerma, 
2005, Ashwell and Barclay, 2010). Analysis of interviews also suggested that weaknesses in 
surveillance, and in how data are being disseminated, contribute to shaping perceptions among 
domestic actors, and potentially form social narratives around persons with TB and HIV and 
affected marginalised populations. Some domestic respondents tended to blame marginalised 
population groups (e. g. prisoners, IDUs) as the main causes of epidemics. During the 
interviews, such statements were not backed up with epidemiological or operational research 
data. 
Pre-occupation of international actors with achieving targets and measuring indicators is well- 
documented. However, even a robust indicators system has limited value without systematic 
quality assurance, and information on the quality of data collection, analysis and interpretation. 
This is especially problematic when meeting targets is attached to obtaining financial support or 
reporting on grants' implementation. 
I discuss these challenges further below, taking the TB programme as an example. 
DOTS indicators (i. e. 75% case detection rate and 85% treatment success rate among sputum 
positive TB cases) were developed based on a mathematical modelling exercise, with a 
proposition that reaching these indicators would contribute to reduction of TB incidence and 
mortality (Dye and others, 1998). Under these propositions, these measures were included as 
core indicators for assessing the performance of national TB programmes. However, TB 
transmission patterns and the propensity to developing TB disease intrinsically has considerable 
heterogeneity among and within population groups (Anderson, 1998, Anderson, 1991). Thus, 
the application of such targets may not result in the same public health benefits in different 
social settings. Additionally, the focus on measuring a TB programme's performance based on 
treatment success of sputum positive TB cases arguably does not provide a whole picture of 
whether the programme works or does not (Cox, Ford, and Reeder, 2009). This is particularly 
relevant in the context of the central Asian FSU, where diagnostic capabilities are weak and 
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where the destiny of TB patients who do not fall into the WHO definitions is often not 
known"'. 
In a setting with a potentially high prevalence of drug-resistant forms of TB, such as in 
Kyrgyzstan, the key indicator of the quality of TB care should be the emergence of MDRTB. In 
particular, one of the approaches could be monitoring of changes in the drug resistance pattern 
and development of MDRTB over the course of treatment (Richard Coker, personal 
communication). Such monitoring does not exist in Kyrgyzstan. This study reasserts the need 
for a robust surveillance system to monitor the emergence of MDRTB, determine the causes of 
this emergence (including patient, professional and health system), and provide insights into the 
effectiveness of interventions aimed at controlling this disease. In Chapter 8,1 have shown that 
the response to MDRTB in Kyrgyzstan is being shaped by the key domestic actors in TB 
control (i. e. specialised TB services) as caused by the lack of regulatory control over persons 
who are difficult to find and treat. The health system's failures (e. g. application of improper 
treatment regimens, access to TB treatment) are not routinely monitored and rarely 
acknowledged. 
10.2.6. Global health initiatives in Kyrgyzstan 
Sustainability of donor-supported initiatives has been a central concern of international 
assistance historically (Atun and others, 2005e, Bossert, 1990, Gonzalez, 1965, LaFond, 1995b, 
Le Loup and others, 2010, Lienhardt and Ogden, 2004, Stefanini, 1992, Yang, Farmer, and 
McGahan, 2010). The concerns have been often centred on an inherent contention of 
sustainability, that is tensions between a necessity to promptly address current needs and the 
long-term needs of the population for health system development, well being and health. These 
sustainability concerns have been embedded in the vertical vs horizontal debate, in which 
`vertical' programme proponents argued for an efficient and prompt impact, and proponents of 
the `horizontal' approach insisted on a long-term health system development. The contribution 
of my study to this debate is demonstrating the need of both, targeted assistance for addressing 
communicable diseases of public health importance and efforts to strengthen the overall health 
system. 
This study highlights challenges with ensuring continuity of donors-supported innovations in 
Kyrgyzstan, a country with a difficult socio-economic context compounded with political 
The TB system historically manages so-called 'chronic' patients, who do not fall into the WHO definition of 
chronic TB patients and who often do not have bacteriological confirmation of TB disease. 
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instability. Since the disintegration of the USSR, international actors have played an important 
role in assisting Kyrgyzstan to reform socio-economic and health systems. Whilst the health 
system reform programme has reportedly made important achievements (Falkingham, 
Akkazieva, and Baschieri, 2010, Rechel and others, 2011), the health system remains weak 
with limited capacity to manage the public health crisis or provide quality health care. The 
country is one of the poorest states in the FSU region, with estimated spending on health per 
capita of US$ 152 in 2009 (WB, 2010). 
The role of GHIs in addressing TB and HIV/AIDS epidemics in Kyrgyzstan is important, as has 
been discussed throughout the previous sections. In summary, one of the key challenges for 
continuous implementation of disease control innovations in Kyrgyzstan is financial and 
political dependence on GHIs. Domestic respondents of both programmes expressed concern 
that continuous implementation of innovations, if donors' funding stops, would likely be 
impossible. International actors, on the other hand, argued that they have contributed to 
building the country's capacity for implementing novel TB and HIV interventions. 
Vulnerability to donors' funding and policies was profound in the case of the HIV programme. 
GHIs in HIV/AIDS have turned political attention to marginalised groups who are at risk of 
HIV. However, this study indicates that the political support has not reached a level to embed 
novel interventions into mainstream political, social and health systems. Arguably, the question 
exists of whether national policy makers would keep problems of HIV and IDU as a priority, if 
international priorities should change. This is in contrast to TB services, which historically are 
viewed by domestic decision-makers as legitimate and politically important. The main 
challenge for the TB programme is that, in the absence of international attention, the programme 
might end up in a `vicious cycle' to continue building its strategies based on the legacy of the 
inefficient practices that existed in the Soviet Union. 
In the preceding discussion, I also highlighted that an effective response to TB and HIV/AIDS 
epidemics in Kyrgyzstan would not be possible without strengthening the capabilities of the 
general health system. There are efforts in Kyrgyzstan to coordinate donors' aid through the 
sector-wide approach (SWAp) (Chapter 7). Though the effectiveness of SWAp in strengthening 
the overall health system has not been empirically proven, there is arguably a need for better 
coordination of TB and HIV/AIDS funds with other efforts in Kyrgyzstan. Channelling 
substantial amount of funds specifically for TB and HIV/AIDS has resulted in unintended spill- 
over effects such as preventing development of interactions between key actors of both 
programmes. 
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10.3. CONTRIBUTION TO KNOWLEDGE 
10.3.1. Application of 'systems thinking' to the study of sustainability of communicable 
disease programmes 
The main contribution of this thesis is to the conceptual developments aimed at understanding 
the role of health systems in the sustainability of communicable disease programmes. I did this 
by extending the conceptual framework of Atun and others (2004) on the functioning of 
communicable disease programmes in health systems, and bringing some perspectives of 
complex systems theories 112. The novelty of my work, as compared to the authors upon whom I 
build, includes the clarification of conceptual understanding on what constitutes integration, 
sustainability and the link between these two notions. In contrast to linear and deterministic 
explanations of sustainability, which are traditionally applied in research on sustainability in 
health systems, theories of complex systems highlight multiple causations and dynamics 
relations (both temporal and spatial) among system components and agents (e. g. individual, 
actors, organisations, institution). Uncertainty in predicting outcomes is a norm as multiple 
system pathways are possible. To sum up, my contribution to the development of theories 
explaining sustainability of communicable disease programmes highlights: 
" Integration of a programme with other health system components is likely one, but not the 
only, precursor of the programme's sustainability; 
" Though integration with other system components is important, its role in sustainability is 
context specific and difficult to predict (as sustainability overall). The focus in my proposal 
is on recognition of the patterns of system evolvement and not on searching for bi- 
directional relations between integration and sustainability. 
10.3.2. Framework for analysis of sustalnability 
A realist's research starts with building an initial model of structures and/or mechanisms that 
can provide better representations of the phenomenon being studied (Bhaskar, 1975, Blaikie, 
2007, Healy and Perry, 2000, Olsen, 2010). These propositions then explained or new 
explanations found in an empirical study to generate empirically based conceptual framework 
112 As discussed in the section 10.1.4, I build on theoretical insights on sustainability originating in theories of 
complex adaptive systems. I extend upon the framework by Atun and others (2008) on integration and health system, 
and by Gruen and others (2008). Both these developments draw upon theories of complex systems. 
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(Sobh and Perry, 2006). The initial framework for analysis (Chapter 5, Figure 5.1) applied in 
this study provided a guide for understanding the existence and influences upon sustainability 
precursors at different levels of the health system (e. g. national, regional, local). The schematic 
representation of the framework for analysis had several limitations. At the inception of this 
research, I did not put precursors of sustainability schematically into the Figure 5.1 (Chapter 5), 
instead I outlined these relations in Box 5.1 of the Chapter 5. 
The Figure 10.2 offers a modified representation of the conceptual framework for analysis a 
progarmme's sustainability (i. e. a potential for sustainability) based on the empirical findings of 
this research. Briefly, the results of my study have suggested that all five presumed precursors 
of sustainability (i. e. mechanism) may act upon the functioning of a disease control programme, 
the choice and delivery of disease control interventions. Consequently, these mechanisms 
influence the scale and the actions of interventions on a disease problem, leading (or not) to a 
reduction of disease incidence or associated mortality and morbidity (i. e outcomes). The 
precursors of sustainability, in turn, depend upon complex interrelationships among actors and 
their institutional roles and interests, structural and functional arrangements of a health system 
and a disease control programme, and context. Historical paths of health system , disease 
control programmes and disease itself may play the important role in determining the existence 
and actions of mechanisms such as the programme's capacity (i. e. dedicated resources), 
flexibility and interactions. Additionally, the proposed framework suggests that political and 
economic environments, institutional interests of actors and health system's arrangements may 
directly affect the existence and functioning of a disease control programmme, choice and 
continuous implementation of interventions. 
My research is about the theory-building. The modified framework was generated based on one 
case study. The framework may require further operationalision before generalisability of the 
propositions offered in my thesis are tested in further empirical studies. I reflect on this further 
in the section 10.4.1, where I discuss the limitations of a framework approach to the study of 
complex systems. 
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Context 
Economical, political, social, epidemiological, regulatory environment, history 
Health system: 
governance, financing, 
service delivery, M&E 
Mechanisms 
0 
leadership 
moors Capacity 
Institutional or individual 
role, interests, influences Interactions with other 
health system components 
Flexibility 
Disease control programme: 
governance, financing, Performance 
service delivery, M&E 
E 
Disease problem 
e. g. persons with TB 
disease 
Disease control 
interventions 
e. g TB treatment 
Outputs Outcome 
e. g completion 1 e. g reduction of TB 
Lof TB treatment incidence 
Figure 10.2 The revised framework for the analysis of sustainability of a disease 
control programme 
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10.3.3. Implications of the study's empirical findings for TB and HIV/AIDS control in 
central Asia 
This PhD research contributes to the scarce literature on health systems responses to 
communicable diseases epidemics in the central Asian region of the FSU. Overall, this study 
highlights the profound influences of a health system's historical path on the evolution of TB 
and HIV/AIDS programmes. I emphasised, as other authors (Coker, 2001a, Sbarbaro, 2002), 
that structural changes in the health system are difficult to implement. Strikingly, several 
findings of my case study, which was conducted in 2009, were similar to conclusions of the 
studies conducted in Russia and Ukraine in 2001/2002. This is despite Kyrgyzstan's relative 
progress in moving forward with the health system's reform (Rechel and others, 2011) and 
considerable investments in TB and HIV/AIDS programmes (presented in Chapters 8 and 9). It 
is likely, that in other central Asian countries, health systems responses to TB and HIV/AIDS 
epidemics are influenced by the legacy of the Soviet health care system. Among factors that 
have shown profound persistence in Kyrgyzstan are practices of managing persons within a 
single speciality, and regulatory control over people at risk of and with TB and HIV/AIDS. 
A key implication of this study is that targeted financial assistance for priority diseases such as 
TB and HIV/AIDS, though having benefits in the short-medium terms, would not likely ensure 
sustainability of programmes. It is likely that in the central Asian region, with a history of high 
health systems fragmentation, targeted international assistance might have unintended 
consequences such as preventing the establishment of interactions of programmes with other 
health system's components. Health problems in central Asian countries have become more 
complex, requiring the establishment of comprehensive and integrated approaches to addressing 
the overall public health crisis and weaknesses of health systems. At the same time, I also argue 
that there is a need for international political attention focused on the problems of the IDU- 
driven HIV epidemic and persistent TB problem in the region. This is relevant for both political 
and financial reasons. Momentum in national political attention to IDU and HIV problems 
needs to be maintained including in economically advanced Kazakhstan. For low income and 
vulnerable states such as Kyrgyzstan and Tajikistan, there is a need for financial assistance to 
address specific challenges relevant to TB and HN/AIDS epidemics. 
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10.4. LIMITATIONS OF THIS RESEARCH 
10.4.1 Applying a framework approach for studying complex systems 
Though I argue that my thesis makes a contribution by bringing perspectives of complexity 
theories to the study of sustainability of communicable diseases programmes, I recognise the 
limitations. A framework approach to studying complex social systems has its limitations as 
frameworks include selective constructs putting emphasis on some information and minimizing 
the other (Coker and others, 2010). 
Despite that the conceptualisation of sustainability in this thesis builds on established theories 
that explain sustainability (i. e. resilience of complex systems), these theoretical perspectives 
have their roots in natural and physical sciences. There is a long-standing recognition of 
complexities in social systems, including health systems, and growing attraction in applying 
concepts and constructs from complex systems theories (Anderson, 1999, Kernick, 2006, Plsek, 
2003, Sturmberg and Martin, 2009). However, diffusion of application of complex theories in 
health systems research has been relatively slow (Begun and Zimmerman, 2003, Martin and 
Sturmberg, 2009), including as applied to health systems in low- and middle-income countries 
(Paine and Peters, 2011). Many applications of complexity theory to social systems research 
have been limited to metaphorical use of underlying assumptions (e. g. self-organisation, 
emergence, feed-back loops, phase transition) (Begun and Zimmerman, 2003). One of the key 
impediments, as Begun and Zimmerman (2003) argue, is under-developed analytical and 
methodological approaches. Social systems, in contrast to natural systems, are difficult to 
model13. In my conception of sustainability, the abovementioned challenges particularly 
concern the flexibility (adaptability) dimension, which only to some extent encompassed 
insights on notions of innovations, learning and change. In future developments of this 
construct, there is a need to incorporate theoretical perspectives from sociology, organisational 
learning and organizational psychology, including theories explaining dynamics within interests 
groups such as neoinistitutional theory. 
In the conceptual framework for analysis (Chapter 5), my focus has been particularly on formal 
structural and fimctional arrangements of a health system, whilst neglecting the individual level 
such as individual providers and patients. Thus, my framework does not fully address informal 
113 A main approach in studying economic and ecological systems within complexity sciences is mathematical 
modelling, non-equilibrium statistics. Another relevant issue is the lack of well-agreed meanings and definitions of 
key contracts (e. g. self-organization) in complexity sciences (Andreson, 1999, Eidelson, 1997). 
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interactions and relations between providers and patients, national and international policy 
makers and others. Informal interactions, on the other hand, indeed may play one of the key 
roles in the evolvement of complex social systems (Atkinson, 2002, Gilson, 2003, Gilson, 2006, 
McPake, Blaauw, and Sheaff, 2006, Schneider, Hlophe, and van Rensburg, 2008). 
Another important aspect that was not addressed in my work is dynamics of biological systems. 
On reflection, the future studies on sustainability of communicable diseases programmes may 
apply the methodologies to encompass dynamic relations in the biological and human systems 
such as non-equilibrium statistics, network analysis, agent-based modelling or scenario 
modelling (Anderson, 1999, Paina and Peters, 2011). 
Lastly, though I build upon a body of theoretical and empirical literature (Chapters 3 and 4) in 
the conceptualisation of sustainability, my literature reviews have limitations. Literature has 
been limited to those papers published in English and accessible through the University of 
London libraries. There is likelihood that I have missed developments in the study of 
sustainability in health systems that were published in other languages or in journals that were 
not accessible to me at the time. 
10.4.2. Limitations of the realistic evaluation 
In my research, I applied systematically a validated analytical and methodological tool (Atun 
and others, 2006 ) drawn on principles of realistic evaluation (Pawson and Tilley, 1997). 
Pawson and Tilley's evaluation model proposed the Context-Mechanisms-Outcome 
configuration to explore the phenomenon in question (e. g., why an intervention works, for 
whom and in what circumstances). The way in which my conceptualisation of sustainability 
builds on, and extends, the work of Atun and others (2004) is presented in Figure 10.1. 
During the analysis, I had difficulties in separating influences on the delivery of interventions 
(and consequently outcomes) between the precursors of sustainability and the health system or 
the context. Additionally, the mechanisms themselves, for example interactions and flexibility, 
appeared to interact in a complex way. The application of realistic evaluation as the 
methodological approach did not allow me the assessment of what exact contribution each 
mechanism makes on delivery of intervention. I did not provide an answer on what precursors 
for sustainability are the most important in Kyrgyzstan's context. What my research provided 
are the explanations on the existence and actions of multiple and interrelated determinants of the 
potential for TB and HIV/AIDS programmes' sustainability on the national level (section 
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10.2.1). Among these many factors were the interactions of programmes with broader health 
system. However, application of realistic evaluation did not allow the insights on relative 
importance of each level of interactions (i. e. linkages, coordination or full integration) in 
ensuring sustainable outcomes. 
The case study also had several limitations. The methodological tool of Atun and others (2004) 
was developed to be applied by a research team with various disciplinary backgrounds and 
expertise (e. g. sociology, economics, epidemiology), including triangulating different 
perspectives on the reality based on these different expertises. I relied on secondary sources to 
explore programme outputs and on surveillance data to elaborate on outcomes (i. e. occurrence 
of infection and disease). As has been presented, available approaches to surveillance of both 
TB and HIV/AIDS in Kyrgyzstan have substantial limitations; conducting studies on TB and 
HIV/AIDS incidence and prevalence is not feasible within a PhD project. Additionally, several 
potential respondents were unavailable for an interview despite numerous attempts to arrange a 
meeting. The important decision makers, who represent the Parliament's section that oversees 
social programmes, were not recruited into the study. 
A study of sustainability of a communicable disease programme should ideally attempt a 
longitudinal empirical assessment of changes in disease transmission, occurrence of disease and 
population's risk behaviour, an assessment of the programme's characteristics (e. g. leadership, 
capacity, connectivity, flexibility and performance) at all the health system's levels (e. g. 
individual providers and institutions, specific interventions, programmes, and overall health 
system), and include multiple geographic sites at all administrative levels (e. g. national, 
provincial, district). To encompass all this within a PhD project's financial and time constraints 
was not feasible. Due to these constraints, the case study in Kyrgyzstan has been limited to the 
national level. 
10.4.3. Conducting PhD research in central Asia - personal reflections 
In addition to the methodological limitations outlined above, there have been administrative 
challenges related to implementation of this research in central Asia. Originally a case study in 
central Asia was planned to be conducted in Kazakhstan. As I mentioned earlier (Chapter 6), 
my position has been that of an independent researcher. I was not affiliated with, nor had 
financial support from, any national or international institution. Being a native of 
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Kazakhstan' prior to the upgrading seminar I had established arrangements with the National 
TB institute in Almaty, Kazakhstan to conduct the PhD project. The original PhD research 
project was aiming to focus primarily on questions of financial sustainability of the TB 
programme, and included in-depth analysis of spending on TB control, which required access to 
accounting information. However, during the initial stages of the field trip the director of the 
Kazakhstan's institute withdrew an agreement to provide me with access to financial data 
despite prior commitments. 
As a result, I had to refocus the project on questions of integration and sustainability. Attempts 
to establish support for re-focused research in Kazakhstan were not successful. A case study 
thus was conducted in Kyrgyzstan. In Kyrgyzstan, substantial efforts, including time, were put 
into building working relations with key actors, and obtaining access to documents and 
information (presented in Chapter 6, `Field work'). Data was often difficult to obtain. For 
example, I did not manage to obtain data on costs of disease control interventions. 
Despite considerable changes that have occurred in central Asia since the disintegration of the 
USSR, there is still a fundamental need for disseminating the value of public health, economic 
and health policy research in the region. Most research is conducted in the region under the 
umbrella of key international organisations such as WB, WHO, GFATM and so on. Thus, only 
relatively few domestic researchers are involved in health policy and public health research. 
There remains relatively limited empirical research in the area of TB, HIV/AIDS control or 
overall health system reform conducted in the region and published in peer-reviewed journals. 
International partnerships between research and educational institutions need to establish. 
Ultimately, there is a need for building local capacity for public health and health policy 
research. 
10.5. RECOMMENDATIONS 
This study revealed several inter-related factors that affect the potential for sustainability of TB 
and HIV/AIDS programmes in Kyrgyzstan. Among overarching challenges for sustainability of 
both programmes are overall weak capacity of the health system and the reliance on 
international assistance for implementing the efforts to control the epidemics. This thesis also 
highlighted the importance of health system's structural and functional arrangements in 
sustaining the programmes into the future. In Kyrgyzstan, the factors such as fragmentation of 
114 1 have emigrated from Kazakhstan, becoming a Canadian national. 
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governance and financing impede the development of effective interactions at the level of 
service delivery. in turn, fragmentation of service delivery remains the key impediment for 
efficiency, effectiveness and equity of disease control interventions. The prospects for 
sustainability of both programmes are constrained by institutional interests of domestic and 
international actors, who rarely consider the central question for sustainability that is efficiency 
of resources allocation and use. Weak disease surveillance and M&E systems emerged as one 
of the key barrier for development of effective disease control policies in the country and 
efficient planning of resources. Because of weaknesses of surveillance, this study could not 
provide the answer whether disease control efforts have resulted in the reduction of mortality 
and morbidity associated with TB and/or HIV/AIDS. 
Sustainability of disease control programmes is difficult to predict. The government and 
international policy makers in Kyrgyzstan and other central Asian FSU countries can contribute 
to the establishment of the supporting environment for sustaining the programmes into the 
future. Several specific efforts may include: 
" Changing the financial mechanisms for TB and HIV/AIDS programmes. For TB 
programme, there is a necessity to consider the reform of providers' payment mechanisms 
to remove incentives of unnecessary hospitalisations, to include considerations of 
performance and to strengthen financial interest (and therefore responsibility) of primary 
care providers in delivering TB care. For HIV programme, there is a need to evaluate cost- 
effectiveness of implemented interventions in order to improve efficiency of resources 
allocation and use. 
" International policy makers may consider the balanced approach to financing of TB and 
HIV/AIDS control programmes in low income FSU countries such as Kyrgyzstan. One of 
the options could be aligning, at least partially, financial mechanisms with approaches such 
as SWAp. 
" Establishing mechanisms for financing NGOs from domestic sources. NGOs may play an 
important role not only in service provision but also in advocacy for legislative change and 
protection of rights of the marginalised groups and people with communicable diseases such 
as TB and HIV/AIDS. 
" Building knowledge base and capacity of institutions governing public health systems and 
individuals on all levels of health system. This includes, but not limited to, capabilities to 
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conduct epidemiological and economic research, strengthening disease surveillance, skills 
in planning and allocation of resources in accordance with epidemiological evidence. In 
this regard, the government and international actors may collaborate to strengthen relevant 
training programmes in the mainstream educational system. 
" Strengthening communicable disease surveillance and M&E systems. Stakeholders need to 
consider the development of surveillance systems that encompass fundamental principles 
such as monitoring accuracy and quality of data, timeliness and efficiency of data 
collection. 
CONCLUSION 
A lack of common conceptual understanding and agreement on what constitutes integration has 
impeded empirical analysis of integration in health systems. Similarly, frequently used rhetoric 
of influence of integration on sustainability has never been justified through empirical studies. 
I have developed a novel conceptual framework for analysis of programme's sustainability in a 
health system, building on body theoretical and empirical work. The framework might serve as 
a basis for further evaluations in understanding complex interplay between programmes and 
broader health systems in the development of sustainable responses to communicable diseases. 
By applying this framework in the case study in Kyrgyzstan I have demonstrated the importance 
of effective interactions of communicable disease programmes with other health system 
components in increasing the potential for long term sustainability of these programmes. This 
study concludes that increased input of external funds channelled separately for each 
communicable disease, which functions in parallel to domestic financial mechanisms, does not 
ensure sustainability of programmes. This study highlights importance of robust communicable 
disease surveillance systems, and their use in informing public health actions beyond selected 
health problems. 
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Appendix 1. Ethics Clearance, study assessment tool and interview guides 
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1) Ethics committee of the London School of Hygiene and Tropical Medicine 
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ETHICS COMMITTEE wi 
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Department Public Health and Policy 
Head of Department Professor Anne Mills 
Title: Tuberculosis control reform in Central Asia: Health system 
challenges to sustainability 
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Chair of the Committee...... .................................. 
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Approval is dependent on local ethical approval having been received. 
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2) Ethics approval of the Committee of Bio-ethics at the Medical Academy of the Ministry of Health (in Russian). 
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3) Translation from Russian of the Ethics approval of the Committee of Bio-ethics at the 
Medical Academy of the Ministry of Health. 
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1. Approval is dependent upon the approval from the counterpart agency; 
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Chair, the Bioethics Committee 
of the Ministry of Health of the Kyrgyz Republic, 
the official stamp of the Ministry of Health Kyrgyz Medical Academy 
the official stamp of personal signature of Or. Tllekeeeva 
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4) Supporting letter from PhD supervisor to the Kyrgyz Ethics Committte 
London School of Hygiene & Tropical Medicine 
(UnwersityafLondaý) 
Keppel Streit. Lvtidon WCIE 711T r ^' 
` 
Tel 020 7636 8636 rax, 020 7436 5389 Web ilte: //www. ishtm. ac. uk Improving health worldwide 
Dr. Tilekeeva U. M., 
Chair, the Bioediics Comma lee 
of the Ministry of Health of the Kyrgyc Republic. 
KyTgyr State Medical Academy, 
92 Ahunbacv Street, 
Bishkck 720020, Kyrgyzstan 
July 28,2009 
Dew Ulankul Muchtarovna. 
The Communicable Diseases Policy Research Group at the Department of Public Health and 
Policy, London School of Hygiene and Tropical Medicine (LSHTM) would like to thank the 
Biocth7cs Committee of the Ministry of Health of the Kyrgyz Republic for reviewing the 
ethics application for the study 'Health systems challenges in Central Asia to ensure 
sustainability of national tuberculosis and 1-11WAIDS comml programtnas', 
'Ibis letter is to confirm that the principal inveadgator of this study is Mr. Altynay Shigayeva. 
a PhD graduate teaching assistant at the Health Policy Unit, Department of Public Health and 
Policy, LSHTM. The LSHTM Ethics Committee has approved this study under application 
number 5254 on January 31,2008; an amendment to conduct a case study in Kyrgyhstan was 
approved on April 28,2009. The principal investigator for this study should provide you with 
copic. s of standard electronic LSHTM Ethics Committee approval forts. 
In Kyrgymruan, the study is being conducted in collaboration with the Health Policy Analysis 
Centre. Bishkck, Kyrgyasten (formerly - Hod di Policy Analysis Unit at the Centre for Health 
System Development). 
Please feel free to contact me or W. Altynay Ship)-eve at if 
you have any questions or require additional information. 
Sinccid y, 
QNJ' 
P of c or Richard Coker, 
Eisud, the Communicable Discuses Policy Rcscurcb Group. 
Department of Public Health and Policy, 
London School of Hygiene and Tropical Medicine, 
Kcppcl Str w, London, WCIE 7HT, UK 
Tel: +44 (0) 20 7636 8636 
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A1.2. Study participant information sheet and consent form 
Study title: Health systems challenges In Central Asia to ensure sustainability of 
national tuberculosis and HIV/AIDS control programmes 
Principal Investigator: Altynay Shigayeva, PhD candidate, Health Policy Unit, 
London School of Hygiene and Tropical Medicine 
e-mail: altvnav. shiaaveva(dlshtm. ac. uk 
phone: + (996) 312 54 39 96 ; (+996) 555 261 051 (in 
Bishkek) 
(+44) 7960514451 (in London) 
In Kyrgyzstan, a case study is being conducted as collaborative effort between the 
Communicable Diseases Policy Research Group, Health policy unit, Department of Public and 
Policy, LSHTM and the Centre for Health system development, Togolok Moldo 1, Bishkek (the 
Centre for Health System Development 2nd floor) 
This informed consent has two parts: 1) Study participant information sheet, and 2) Study 
participant consent form. 
Part 1. Study Participant Information Sheet 
You are being invited to participate In a research study aimed to explore how Integration of 
tuberculosis (TB) and HIV/AIDS control programmes with broader health system can Influence 
sustainability of these programmes. 
Methods for this study involve review of relevant policy and programme documents and 
interviews with stakeholders and specialists from national, regional and International agencies, 
working in Kyrgyzstan in the areas of health system reform and response to TB and HIV/AIDS 
epidemics. 
You are being invited for an interview because of your expertise and experience. Your Insights 
are critical for in-depth understanding of health system responses to TB and HIV/AIDS 
epidemics in Kyrgyzstan. 
The participation in this study Is voluntary. Before you decide whether take or do not a part In 
an interview, please take your time to read (or let me read you) the following information about 
study rationale, Interview process, how your confidentiality will be protected, and ask me if there 
is anything that is not clear or if you would like more Information. 
Interview procedures 
A questionnaire includes open-ended questions about role of your organization/department in 
health system reform in Kyrgyzstan, particularly role in formulating and implementing HIV/AIDS 
and/or TB control policies and participation in decision-making regarding functioning and 
capacity development of both programmes. Questions are also concerned your views on 
HIV/AIDS and TB problems In the country, and opinion about overall health system responses 
to both problems - leadership, coordination mechanisms, and capacity (e. g. funds, services 
structures, human resources, etc) of local organizations/services for implementing effectively 
disease control interventions. A focus will be made on achievements and barriers In involving 
of general health services in delivery of TB and/or HIV/AIDS interventions, and development of 
closer interactions between TB and HIV/AIDS services. Because HIV/AIDS epidemic Is driven 
by intravenous-drug use, I also would like to ask your opinion or experience about policy 
development related to harm reduction among IDUs. 
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An interview will last approximately from 45 minutes to one hour. You will be interviewed 
individually by the principal investigator; the session be conducted either In English or Russian. 
With your permission, the interview will be audio-taped; otherwise, it will be recorded In writing. 
Potential risks to you are minimal. You may feel discomfort or become afraid to disclose/answer 
some questions. You have the rights to decline answering questions that make you feel 
uncomfortable or concerned; or to withdraw from the interview completely. 
You will not be paid or receive any material Incentives for taking part In this research. 
Confidentiality 
Principal investigator of this study Is solely responsible for assuring and maintaining your 
anonymity (if requested) and confidentiality. Prior to interview, you will be asked whether you 
wish to remain anonymous. If you do, this request will be respected. In addition, if you would 
wish any parts of or all interview to be 'off the record' this request will also be respected. 
Regardless whether anonymity is requested or not, all information collected during the course of 
the interview process will be treated as confidential. No personal Identifiers such as your name, 
job title or position will appear on Interview's transcripts, audio tapes or summaries; nor will 
these be listed in any future research reports or publications. Signed consent forms will not be 
linked to study materials. The results of interviews will be described and presented In non- 
attributable manner, thus, it will not be possible to Identify you or any other study participant. 
Only if you consent, the information you provide will be quoted in a research report, thesis or 
consequent publications. 
A copy of consent form will be provided to you for your records. The consent forms and hard 
copies of interview records will be kept in a locked cabinet until the end of this study (scheduled 
for September, 2010), afterwards these will be destroyed. Similarly, any electronic records of 
transcribed interviews or audio records will be password protected; and these materials will be 
destroyed at the end of study. 
This study has been approved by the Ethics Committee of the London School of Hygiene 
and Tropical Medicine (application number 5254, approved April 28,2009), and the 
Bloethics Committee of the Ministry of Health of the Kyrgyz Republic (protocol of the 
Committee 29, June 1,2009). 
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Part 2. Study Participant Consent Form 
Study title: Health systems challenges In Central Asia to ensure 
sustainability of national tuberculosis and HIV/AIDS control 
programmes 
Principal Investigator: Altynay Shigayeva 
e-mail: aItvnav. shiaaveva(a2lshtm. ac. uk 
phone: (+44) 7960514451 (in London) 
(+996) 555 261 051 (in Blshkek) 
I have read the information sheet concerning this study [or information has been provided to me 
verbatim] and understand what will be required from me and what will happen to me if I take 
part in the study; 
My questions concerning this study has been answered by the principal Investigator; I 
understand that if any further questions arise I can contact the principal Investigator; 
I understand that I have the rights to refuse answering any question and to withdraw from the 
interview at any time without giving a reason; 
I hereby fully and freely consent to participation in this study, I understand that I will receive a 
copy of this consent form. 
Please tick the appropriate box: 
Q! agree my interview to be audio recorded (! f not checked, an interview will be recorded 
only in writing by the principal investigator) 
QI would like to remain anonymous 
Q The information I provide or my statements can be quoted in a PhD thesis or future 
publication(s); provided these will meet my requirement for anonymity 
Q The Information I provide or my statements can not be quoted, either anonymously or 
otherwise 
Q The information I provide or my statements can not be used for analysis and have to 
be kept 'off record'. 
Study participant Date 
(participant signature, or type 'anonymousl 
Principal Investigator Date 
Ms. Altynay Shigayeva signature 
*I copy for participant, I copy for investigator 
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A1.3. Systematic rapid assessment toolkit 
BROADER CONTEXT 
1. What is the nature of political, economic, social, technological, regulatory, cultural contexts, how 
these have been changing during the last decade? 
Using published data and reports idenafy: 
a. trends in key economic indicators 
b. trends in key medico demographic indicators (life expectancy, death rate, birth rate, population growth, major causes of 
mortality and morbidity, maternal and infant mortality) 
c. changes in political system, including eurem national policy on socio-economic development; 
d. major changes in technological contest (access and development of new health care technologies, access to international 
health information/evidence based medicine, ); 
C. major changes in socio-cultural context; 
f. health legislation (e, g. health protection, right for heath care, ). 
HEALTH SYSTEM 
2. What health system reforms initiatives have been undertaken within last decade, and are currently 
underway? 
a. major achievements and impediments 
Governance 
3. What organisations/institutions are involved in the strategic planning and policy formulation in health 
sector (including financial decisions) ? Include parallel health structures such as those provided 
within the prison service, military, police forces, etc. 
a. How these organizations/institutions relate to each other? (e. g. formal linkages) 
b. How and whether available evidence is used for priority settings and health policy development (e. g whether economic 
evaluation is conducted, epidemiological/health services research, etc). How policy making is changed in the last decade? 
c. Is there a clearly articulated accountability framework within the health system? How is this framework applied, 
monitored, and enforced? 
i. What feedback mechanisms exist from users to providers, managers and policy makers? 
ii. How are complaints about services dealt with? 
4. What is the structure of the health system? Has health system's structural arrangements changed in 
the last decade? 
Financing 
5. What are sources of funds for health system? Using published data, identify trends, and contribution 
of each source 
6. What are trends in health expenditure in the last >=5 years (total, % of GDP, etc) 
7. What are the pooling arrangements for the health funds? 
a. How these have changed in the last decade (years)? 
8. Do budgets correspond to actual expenditure? 
9. What are mechanisms for funds allocation? 
a. How providers are paid 
b. Is there transferability of funds between health programmes? What are mechanisms? 
c. How these changed in the last decade? 
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Service delivery 
Pattern of provision 
10. What is the number of hospital beds per capita for general health care and specialised health 
programmes? (If possible provide distribution in urban and rural areas) 
11. What is the number of hospitals? 
12. What is the number of primary health centres, the average size of population served and average 
distance a patient must travel to a primary health centre? 
13. Do the hospitals and primary health centers have adequate infrastructure (road and transport links, 
communication, electricity, appropriate buildings)? 
14. How above indicators changed in the last decade? Why and why not? 
15. Is service quality assessed? If so, how? 
16. In your view, are services provided equitably? 
Human resources 
17. Using published data, summarise the number of nurses, doctors, laboratory personnel (total and per 
capita) and their distribution ( rural/urban) 
a. Is there perceived shortage/excess of human resources? 
18. Are health managers, economists, public health specialists employed in the health system? 
(perceived shortage/excess of these specialists) 
19. Medical/Clinical training and accreditation system, how these changed in the last decade? 
20. How are human resource requirements planned for? 
21. What formal and informal incentives are available to staff? 
Pattern of utilization 
22. Using published routinely collected data; identify key trends in healthcare utilisation. (disaggregated 
by age, sex and region if possible) 
Hospitalisation rates 
Average length of stay for hospital admissions 
Average number of visits made by a person to a primary health centre or an outpatient facility per year 
How these indicators changed in the last decade? 
Performance assessment 
23. Are performance targets set at each level of the health system? 
Are targets process or outcome based? 
Who determines the targets? 
How are they measured? 
Are they being achieved? 
Informational system 
24. Is there a national or regional policy on Health Information Systems or is one planned? 
What is the overall organisational structure of the national or regional HIS? 
What are financial resources are available to the HIS? 
What information and communication technologies are available for the Ministry of Health HIS and what is their 
distribution? 
What IT technologies and skills are available for health information systems? 
What are the flows of information between the levels of the health system? 
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25. What information is collected routinely? 
26. How collected information is used? (e. g. for strategic planning, decision making, economic 
evaluations, epidemiological surveillance) 
27. What data quality assurance (QA) systems are in place at different levels of health [information] 
system? 
TB CONTROL PROGRAMME 
TB problem 
1. How character of TB epidemic has been changing during the last decade? 
Using published data and reports identify trends: 
a. TB case notifications [all new, pulmonary (proportion smear positive/culture confirmed), extra-pulmonary, 
children/adults, males/females, by age, by risk groups/unemployed/etc [as collected by the national programme]; 
civil/penitentiary sector), recurrent TB/chronic TB] 
b. TB mortality (all, pulmonary, extra-pulmonary, children/adult, males/females, by age, by social groups- 
unemployed/etc [as collected by the national programme)) 
c, Pattern of ant tuberculosis drag resistance, including MDRTB/XDRTB in newly diagnosed/previously treated 
patients (identify whether drug susceptibility testing is performed routinely, and since when) 
d. Pattern of registered TB/HWV cases 
2. In your view or based on your knowledge of statistics which socio-demographic groups are more 
likely to contract TB? 
3. Are there any socio-demographic patterns that impact on TB control (e. g. migration, unemployment, 
high imprisonment rates, etc. )? 
4. What is the estimated national economic burden of TB? 
a How has this been estimated? 
b. What is the burden relative to other diseases? 
Governance 
5. What changes in national TB control policy have occurred in the last decade, and what are currently 
underway? 
6. Does a country have a national strategic plan for TB control? 
a. According to national plan, what are the priorities? 
b. How this plan changed in the recent years/decades? 
7. Which institutions and organizations are involved in decisions making regarding strategic planning, 
development and implementation of TB- control policies? 
a. Who are the international development agencies involved in the TB control programme? 
What is their role, particularly in TB policy development/strategic planning? 
b. Are there well-established and recognised advocacy/lobbying organisations for TB patients? 
What is their role, particularly in TB policy development/strategic planning? 
8. What are relationships among organizations/institutions which are involved in policy 
development/strategic planning? 
a. Have structures and relationships changed in recent decade (recent years)? If yes, what 
were the reasons? 
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9. What laws and regulations cover TB control? (in areas of vaccination, screening, diagnosis, 
treatment, isolation, detention)? 
a. What organizations/institutions involved in developing legislative and regulatory framework 
for Tb control? 
b. How existing laws are applied in practice? 
c. Have laws and regulations changed in recent years/decade? If yes, what were the reasons? 
10. Which organisations are responsible for administration and performance management of provision of 
TB interventions? 
a. What are performance management mechanisms? 
b. Who are these organizations are accountable to? 
c. Is performance of TB interventions available to public? 
d. How are complaints about services dealt with? 
11. Is performance information used for policy formulation and decisions making about TB programme's 
structures and functioning? 
12. How needs assessment and priority setting for TB control programme is conducted? 
a. By whom? 
b. How TB organizations in civil and penitentiary sectors interact in needs assessment and 
setting priorities? 
13. What formal [and informal] interactions exit with other health programmes? 
a. In particular, what are interactions with general health system? Is there a need, as perceived 
by the stakeholders, for developing formal interactions (e. g. linking, collaborating or 
integrating) with other programmes so to improve programme's capacity and/or 
performance ? 
Financing 
14. What is total annual expenditure on TB control at present? How has the expenditure been changing 
over the last decade for available trend]? 
15. What proportion/percent of overall health system expenditure is going for TB control (how is this 
changing) 
16. What are sources of funding for TB control? 
a. Is there an identified budget line for the TB programme/specific TB interventions within the 
government health budget? 
b. What proportion of funding is from external sources such as donor agencies? 
c. What is trend in donor funding over the last decade for available trend]? 
d. Has funding from external donors impacted governmental allocation for TB control? 
17. What are mechanism of funds generation? How different sources of funding pooled? 
18. How budget for TB control activities is formed, who are involved and what are mechanisms? (what 
indicators are used? ) 
a. Does budget for TB control in civil and penitentiary sectors prepared jointly? 
b. Have financial planning mechanisms been changing over the last decade/recent years? If 
yes, what changes and what are the reasons? 
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19. What are mechanisms of funds allocation? 
a. Is there a resource allocation formula for allocating funds to TB control? 
b. Are there relationships between priority settings and funds allocation? 
c. How funds are allocated across programme's interventions (prevention, screening, 
diagnostics, treatment, rehabilitation, ]? 
d. How funds are distributed across levels of care [primary, secondary, tertiary]? 
e. How funds are distributed geographically? [per capita allocation for TB] 
f. How expenditure is distributed on items - salary, equipment, consumables, maintenance, 
and capital expenditure? 
g. How are service providers within TB control programme paid? 
i. Are there outcome-related performance incentives built in the service payment 
system ( any informal incentives? 
h. How mechanisms of resource allocation/providers payment have changed over the last 
decade? If changes occur, what changes and what are the reasons? 
20. Do budgets for TB control activities correspond to actual expenditure? What is funding gap 
[estimate]? 
a. If gap exists, what measures are/should be undertaken to close the gap (any alternative 
sources of finances, areas to safe funds? ) 
b. In your opinion, is funding for TB control activities adequate? If not, what activities are 
especially needed additional funding? What options exist to gain additional funding, or 
[improve efficiency]? 
Service delivery 
21. How delivery of TB control interventions is organised (what organizations, what interventions)? 
[General Q about content of services Which organisations are involved to the administration, 
control/monitoring and provision of TB prevention, diagnosis, treatment and rehabilitation]? 
a. In civil sector 
b. In penitentiary sector 
22. How service delivery infrastructure and relationships among providers changed in the recent decade 
(including structures and relationships between civil and penitentiary sectors)? What are the reasons 
for these changes? 
Service delivery infrastructure/Patterns ofprovision 
23. In your opinion, is there sufficient availability of inpatient facilities for treatment of TB patients and 
treatment of MDRTB patients? 
a. How these are distributed geographically (urban/rural]? 
b. How supply of inpatient facilities changed since introduction and implementation of DOTS 
strategy? 
24. Are TB inpatient facilities equipped with infection control supplies and equipment (negative pressure 
ventilation, respiratory masks) ? 
25. In your opinion, is there sufficient availability of outpatient TB ambulatories/offices to provide 
diagnostie/treatment services for TB patients? 
a. How these are distributed geographically [urban/rural]? 
b. How supply of outpatient facilities changed since introduction and implementation of DOTS 
strategy? 
26. How many laboratories are involved in TB control? 
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a. Microscopy, Culture, DST 
b. How these are distributed geographically [urban/rural]? 
C. What proportion of these laboratories are in general hospitals? [rather then in specialised TB 
organizations)? 
d. In your opinion, is there sufficient supply/availability of microscopic and other lab. 
equipment 
27. In your opinion, is there sufficient availability of fluorography equipment? . 
28. Do hospitals, outpatient facilities, and laboratories have adequate infrastructure (roads, 
communication, electricity, water supplies, appropriate buildings)? 
Drugs logistics and distribution 
29. How first line and second line drugs are procured? 
a. Are they procured from local suppliers or overseas? 
b. How supply chain is managed? 
c. What quality control/assurance in place? 
d. In your opinion, is there sufficient supply of the first line drugs? Second line drugs? 
C. Are drugs available in open marker? First line/second line? Is it possible to buy drugs 
without prescription? 
Human resources 
30. What is availability of human resources for TB control programme (Tb doctors per 100 000; nurses 
per 100 000) 
a. How these changed in the last decade, why and why not? 
b. In your opinion is availability of health personnel (TB facilities doctors, TB nurses, 
community workers) sufficient at present? and in a long term perspective? 
31. What is skill mix of personnel involved in diagnosis, treatment and rehabilitation of TB patients? 
a. Which specialist diagnose and treat TB patients? 
b. Which health specialist oversee treatment? [TB nurses? General nurses? Community health 
workers? ] 
c. How these changed in the last decade, why and why not? 
32. What TB clinical training available? 
a. What is accreditation system for TB clinicians? 
b. What is on-going training and development opportunities are available? [international, 
national, local? ] 
c. Is personnel from civil and penitentiary TB services cross-trained (that is have the same 
training programmes on diagnostics and clinical management of TB patients)? 
d. Information and access to international research journals? [including English language 
training? ] 
33. What are staff turnover rates? 
34. How the salary payment level comparing to specialist working in other health services/programmes? 
a. What other incentives mechanisms exist (e. g. bonuses, overtime pay, food, housing? 
b. How would you rate overall motivation level of TB personnel? 
35. Are public health managers, economists employed in TB programme? 
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a. Are principles of public health/epidemiology/evidence based medicine included in regular 
training/staff development programmes? 
36. How needs for human resources are assessed (what criteria are used? ) 
a. what changed in recent years; what is done to cover shortage of human resources, if such 
exists 
Provision of TB interventions 
37. How is TB case finding organised? 
a. What organizations/providers 
b. Is there compulsory x-ray screening practices? If yes, what population groups are screened? 
c. What proportion of cases detected by active, and what proportion by passive case finding? 
[approximately] 
38. What providers are involved in diagnosis of TB disease? 
a. What criteria are used for confirming diagnosis? [x-ray, microscopy, culture]? 
b. What providers are involved in diagnosis of TB infection? (how is TB infection diagnosed? ) 
c. How would you rate quality of diagnosis? 
39. What laboratory quality assurance is in place? 
a. External quality assurance? 
b. Is there a nationally designed reference laboratory? 
40. How TB prevention is organised? What primary and secondary prevention interventions are used? 
a. What organizations are involved in delivering BCG? 
b. Is re-vaccination practiced? 
c. What criteria are used for starting preventative treatment with isoniazid (or other regimen)? 
41. What health organizations provide TB treatment services? 
a. How treatment is organised in civil sector? 
What proportion of patients are treated in patiently and what in ambulatory settings? 
For how long patients are treated in inpatient facilities? (what are criteria for inpatient 
treatment? ) 
What are criteria for admission/discharge? 
What criteria are used for re-admitting patients? 
What methods are used to encourage adherence in patients (especially in ambulatory 
settings) - e. g. food packages, transport support. 
What are barriers for patients accessing ambulatoryfacilitiesfor DOT? 
What are barriers/incentives for health care providers to provide DOT? (visit patients) 
What, in your opinion, should be done to improve compliance with TB treatment? 
b. How treatment is organised in penitentiary sector? (prompts as above) 
c. How transition of patients between civil and penitentiary sectors is managed? 
d. What treatment regimen is applied for drug sensitive TB? 
What criteria are used to change treatment regimen? 
e. What treatment regimen is applied for drug-resistant TB (MDRTB)? What proportion of 
MDRTB patients receive treatment under DOTS-plus (what is DOTS-plus coverage? ) 
f. How many patients are undergoing surgical interventions? (on average, annually) 
g. For how long patients remain registered in the national registry after the completion of 
treatment? 
h. How treatment quality is assessed? 
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i. What health facilities provide rehabilitation services? What patients are eligible for 
rehabilitation services? 
Informational system 
42. What information system is currently in use? 
What information and communication technologies are available within TB control programme; 
How is information shared among TB service providers? [and organizations/institutions) 
How is information shared between civil and penitentiary TB services? [on what level-rayon, 
oblast, national? ] 
Is there parallel TB information system? (eg. those collected by SES, CDC, other agencies? ) 
43. What is the system of recording diagnosis, treatment progress and final outcomes? 
What is the system of reporting? [to what organizations? By whom][assessment of data? ) 
What information [indicators] is collected routinely? 
Organizational structure (facilities, beds) 
Human resources 
Patient f ow 
Service provision (occupancy, ALOS, etc) 
Financial data, and cost 
Outcomes of treatment 
What changes in information collected have occurred in the last decade? 
44. Do civil and penitentiary TB services have unified or separate reporting, monitoring and evluation 
systems? 
a. If yes, how information between sectors is shared? 
45. How patients' personal information is kept? What is done to protect their confidentiality? 
What data quality assurance is in place? 
How data is protected? 
46. How is collected information (what information is collected) being used? 
Who analyses the data? [what training exists for data analysis? ] 
Is the information gathered used to inform decisions at various levels of the TB programme? 
Are decision-makers adequately trained in analysing data? (e. g. epidemiology) 
Programme's outputs/outcomes 
47. What is the overall national DOTS coverage? 
What is the overall national DOTS-plus coverage? [any geographic differences? ] 
48. What is the overall TB case detection rate? How was it changing over the last decade? 
What proportion of overall pulmonary TB cases confirmed by any laboratory procedure (microscopy, 
culture, PCR)? 
a. What is the proportion of pulmonary TB confirmed by positive smear microscopy? 
b. What is the proportion of pulmonary TB confirmed by culture? 
c. What proportion of pulmonary smear positive cases are culture positive? 
d. What proportion of smear negative cases are culture positive? 
49. What proportion of drug sensitive TB patients become drug resistant on therapy per year? 
Are there any particular risk groups that develop drug resistant TB? 
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50. What cure, default, and death rates are among drug susceptible TB? How these were changing over 
the last decade? 
a. What criteria are used for declaring TB patient cured? 
b. What is the proportion of those declared cured, have microscopic/culture confirmation,? 
c. What is the proportion of those declared cured, completed treatment? 
d. What patients are likely to default? 
e. What patients are likely to die? 
f. In your opinion, how would you rate quality of TB treatment? What are areas of concern 
and suggestions for improvement? 
51. What cure, default, and death rates are among MDRTB patients? How are these changing [is 
surveillance/monitoring in place? ] 
a. What criteria are used for declaring MDRTB patient cured? 
b. What is the proportion of those declared cured, have microscopic/culture confirmation,? 
c. What is the proportion of those declared cured, completed treatment? 
d. What patients are likely to default? 
e. What patients are likely to die? 
f. In your opinion, how would you rate quality of MDRTB treatment? What are areas of 
concern and suggestions for improvement? 
52. What is average length of stay in the hospital? 
What is average length of stay in sanatoria? 
What are bed occupancy rates? 
How these changed over the last decade? Why and why not? 
53. What is estimated cost of treatment of one drug susceptible TB? 
What is estimated cost of treatment of one MDRTB patients? 
Are economic evaluations of TB control activities being conducted? By whom? How 
information is being used? 
What in your opinion are the ways to improve efficiency of TB services? TB treatment? [or 
lower cost? ] 
HIV/AIDS CONTROL PROGRAMME 
HIV/AIDS problem 
I. How character of HIV/AIDS epidemic has been changing during the last decade? 
Using published data and reports identl trends: 
a. Number of registered HIV cases per year (all new, children/adults, males/females, by age, 
by social groups- unemployed/etc [as collected by the national programme]; by risk groups 
- IDUs, sex workers, civil/penitentiary sector, by risk groups - IDUs, sex workers, ); 
b. Estimated HIV prevalence (estimated by whom; prevalence in risk groups, etc) 
c. Number of registered AIDS cases per year (all new, children/adults, males/females, by age, 
by social groups- unemployed/etc [as collected by the national Programme]; 
civil/penitentiary sector); 
d. Number ofAIDS-related deaths per year (all new, children/adults, males/females, by age, by 
social groups- unemployed/etc [as collected by the national programme]; civil/penitentiary 
sector); 
e. Pattern of registered TB/HIV cases 
2. What is pattern of STDs case notification rates (trends in syphilis, gonorreah, chlamidia, etc)? 
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3. What is magnitude of IDUs epidemic (what indicators are used? ) 
4. In your view or based on your knowledge of statistics which socio-demographic and risk groups are 
more likely to acquire HIV? (e. g prisoners, IDUs, sex workers, unemployed, MSM, etc) 
5. Are there any political, economic, socio-demographic factors that impact on HIV/AIDS epidemic 
(e. g. migration, unemployment, lack of political attentions, economic transition, patterns of sexual 
behavior. )? 
6. What is the estimated national economic burden of HIV/AIDS? 
a. How has this been estimated? 
b. What is the burden relative to other diseases? 
Governance 
7. What changes in national HIV/AIDS control policy have occurred in the last decade, and what are 
currently underway? 
8. Does a country have a national strategic plan for HIV/AIDS control? 
a. According to national plan, what are the priorities? 
b. How this plan changed in the recent years/decades? 
9. Is there a country's coordinating committee that oversee multsectorial response to HIV/AIDS 
epidemic? 
a. What are functions of this structure? 
b. What organizations/representatives are involved in functioning of this committee? 
10. Which governmental institutions and organizations are involved in decisions making regarding 
strategic planning, development and implementation of HIV/AIDS- control policies? 
a. Who are the international development agencies involved in the HIV/AIDS control 
programme? What is their role, particularly in HIV/AIDS policy development/strategic 
planning? 
b. Who are civil society/non-governmental organizations involved in HIV/AIDS control or in 
advocacy/lobbying interests of HIV/AIDS patients? What is their role, particularly in 
HIV/AIDS policy development/strategic planning? 
11. What are relationships among organizations/institutions which are involved in policy 
development/strategic planning? 
a. Have structures and relationships changed in recent decade (recent years)? If yes, what 
were the reasons? 
12. What laws and regulations cover HIV/AIDS control? (in areas of prevention, screening, diagnosis, 
treatment, social support/stigma)? 
a. What organizations/institutions involved in developing legislative and regulatory framework 
for HIV/AIDS control? 
b. How existing laws are applied in practice? 
c. Have laws and regulations changed in recent years/decade? If yes, what were the reasons? 
13. Which organisations are responsible for administration and performance management of provision of 
HIV/AIDS interventions? 
a. What are performance management mechanisms? 
b. Who are these organizations are accountable to? 
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c. Is performance of HIV/AIDS interventions available to public? 
d. How are complaints about services dealt with? 
14. Is performance information used for policy formulation and decisions making about HIV/AIDS 
programme's structures and functioning? 
15. How needs assessment and priority setting for HIV/AIDS control programme is conducted? 
a. By whom? 
b. How HIV/AIDS organizations in civil and penitentiary sectors interact in needs assessment 
and setting priorities? 
c. Hoe HIV/AIDS governmental and non-governmental/civil society organizations interact in 
needs assessment and setting priorities 
16. What formal [and informal] interactions exit with other health programmes? 
a. In particular, what are interactions with general health system? Is there a need, as perceived 
by the stakeholders, for developing formal interactions (e. g. linking, collaborating or 
integrating) with other programmes so to improve programme's capacity and/or 
performance ? 
17. How functioning of TB control programme is coordinated? What are regulatory mechanisms? 
Financing 
18. What is total annual expenditure on HIV/AIDS control at present? How has the expenditure been 
changing over the last decade [or available trend]? 
19. What proportion/percent of overall health system expenditure is going for HIV/AIDS control (how is 
this changing) 
20. What are sources of funding for HIV/AIDS control? 
a. Is there an identified budget line for the programme/specific HIV/AIDS interventions 
within the government health budget? 
b. What proportion of funding is from external sources such as donor agencies? 
c. What is trend in donor funding over the last decade [or available trend]? 
d. Has funding from external donors impacted governmental allocation for HIV/AIDS control? 
21. What are mechanism of funds generation? 
a. How different sources of funding are directed to the programme pooled? 
22. How budget for HIV/AIDS control activities is formed, who are involved and what are 
mechanisms? (what indicators are used? What organizations are involved? - e, g. do civil society/non- 
governmental groups involved in budget planning processes? ) 
a. Have financial planning mechanisms been changing over the last decade/recent years? If 
yes, what changes and what are the reasons? 
23. What are mechanisms of funds allocation? 
a. How funds are allocated across programme's interventions (prevention, treatment, 
palliative care, social support ] and activities (human resources development, etc]? 
i. What proportion of national (regular) HIV/AIDS budget is allocated to activities 
implemented by civil society/non-governmental organizations? (UNGASS 
indicator) 
b. How funds are distributed across levels of care [primary, secondary, tertiary]? 
c. How funds are distributed geographically? [per capita allocation for HIV/AIDS] 
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d. How expenditure is distributed on items - salary, equipment, consumables, maintenance, 
and capital expenditure? 
e. How are service providers within HIV/AIDS control programme paid? 
i. Are there outcome-related performance incentives built in the service payment 
system ( any informal incentives? 
f. How mechanisms of resource allocation/providers payment have changed over the last 
decade? If yes, what changes and what are the reasons? 
24. Do budgets for HIV/AIDS control activities correspond to actual expenditure? What is funding gap 
[estimate]? 
a. If gap exists, what measures are/should be undertaken to close the gap (any alternative 
sources of finances, areas to safe funds? ) 
b. In your opinion, is funding for HIV/AIDS control activities adequate? If not, what are as 
are especially needed additional funding? What are options exist to gain additional funding, 
or [improve efficiency]? 
Service delivery 
25. How delivery of HIV/AIDS control interventions is organised (what organizations, what 
interventions]? 
[General Q- about content of services , which organisations are involved 
in the administration, 
control/monitoring and provision of HIV/AIDS prevention, diagnosis, treatment and palliative care 
and support]? 
26. How structures, relationships among organizations providing HIV/AIDS interventions changed in the 
recent decade/years? Why and why not? 
Service delivery infrastructure/Patterns ofprovision 
27. What is availability of HIV prevention services? 
a. How many VCT testing sites? 
i. How are VCT sites (or per 100 000 population) distributed geographically? 
(urban/rural, by oblasts) 
ii. In your opinion, is supply/availability of VCT sufficient? How supply of VCT 
sites is changing during the recent decade/years )? 
b. How many sites provide Prevention of Mother to Child transmission interventions? 
c. STD management, including condoms provision (need to include whether STD services 
have HIV prevention activities) 
d. Sites/organizations conducting information and education campaigns, 
e. How many sites/organizations provide harm reduction interventions among IDUs; 
f. [universal infection control in hospitals/blood safety/blood banks) 
28. How many sites provide ART treatment, treatment of opportunistic infections and palliative care? 
a. How these sites are distributed geographically? 
b. In your opinion, is supply/availability of ART treatment sites sufficient? How supply of 
ART sites is changing during the recent decade/years )? 
29. How many laboratories are involved in HIV/AIDS control? 
a. How many laboratories conduct diagnostic testing (ELISA, Western blot, ? rapid tests)? 
How many conduct CD count? Viral load testing? Screening of blood and blood products? 
b. How these are distributed geographically [urban/rural]? 
c. What proportion of these laboratories are in general hospitals/or other health services? 
[rather then in specialised HIV/AIDS centres] 
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d. In your opinion, is there sufficient supply/availability of laboratories that provide 
diagnostic testing for HIV and monitoring of treatment progress (CD count, viral load)? 
Are these laboratories well-equipped? 
30. Do HIV/AIDS centres, facilities providing HIV/AIDS interventions, and laboratories have adequate 
infrastructure (roads, communication, electricity, water supplies, appropriate buildings)? 
Drugs and medical technologies logistics and distribution 
31. How ARV drugs, and other medication are procured? 
a. Are they procured from local suppliers or overseas? 
b. How supply chain is managed? 
c. What quality control/assurance in place? 
d. In your opinion, is there sufficient supply of ARV drugs? 
i. Drugs for treating opportunistic infections (e. g, isoniazid for TB)? 
32. How essential preventative commodities (condoms, drugs for treating STD, sterile needles) are 
procured and distributed? 
Human resources 
33. What is availability of human resources for HIV/AIDS control programme (HIV/AIDS specialists 
per 100 000; nurses per 100 000) 
a. How these changed in the last decade, why and why not? 
b. In your opinion is availability of health personnel (HIV/AIDS doctors, community 
workers) sufficient at present? and in a long term perspective? 
34. What is skill mix of personnel involved in diagnosis and treatment of HIV/AIDS patients (including 
diagnosis and treatment of 0!, and palliative care for AIDS patients)? 
a. What specialist diagnose and treat HIV/AIDS patients? 
b. What health specialists oversee ART treatment? [infectious diseases specialist? General 
nurses? Community health workers? ] 
c. How these changed in the last decade, why and why not? 
35. What HIV/AIDS clinical training available? 
a. What is accreditation system for HIV/AIDS clinicians? 
b. What is on-going training and development opportunities are available? [international, 
national, local? ] 
c. Information and access to international research journals? [including English language 
training? ] 
d. What are staff turnover rates (at governmental services/non-governmental organizations)? 
C. How the salary payment level comparing to specialist working in other health 
services/programmes? What incentives mechanisms exist (e. g. bonuses, overtime pay, food, 
housing? 
36. What specialist provides preventative interventions? 
a. VCT counselling 
b. PMTC 
c. Information, education, communication, 
d. STD management (? this is STD services) 
37. Are public health managers, economists employed in HIV/AIDS programme? 
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a. Are principles of public health/epidemiology/evidence based medicine included in regular 
training/staff development programmes? 
38. How needs for human resources are assessed (what criteria are used? ) 
a. what changed in recent years; what is done to cover shortage of human resources, if such 
exists 
Provision of HIV/AIDS interventions 
39. How HIV/AIDS prevention is organised? 
a. What interventions are provided by governmental HIV/AIDS services? 
b. What interventions are provided by community groups and non-governmental 
organizations? 
c. Is there substitution treatment for IDU in prisons? 
40. How is HIV case finding organised? 
a. What organizations/providers (e. g. at TB services, STD clinics, prisons, so on? ) 
b. Is there compulsory screening practices? If yes, what population groups are screened? 
41. How HIV testing is organised? 
a. Is pre-testing counselling conducted (How? By whom? Any differences among sites, other 
then specifically designed VCT? ) 
b. How people are informed about the results? How confidentiality is protected? 
c. Post testing counselling (How? By whom? Is psychological support provided? ) 
42. How diagnosis of HIV infection is confirmed? 
a. (ELISA, Western blot, rapid tests)? 
43. What laboratory quality assurance is in place? 
a. External quality assurance? 
b. Is there a nationally designed reference laboratory? 
44. How HIV/AIDS treatment is organised? 
a. How treatment is organised in civil sector? 
i. Are there criteria for prioritisation of patients for ARV treatment? 
ii. What criteria are used for monitoring progress of a disease and response to first line 
treatment? (CD count, toxicity, viral load) 
1. What supporting therapy is applied (e. g. nutritional supplements, etc) 
2. What therapy is used if patient does not respond to first line regimens? 
iii. How patients care is managed (by whom? By a HIV/AIDS specialist or at general health 
care facilities? 
1. Where patients are treated for 01? E. g. TB? 
2. Where AIDS patients receive palliative care? 
45. How treatment is organised in penitentiary sector? 
46. What physiological/social support available for PLWHIV? 
47. What are barriers for persons accessing HIV testing and for HIV patients accessing ambulatory 
(other) facilities for HN/AIDS treatment? 
i. What are barriers/incentives for health care providers to provide ARV treatment? 
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ii. What methods are used to encourage adherence in patients to ARV (or TB treatment, etc) 
iii. What, in your opinion, should be done to improve compliance with ARV treatment? 
Informational system 
48. What information system for HIV/AIDS programme is currently in use? 
a. What information and communication technologies are available within HIV/AIDS control 
programme; 
b. How is information shared among HIV/AIDS service providers? [and organizations/institutions) 
c. How is information shared between civil and penitentiary HIV/AIDS services? [on what level-rayon, 
oblast, national? ] 
d. Is there parallel HIV/AIDS information system? (e. g. those collected by SES, CDC, other agencies? ) 
49. What information [indicators] is collected routinely? 
a. Organizational structure (facilities, beds) 
b. Human resources 
c. Patient flow 
d. Serviceprovision 
e. Financial data, and cost 
f Outcomes of treatment 
g. What changes in information collected have occurred in the last decade? 
50. How patients' personal information is kept? What is done to protect their confidentiality? 
a. What data quality assurance is in place? 
b. How data is protected? 
51. How is collected information being used? 
a. Who analyses the data? [what training exists for data analysis? ] 
b. Is the information gathered used to inform decisions at various levels of the TB programme? 
c. Are decision-makers adequately trained in analysing data? (e. g. epidemiology) 
Programme's outputs/outcomes 
52. Using available reports (UNAIDS, GFTAMgrant reports, national programme reports) identl: 
a. Percentage of : 
IDUs reached by prevention interventions (what interventions exactly): 
Percentage of IDU on OST (numerator: number of IDU patients receiving OST; 
denominator: number of opiate IDU) 
[Availability of OST for IDUs in prisons] 
CSW reached by prevention interventions (what interventions exactly) 
Prisoners reached (what interventions exactly) 
MSM reached 
Percentage of persons in risk groups (IDUs, CSW, prisoners, MSM) tested for HIV in the last 12 
months 
Percentage of donated blood units screened for HIV in quality assurance manner 
b. How these indicators are changing in the recent years? Why? 
c. How these indicators have been collected/estimates made? (any survey? By whom? ) 
d. What are main obstacles and achievements in improving coverage of HIV/AIDS 
interventions? What is done to improve? Give examples. 
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53. Using available reports (UNAIDS, GFTAMgrant reports, national programme reports) identi. 
a. Percentage of PLWHIV receiving ART therapy 
i. Percentage of HIV-positive mothers receiving ART 
ii. Percentage of HIV-positive IDUs receiving ART; percentage on ART and Opoid 
Substitution Therapy 
b. Number (proportion) of patients on ART receiving TB preventative treatment (isoniazid) 
c. Percentage of HIV-positive patients known to be on treatment 12 months after initiation of 
therapy 
d. How treatment outcomes are monitored? 
Any available indicators? E. g.: 
i. Percentage of HIV-positive patients alive 12,24 (more) months after initiation of 
treatment 
ii. Number of HIV-positive patients on treatment who changed regimen; interrupted 
treatment 
1. What patients are likely to interrupt treatment? 
e. How these indicators are changing in the recent years? Why? 
£ How these indicators have been collected/estimates made? (any survey? By whom? ) 
g. What are main obstacles and achievements in improving access to and quality of ART 
treatment? What is being done to improve? Give examples. 
54. Using available reports (UMAIDS, GFTAMgrant reports, national programme reports) identi&: 
a. Number of HIV-positive children infected through mother-to-child transmission (in a 
period) 
b. Number of HIV-cases who acquired HIV in health care setting (nosocomial transmission 
and blood transfusions) 
55. What is estimated cost of ART treatment of a HIV positive patient (e. g. with advanced disease) ? 
Are economic evaluations of HIV/AIDS control activities being conducted? By whom? How 
information is being used? 
What in your opinion are the ways to improve efficiency of HIV/AID services? HIV/AIDS 
treatment? 
INTERACTIONS BETWEEN TB AND HIV/AIDS PROGRAMMES 
TB/HIV problem 
1. Number of PLWHIV diagnosed as co-infected with TB (? annually) 
2. Number of TB patients diagnosed as HIV-positive (? annually) 
3. Is there an overlap of population groups who are at risk for both TB and HIV? 
a. Age, gender 
b. ID Us 
c. Unemployed 
d. Prisoners 
4. How TB/HIV problem is perceived by drivers of both programmes? (this will be assessed in 
interviews with drivers) 
a. Is there a consensus that a problem of [potential/existing] TB and HIV co-epidemics should 
be addressed jointly? 
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i. If yes, then how? 
ii. If not, then what are the reasons? 
Governance 
5. Is there a policy that addresses TB/HIV problem? (e. g. national plan for collaborative TB/HIV 
activities) 
a. If yes, what is content of TB/HIV policy (e. g. what are collaborative activities? ) 
b. If not, how TB and HIV/AIDS control policies address TB/HIV problem separately? And 
what is content of these policies. 
i. What programme/entity is accountable to TB/HIV patients? 
c. For both a) and b) - 
i. Is policy in place to screen HIV-positive patients for TB? 
ii. Is policy in place for TB prophylactic treatment of HIV-positive patients? 
iii. Is policy in place for VCT of TB patients? 
6. Do TB and HIV/AIDS programmes have at present common strategic and/or operational goals? 
7. Is there a structure that governs collaborative activities conducted by TB and HIV/AIDS 
programmes? 
(e. g. Coordinating committee; an unit at MOH, or a staff member responsible for collaborative 
activities 
a. If yes, what are functions of this structure? 
What are regulatory mechanisms that govern collaborative activities? 
a. For funding, how allocation of funds for joint activities is regulated; 
b. For service delivery, are there guidelines for referral procedures of patients between 
programmes or procedures for managing patients who present with both, TB and HIV? 
Financing 
9. Are funds for both programmes pooled, if yes on what level -national, regional, local? 
10. Do both programmes depend on the same external agencies for resources (e. g funds, or technical 
expertise)? 
a. If yes, are programmes financed separately (that is earmarked? ) 
b. Do donors support collaborative TB/HIV activities? If yes, how both programmes are 
financed for these activities? 
11. Do TB and HIV/AIDS programmes perform budget planning (funds allocation) jointly? 
a. If yes, 
i. Is there an administrative structure where budget planning for both programmes is 
performed? 
ii. Is joint planning includes functioning of programmes overall, or restricted to only 
collaborative activities? 
iii. how decisions about budget for both programmes are made, by whom? (e. g. who 
participate) 
iv. If collaborative activities exist, how decisions about budget for these activities are 
made? 
Service delivery 
12. Do clinical personnel of TB programme trained on VCT for HIV? 
a. Where TB patients undergo VCT for HIV? 
b. If TB programme carry responsibility of HIV testing, what laboratories are used? 
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c. How TB programme is informed about HIV status of a TB patient? How HIV/AIDS 
programme is informed about HIV status of a TB patient? 
13. Do clinical personnel of HIV programme trained on TB diagnosis? 
a. Where HIV-positive patients undergo TB screening/diagnosis? 
b. If HIV/AIDS programme carry responsibility of TB screening/diagnosis, what laboratories 
(microscopy, culture, DTS) are used? 
c. How TB programme is informed about TB status of a HIV patient? How HIV/AIDS 
programme is informed about HIV status of a TB patient? 
14. Is there a joint training for clinical personnel of TB and HIV programmes on clinical management of 
TB/HIV patients? 
a. Is management of TB/HIV a part of governmental medical training and development 
programme? 
15. Where TB/HIV patients undergo treatment for TB and HIV? 
a. Does staff of HIV clinic also administer, in addition to ART, TB therapy? 
b. Does staff of TB clinic also administer, in addition to TB chemotherapy, ART? [limited to 
duration of TB treatment] 
c. If separately for each disease, what are referral procedures? 
i. Is there a clinical care coordinator for patients with TB/HIV, who coordinates transition 
of patients between programmes and facilitates informational exchange between two 
programmes (e. g. clinical progress, on-going test results, so on) 
ii. If not i), how information about clinical progress is shared between programmes? 
16. Do TB and HIV/AIDS programmes share drugs procurement and distributions system (e. g. 
isonioazid, )? 
Informational system 
17. Do programme have a common informational system? 
18. If not in 17, 
a. What programme is responsible for monitoring and evaluating joint activities and/or 
TB/HIV problem? 
i. TB programme 
ii. HIV/AIDS programme 
iii. Responsibilities shared 
b. How information is shared between TB and HIV/AIDS programmes? 
i. Regular reports 
ii. Upon request 
19. If yes in 17, 
a. How information used for decisions about joint activities? Policy making? 
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A1.4. Interview guides 
INTERVIEW GUIDE, TB PROGRAMME ACTORS 
" Bullet points are prompts 
1. Role and responsibilities in TB control efforts 
" What are your organization's current (and long term) objectives and priorities in controlling TB? 
2. Role in formulating and implementing TB control policies 
" What are other organizations/groups/individuals play key role in TB policy making processes? 
" Are there other organizalions/groupsfindividuals which play most important [leading] role? 
" How you/your organization interact and coordinate your activities with these organizations/groups? 
3. Role in making decisions regarding resource capacity and functioning of TB control 
programme 
" What are other organizations/groups/individuals play key role in decisions about resources 
4. Resource capacity 
" Are there alternative source of funds/or other ways of mobilizing additional finances 
" What structural or functional changes in health system are possible/feasible 
5. Opinion about current TB epidemiological situation [in the country] 
" changes in TB epidemiology observed during the last decade 
" features in TB epidemic are most serious? (e. g. risk groups, etc) 
" what aspects/issues of TB epidemic require a priory attention? 
6. Opinion about HIV/AIDS epidemic 
7. How does the government support national TB control programme 
" Please provide examples 
8. Changes in TB control policies that have occurred during the last decade/recent years 
" Changes in regulatory and legislative framework goveming TB control? 
" How implementation of these policy changes contribute to achievement of programme goals? 
9. Main achievements and challenges with implementing the national TB control efforts 
10. Implementation of WHO-recommended strategy for TB control. 
" Main achievements and difficulties with implementing DOTS and DOTS-phis 
" How and whether WHO strategy has been adapted to Kyrgyzatan health system 
" Any changes in financing, service delivery, M&E 
" What expectations did you have from implementing DOTS/DOTS"plus (or generally, WHO recommendations)? 
Where these expectations met? 
" In your opinion, what benefits has WHO strategy provided to health system overall, and your organization in 
Particular? 
11. Interactions between TB control and HIV/AIDS programmes in Kyrgyzstan. 
" Is closer interaction/collaboration necessary? If yes or no, then why? 
" Do you participate in developing a policy on integrating thew two programmes? 
" If yes, how do you see an optimal way of integrating these programmes? 
" What benefits would integration of TB and HIWAIDS programmes bring to health system overall, and TB control 
programme in particular? E. g: 
" What are potential barriers in implementing integration of TB and HIV/AIDS programmes? 
12. Interactions between TB services and primary care providers 
" Main challenges and achievements with developing closer interactions between TB providers and general health 
services? 
" What benefits would involvement of general health services in TB control would provide to health system in 
overall, and TB control programme in particular? 
" What are potential barriers in implementing integration of TB control and general health services? 
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INTERVIEW GUIDE HIV/AIDS PROGARMME ACTORS 
" Bullet points are the prompts 
1. Role and responsibilities in HIV/AIDS prevention, treatment, care 
b. organization's current (and long term) objectives and priorities in controlling HIV/AIDS 
2. Role in formulating and implementing HIV/AIDS control policies 
" What are other organizations/groups/mdividuals play key role in HIV/AIDS policy making processes? 
" Are there other organizations/groups/individuals which play most important [leading) role? 
" How you/your organization interact and coordinate your activities with these organizations/groups? 
3. Role in making decisions regarding resources 
" What are other organizations/groups/individuals play key role in decisions about resources (ie. Funds, human 
resources, medicines) 
4. Resource capacity 
" Are there alternative source of funds/or other ways of mobilizing additional finances? 
" What structural or functional changes are possible/feasible? 
5. Opinion about current HIV/AIDS epidemiological situation [in the countryl 
" changes in HIV/AIDS epidemiology observed during the last decade 
" what trends in HIV AIDS epidemics are most serious? Why? 
6. How does the government support national HIV/AIDS control efforts 
" Please provide examples 
" What is governmental policy on broader involvement of civil society and non-governmental organizations in 
HIV/AIDS control? 
7. Opinion, or experience, in developing (or implementing) multisectorial response to HIV/AIDS 
" Main challenges and achievements with developing closer interactions between governmental HIV/AIDS services 
and other health programmes? With civil society? With educational and social protection services? With law 
enforcement and justice? 
8. Changes in HIV/AIDS control policies that have occurred during the last decade/recent years 
" Changes in regulatory and legislative framework governing HIV/AIDS control? 
" In your opinion, how implementation of these policy changes contribute to achievement of programme goals? 
9. Main achievements and challenges with implementing the national HIV/AIDS control efforts 
" What challenges/issues require a priory attention? 
" aspects of HIV/AIDS programme capacity (funds, human resources, infrastructure, supplies) require improvements 
or changes so to achieve HN/AIDS programme goals? 
10. IDU treatment and support, implementation of harm reduction interventions 
" Main achievements and difficulties with developing policy/implementing opioid substitution therapy and NSP 
" How financing, service delivery for drug dependence have changed in the last decade 
" What changes are necessary to improve effectiveness of harm reduction interventions? 
13. Interactions between TB control and HIV/AIDS programmes 
" Is closer interaction/collaboration necessary? If yes or no, then why? 
" Do you participate in developing a policy on integrating these two programmes? 
" If yes, how do you see an optimal way of integrating these programmes? 
" What benefits would integration of TB and HIV/AIDS programmes 
" What are potential barriers in implementing integration of TB and HIV/AIDS programmes? 
14. Interactions between HIV/AIDS sevices and primary care providers 
" Main challenges and achievements with developing closer Interactions between HIV services and general health 
services? 
" What benefits would involvement of general health services in HIV prevention and control 
" What are potential barriers 
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A1.5. List of organizations involved in the study and interview timeline 
LIST ORGANIZATIONS S INVOLVED IN THE STUDY 
WB 
DFID 
WHO/ Kyrgyz Office 
UNODC 
UNDP 
KfW Chief Health Sector 
GFATM, 
International Society Red Cross&Crescent 
Medicines de Frontiers 
USAID 
International NGO AFEW 
Central Asia Harm Reduction Project 
Central Asia AIDS Control Project (WB) 
Ministry of Health 
Ministry of Justice, Health services 
National TB Institute 
Chui Oblast TB centre 
Rayon TB coordinator 
National Narcology centre 
National AIDS Centre 
Bishkek city AIDS centre 
HIV-service NGOs 
National Association of Family Medicine 
Bishkek city Family Medicine Centres 
Chui Oblast Family Medicine Centres 
Red crescent society of Kyrgyzstan 
Sanitary epidemiological services 
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INTERVIEW DATES 
OHN 
OHN 
OTB 
OHS 
Date 
Oct-29,2009 
Nov-25,2009 
Oct-22,2009 
Sep-17,2009 
Sep-23,2009 
Nov-26,2009 
Sep-24,2009 
Sep-01,2009 
Spet 03,2009 
Sep-08,2009 
Sep-08,2009 
......................................................... Oct-14,2009 
Oct-15,2009 
Oct-15,2009 
Sep-21,2009 
Nov-25,2009 
Oct-08,2009 
Oct-09,2009 
Oct-09,2009 
Oct-20,2009 
Oct-27,2009 
Nov-02,2009 
Nov-03,2009 
Nov-05,2009 
Nov-05,2009 
Nov-18,2009 
03,2009 
29,2009 
10,2009 
02,2009 
06.2009 
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Appendix 2. Systematic literature review on sustainability in health systems 
A2.1. Literature search approach 
Search strategy used for electronic databases 
Search terms 
Medline 
1. resilience$. mp. 
2. viability$. mp. 
3. institutionaiizatlon$. mp. 
4. routinization$. mp. 
5. durability&. mp. 
6. stability$. mp. 
7. persistence$. mp. 
8. continuation$. mp. 
9. sustainab$. mp 
10.6 or 3 or 7 or 9 or 2 or 8 or I or 4 
or 5 
11. exp health services/og 
12. exp delivery of health care/og 
13. (health adj system). mp. 
14. exp Health Care Reform/ 
15. (health adj program$). mp. 
16. (health adj intervention). mp. 
17.11 or 16 or 13 or 12 or 15 or 14 
18.10 and 17 
1. resilience$. mp. 
2. viability$. mp. 
3. lnstitutionalization$. mp. 
4. routinlzation$. mp. 
5. durability&. mp. 
6. stability$. mp. 
7. persistence$. mp. 
8. continuation$. mp. 
9. sustalnab$. mp, 
10.6 or 3 or 7 or 9 or 2 or 8 or 1 or 4 or 5 
11. health care delivery/ 
12. health program/ 
13. health service/ 
14. health care system/ 
15. (health adj lntervention). mp. 
16. (health adj system). mp. 
17. health care/ 
18. health care reform. mp. 
19.11 or 18 or 16 or 13 or 17 or 12 or 15 or 14 
Limits 
Papers selection criteria 
General criteria: 
1j Relevant to sustainability of -Health Interventions, health programmes, health services, health 
organizations (NGOs or coalition working on health issues), or health systems. 
2) Sustainability is a central focus of a paper, and It Is not just simply mentioned in passing whilst 
discussing other central Issues of a paper. 
Types of articles: 
1. Conceptual papers on sustain ability including conceptual or analytical frameworks; 
2. Empirical studies evaluating, assessing, or analysing sustainability, explicitly stating It In the 
objectives/aim of the paper. 
3. Meta-analysis, systematic, or structured literature of empirical studies on sustainability; 
4. Narrative literature review of conceptual, methodological and empirical approaches to 
sustainability; 
5. Editorials and opinion papers 
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1.1. Data extraction form for selected papers 
Relevance Yes/No (see general criteria) 
Type of paper 1- Theory or conceptual framework (or analytical framework) 
2- Editorial review/ commentary or opinion 
3- Systematic lit review 
4- Narrative lit review 
5- Randomised controlled trial 
6- Non-randomised experimental or quasi experimental study 
7- Survey 
8- Case study approach (miti-case, single case 
9- Ethnographic, anthropological study 
10- Action/operational research 
11- Evaluation report, multi-method evaluation 
12- Guideline/protocol 
13- Other 
Assessment of frameworks Definition of sustainability 
Unit of analysis 
1. Intervention 
2. Programme 
3. Organization (including NGOs, networks, coalitions) 
4. Services 
5. Health system 
Theoretical framework (or what view or perspective Is drawn upon) 
Factors Influencing sustaInability 
Assessment of selected studies 
Research question Research question is clearly stated, or research purpose, or 
....... _ .......... 
hypothesis, or general line of inquiry. 
Unit of analysis 6. Intervention 
7. Programme 
8. Organization (including NGOs, networks, coalitions) 
9. Services 
........... ... ..... .......... 
10. Health system 
... ....... ..... - Study design 
r_W ry w t 
Study design or research approach is articulated 
------ - ------ Definition of sustainabili ty Present/Not present - concept Is defined, clearly outlined what is 
meant by sustainability 
Theoretical, or conceptual, Yes/No 
Analytical framework 
Methods of data collection 
Time Whether time factor is articulated 
Data analysis An approach to data analysis is specified 
Results Results are outlined and clear?, Limitations of methodological 
approach are outlined?. 
1) Summarise main results 
2) Factors influencing/critical for sustainabllity - hypothetical, 
assumed, actual, etc 
3 An limitations/reflections for measuring sustainabilit 
335 
A2.2. Search results 
Electronic databases search: 
5198 citations* 
Titles review: 3765 excluded 
1433 abstracts reviewed 
Abstracts review: 1184 excluded 
230 articles reviewed 
Articles review: 94 papers excluded 
Selected 136 papers, citation 
tracking additional 22 papers 
Identified 
Total search results: N=158 
26 conceptual framework 
92 empirical studies" 
4 structured literature reviews 
'duplicates excluded at any stage 
"' 19 referred by others or according to abstract - were not accessible 
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Appendix 3. Structured literature review on integration in health systems 
A3.1. Literature search approach 
Search strategy used for electronic databases 
Search terms 
Limits 
Medline 
1. "Delivery of Health Care, 
Integrated"/ 
2. integrat'. mp. 
3. link'. mp. 
4. coordinat'. mp. 
5. co-ordinat'. mp 
6. collaborat'. mp. 
7. exp health services/og 
8. exp delivery of health care/og 
9. (health adj system). mp. 
10. (health adj program$). mp. 
11. (health adj intervention). mp. 
12. model. mp. 
13. framework. mp. 
14. measure'. mp. 
15.2 or 3 or 4 or 5 or 6 
16.7 or 8 or 9 or 10 or 11 
17.15 and 16 
18.1 or 17 
19.12 or 13or14 
20.18 and 19 
Papers selection criteria 
General criteria: 
Embase 
1. integrat . mp. 2. link'. mp. 
3. coordinat*. mp. 
4. co-ordinat'. mp 
5. collaborat'. mp. 
6. integrated health care system/ 
7. health service/ 
8. health program/ 
9. health intervention. mp. 
10. health care/ 
11. health system. mp. 
12.1 or2or3or4or5 
13.7 or 8 or 9 or 10 or 11 
14. conceptual framework/ or 
framework'. mp. 
15. model'. mp. 
16. measure'. mp. 
17.12 and 13 
18.6 or 17 
19.14 or 15 or 16 
20.18 and 19 
Huma 
Conceptualizing, analysis or measuring integration in health system (i. e. health interventions, 
services, organizations, systems) is a central focus of a paper and it is not just simply mentioned in 
passing whilst discussing other central issues of a paper. 
Types of articles: 
6. Conceptual papers on integration including conceptual or analytical frameworks; 
7. Proposed frameworks for integration (practical not necesserely for analysis) 
8. Meta-analysis, systematic, or structured literature of empirical studies on integration in health 
system ; 
9. Any literature review of conceptual, methodological and empirical approaches to sustainability; 
364 
A3.2. Search results 
Electronic databases search: 
7923* 
Titles review: 5334 excluded 
abstracts reviewed 
2589 
Abstracts review: 2442 excluded 
147 articles reviewed 
Articles review: 102 excluded 
Selected 45 papers, citation 
tracking additional 24 papers 
identified 
Total search results: N= 69 
53 conceptual or practical framework 
16 systematic or structured literature 
reviews 
*duplicates excluded at any stage 
365 
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